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Neonatal meningitis-bacteraemia from Listeria
monocytogenes
D.G. Garatziotou, M. Vlachou, P.M. Michail, S. Paratiras,
O. Koureli, A. Gatopoulou, A. Spiliopoulou (Patras, GR)
Introduction: Listeria monocytogenes is a Gram-positive micro-
organism that causes infection mainly to pregnant women and
immunocompromised patients. Infection during pregnancy can
lead to abortion or premature birth of a dead or infected baby.
Infection during or after birth may lead to a late onset disease,
septicemia or meningitis.
Methods: Blood cultures and CSF cultures were done by
conventional methods as Bact Alert (Biomerieux) and the
identiﬁcation of Listeria by API Coryne (Biomerieux). Sensitivity
tests against antibiotics involved the determination of MIC (E-
Test) in Mueller Hinton agar with blood according to the
guidelines of NCCLS.
Case-results: A case of a 13-day newborn female with fever
(T:380C) is presented. Laboratory tests were done. Blood:
Hct = 38.5% WBC = 27,200 (Neu. = 65%) TKE = 43 mm
CRP = 1.69 mg/dl CSF: WBC = 1293/mm (Neu = 53%) Glu-
cose = 45 mg/dl Total protein = 140 mg/dl Gram stain: negat-
ive. A Gram-positive bacterium, catalase positive, oxidase
negative, was isolated by blood and CSF cultures. API Coryne
identiﬁed Listeria monocytogenes. The microorganism was sus-
ceptible to penicillin, ampicillin, gentamicin, erythromycin,
vancomycin and resistant to second and third generation
cephalosporins. The patient was treated successfully (intraven-
ous therapy with ampicillin, gentamicin).
Conclusion: L. monocytogenes may cause severe infections as
bacteraemia, meningoencephalitis to the newborns. Early labor-
atory diagnosis and initiation of treatment has been associated
with successful therapy. Clinical microbiologists have to apply
the appropriate methods for the rapid isolation and accurate
identiﬁcation of Listeria monocytogenes.
P1668
Acute bacterial meningitis: epidemiological
pattern in a paediatric hospital
A. Gentile, J. Bakir, M. Turco, V. Umido, N. Orlando,
V. Romanin, A. Procopio (Buenos Aires, RA)
Objectives: To establish the incidence, epidemiological pattern
and etiology of ABM.
Methods: A prospective epidemiological study of patient with
ABM diagnosis hospitalized in Ricardo Gutierrez Children
Hospital from Jan/92 to Dec/03 inclusive (12 years), was
performed.
Results: A total of 631 cases of ABM were studied, 61.6% were
male, median of age were 10 month (range: newborn-14 years
old) and 69.6% were from the suburbs. One hundred and sixty-
one patients (25.5%) received antibiotic treatment previously to
admission (parenteral 47.2%). The isolation rate was 58.8% (371/
631). The organism were:Neisseria meningitidis (Nm) 39.9% (148/
371), Haemophilus inﬂuenzae (Hib) 19.1% (71/371), Streptococcus
pneumoniae (Sp) 23.5% (87/371) and other agents 17.5% (65/371).
The annual incidence was: 1992 (n = 32) Nm:15 (46.9%) serotype
B:15, Hib:10 (31.3%), Sp:6 (18.8%); 1993 (n = 63) Nm:34 (54%)
B:30, C:1, no typied:3, Hib:19 (30.2%), Sp:8 (12.7%); 1994 (n = 42)
Nm:23 (54.8%) B:22, C:1, Hib:10 (23.8%), Sp:6 (14.3%); 1995
(n = 46) Nm:12 (26.1%) B:7, C:5, Hib: 9 (19.6%), Sp:11 (23.9%);
1996 (n = 45) Nm:14 (31.1%) B:3, C:9, no typied:2, Hib:12
(26.7%), Sp: 12 (26.7%); 1997 (n = 21) Nm:4 (19%)B:2, C:2,
Hib:3 (14.3%), Sp:3 (14.3%); 1998 (n = 23) Nm:6 (26.1%) B:2, C:3,
Y:1, Hib: 7 (30.4%), Sp:5 (21.7%); 1999 (n = 31) Nm:14 (45.2%)
B:5,C:6,W135:2 no typied:1, Hib:0 (0%), Sp:10 (32.3%); 2000
(n = 17) Nm:10 (58.8%) B:5, C:5, Hib: 0 (0%), Sp:2 (11.8%); 2001
(n = 21) Nm:8 (38.1%) B:6, C:1, no typied:1, Hib:1 (4.8%), Sp:12
(57.1%); 2002 (n = 15) Nm: 6 (40%)B:3,C:2, no typied:1; Hib:0
(0%), Sp:4 (26.7%); 2003 (n = 15) Nm:2 (13.3%) C:1, no typied:1,
Hib:0 (0%), Sp:8 (53.3%). School and day care contacts were
found in 26.4% Nm cases; 2.7% were secondary cases. Most of
cases were children <2 years: Nm 54.7%, Hib: 88.7% and Sp :
63.2%. Neurological complications depended upon agent: Nm:
9.5%, Hib: 38% and Sp 54% [Sp vs Nm RR 5.71 (3.35–9.75)]; and
letality was 6.1%, 5.6% and 16.1% respectively [Sp vs Nm RR
2.65 (1.20–5.86)].
Conclusions: (1) There was a peak of Nm in 1993–94 with a
decreasing incidence in 1995–03. Although Nm B is the most
prevalent, Nm C incidence was increasing since 1995, and Y and
W135 cases were sporadics. (2) After the Hib vaccine incorpor-
ation , since 1999 there are no cases, except 1 case in 2001. (3) Sp
pattern has not changed through the years, and it had a higher
morbimortality than the other organisms.
P1669
Bacterial meningitis guidelines and risk-factors:
initial microbiological laboratory registration
C.N. Meyer, A. Korshin, E. Ronneberg, R. Koster-Rasmussen on
behalf of the Danish Bacterial Meningitis Group
Objectives: The Dutch national guidelines for empiric treat-
ment of bacterial meningitis (BM) takes into account age, speciﬁc
risk-factors, and recent neurosurgery, and this information
should be available for relevant microbiological advice. As
antibiotic sensitivity patterns are similar in Danish bacteria and
thus relevant for these guidelines, we explored if initial
knowledge of these risk-factors, initial biochemical results,
hospital- or community acquisition, and the advice given to
the clinician were documented in the microbiologist’s notes in a
national 2-year survey.
Methods: In 2002 and 2003 all Danish departments of clinical
microbiology reported data on culture-positive spinal ﬂuids
judged not to be contamination. Personal identiﬁcation data,
results of microscopy and culture, antibiotic sensitivity tests,
and the 4 mentioned parameters (initial knowledge of risk-
factors, initial biochemical results, whether hospital- or commu-
nity acquisition, and documentation of the advice given) were
reported.
Results: 427 episodes of BM were registered in the 2-year
period. In 235 cases, the microbiologist’s notes were not reported
and thus not available. Concerning the 4 parameters, knowledge
of risk-factors was documented in 31% (59/191; presence in 21);
the initial biochemical results in 54% (103/192); the place of
acquisition in 45% (72/192; nosocomial in 24); and documenta-
tion of the advice given in 93% (176/190).
Conclusion: Documentation in the microbiologist notes was
incomplete in terms of place of acquisition, knowledge of risk-
factors and initial biochemical results. The design of the survey
was retrospective and the information may have been available,
although not documented. Data availability is a prerequisite for
optimal and relevant microbiological consultation in BM.
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An evaluation of bacterial antigen detection tests
in CSF of children in developing communities
G. Revathi (Nairobi, KEN)
Acute childhood meningitis is a life threatening condition often
leaving the survivors with various degrees of neurological
impairments including learning problems. Rapid diagnosis is
imperative for timely and speciﬁc treatment. Bacterial antigen
detection tests by latex agglutination (L.A. tests) have been
available for several years for this purpose.
Objective: To analyze the available data on L.A. tests retro-
spectively to observe their performance as to their sensitivity
speciﬁcity and cost effectiveness in a resource poor setting.
Methods: Data was collected from CSF samples analysed over
10 years(1993–2003). Sources were A. ﬁve post graduate thesis
projects supervised by the author in teaching hospitals 1993
(360CSFs) 1995 (420 CSFs) in GTB hospital, Delhi, India. 1999,
2001, 2003 in Kenyatta National Hospital, Nairobi (480 CSFs)
B.983 CSFs data was contributed by two private sector hospitals
in Nairobi, the Aga Khan Hospital and the Gertrude Garden
children’s hospital where the author is a sessional pathologist.
Data from A and B were separately analysed for comparison
purposes. Selected case ﬁles were reviewed to compile the
outcomes.
Results: A striking difference was seen between the data from
A and B. Data A found the L.A test an important diagnostic tool,
the high cost being seen as the only limiting factor. In contrast
data B brought out serious draw backs as follows: 1. these tests
were negative in early meningitis cases, 2. important and
frequent bacterial pathogens like enterric bacilli and staphylococci
cannot be diagnosed, 3. Haemophilli other than type B were
missed. 4. 5% of positive L.A tests were non speciﬁc agglutina-
tions 5. 8% were non speciﬁc cross reactions 6. sensitivity on the
whole was no greater than that of gram staining 7.for detection
of Strpt. pneumoniae and H. inﬂuenzae b gram stain was found to
be more sensitive than L.A test.
Conclusions: To justify the high costs of L.A tests must be used
very selectively. The tests are cost effective if used in situations
like 1. high clinical suspicion of bacterial meningitis where gram
stain is negative 2. partially treated meningitis where culture is
likely to be negative 3. the results of L.A test can only augment
other parameters of diagnosis rather than replacing them. 4.
routine use of L.A tests on all CSFs is not cost effective in a
resource poor setting. Author is deeply indebted to the post
graduate students involved in this work.
P1671
The prognostic value of cerebrospinal ﬂuid
procalcitonin in acute bacterial meningitis in
children
R. Iubu, C. Jianu, D. Tatulescu, C. Marcu, L. Ursu (Cluj-Napoca,
RO)
Background: It was shown that serum procalcitonin (PCT) was
a better marker than serum C – reactive protein and cerebro-
spinal ﬂuid (CSF) parameters in differentiating between acute
bacterial meningitis (ABM) and viral meningitis in children. The
production of PCT during inﬂammation is linked with a
bacterial endotoxin and with inﬂammatory cytokines (TNF, IL-
6). In children PCT is generally not detectable in CSF.
Objectives: The aim of our prospective study was to evaluate if
a detectable level of PCT in CSF might be correlated with
severity of disease and can therefore be used as a prognostic
marker in ABM in children.
Methods: PCT levels was measured in serum and CFS of 33
children patients diagnosed with ABM admitted in our depart-
ment. Meningitis was considered to be bacterial by a positive
result on gram staining and/or bacterial culture of CFS or a
positive blood culture in combination with clinical evidence of
meningitis and CFS parameters (PMN counts, protein levels,
ratio of glucose in CFS to glucose in serum, lactat CFS levels).
PCT was estimated by an immunochromatographic assay
(Brahms PCT – Q).
Results: The median age of the patients was 4.1 years (range,
3 months to 8 years). The microbiologically results yielded
Neisseria meningitidis in 18 patients, Streptococcus pneumoniae in
9, Haemophilus inﬂuenzae type b in 4 and Escherichia coli in 2. A
high serum PCT concentration (>10 ng/ml) identiﬁed in all 33
studied patients, except in two patients with previous antibiotic
therapy; these had a lower serum levels of PCT (>5 ng/ml), that
demonstrated the PCT decrease during treatment for ABM. In 16
children we found a detectable level of CFS procalcitonin:
>10 ng/ml in 4, >2 ng/ml in 7 and >0.5 ng/ml in 5 patients.
Levels of CFS procalcitonin >2 ng/ml (11 patients) were
correlated with severity of disease (two children died, 5
recovered with serious neurological sequelae and 4 developed
complications and required more than 21 days of treatment) and
with young age (the median age was 2.2).
Conclusions: A CFS procalcitonin concentration >2 ng/ml, in
MAB, was highly associated with a poor prognosis. We consid-
ered that measured of PCT in CFSwill enable accurate prediction
of mortality risk in childrenwith ABM, particularly younger than
3 years age and can be included in a prognostic scoring system.
P1672
PCR-based surveillance in ﬁve districts in
Burkina Faso and Togo during the 2003–04
epidemic season
J.F. Aguilera, M. Lourd, S. Yaro, K. Adjogble, Y. Traore´,
B. Lafourcade, M. Oue´draogo, A. Leblond, B. Gessner (Paris, F;
Bobo Dioulasso, BF; Lome´, TG; Ouagadougou, BF; Ancorage, USA)
Objectives: To determine in selected districts of Burkina Faso
(BF) and Togo during the 2003–04 meningitis epidemic season
epidemiological characteristics of acute bacterial meningitis
(ABM) and the sensitivity and speciﬁcity of cerebrospinal ﬂuid
(CSF) testing using polymerase chain reaction (PCR) versus
culture.
Methods: We conducted a prospective health centre and hos-
pital-based surveillance study. We collected CSF specimens and
clinical/demographical information from suspected cases of
ABM detected within all health facilities in three districts of BF
and two district referral hospitals in Togo. A conﬁrmed case was
deﬁned as detection of bacteria in CSF using latex agglutination,
culture or PCR. Routine microbiological techniques were
strengthened (only in BF) and we established for both countries
appropriate specimen transport systems to National Reference
Laboratories in BF for PCR testing or culture.
Results: A total of 329 clinical cases of ABM were included
from BF and 207 from Togo. Among 117 (36%) conﬁrmed cases
from BF, we identiﬁed 53 (45%) Streptococcus pneumoniae (Sp), 49
(42%) Neisseria meningitidis (Nm) and 15 (13%) Haemophilus
inﬂuenzae (Hi). Among 143 conﬁrmed cases from Togo, we
identiﬁed 66 (46%) Nm, 52 (36%) Sp and 25 (17%) Hi. In BF and
Togo, Nm A represented 55% and 83%, and Nm W135 31% et
8% of Nm cases, respectively. In BF, most isolated Sp were
serotype 1 (8/22) or 6 (5/22) (preliminary results, genotyping
under process). The case fatality ratio in BF was 54%, including
44% for Sp, 6% for Nm and 27% for Hi. In BF, PCR sensitivity
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and speciﬁcity varied from 94–96% and 97–100%, respectively,
depending on the etiology. In Togo, PCR allowed conﬁrmation
of an additional 65% of cases compared to culture or latex
agglutination.
Conclusion: Most ABM cases in selected areas of BF and Togo
were due to Sp or Nm A; the proportion of W135 varied
depending on the country and was lower in BF when compared
to the previous epidemic season. The continued conﬁrmed
circulation of Sp serotype 1 emphasizes the need to include this
serotype in any vaccine formulation designed for use in Sub-
Saharan Africa. PCR performs well relative to culture and
allows identiﬁcation of substantially more cases than culture or
latex agglutination. We recommend expanding similar surveil-
lance to other areas of the African meningitis belt.
P1673
Invasive meningococcal disease in children in
1999–2003
E. Bronska, O. Dzupova, V. Maresova, K. Soltysova (Prague, CZ)
Objectives: Invasive meningococcal disease (IMD) is still life-
threatening state. The aim of our study was to analyze clinical
course and possibilities of diagnostics of IMD in children.
Methods: Retrospective analysis of IMD in children hospital-
ized at Department of Infectious Diseases of University Hospital
in Prague in 1999–2003. Along with demographic data we
evaluated also risk factors, clinical course, therapy and role of
various diagnostic methods in clinical praxis.
Results: In monitored time period there were 29 children
hospitalized at the clinic (11 boys and 18 girls), average age
11 years (6M-18Y). 43% of patients were admitted from another
hospital. Average time of hospital stay was 15 days (9–31 days).
Majority of children suffered from purulent meningitis with
sepsis (14), meningitis (9), sepsis (2) and acute meningococcemia
(4). Petechial rash was observed in 82% of cases, other skin
symptoms in 27%, 10% of patient came for diarrhoea. 86% of
patients showed neck stiffness at the time of admission. Fever
was recognized as the most frequent symptom (72%), often
accompanied by vomiting (45%) and headache (45%). Intraven-
ous antibiotics were used in average 9.8 days. The ﬁrst choice
was penicillin G (31%) or 3rd generation cephalosporin (69%).
Antibiotics in prehospitalisation care were used in 51% of cases.
Neisseria meningitidis was detected in 34% by both culture and
PCR, in 39% only by PCR, in 14% only by culture and once only
by latex agglutination. 10% of cases were suspected only on base
of clinical symptoms. Prevalence of serogroups: 54% B, 31% C,
15% non-determined.
Conclusion: We observed an increasing number of adolescent in
last 3 years. It is related to the epidemiological situation in Czech
Republic. The culture showed positive results only in 48%, it is
related to the fact that in 51%of patients the antibiotic therapywas
started before admission to hospital. In more than one third of
cases the aetiology was conﬁrmed only by PCR method. PCR is
possible to increase percentage of laboratory conﬁrmed cases.
Culture still remains an importantmethodwith respect to the fact
that it serves for determination of sensitivity to antibiotics.
P1674
Invasive meningococcal disease: a review of 33
recent episodes in a general hospital
E. Kalogeropoulou, A. Kyratsa, E. Kontekaki, F. Ioannidou,
E. Trikka-Graphakos (Athens, GR)
Objectives: The aim of study was to evaluate retrospectively
the laboratory features of invasive meningococcal disease in
patients admitted to Thriasio General hospital.
Methods: During a 6-year period (1999–2004), 33 specimens
from clinical suspected cases of meningococcal disease,(26
children and 9 adults), were received for laboratory conﬁrma-
tion. The diagnosis was established on CSF cytochemical
characteristics, positive Gram stain, CSF or /and blood culture
and non-cultural methods (detection of antigens, PCR).The
antimicrobial sensitivity was determined by MIC (E-test). PCR
and E-test were determined by the National Meningitis Refer-
ence Laboratory.
Results: 17 out of 33 specimens (51.5%), were positive for
Neisseria meningitidis. The combinations of cultures and PCR
results were as follows: 16-culture negative and PCR negative, 7-
culture negative and PCR positive and 10- culture positive.13/
17 strains were classiﬁed as serogroup B, 3/17 as serogroup C
and 1/17 as serogroup A (polyvalent group).Resistance to
sulphamethoxazole (MIC greater than or equal to 16 mg/l) was
found in 4 out of 10 strains. All strains were sensitive to
penicillin, rifampicin, cefaclor and ciproﬂoxacin.
Conclusions: Bacteriological culture remains the main laborat-
ory method for detection of Neisseria meningitidis and for
determination of antimicrobial resistance. In cases that Gram
stain and culture are negative, PCR is a useful tool for diagnosis
of invasive meningococcal disease.
P1675
The outbreak of nosocomial sepsis and
meningitis caused by Escherichia coli in a
neonatal intensive care unit
M. Mueller-Premru, H. Mole, L. Kornhauser Cerar (Ljubljana,
SVN)
Objectives: In three premature babies, treated in the Neonatal
Intensive Care unit (NICU) in a period of 37 days of the year
2004, late-onset Escherichia coli sepsis and meningitis were
recorded. Because babies were treated in the same room, the
possibility of an outbreak was postulated and bacterial typing
was requested.
Methods: Three babies were treated for some time together in
the same six-bed room of NICU. Their gestational age was from
24–29 weeks and their birth weight from 660 to 1070 g. Two
babies needed ventilatory support. The acute onset of illness
occurred in the ﬁrst baby at the age of 21 days. In the second and
the third baby the illness occurred 32 and 37 days later at the age
of 26 days and of 16 days, respectively; at this time the ﬁrst baby
has already left the room. E. coli, susceptible to tested antibiotics,
was isolated from blood and CSF of all neonates. It was also
isolated from tracheal aspirate of the ﬁrst and nasopharynx and
urine of the third neonate, but in none of the other samples. All
babies were successfully treated with cefotaxime. Capsular
antigen of invasive isolates was determined by agglutination,
using bacterial antigen kit (Wellcogen). Typing was performed
by macrorestriction analysis of chromosomal DNA in pulsed-
ﬁeld gel electrophoresis (PFGE). Bacterial DNA was isolated in
agarose plugs and digested by the rare cutting enzyme Xba I
(Roche) during overnight incubation. DNA fragments were
separated in molecular biology-grade agarose (Bio Rad) in a
CHEF DR III drive module in 0.5 M TBE running buffer.
Results: E. coli isolates from all babies carried K1 capsular
antigen. Macrorestriction analysis of chromosomal DNA
showed that all isolates had identical PFGE pattern.
Conclusions: Typing conﬁrmed the outbreak of nosocomial
sepsis and meningitis caused by E. coli in three neonates.
Unfortunately, staff and environmental samples were not taken
for investigation. By reinforcement of strict hygienic precau-
tions, the outbreak terminated.
Abstracts
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Microbiology of meningitis in hospitalised
patients of Ural region, Russia: 7-year
surveillance
L. Boronina (Yekaterinburg, RUS)
Objectives: To study microbiology of meningitis in hospitalised
patients of Ural region (Regional Children’s Hospital, Yekater-
inburg) in a 7-year period (1995–2001).
Methods: CSF of meningitis suspected patients from 1 month to
14 years old hospitalized at Regional Children’s Hospital were
studied at Microbiology Laboratory. Complete cultures, bio-
chemical identiﬁcation, API and automated media as well latex
agglutination with CSF were used to classify isolated organisms.
Results: In studied period 568 samples of CSF were submitted
to Microbiology Laboratory. From this total, 135 (23.77%) had
bacterial growth. Most isolated organisms were: Neisseria men-
ingitidis (39.26%), Streptococcus pneumoniae (22.22%), Haemophilus
inﬂuenzae (14.81%), Staphylococcus aureus (8.15%), Acinetobacter
calcoaceticus (5.93%), Pseudomonas aeruginosa (2.22%), Candida
albicans (2.22%), S. pyogen (2.22%) and others (2.96%).
Conclusions: Most cases of bacterial meningitis (76.30%) in
children were caused by Neisseria meningitidis, Streptococcus
pneumoniae and Haemophilus inﬂuenzae. The most common cause
of meningitis were Neisseria meningitidis of different types.
Gram-negative bacilli isolation (Acinetobacter calcoaceticus, Pseu-
domonas aeruginosa), was due to a nosocomial infections.
P1677
Bacterial meningitis in infants under 1 year of age
– our experience
C.M. Luca, A. Vata, M. Hurmuzache, V. Luca (Iasi, RO)
Objectives: To determine the clinical, bacteriological and thera-
peutic proﬁle of this type of infection in newborns and
sucklings.
Material and Method: Eighty less than one-year-old infants (15
newborns and 65 infants older than 1 month) with bacterial
meningitis, admitted in our hospital between January 2000 and
December 2003 were retrospectively studied.
Results: Most of the children were boys (67.5%), had signiﬁcant
co-morbidities (75%); the mean duration from the onset of the
disease to hospital admission was 2.75 days and 32.25% of them
already received antibiotics. Symptoms and signs were unspe-
ciﬁc and in 23.75% cases the diagnosis was suspected only after
the onset of generalized seizures. Only 60.1% of the CSF
specimens were purulent. Other septic foci were present in
32.5% cases. The etiology of the disease could be established in
only 48.75% of cases. In newborns, from 10 cases with known
etiology, we isolated gram positive cocci: group B. Streptocococcus
in 3 cases, S. aureus – 2 cases, gram negative bacilli – 3 cases and
gram negative cocci: Neisseria meningitides – 2 cases. After
1 month of age, from 29 patients with known etiology, the
main pathogen was Neisseria meningitides (12 cases) followed by
H. inﬂuenzae (6 cases) and S. aureus (4 cases). Most organisms
were sensitive to beta-lactam antibiotics (76.92%). The empirical
etiological treatment used an association of two antibiotics
(ampicilin 11.63% cases, a third generation cephalosporin in
39.54% cases, a ﬂuoroquinolone 12.7% cases, Vancomicin 4.65%).
Dexamethazone was used, for a mean duration of 5.62 days, in
32.5% of cases. The mortality rate was 21.25% (33% in newborns).
Conclusion: During the studied period and for this age group,
bacterial meningitis was an elusive disease, still with a poor
prognosis, despite vigorous etiological and supportive care.
P1678
Chitotriosidase activity in cerebrospinal ﬂuid of
children in diagnosis of serous and purulent
meningitis
T.A. Korolenko, S.Y. Zhanaeva, N.I. Gavrilova (Novosibirsk,
RUS)
Mammalian chitotriosidase belonging to chitinase family, plays
the defense role as universal protector against chitin-containing
pathogens (Fusetti et al., 2002). It was suggested that humans
deﬁcient in chitotriosidase activity are more susceptible to
infections. The aim: to evaluate chitotriosidase activity of
cerebrospinal ﬂuid of children and teenagers with serous and
purulent meningitis.
Objectives: 53 persons of 5 months to 14 years old, including
17 patients studied – 2–4 times in dynamics of serous and
purulent meningitis.
Methods: Chitotriosidase activity was measured against ﬂuo-
rogenic substrate according to method of Guo et al. (1995).
Results: Low chitotriosidase activity was registered in cerebro-
spinal ﬂuid of children with serous meningitis (similar to
activity in serum). In purulent meningitis this index was
increased 5-times in the beginning of disease (correlation with
increased PMN number, young PMN forms and protein
concentration) and 2-times after effective treatment course
(with normalization of peripheral blood leukocytes number).
The cellular origin of elevated chitotriosidase in cerebrospinal
ﬂuid is unknown, possibly – from activated macrophages. The
dramatic (up to 1000-times) increase of serum chitotriosidase
(originated from overloaded macrophages) was registered in
Gaucher disease, lysosomal storage disease. We have observed
that macrophage activation in rat and mice models was followed
by several times increase of serum chitotriosidase activity.
Conclusion: One can conclude that chitotriosidase activity in
cerebrospinal ﬂuid can be used in differential diagnostic of
serous and purulent meningitis in children and enzyme is
involved into pathogenesis of purulent meningitis in children.
P1679
A case of ventricular drainage infection with a
rare pathogen in cerebrospinal ﬂuid: vancomycin-
resistant Enterococcus faecium
M. Baysallar, Y. Izci, A. Kilic, I.Y. Avci, Z. Senses,
L. Doganci (Ankara, TR)
Objectives: To describe a patient, 7-month-old child with
ventriculoperitoneal shunts for hydrocephalus who developed
ventriculitis caused by VREF.
Methods: Two ventriculoperitoneal shunts were inserted just
after birth and on the 2nd month of age. On the 6th month, both
of them were removed because of dysfunction and external
drainage was inserted. Then, he developed fever and lumbar
puncture revealed high leucocyte count and protein concentra-
tion. CSF cultures yielded E. faecium which was resistant to
ampicillin, erythromycin, gentamicin, penicillin G, vancomycin,
teicoplanin and susceptible to chloramphenicol, ciproﬂoxacin,
streptomicin, levoﬂoxacin and rifampin by disk diffusion
method. On the antimicrobial susceptibility tests, multidrug
antibiotic therapy was changed from vancomycin and ceftazi-
dime to chloramphenicol, rifampin and meropenem, and also
rifampin–clindamycin-impregnated bactericeal shunt (Codman-
USA) was inserted.
Results: He become a febrile and CSF cultures was sterile after
15 days of yielding E. faecium.
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Conclusion: Implanting rifampin–clindamycin-impregnated bac-
tericeal shunt and timely use of appropriate antibiotics for
10 days according to antimicrobial susceptibility testing seemed
to be important in the resolution of VRE infections, especially in
countries where linezolid and quinupristin–dalfopristin are not
in use yet.
P1680
Linezolid in patients with pneumococcal
meningitis
F. Faella, P. Pagliano, U. Fusco, V. Attanasio, M. Conte
(Naples, I)
Efﬁcacy of Linezolid in patients with meningitis sustained by
methicillin-resistant strains of Staphylococci and Enterococci has
been reported, but only a few data are available about its
efﬁcacy in the treatment of pneumococcal meningitis. We
enrolled consecutive adult comatose patients affected with
severe pneumococcal meningitis, referred to our tertiary care
centre during a period of 12 months, at risk for carriage of
penicillin-nonsusceptible strains of S. pneumoniae. Patients with
clinical pictures consistent with community-acquired bacterial
meningitis were managed as follows: (i) S. pneumoniae antigen
was searched on the Cerebro-spinal ﬂuid (CSF) specimen by
rapid immunochromatographic membrane assay; (ii) Ceftriax-
one (100 mg/kg/day) and Linezolid (1200 mg/day) were
administered to the pneumococcal antigen positive cases; (iii)
linezolid was withdrawn when a penicillin-susceptible strain of
S. pneumoniae grew form cultures. Combined treatments with
Linezolid and Ceftriaxone or Cefriaxone alone were adminis-
tered for 20 days. Thirteen patients with positive CSF and/or
blood culture were included in the study. Median age was
57 years (range 27–79). Eight patients had chronic underlying
diseases. All cases had low CSF glucose and high CSF proteins
and cells. S. pneumoniae strains were penicillin-susceptible in 7
cases, penicillin-tolerant in 3 and penicillin-resistant in 3. On
presentation, 11 cases had nuchal rigidity, 10 fever, 7 hypoten-
sion. Five had generalized seizures before our observation. Six
cases required mechanical ventilation within 48 hours from
appearance of symptoms. Eight patients (3 infected with
penicillin-susceptible strains of S. pneumoniae) had 2 or more
factors associated with adverse clinical outcome. Forty-eight
hours after admission, all cases showed increase of CSF glucose
and reduction of CSF proteins and cells, none tested positive for
CSF S. pneumoniae antigens, blood and CSF cultures were
negative. Overall, 2 patients died, 3 reported sequelae. Evalu-
ating only patients infected with penicillin-nonsusceptible
strains of S. pneumoniae, one died, one reported severe disability,
4 fully recovered. No haematologic, nefro- or hepato-toxicity
was reported. Combined therapy with III generation cephalosp-
orin and Linezolid should be considered in patients with severe
meningitis, particularly when a MDR strain of S. pneumoniae is
suspected and factors associated to high mortality rates are
present.
P1681
Severe polymicrobial central nervous system
infections and potential therapeutic role of
linezolid
R. Manfredi, S. Sabbatani, F. Chiodo (Bologna, I)
Introduction: The emerging of resistant gram-positive cocci in
the setting of surgery and intensive care units, recommends
particular attention in the selection of effective therapeutic
choices, leading to overcome microbial resistances, and blood-
brain barrier.
Case reports: Three representative case reports (2 brain absces-
ses and 1 post-surgical meningitis), are discussed: in all patients
(p) a salvage linezolid (L) therapy proved resolutory. In a
patient (p),we could not rely on culture isolations of clinical,
probably due to the prolonged antimicrobial therapy preceding
neurosurgery. An empirical post-operative combination inclu-
ded imipenem and L. After improvement of neuroradiology,
treatment was continued with oral L, avoiding i.v. administra-
tion and accelerating p discharge. From another p, a rare gram-
negative oxidase-negative bacillus was isolated from local
purulent drainage. The absence of immunosuppression, and
combined surgical-antibiotic therapy, prompted clinical-bacteri-
ologic success of this unusual localization of Capnocytophaga spp
disease. Should the ﬁrst-line therapy allowed microbial eradi-
cation, L achieved complete resolution of CNS abscess, which
did not ameliorate after over 3 weeks of combined imipenem–
amikacin–ﬂuconazole administration, preceded by surgical
drainage. With our third p, we underline the clinical-therapeutic
evolution of a p who developed a post-surgical nosocomial
purulent meningitis, failed to respond to a 3-drug association of
vancomycin,imipenem,and gentamicin, but had a very favorable
and rapid (10-day) course after L administration, in absence of
relapses or sequelae. A post-surgical infection caused by
multiresistant gram-positive agents may be strongly hypothes-
ized, based on prior therapeutic failure, and immediate L
response.
Discussion: Therapeutic options for CNS infection are still
limited, and the prognosis remains severe, especially when
gram-positive infection is of concern. In the treatment of post-
neurosurgical cerebral abscess and meningitis, a key issue is
represented by the low CSF concentration of glycopeptides,
usually recommended as ﬁrst-line therapy of resistant gram-
positive organisms. When severe CNS infections are of concern,
L is a safe and effective choice for the management of
ascertained or highly suspected infections caused by Gram-
positive pathogens.
P1682
Epidemiological features of meningococcal
disease in Belarus
I. Karpov, A. Kachanka (Minsk, BLR)
Objectives: Group B Neisseria meningitidis has been the leading
cause of meningitis in Belarus over the past 5 years, and has also
been a frequent cause of meningococcemia and other general-
ised forms of disease. We present an updated appraisal of
meningococcal disease in this country.
Methods: All data refer to the period 2000–2004, and were
collected at the Medical State University, Reference Center for
Infectious Diseases of the Belarus Ministry of Public Health.
Results and Conclusion: The correlation between a local
meningococcal colonisation and the meningococcal disease
shows one patient with purulent meningitis per 100–200 patients
with pharyngitis and per 2000–3000 nasopharyngeal carriers (in
practice, 2–5% of the population are healthy carriers of men-
ingococci). Belarus shows, together with Russia, one of the
highest rate of generalized meningococcal infection among all
the former-USSR republics, namely 2.8 cases per 100,000
inhabitants in 2003. The age distribution for this infection has
been quite unusual since from many years. So in 2004 the rates
of meningococcal infection were 56.7 cases per 100,000 infants,
30.3 cases in the age from 1 to 2 years old, and 3.8 in the age
from 3 to 6 years old, respectively. This distribution would
suggest that parents and other household contacts are the main
Abstracts
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source of infant infections. In 2004, both morbidity and mortality
from meningococcal disease seem to have increased. The
observed group consisted of 17 children that all died from
bacteriologically-conﬁrmed meningococcemia. 7 out of the 17
cases were infants and presented thymomegalia, which is
known as one of the adverse comorbidity factors. All
N. meningitidis isolates showed high and moderate susceptibility
to penicillin, as determined by standard disk method, but
penicillin therapy was not effective in these cases. All cases were
accompanied by a strongly marked tendency to cardio-circula-
tory failure, with death ensuing within the ﬁrst twenty-four
hours of the onset of meningococcemia, and being accompanied
by adrenal hemorrhage in the infants with thymomegalia.
P1683
Human ehrlichiosis in a group of patients with
aseptic meningoencephalitis
D. Picha, L. Moravcova, S. Lasikova, K. Soltysova (Prague, CZ)
Objective: Human Ehrlichiosis is usually an uncomplicated
tick-borne infection with unspeciﬁc symptoms that can be very
similar or identical to common viral or aseptic meningoen-
cephalitis. In patients hospitalized with aseptic meningitis and
reporting the recent withdrawal of a tick, speciﬁc antibodies and
PCR were examined.
Patients and methods: During the spring season 46 inpatients
diagnosed with aseptic meningoencephalitis were enrolled into
the study. The included criteria were: (1) a tick having been
removed 2–6 weeks before the onset of the symptoms; (2)
clinical symptoms of an acute viral-like disease; (3) CSF ﬁndings
typical for viral infection. All patients with abnormal liver
markers were tested for hepatitis A, B, C and all suspect cases
were excluded, as well as all patients with laboratory positive
Tick-borne encephalitis and Lyme borreliosis (one patient had low
titre of IgG anti-TBE antibodies after vaccination). Antiehrlichial
antibodies (E. chaffeensis, A. phagocytophylum) were detected by
commercial kits (MRL Diagnostics, Germany). A nested PCR
technique described elsewhere was used for detection of DNA.
The target sequence was the Ank gene of A. phagocytophylum.
Positive controls were isolated from the culture A. phagocyto-
phylum (KlinLab, Prague, CZ).
Results: Anti-A. phagocytophylum antibodies IgM were detected
in 1 patient (2%), IgG in 6 (13%) and both of them in an
additional 6 cases (altogether 28%). IgG anti-E. chaffeensis
antibodies were found in 5 (11%) patients. In any case antibodies
against both agents were not found. Speciﬁc DNA (A. phagocy-
tophylum) was found in the plasma of 5 patients. In all PCR
positive cases, plasma anti-A. phagocytophyllum antibodies were
found – once IgM, two times IgG and in two cases IgG and IgM
antibodies were detected together. In four cases the clinical
symptoms of meningoencephalitis were found, and in one
patient mild meningitis was diagnosed. In two cases a macular
rash was described with an elevation of liver enzymes. Hema-
tologic abnormalities were found in three patients – leukopenia,
leukocytosis and anemia. Four patients recovered quickly after
two-week oral tetracycline treatment, one remained without
treatment due to rapid improvement and was discharged.
Conclusion: The Czech population is exposed to ehrlichia
infection and more intensive laboratory examination is advis-
able for endangered peoples.
Experimental CNS infections
P1684
Experimental study of fosfomycin combined with
ceftriaxone, teicoplanin or vancomycin in the
treatment of cephalosporin-resistant
pneumococcal meningitis
S. Ribes, F. Taberner, A. Domenech, C. Cabellos, F. Tubau,
J. Lin˜ares, P.F. Viladrich, F. Gudiol (Hospitalet de Llobregat, E)
Objectives: The optimal therapy of cephalosporin-resistant
(CepR) pneumococcal meningitis is still a problem and new
antimicrobial combinations deserve to be tested. The aim of this
work was to assess the in vitro and in vivo efﬁcacies of
fosfomycin (F) tested alone and in combination with: ceftriaxone
(C), teicoplanin (T) or vancomycin (V) against a CepR pneumo-
coccus.
Methods: we used the HUB 2349 strain (serotype 23F) with
MICs (mg/l): C 2; F 16; T 0.03; V 0.25. Time-kill curves were
performed using achievable CSF concentrations. Synergy,
additive and indifference of a combination were respectively
deﬁned as >2, between 1 and 2, ±1 log 10 CFU/ml decrease
compared to the most active agent alone. Meningitis in rabbits
was induced by intracisternal inoculation of 10E6 CFU/ml.
Eighteen hours later, therapy (Tx) was given (n > 8/group)
over 26 h. Controls (n = 10) were inoculated and not treated.
Tx groups (dose in mg/kg/d) were: F (1200), C (100), T (15),
V (30), F + C, F + T, and F + V, and the standard regimen
was C + V. Emergence of resistance to F was studied at 24 by
performing E-test. ANOVA test was used in statistical
analysis.
Results: In vitro studies at 6 h showed that F + T presented
indifference and some combinations of F + C and F + V were
synergistic or additive. In vivo, all combinations improved the
activities of any antibiotics tested alone, being F + C and F + V
statistically signiﬁcant versus F monotherapy. Statistical data
and bacterial killing rates (KR) in CSF calculated as delta-
log10 CFU/ml (±SD) at 6 and 24 h, are resumed in the table.
Emergence of resistance to F was detected in vitro when F alone
and combined was studied at 24 h. In the animal model after
24 h of Tx, development of resistance was only found when F
was administered alone (33.3%), all combinations prevented it.
Conclusions: The addition of fosfomycin to monotherapies
(ceftriaxone, teicoplanin or vancomycin) improved the efﬁcacy
of antibiotics tested alone in the therapy of CepR experimental
meningitis. F + Cshowed tobe themost effectivealternative,with
Tx group KR 0–6h KR 0–24h
Control +0.34 (±0.83) +1.63 (±1.96)
F )1.80 (±0.81) )2.46 (±1.77)
C )2.73 (±0.72) )3.38 (±1.38)
T )2.33 (±0.79) )3.83 (±0.86)
V )2.99 (±0.99) )4.20 (±1.37)
C+V )3.07 (±0.54)* )4.95 (±1.21)*
F+C )3.50 (±0.96)* )4.52 (±0.84)*
F+T )2.38 (±0.59) )4.30 (±0.65)
F+V )3.60 (±0.66)* )4.30 (±0.97)
*p < 0.05 vs F alone (ANOVA)
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a similar activity of the standard empirical therapy (C + V). All
combinations prevented the emergence of resistance to fosfomy-
cin in the animal model unlike what occurred in time kill curves.
P1685
Efﬁcacy of imipenem, sulbactam and rifampin in
an experimental meningitis model caused by
multiresistant Acinetobacter baumannii
F. Docobo-Pe´rez, M.E. Pacho´n-Iba´n˜ez, D. Fatela-Cantillo,
M.E. Jime´nez-Mejı´as, C. Pichardo, A. Garcı´a-Curiel,
J. Pacho´n (Seville, E)
Objectives: Postsurgical meningitis due to multiresistant
(resistant to all clinically used antibiotics except colistin)
Acinetobacter baumannii (MrAb) is an important therapeutical
problem. It is necessary to know the antimicrobials or synergis-
tic active-combinations against MrAb in this clinical process.
The aim of this study was to evaluate the efﬁcacy of rifampin
(RF), sulbactam (SB), and imipenem (IMP) in monotherapy and
in combinations in an experimental meningitis model due to
MrAb.
Methods: A multiresistant bacteremic strain was used. In vitro
studies: MIC and MBC; bactericidal activity and synergy of the
combinations (time-killing curves). PK parameters (Cmax, AUC,
t1/2) were measured after administration of a single dose of each
antimicrobial. In vivo studies: 1st phase, characterization of a
meningitis experimental model due to MrAb in New Zealand
rabbits (2–3 Kg), with an intracisternal inoculum of 6–7 log
cfu/ml. 2nd phase: Rabbits were grouped as CON (controls,
without treatment), IMP (120 mg/Kg/d), SB (240 mg/Kg/d),
RF (100 mg/Kg/d), IMP + SB, IMP + RF and SB + RF; animals
received a single dose of treatment. Measures: bacterial clear-
ance in CSF; WBC, brain edema, and lactate concentration in
CSF. Statistical tests: Friedman and Kruskal-Wallis.
Results: MIC/MBC (mg/l): SB 32/32, IMP 32/32, RF 4/8. IMP
(MIC) showed bactericidal in vitro activity; no synergies were
found. The PK parameters were: Cmax (mg/l), 16.62, 75.33,
25.35; AUC (mgÆh/l), 40.28, 57.07, 50.45; t1/2(h), 3.38, 0.54, 1.74;
for RF, SB and IMP respectively. All of the rabbits presented
high levels of lactate, WBC and an increased brain weight due to
the infection and brain edema. The treatments that showed a
reduction of the bacterial concentration in CSF were: RF
(p < 0.001), RF + IMP (p < 0.01), RF + SB (p < 0.05) and
IMP + SB (p < 0.05).
Conclusions: In the experimental meningitis caused by multi-
resistant A. baumannii, rifampin in monotherapy and the
combinations of rifampin plus sulbactam or imipenem, and
imipenem plus sulbactam were effective in the clearance of
bacteria from CSF.
P1686
Vancomycin versus teicoplanin in the therapy of
experimental methicillin resistant Staphylococcus
aureus meningitis
O. Sipahi, B. Arda, T. Yurtseven, H. Sipahi, E. Ozgiray,
M. Suntur, S. Ulusoy (Izmir, TR)
Objective: MRSA is an emerging problem in bacterial menin-
gitis. The main therapeutic choices in MRSA meningitis are
glycopeptides. There is no human or animal study comparing
teicoplanin and vancomycin in MRSA meningitis. In this study
we aimed to compare antibacterial activity of teicoplanin and
vancomycin in the treatment of MRSA meningitis in rabbit
meningitis model.
Methods: Meningitis was induced by direct inoculation of
ATCC 43300 MRSA strain into cisterna magna of New Zealand
rabbits. After 16 h of incubation time, rabbits were separated
into three groups vancomycin (V), teicoplanin (T) and control.
(C). Group V received 20 mg/kg vancomycin q12 h, group T
received 6 mg/kg teicoplanin q12 h and group C did not receive
any treatment. Drug levels were measured by bioassay tech-
nique.
Results: At 0 h, CSF bacterial counts were similar in all groups
(p > 0.05). When three groups were compared (table 1), bacterial
counts in both treatment groups at either 12th or 24th h were
signiﬁcantly lower (p < 0.05) than control group. When two
treatment groups were compared bacterial counts at either 12th
or 24th h (table 1) and serum drug levels at 24th h (V: 7.9 ±
3.64 mg/l, T:10.8 ± 5.6 mg/l) were similar (p > 0.05).Number of
living animals during the study period were similar in three
groups (table 2). Drug level in CSF was higher than lowest limit
of sensitivity (1–2 mg/L) in only 6 rabbits (4 animals in group T,
2 animals in group V) CSF/serum ratio ranged between 20 and
48% in group T and was 32% and 47% in the 2 rabbits in group V.
Table 1. Bacterial counts in CSF of rabbits during study period
Table 2. Number of living
Conclusion: These data suggest that antibacterial activity of
vancomycin and teicoplanin are similar in the treatment of
experimental MRSA meningitis of rabbits
P1687
Increased expression of BDNF and proliferation
of dentate granule cells after bacterial meningitis
S.C. Tauber, C. Stadelmann, A. Spreer, R. Nau,
J. Gerber (Goettingen, D)
Objectives: Proliferation and differentiation of neural progen-
itor cells is increased after bacterial meningitis. In order to
identify endogenous factors involved in neurogenesis, expres-
sion of BDNF, NGF and GDNF was investigated in a mouse
model of pneumococcal meningitis.
Methods: Male C57BL/6 mice were infected by injection with
log 4 CFU of S. pneumoniae into the right forebrain. Control
animals received saline only. Mice were killed 30 h later (each
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group n = 19) or treated with CRO (100 mg/kg twice daily) and
killed 4 days after infection (each group n = 19). Gene expres-
sion levels of neurotrophins were measured by real-time PCR
and BDNF protein synthesis was determined by Western blot.
Immunohistochemistry was performed for BDNF and TrkB.
Results: Four days after infection, hippocampal BDNF mRNA
levels were increased 2.4-fold (p = 0.026). Similarly, BDNF
protein levels in the hippocampal formation were higher in
infected mice compared to control animals (p = 0.0003). This
was accompanied by an elevated proliferation of dentate
granule cells as indicated by BrdU-incorporation (p = 0.0002).
Conversely, NGF mRNA levels at 30 hours after infection were
reduced by approximately 50% (p = 0.004). No signiﬁcant
changes in GDNF expression were observed. BDNF protein
was located predominantly in the hippocampal CA3/4 area and
the hilus. The density of dentate granule cells expressing the
BDNF receptor TrkB was increased 4 days after infection
(p = 0.027).
Conclusion: The increased synthesis of BDNF and TrkB sug-
gests a contribution of this neurotrophic factor to neurogenesis
after bacterial meningitis.
P1688
Anti-herpetic activity of phosphorylated
derivative of plant polyprenols
A.N. Narovlyansky , M.V. Mezentseva , N.P. Kosyakova ,
T. Kuritz , I.K. Zubashev , A.V. Pronin , A.V. Sanin , S.D. Maltsev,
L.L. Danilov , V.V. Veselovsky , F.I. Ershov (Moscow, RUS; Oak
Ridge, USA)
Objectives: This study was aimed at the assessment of anti-
herpetic activity of phosphorylated derivatives of plant poly-
prenols.
Methods: In vitro experiments were carried out in the continu-
ous culture of VERO cells. Polyprenyl immunostimulant (PI,
phosphorylated polyprenyl with 10–14 prenyl residues) was
added as 0.4% solution into culture at days –1, 0, and +1 in
respect to herpes simplex virus type I (HSV-1) inoculation
(strain L2, titre 107 TCID50/ml). HSV-1 was added into culture
at a dose of 0,1 TCID50/ml. Then the effect of PI upon HSV-1
cytopathogenicity was assessed. In vivo experiments were
carried out in mice and guinea pigs. Suckling mice (10–12 g)
were inoculated i.p. with 10% of HSV-1-containing brain
suspension of mice (dose 100 LD50). PI at a dose of 400 mcg
was inoculated i.p. at days –1, or 0, or +1 in respect to HSV-1-
containing suspension inoculation. Anti-herpetic activity was
assessed by increase in average life expectancy (ALE). In parallel
the levels of IFN-a, and -g were determined in the spleen cells of
mice inoculated with PI and HSV-1. Male guinea pigs (250–
300 g) were infected with HSV-2, strain EC, by rubbing of HSV-
2-containing suspension on scariﬁed penile surface. PI was
inoculated i.p. at days - 1, 0, +1, and +2 in respect to infection.
The animals were monitored for 15 days.
Results: PI at a dose of 100 and 200 mcg/ml inhibited HSV-1
reproduction in the VERO cells culture approximately 100-fold
when added into culture 1 day previous to HSV-1, or simulta-
neously. PI at a dose of 400 mcg exerted protective effect in mice
following inoculation at day –1 in respect to HSV-1 (protective
effect was 40%, and ALE 14.6 ± 0.29 days, compared with
10.0 ± 1.31 days in control, (d < 0.01); at day 0 (protective effect
was 50%, and ALE 14.1 ± 0.85 days, d < 0.05). The protective
effect was accompanied by increase in duration and a level of
the IFN-a, but not the IFN-g synthesis. In parallel experiment
with testing of HSV-1-containing brain suspension of mice in
VERO cells PI treatment was found to decrease the HSV-1 titres
by 2.0–3.5 lg. PI was very effective (d < 0.01) against genital
herpes infection of guinea pigs. The maximal protective effect of
PI (39.4%) was revealed at day 5 following infection. In the PI-
treated group average duration of the disease was reduced up to
4.3 days in comparison with non-treated controls.
Conclusion: PI exerted pronounced antiviral effect against
HSV-1 and HSV-2 in various in vitro and in vivo models.
P1689
Antiviral activity of phosphorylated derivatives
of plant polyprenyls in different tick-born
encephalitis models
A.V. Sanin, R. Godunov, T. Kozhevnikova, T. Kuritz,
S. Ozherelkov, A.V. Pronin, A.N. Narovlyansky (Moscow, RUS;
Oak Ridge, USA)
Objectives: This study was aimed at the assessment of antiviral
activity of phosphorylated derivatives of plant polyprenyls in
the in vivo experimental murine tick-born encephalitis (TBE)
model, and in the in vitro TBE virus (TBEV) experiments.
Methods: In vivo studies employed BALB/c male mice, 12–
14 g body weight, and unbred 2–3-day-old suckling mice. In
vitro experiments were carried out in PEKF cell culture. The
following substances were tested: 0.4% solution of polyprenyls
of different chain lengths, including Phosprenyl (PP) with 14–18
prenyl residues, and polyprenyl immunostimulant (PI) with 10–
14 prenyl residues. TBEV (a highly pathogenic Absettarov
strain) was used as a culture ﬂuid containing 1010 lg PFU50/ml.
Antiviral effects of PP and PI were assessed by numbers of mice
surviving a combination of i.p. inoculation with 100 LD50 in
0.2 ml of TBEV, with the simultaneous i.m. administration of
100 mcg of PP or PI in 0.2 ml. Blood samples were collected
daily from all infected mice for 7 consecutive days following the
infection, and the sera were added to PEKF in order to reveal
infectious TBEV. In the in vitro experiments TBEV titres in the
culture were determined after enumeration of negative colonies
in ﬂasks with PEKF cells, and calculation of PFU. The
experiments in PEKF were performed in the presence of PP
or PI.
Results: Intracerebral inoculation of suckling mice with 0.03 ml
of suspension containing the TBEV and 60 mcg PP resulted in
1000-fold inhibition of TBEV replication in the CNS of suckling
mice: TBEV titres in the brain tissues were 3 lg LD50, whereas in
control mice TBEV titres reached 6 lg LD50. Administration of
100 mcg PP and PI per mouse protected up to 80% mice against
lethal TBEV infection. Infectious TBEV was recovered from
blood sera of PP-treated mice only at days 6–7 (1 and 2 lg PFU50,
correspondingly) following the infection with TBEV and PP
administration, while in the blood sera of control mice (without
PP treatment), infectious TBEV was recovered at days 2–7 (2.5–
4.5 lg PFU50). PP and PI in concentrations 200 and 400 mcg/ml
were shown to inhibit replication of TBEV in the PEKF culture
30-fold and 100-fold, respectively.
Conclusion: 1. Polyprenyl phosphates of different chain length
(PP and PI) protected up to 80% of mice against TBEV-
associated lethality in vivo. 2. PP and PI inhibited TBEV
replication in PEKF cultures. The antiviral effect may occur at
a stage of TBEV penetration into target cells.
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Bloodstream infection
P1690
Time trend and seasonality of community-
acquired bacteraemia in a Danish county as
assessed from hospital registers
M.D.S. Engebjerg, S. Lundbye-Christensen, T. Højbjerg,
H.C. Schønheyder (Aalborg, DK)
Objectives: Origin of infection is an important distinction to
make in bacteraemia research. Time trend and seasonality of
community-acquired bacteraemia (CAB) have been ascertained
in Denmark only for selected groups of pathogens. Therefore,
we have done an 8-year register based study including all
pathogens.
Methods: This retrospective study was done in North Jutland
County (app. 490,000 inhabitants). Blood cultures (BCs) were
processed by the Dpt. Clinical Microbiology, Aalborg Hospital.
BCs were recorded as positive only if believed clinically
relevant. Data on all BCs processed during 1995–2002 were
retrieved from a departmental database and linked to date of
admission by the unique Danish personal identiﬁcation number.
BCs drawn within 2 days of admission were deemed related to a
community-acquired infection; likewise we took positive BCs
within this time frame to indicate CAB. We analysed data
graphically and by a log-linear model where time trend was
ﬁtted as a linear function and seasonality as a trigonometric
function with a period of 1 year.
Results: The study base included 100,023 BCs. Of these 63,347
were potentially related to a community-acquired infection.
Time trend was statistically signiﬁcant with an annual increase
of 6.9% (95% conﬁdence interval (CI): 6.5–7.2%). There was a
consistent seasonal pattern with 8–14%more BCs being obtained
during the 1st quarter than during any other quarter of the year.
A total of 6298 positive BCs (from 4833 patients) were obtained
during the ﬁrst 2 days of admission. Time trend was statistically
signiﬁcant with an annual increase of 6.0% (95% CI : 4.9–7.2%).
Compared to the 1st quarter 7.7% more positive BCs were
recorded in the 4th quarter and 5.3% less in the 2nd quarter; the
3rd quarter was nearly at level with the 1st (+2.3%). The peak-to-
trough ratio was 1.10 (95% CI : 1.03–1.18). This had the conse-
quence that the rate of positive BCs was lowest in the 1st and
highest in the 3rd quarter.
Conclusion: We demonstrated rising trends both for total
numbers and numbers of positive BCs. Patterns of seasonality
were markedly different: most BCs were drawn during the 1st
quarter, most positives were detected during the 4th quarter and
the rate of positive BCs was highest during the 3rd quarter.
Thus, both occurrence of CAB and the diagnostic efforts showed
distinct annual variation.
P1691
Severe sepsis and septic shock: recent trends in
the intensive care unit of a university hospital
Y.A. Que, M. Oddo, M.D. Schaller, T. Calandra,
L. Liaudet (Lausanne, CH)
Objectives: Severe sepsis and septic shock are associated with
mortality in the range of 20–35% and 40–80%, respectively. Yet, a
recent US survey among patients with sepsis has suggested that
mortality may be declining and etiology is changing (NEJM
2003;348:1546). The aim of this 3-yr study was to review the
etiology and outcome of patients with severe sepsis and septic
shock admitted to the MICU of a university hospital in Western
Switzerland.
Methods: Retrospective analyses of demographic, clinical,
microbiological and laboratory data and therapeutic interven-
tions of all consecutive patients admitted for severe sepsis and
septic shock in the MICU. Patients referred from other hospitals
were excluded.
Results: From Jan 2001 to Dec 2003, 218 patients developed
severe sepsis (n = 78, 35.7%) or septic shock (n = 140,
64.3%)(mean: 6 cases/month). Mean age was 60 ± 16 yr., M/
F ratio was 62/38%, median APACHE II score was 22.5 ± 9.5.
Sepsis was due to Gram-positive bacteria in 41.6% of cases,
Gram-negative bacteria in 25.4%, fungi in 4.4%, malaria in 0.9%
and was culture-negative in 27.7%. All-cause day 28 mortality
was 25.6% (severe sepsis: 5.5%, septic shock 37.1%). While
APACHE II score increased from 24.1 to 26.3, mortality of
septic shock decreased from 43% (2001) to 31% (2003), possibly
in relation with the introduction of new strategies (early goal-
directed therapy and lung protective ventilation, only 2
patients were treated with activated protein C) during the
study period.
Conclusion: Gram-positive are a leading cause of severe sepsis
and septic shock in the MICU of a Swiss university hospital.
All-cause day 28 was much lower than anticipated and
decreased during the study period conﬁrming some recent
trends.
P1692
A comparative study of risk factors and outcome
among outpatient-acquired and nosocomial-
acquired candidemia
A.C. Pasqualotto, W.L. Nedel, T.S. Machado, L.C. Severo (Porto
Alegre, BR)
Objectives: To describe all cases of candidemia that occurred in
the outpatient setting and to compare risk factors and outcome
among patients with outpatient-acquired and nosocomial-
acquired candidemia.
Methods: Retrospective cohort study conducted in Santa Casa
Complexo Hospitalar, Brazil, during 1995 and 2003.
Results: During the period of study, 210 patients developed
candidemia at our Institution, and 9.0% were outpatient-
acquired. Most of these outpatients were male, median age
was 51 years old, and major underlying diseases were cancer
(47.4%) and chronic renal failure (36.8%). Most of the candide-
mias in the outpatient group occurred within 24 h of hospital-
ization (63.2%) and 83.7% were caused by species other than
Candida albicans,mainly Candida parapsilosis (36.8%). Candidawas
isolated from catheters in 21%, and most of them (52.6%) had
been admitted to the hospital in the 60 days preceding
candidemia. Compared to patients with nosocomial-acquired
candidemia, chronic renal failure was more frequent in the
outpatient group, who were also more commonly exposed to
hemodialysis. Ileus, gastrointestinal bleeding, previous bacterae-
mia, use of proton pump inhibitors, previous stay in the ICU
and requirement for antibiotics, blood transfusion, vasopressors
and invasive medical procedures were more frequent in the
nosocomial group. Overall mortality rate was higher than 50%
in both groups.
Conclusion: Candidemia must be remembered as a potential
etiology for sepsis in the community, and it is associated with a
high mortality.
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P1693
Soluble haemoglobin scavenger receptor is a
prognostic marker in patients with bacteraemia
S. Gaı¨ni, S.S. Pedersen, S.K. Moestrup, H.J. Møller (Odense,
Aarhus, DK)
Objective: Soluble haemoglobin scavenger receptor (sCD163) is
a macrophage-speciﬁc marker and elevated levels have been
observed in patients with pneumonia and sepsis. The objective
of our study was to evaluate sCD163 as a diagnostic and
prognostic marker in patients with bacteraemia.
Methods: 42 adult patients with community acquired bacterae-
mia admitted at a department of internal medicine at a tertiary
hospital were included in a prospective manner. Daily blood
sampling for sCD163 analysis was performed for up to ﬁve
days. Laboratory analyses were performed with a sandwich
ELISA using polyclonal rabbit anti-CD163 as the catching
antibody and monoclonal anti-CD163 as the secondary anti-
body. The patients were classiﬁed according to SIRS criteria.
Demographic data, co-morbidity, microbiological etiology, rout-
ine biochemical parameters, focus of infection, severity score
and mortality on day 28 were recorded. The patient sCD163
levels were compared with a non-infected control group which
consisted of 130 healthy blood donors.
Results: The median age was 71 years (range 20–97). The male-
female ratio was 1.2. 23 patients had gram positive bacteraemia.
19 patients had gram negative bacteraemia. The mortality rate
on day 28 was 16.6%. 5 patients had bacteraemia without SIRS.
17 patients had sepsis. 20 patients had severe sepsis. sCD163
concentrations are presented as median and range: 5.27 mg/L
(1.13–35.95) in the 42 patients with bacteraemia, 4.78 mg/L
(1.13–17.62) in patients with sepsis, 8.27 mg/L (2.01–35.95) in
patients with severe sepsis. These measurements were signiﬁ-
cantly higher compared to the control group (median 1.87 mg/
L)(P < 0.0001). The survivors had a median of 4.4 mg/L (range
1.13–35.95). The non-survivors had a median of 15.74 mg/L
(range 4.41–20.8). This was a signiﬁcant difference
(P = 0.009). No correlation was found between levels of
sCD163 and C-reactive protein, leukocytes or polymorpho-
nuclear leukocytes.
Conclusion: Higher levels of sCD163 were observed in patients
with bacteraemia compared to a non-infected control group. A
high level of sCD163 indicated a poorer prognosis in patients
with bacteraemia. Further studies are needed to unravel the role
of sCD163 as a prognostic marker of severe infections.
P1694
Bacteremia in neonatal intensive care units:
bacterial isolates and susceptibility patterns
K. Koraki, P. Karapavlidou, M. Tsivitanidou,
D. Soﬁanou (Thessaloniki, GR)
Objective: To determine the frequency of bacterial isolates from
neonatal blood cultures and investigate their susceptibility
patterns.
Methods: Blood cultures were performed using the BacTAlert
30 automated system. Identiﬁcation of microorganisms and
susceptibility testing was performed using the Vitek 2 automa-
ted system (bioMerieux, France).
Results: From January 2001 to October 2004, 304 bacterial
strains were isolated from neonatal blood cultures. 60% were
Gram-positive and 40% were Gram-negative. The bacterial
pathogens encountered were: coagulase-negative Staphylococci
(CoNS) 45%, Klebsiella spp 19.4%, Enterobacter cloacae 7.9%,
Enterococcus spp 6.2%, Staphylococcus aureus 5.6%, Escherichia coli
5.2%, Pseudomonas aeruginosa 4.2%, Streptococcus group B 2.3%,
other Gram-negative 4%, other Gram-positive 0.2%. The Gram-
negative organisms demonstrated high degree of resistance to
ampicillin and ceftazidime (92.7% and 73.7% respectively),
moderate degree of resistance to tobramycin, cefotaxime, cefox-
itin and gentamicin (66.4%, 58.7%, 50% and 49% respectively)
and low resistance to cotrimoxazole and amikacin (29.3% and
14.7% respectively). All were susceptible to imepenem. Accord-
ing to resistance phenotypes more than half of Klebsiella spp
isolates (57.8%) and three E.coli isolates were characterized as
extended spectrum beta-lactamase (ESBL) producers. Resistance
rates for S. aureus were: oxacillin 58.8% (MRSA), gentamicin and
tobramycin about 55%, erythromycin 5.8%. Full susceptibility
was reported for clindamycin. CoNS presented 90% resistance to
oxacillin, 75% to gentamicin and tobramycin and 50% to
clindamycin and erythromycin. Nearly all Staphylococci were
resistant to penicillin, while all were susceptible to glycopep-
tides. Resistance rates for Enterococcus spp were: ampicillin 21%
and imipenem 29.4%. High-level resistance to gentamicin and to
streptomycin was observed to 15.7% and 42.1% of isolates,
respectively. One isolate was resistant to glycopeptides expres-
sing a Van A phenotype. All group B Streptococci were
susceptible to penicillin.
Conclusion: Periodic bacteriologic surveillance in neonatal
units is necessary leading to effective empiric treatment of
neonatal bacteraemia.
P1695
Epidemiology and clinical features of
bacteraemia in a tertiary care hospital over a
twelve-year study period
J. Garbino, D. Lew, M. Puppo, J. Schrenzel, V. Jacomo,
P. Rohner (Geneva, CH)
Introduction: During the past three decades, a dramatic shift in
the incidence of certain bacterial infections in both the commu-
nity and hospital settings has been observed. In particular, the
percentage of Staphylococcus aureus strains resistant to methicil-
lin (MRSA) is continuously increasing as well as coagulase-
negative Staphylococci resistant to methicillin and a considerably
increasing number of infections due to gram negative bacteria.
Objectives: The objectives were to determine the rates and
secular trends in bacteraemia at a tertiary care hospital, and the
trends in antimicrobial resistance. Furthermore, relative risk
factors for death by univariate analysis were evaluated.
Methods: During a 12-year period, from January 1992 to
December 2003, a retrospective study was performed at the
University Hospitals of Geneva (HUG) to obtain the proﬁle of
patients with positive blood cultures using data available at the
HUG. These data included patient demographic characteristics,
microbiological results, in-hospital patient hospitalization and
outcome. All bacteremic patients with a positive blood culture
were included in the study.
Results: During the study period, 469,418 patients were admit-
ted to the HUG, averaging 39,119 patients per year representing
a total of 8,947,654 patient-days of care. Over this period, 220,491
blood cultures were performed. Of these, 11,327 episodes of
bacterial bloodstream infections were identiﬁed in 8,735
patients. The patient’s mean age was 57.6 years. Fifty-eight per
cent (n = 6595) of the episode occurred in men (4732 in females).
The most commonly identiﬁed species were: coagulase negative
Staphylococcus (CNS) followed by Escherichia coli, S. aureus and
Streptococcus pneumoniae. The overall incidence of bacteraemia
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was 0.04 episodes per 1000 admissions, or 0.078 episodes per
10,000 patient-days. Among the bacteremic episodes, 85.4%
were caused by a single organism, and 47.3% were community-
acquired. No signiﬁcant changes in resistance patterns for the
different bacterial species were observed, except for an increas-
ing number of bacteraemia due to MRSA. The crude mortality
rate was signiﬁcantly higher in patients with nosocomial
bacteraemia compared to community-acquired bacteraemia.
Conclusion: A progression in MRSA was observed and with a
slight progression in CNS. There were no signiﬁcant changes in
resistance patterns. A predominance of nosocomial septicemia
with a higher mortality rate was also documented.
P1696
Signiﬁcance of staphylococcal bacteruria in the
course of S. aureus bacteraemia
H. Monzo´n, E. Calbo, L. Cuadra, M. Xercavins, J. Garau,
S. Quintana (Terrassa, E)
Introduction: It has been reported that about 30% of
patients with SA bacteraemia, have simultaneously a posit-
ive urine culture without a clear correlation with an
apparent urinary tract infection. We performed a retrospec-
tive study to assess the signiﬁcance of SA bacteriuria in
patients with bacteraemia.
Materials and methods: From 2001 to 2004, 55 patients with SA
positive blood cultures in whom urine cultures were obtained
within 24 h of drawing of blood were identiﬁed from the
Clinical Microbiological Laboratory. SA bacteraemia was
deﬁned by the presence of one or more positive blood cultures,
and bacteriuria by the presence of any colonies of SA in the
urine culture. Demographic variables, comorbidities, immuno-
suppression, urinary tract pathology or manipulation, renal
function, proteinuria, pyuria, hematuria, source of bacteraemia
and mortality were obtained from the medical charts. High
grade bacteraemia was deﬁned by positivity of all blood culture
bottles taken in which bacterial growth was became apparent in
less than 24 h.
Results: In 18/55 (32.7%) patients, blood and urine were
positive for SA (group A) versus 37/55 (67.3%) where SA was
present only in blood (group B). The two groups were similar
in gender (men: 77% vs 76%), mean age (63 vs 61 y),
immunosuppression (39% vs 50%), chronic renal failure (50%
vs 31%), diabetes (11% vs 30%) and mortality (39% vs 28%).
Urinary tract abnormalities or manipulation were present in
50% vs 30%(NS) and 17% vs 27%, (NS) respectively. Means of
Charlson scores between groups were 2.28 and 2.74 (NS); mean
renal creatinine clearance values were 51 and 57.7 ml/min
(NS); pyuria, proteinuria and hematuria were present in 76% of
group A vs 42% of group B (p = 0.022), 87% vs 53% (p = 0.18),
81% vs 56% (p < 0.001), respectively. In those patients with a
clearance >40 mL/min, high grade bacteremia was present in
55.5% (5/9) of group A vs 20% (5/25) in group B (p = 0.081).
In multivariate analysis only high grade bacteremia was
related to the presence of SA in urine culture (OR = 22.1,
(1.34–363.7; p = 0.03).
Conclusions: Pyuria, hematuria proteinuria and high grade
bacteraemia are related to the simultaneous presence of SA in
blood and urine. In patients with SA bacteraemia, the presence
of the organism in the urine does not necessarily mean
intravascular infection and /or higher mortality. However, in
patients with preserved renal function the high grade bacterae-
mia could explain the presence of a positive urine.
P1697
Ten-year experience in bloodstream infections in
liver transplant recipients. Changes in
microbiological patterns between 1991–1995 and
1996–2000
C. Cervera, A. Moreno, M. Almela, G. Soto, N. Benito,
J.A. Martı´nez, F. Marco, J. Ferna´ndez, M. Navasa, A. Mas,
M.T. Jime´nez de Anta, J.M. Gatell (Barcelona, E)
Objective: Bacteremia is a major cause of death in recipients of
solid organ transplantation. After liver transplantation, bac-
teraemia has been documented in 24–35% of patients and
accounts for 19–30% of all major infections. Mortality ranges
between 24% and 36% in bacteriemic liver transplant recipients.
The most frequent sources for bacteraemia in liver transplant
patients is catheter related, pneumonia, and biliary. The aim of
this study is to evaluate prospectively all cases of bacteraemia
and fungaemia in liver transplant patients, source, mortality,
and changes in microbiological isolations among 1995–1996 and
1996–2000 periods.
Methods: We prospectly collected all episodes of bloodstream
infections in liver transplant patients since 1991 to 2000. In each
episode, we collected the following variables: sex, age, date of
transplantation, source of infection, type of microorganism, and
outcome.
Results: In this period of time, 673 liver transplants were done
in 628 patients, and 189 episodes of bloodstream infections in
149 patients occurred (24%). Male sex was 65%. Mean age was
49.6 (SD: 12.4, R:19–72). Crude mortality was 18% (34 patients).
Nosocomial origin occurred in 135 (71%). Of 203 isolations, the
most frequent were: Escherichia coli 47 (23%), plasmocoagulase-
negative Staphylococcus 34 (17%), Staphylococcus aureus 30 (14
MRSA) (15%), Enterococcus faecalis 19 (9%), and Pseudomonas
aeruginosa 16 (7%). Fungemia was present in 7 patients, 3 by
Candida albicans, 2 by Candida glabrata, 1 by Candida parapsilosis,
and 1 by Cryptococcus neoformans. We compared the periods 91–
95 and 96–00 to analyze differences between groups. Middle age
of patients was signiﬁcantly lower in the period 91–95. We
found no differences in mortality between the 2 groups.
Nosocomial origin was more frequent in the ﬁrst period
(p < 0.001). In the second period, we found a higher number
of abdominal source (p = 0.001), and the number of catheter-
related bacteremia decreased (p = 0.014). In the second period,
E. coli bacteraemia was higher (17 vs 30, p = 0.035) and S. aureus
isolations lower (25 vs 5, p < 0.001).
Conclusions: Mortality in bacteremic liver transplant patients is
high, and we found no differences between 1991–1995 and 1996–
2000 periods. Nosocomial infections are lower in the last 5 years,
with an increase in E. coli and a decrease in S. aureus
bacteraemia.
P1698
Invasive listeriosis in Denmark
P. Gerner-Smidt, P. Schiellerup, J.J. Christensen, J. Engberg,
V. Fussing, A. Jensen, C. Jensen, A.M. Petersen,
B.G. Bruun (Copenhagen, DK)
Objectives: To review epidemiological, clinical, and microbio-
logical data on 299 cases of invasive listeriosis, excluding
materno-fetal cases, occurring in Denmark during the last
10 years.
Methods: Data regarding age, sex, isolation site, underlying
diseases or conditions, immunosuppressive treatment, and
clinical outcome within 1 month of diagnosis of infection, were
analysed. Strains were submitted from 294 cases. The strains
were serogrouped using antisera and further serotyped by PCR.
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Results and conclusions: The annual incidence of invasive
listeriosis ranged from 0.42 to 0.73 per 100,000 inhabitants. Of
the 299 invasive cases in 298 patients, 221 were blood stream
infections, 71 CNS infections, and seven focal infections (pros-
thetic infections in bones and joints plus peritonitis). Conditions
known to predispose to infection were found in 70% of cases.
Patients were evenly distributed throughout Denmark, and half
of them were older than 70 years. Death occurred in 21% of
cases. Blood stream and CNS infections carried the same
mortality, while there were no deaths in patients with focal
infections. Multivariate analysis disclosed the following: condi-
tions known to predispose to infection were strongly related to
death in patients below 70 years of age; above this age
underlying conditions were not related to increased risk of
death; and strains of serotype 4b caused higher case fatality than
strains of serotypes 1/2a and 1/2c.
P1699
Morphological changes of Listeria monocytogenes
when subjected in mild alkaline conditions
E. Giotis (Newtonabbey, UK)
Objectives: To investigate the effect of marginal alkaline con-
ditions on the morphology of Listeria monocytogenes and its
derived (sigB deﬁcient) mutant strain.
Methods: Overnight cultures were resuspended and grown for
12 h in buffered and non buffered media at pH 7.4 (control), 9.0,
9.2, 9.5 and 9.7. Appropriate samples were taken at 3, 6 and
12 hours and the cellular dimensions (length, width and
volume) were calculated using Scanning Electron Microscope
(SEM) photomicrographs.
Results: SEM studies revealed that sublethally stressing alka-
line treatment of Listeria monocytogenes induced cell elongation
and the development of populations containing a wider diver-
sity of cell sizes than non-sublethally stressed cells. At pH
values above 9.0, atypical forms of Listeria were observed as
single or paired ﬁlaments. The neutralisation of the medium
appeared to reduce the increased cell size in non-buffered media
while in buffered media there was a relationship between the
exposure and the corresponding morphological changes. Filam-
entation was independent of the presence or absence of the sigB
factor. Such effects were reversed by neutralisation of the
suspension medium in buffered and non-buffered media, with
septation within ﬁlaments, and division/separation of resultant
cells within 3 hours.
Conclusion: Such alkaline induced sublethal stress may occur
during a number of clinical circumstances, and during the usage
of alkaline cleaning agents in food production and processing
environments. The occurrence, persistence and recovery of
ﬁlamentous and or other atypical forms of this undesirable
pathogen may lead to failure to detect, or underestimation of the
incidence/numbers of this organism in such environments, with
signiﬁcant implications for its control in clinical circumstances
and public health.
P1700
Immunological and microbiological study of
abortion samples for serotype determination of
Listeria monocytogenes in Iran
S. Mirdamadi (Tehran, IR)
Listeria monocytogenes is a small gram positive rod which shows
beta-hemolysis in sheep blood agar. The host range is wide,
including mammals, birds, crustaceans, ticks and ﬁsh. Trans-
mission from animal to man occurs by handling of newborn
calves, infected foods and drinking infected milk. A wide
variety of clinical syndromes are caused by Listeria monocyto-
genes ranging from a mild inﬂuenza-like illness to fulminant
neonatal listeriosis associated with mortality rates of 54–90%.
Under sterile conditions, 200 abortion samples and sera from
patients were collected and stored at )70C. The abortion
samples were tested bacteriologically and the sera of these
pregnant women tested by immunoﬂuorescence method (IF).
Samples were cold enriched at 4C and subcultured in common
and selective media. The results showed that 72 pathogenic
bacterial strains were isolated and 5 of them were L. monocyto-
genes, which had caused abortion. The mother’s sera was tested
against 12 serovars of L. monocytogenes separately(IF test).
Among the tested cultures, only 2.5% of samples were positive,
but IF tests showed the existence of antibody against
L. monocytogenes in 70.7% of sera. From positive aborted
samples, strains of bacteria such as Staphylococci, Streptococci,
Enterobacteriace, and Bacillus spp. were also isolated. False-
positive reactions are caused by cross-reactions between L.
monocytogenes and these bacterial strains. On the contrary, it is
possible that many of these patients were contaminated by L.
monocytogenes for a short period of their life before aborting, and
as a result they had positive IF tests without true infection. Also
Some reports shows fecal carriage of L. monocytogenes in about
0.6–16% of the population at any time .All the sera showed
negative IF reaction for serovars 4a, 6a and 6b. A faint (weak)
result was obtained with serovars 2,4d, 4e, 5 and 7.Serovars la,3
and 4b showed strong reactions with titres of 3200 in bacteri-
ologically positive samples. So, the results showed that the most
dominant serovars of L.monocytogenes which cause listeriosis in
Iran are 4b, la ,and 3.The obtained results from this investigation
compare with other researchers who determined serogrops of 1,
3 and 4 in UK , serogroups of 1, 3 and 4 in Europian contries (1 is
the predominant type whereas in the mid-1960s, the dominant
type was 4b). and serotypes of 1 and 4b in United States (but
types 2 and 3 are rare). Type 4b comprises approximately two-
thirds of all cultures.
P1701
Pseudobacteraemia due to contaminated normal
saline sponges
D.-M. Kim, S.-H. Lee, S.-J. Jang (Gwang-Joo, KOR)
Objectives: During 2004, Enterobacter species were isolated
from blood cultures of 2 patients in Chosun University Hospital.
One was Enterobacter aerogenes and the other was Enterobacter
amnigenus. But, two patient bacteria culture sensitivity and MIC
were nearly same. We tried to ﬁnd the origin and cause of
Enterobacter spp bacteraemia outbreak. We retrospectively
reviewed clinical record of two patients. One patient is healthy
woman, but, the other woman is Liver cirrhosis patient. Both
patients are asymptomatic, their vital and lab ﬁndings were
within normal range. No common exposures other than veni-
puncture correlated with positive blood cultures were seen.
Enterobacter spp. was cultured from Normal saline sponge used
for wiper of skin disinfectant prior to venipuncture for blood
culture.
Methods: Two clinical isolate and Normal saline sponge isolate
were identiﬁed by phenotypic method and a nucleic acid based
conﬁrmatory test (i.e. 16S rRNA gene sequencing).
Results: Two clinical isolates and Normal saline sponge isolate
were identiﬁed as Enterobacter amnigenus.
Conclusions: When unusual human pathogen such as E. amni-
geneus was isolated with no clinical signs of sepsis. A psedobac-
teraemia should be suspected especially in case bacteria culture
sensitivity and MIC were nearly same. Correct procedures for
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blood culture were immediately reinstituted, No further cases of
E amnigenus bacteraemia occurred after prohibition of the use of
Normal saline sponge.
P1702
Prediction of bloodstream infections using
TREAT. A causal probabilistic network for
diagnosis and treatment of infections
M. Paul, A.D. Nielsen, E. Tacconelli, N. Almanasreh, A. Fraser,
U. Frank, R. Cauda, S. Andreassen, L. Leibovici on behalf of the
TREAT study group
Background: Predicting the existence of bloodstream infection
at sepsis onset allows for appropriate and economical manage-
ment decisions. Withholding blood cultures may reduce both
direct costs and those related to contamination, but can be
guided only by highly speciﬁc criteria. TREAT is a computer-
ized system modeled to diagnose the probability of sepsis,
source of infection, microbiology, and recommend therapy
based on its coverage and costs. Calibration to different
locations is inbuilt.
Methods: Derivation: The system is a causal probabilistic
network modeled from risk factors through pathogens to
disease. Blood cultures were modeled using data derived from
literature and local data (table). Validation: TREAT was calib-
rated to 3 sites (Israel, Germany, Italy) and tested in a
prospective observational trial. All consecutive adults fulﬁlling
criteria for sepsis were included. Opportunistic infections were
excluded. Clinical, laboratory, and radiological variables avail-
able prior to prescription of empirical therapy were entered to
the system. We evaluated TREAT’s ability to predict clinically
signiﬁcant bloodstream infections. Discriminative power was
assessed using a ROC curve.
Results: We included 1202 patients with a mean age of
59.4 years. Infection was community-acquired in 70.5%. Overall
30-day mortality was 10.2%. True bacteraemia was detected in
10.0%, while contamination occurred in 2.2% of patients. The
most prevalent pathogens were Escherichia coli (27.5%), Staphy-
lococcus aureus (14.2%) and Klebsiella pneumonia (7.5%). The area
under the ROC curve generated using the probability for
bacteraemia given by TREAT was 0.702 (95% CI 0.654–0.750).
We identiﬁed 3 TREAT bacteraemia probability categories,
signiﬁcantly associated with documented bacteraemia
(p < 0.001, Chi-Square test). The highest probability category
identiﬁed a group of 240 patients of whom 22.9% were
bacteremic. The lowest category identiﬁed 240 patients of
whom only 1.3% were bacteremic (table), while contaminant
growth was detected in 2.1%.
Conclusions: Using simple variables available within a few
hours after sepsis presentation TREAT accurately predicted the
occurrence of bacteraemia. Performance was demonstrated in 3
different countries. Using TREAT clinicians can rule out bac-
teraemia in 20% of patients presenting with sepsis with a
speciﬁcity of 98.7%. TREAT identiﬁed a large group of inpa-
tients evaluated for sepsis that can be safely managed without
obtaining blood cultures.
P1703
Controlled clinical comparison of VersaTREK
versus BacT/ALERT blood culture systems
L.B. Reller, K. Hanson, S. Mirrett (Durham, USA)
Objectives: To assess the relative yield of bacteria and yeasts
isolated from the blood of adult patients with suspected sepsis,
we compared the new VersaTREK (TREK Diagnostic Systems,
Cleveland, Ohio) automated continuously monitoring blood
culture system to the BacT/ALERT 3D system.
Methods: Identical protocols were followed for both systems.
Paired standard aerobic and anaerobic media were used; each of
the 4 culture bottles was ﬁlled with 6–9 ml of blood. All bottles
ﬂagged positive by the instruments were subcultured to deter-
mine both true- (growth) and false- (no growth) positive
cultures. Additionally, to assess false-negative bottles, terminal
subcultures were done on all negative companion bottles to
true-positive bottles. All isolates were identiﬁed by standard
methods.
Results: All 4 bottles were adequately ﬁlled in 5,468 (79%) of
the 6,884 4 bottle sets obtained. Of 413 clinically signiﬁcant
(based on previously published criteria) isolates detected in one
or both blood culture systems, there was no overall difference in
recovery of microorganisms; however, Streptococci and Entero-
cocci (P < 0.05) were detected more frequently with VersaTREK.
Of 233 clinically signiﬁcant positive cultures detected in the
aerobic bottles of both systems within 72 hours, growth was
detected sooner in the VersaTREK (mean of 14.9 h) versus the
BacT/ALERT 3D (17.9h) system. The reverse was seen in 181
comparisons with the anaerobic bottles: VersaTREK (mean of
21.9 h) and BacT/ALERT 3D (15.7 h). Both systems were
comparable (P = NS) in detecting the 179 unimicrobial episodes
of bacteraemia seen: 137 (77%) were detected in both systems, 23
(13%) only in VersaTREK and 19 (11%) only in BacT/ALERT 3D.
False-positive rates for aerobic and anaerobic bottles, respect-
ively, were 1.6% and 1.0% for VersaTREK and 0.7% and 0.8% for
BacT/ALERT 3D. The number of false-negative aerobic bottles
found were 3 with VersaTrek and 4 with BacT/ALERT 3D,
whereas the corresponding numbers for anaerobic bottles were 3
with VersaTREK and 23 with BacT/ALERT 3D.
Conclusion: We conclude that the VersaTREK and BacT/
ALERT systems are comparable for detection of bloodstream
infections with bacteria or yeasts.
P1704
Solitary blood culture rate as a measure of
institutional total quality
A. Camporese (Pordenone, I)
Objectives: It is generally accepted that the solitary blood
culture rate represent a good measure of routine institutional
quality control. Our objective was to determine the frequency
with which solitary blood culture samples obtained from adult
TREAT Database Calibration Database
Probability of bacteremia per site of
infection and pathogen
Overall contamination rate
Probability of growth pre pathogen
in aerobic and anaerobic bottles
Pathogen speciﬁc contamination
rate
Probability of growth in multiple
bottles, within same or different sets
Pathogen speciﬁc
contamination rate per bottle
Automated detection sensitivity
Previous antibiotic treatment effect
Blood letting technique- associated
contamination rates
Israel Germany Italy All
N patients 348 611 243 1202
% bacteremia 11 8.9 9.1 10.0 (N = 1202)
% in category 1 1.7 0 1.5 1.3 (N=240)
% in category 2 9.7 6 9.1 8.6 (N=720)
% in category 3 27.3 18.5 24.2 22.9 (N=240)
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inpatients and outpatients were submitted to our laboratory
during the ﬁrst six months of 2004, as a measure of institutional
total quality.
Methods: We measured the rates with which our laboratory
received only solitary blood culture sets on adult inpatients and
outpatients with suspected sepsis in the ﬁrst six months of 2004.
We did not evaluate the consequences of solitary blood cultures
on clinical outcomes. The solitary blood culture rate was deﬁned
as the number of instances in which only 1 blood culture was
performed on an individual patient during a 24-hour period
divided by the total number of cultures performed during the
study period in the outpatients and inpatients. Outpatient blood
cultures came not only from community strictly, but also from
nursing homes and residential home care centers.
Results: During the study period (the ﬁrst six months of 2004), a
total of 1884 blood culture sets was obtained from adult
inpatients, 269 of which were solitary (rate:14.3%) and 1615 of
which consisted of 2 or more sets (rate: 85.7%). In the same
period, a total of 262 blood culture sets was obtained from adult
outpatients, 75 of which were solitary (rate:28.7%) and 187 of
which consisted of 2 or more sets (rate: 71.3%).
Conclusion: Data showed that solitary blood culture rates were
lower in hospital (14.3%), where standard practice protocols to
improve the efﬁciency of sepsis diagnosis exist, where these
kind of measures are monitored as part of routine institutional
quality control programmes and where workers are speciﬁcally
trained to perform specialized tasks. Instead, solitary blood
culture rates are higher in community setting, where standard
practice protocols and solitary blood culture rates are not
monitored routinely. We think that the frequency with which
solitary blood culture samples were obtained from community
patients should stimulate the community institutions to initiate
speciﬁc corrective actions and continuous quality improvement
programmes.
P1705
Clinical factors associated with contamination of
blood cultures in the emergency room
J. Modol, M. Sanchez, R. Gamiz, L. Garcia, M. Gime´nez,
A. Marcas, P. Tudela (Badalona, E)
Objective: Contamination of blood cultures has important
consequences in hospital dynamics since it may complicate the
diagnosis and treatment of patients and delay hospital dis-
charge. Some studies have compared different skin disinfectants
or withdrawal techniques however there is another factor which
should be taken into account, the patient. The objective of this
study was to identify the clinical proﬁle of adult patients with
contaminated blood cultures (CBC) obtained in the emergency
room (ER).
Methods: we retrospectively analysed all the adult patients
with CBC performed in the ER in a 4-month period (June–Sept.
2003) and compared their features with a randomised sample of
non contaminated blood cultures (NCBC) in the same period.
We collected demographic data, underlying diseases, tempera-
ture, level of consciousness (LOC) and ﬁnal diagnosis.
Results: 2979 blood cultures were submitted to the laboratory
with 187 CBC (6.3%),corresponding to 151 episodes in 148
patients. We could analyze 146 of these episodes (96.7%). Mean
age was 64.5 years,82 (56.2%) being males. The main bacteria
implicated were: coagulase-negative Staphylococci (85.8%),
Corynebacterium spp. (5.7%), Bacillus spp (3%) and polymicrobial
(1.5%). Among the underlying diseases the presence of cognitive
deterioration was of note in 27% of cases, diabetes mellitus
(24.8%), neoplasm (13.1%), cirrhosis (8%), HIV infection (7.3%)
and COPD (5.1%).No underlying diseases were found in 13.1%
of these patients. A decrease was detected in the LOC in 44.5%
of patients and only 36.6% had fever (T > 38C).The main ﬁnal
diagnoses of these episodes were: urinary tract infections
(25.7%) and respiratory infections (24.3%). Infection, fever or
blood cultures were not described in 21.4% of the discharge
reports. When we compared this group with NCBC group, CBC
patients were older (64.5 vs 59.3), more often had cognitive
deterioration at baseline (27% vs 7.3%), cirrhosis (8%vs2.4%) or
any underlying disease (86.9% vs 61.4%) and more frequently
showed a decrease in the LOC (44.5% vs 20%). In contrast,
NCBC more often had neoplasm (26.8% vs 13.1%) and COPD
(18.3% vs 5.1%). No other statistical signiﬁcant differences were
found.
Conclusions: Contamination of blood cultures affect older
patients, almost all with underlying diseases, specially demen-
tia, and often with a decrease in the level of consciousness. Thus,
special care should be taken when performing blood withdrawal
and interpreting blood cultures in these patients.
P1706
Evaluation of quantitative antibiotic
susceptibility testing as a routine method
to predict strain relatedness of coagulase-
negative Staphylococci isolated from blood
cultures
A. Camerer, D. Stefanik, H. Seifert (Cologne, D)
Objectives: To date no precise criteria exist to predict genetic
identity of coagulase-negative Staphylococci (CoNS) isolates
recovered from consecutive blood cultures based on routine
antibiotic susceptibility testing (AST) results to help differentiate
true bacteraemia from contamination.
Methods: A total of 119 consecutive CoNS isolate pairs from
patients with 2 or more blood cultures positive for CoNS that
had been obtained within 7 days were selected from stored
blood culture isolates recovered during a recent 2-years period.
Isolates were identiﬁed to species level and tested for antimi-
crobial susceptibility by VITEK2 (BioMerieux, , France). Based
on MIC data and the resistance category (S vs R) of each of the
antibiotics – penicillin, oxacillin, ciproﬂoxacin, erythromycin,
clindamycin, cotrimoxazol, tetracycline, gentamicin, fosfomycin,
fusidic acid, and rifampicin – we classiﬁed pairs of isolates as
concordant or discordant (i.e. ‡3 log 2 dilutions difference in
MIC). The results were compared with molecular analysis of
isolate pairs using pulsed-ﬁeld gel electrophoresis as the gold
standard.
Results: Concordant AST results were predictive for genetic
identity: 100% sensitivity, 100% speciﬁcity, 100% positive pre-
dictive value (PPV), 100% negative predictive value (NPV). With
a threshold of two or more antibiotic discrepancies to deﬁne
non-identity, discordant AST results were predictive for genetic
diversity: 100% sensitivity, 100% speciﬁcity, 100% PPV, 100%
NPV. If discrepancy in just one AST result was used to deﬁne
non-identity of isolates (n = 6), AST was only 50% predictive of
genetic diversity.
Conclusions: AST determined by VITEK2 is a reliable, easy to
perform, time and cost efﬁcient tool to predict genetic related-
ness of CoNS isolates from blood cultures. Our criteria may help
distinguish true bacteraemia from contamination when confron-
ted with 2 or more blood cultures yielding CoNS.
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P1707
Typing of Staphylococcus epidermidis using
multiple-locus variable-number tandem repeat
analysis
A. Johansson, P. Gottfridsson, S. Koskiniemi, J. Wistro¨m,
A. Sjo¨stedt, T. Monsen (Umea˚, S)
Objectives: The emergence of Staphylococcus epidermidis as an
important nosocomial pathogen is related to advances in
modern medicine. There is a lack of methods to distinguish
clinically signiﬁcant S. epidermidis from contaminant strains and
rapid and reproducible methods for epidemiological studies.
Multiple-locus variable-number tandem repeat analysis (MLVA)
has proved efﬁcient for high-resolution typing of several
bacterial species. The aim of the present study was to develop
a MLVA system for molecular typing of S. epidermidis.
Methods: The genome sequence of S. epidermidis ATCC 12228
was analysed for the presence of tandem repeated sequence
using software programmes. Genomic DNA of 30 clinical
isolates of multi-resistant S. epidermidis was subjected to PCR
ampliﬁcation of multiple genomic regions that exhibited tandem
repeats. Variation in repeat copy numbers among isolates was
determined by sizing of PCR fragments on agarose gels and
veriﬁed by sequencing. All S. epidermidis isolates were typed
using SmaI digestion and pulsed–ﬁeld gel electrophoresis.
Diversity values (D) were calculated using the formula
D = 1)SUM(allele frequency)2.
Results: The analysis of the genome of S. epidermidis ATCC
12228 identiﬁed 137 genomic regions with tandem repeated
sequences. Fourteen regions were analysed in a subset of
S. epidermidis isolates. Five regions showed variable numbers
of tandem repeats and were further analysed in 30 clinical
S. epidermidis isolates from a University Hospital. The variable
repeat motifs displayed repeat sizes ranging from 18 bp to 58 bp
in length. The number of detected alleles at individual repeat
loci ranged from three to ten. Calculated D-values ranged from
0.50 to 0.82. The D-value for the combination of ﬁve repeat loci
(all loci treated as a single allele) was 0.87. MLVA revealed 16
genotypes among 30 isolates. Observed PFGE genotypes resul-
ted in a D-value of 0.84. It was apparent that MLVA and PFGE
resulted in very similar clustering of isolates (Figure 1). Three
out of ﬁve identiﬁed polymorphic tandem repeat loci were
located in genes predicted to encode surface binding proteins
that may have a functional role in adherence to host ﬁbrinogen.
Conclusion: MLVA is a promising typing approach for molecu-
lar epidemiology studies of S. epidermidis due to the speed of
analysis, a high discriminatory power, and an ability to produce
discrete character data that can be easily exchanged among
laboratories.
P1708
A pathogen or a contaminant: the emerging
signiﬁcance of Kytococcus schroeteri
K. Becker, C. Berchiche, C. Aepinus, J. Wu¨llenweber, J. Etienne,
A. Podbielski, M. Herrmann, G. Peters, C. von Eiff (Munster, D;
Lyon, F; Rostock, Homburg/Saar, D)
Background: Micrococci are found as normal inhabitants of
human skin and mucous membranes and are usually disregar-
ded as contaminants in clinical isolates. Nevertheless, strains
identiﬁed as members of the Micrococcinae suborder have been
described to be increasingly involved as causative organisms in
septicemia, endocarditis peritonitis, pneumonia and other
severe systemic infections.
Patients and results: Following the recent description of Kyto-
coccus schroeteri, four severe infections due to this pathogen were
observed in different hospitals. After the ﬁrst case, reporting a
prosthetic valve endocarditis in a 34-year-old female without
any other known diseases, a K. schroeteri infection associated
with a prosthetic aortic valve was observed in a 38-year-old
diabetic women. A further prosthetic valve infection affected the
mitral valve of a 79-year-old patient. The ﬁrst fatal case due to
K. schroeteri was noted in a patient with asthma chronically
treated with corticosteroids. This 71-year-old female referred to
a French medical ICU for management of severe respiratory
distress developed bacteremic pneumonia leading to distribu-
tive shock that progressed to multiorgan failure. In addition to
phenotypical analyses, all isolates were conﬁrmed on species
level by 16S rDNA sequencing. K. schroeteri strains hitherto
recovered were resistant to penicillin and oxacillin, but suscept-
ible to glycopeptides, gentamicin, and rifampin. Of particular
interest, rifampin in combination with other antibiotics (gen-
tamicin, glycopeptides) was administered in all non-fatal cases.
Conclusions: Though it appears to be an organism of low
virulence, the emerging number of reported cases of K. schroeteri
infection has established the pathogenic potential of this
organism. Thus, if an infection is clinically suspected, the
repeated isolation of such isolates in the absence of other
microorganisms should not be underestimated. Accurate iden-
tiﬁcation of Kytococci is of importance as these species have been
shown to be resistant to penicillin and -lactamase-resistant
penicillins in contrast to members of other micrococcal
genera.
P1709
The changing spectrum of diseases causing fever
of unknown origin in Turkey: a multicentre study
Y. Kucukardali, O. Oncul, S. Cavuslu, M. Danaci, S. Calangu on
behalf of the Fever Unknown Origin Study Group
Objectives: The spectrum of diseases causing Fever of
Unknown Origin (FUO) not only seems to be determined by
geographical factors but also appears to change over time. To
update information on FUO and incorporate these new ideas,
we conducted a prospective multicentre study on patients with
FUO in ten Turkish University Hospitals.
Methods: The present study was undertaken between January
2003 and June 2004. The Petersdorf criteria (illness characterized
by rectal temperature exceeding 38.3C, evolving least 3 weeks,
with no diagnosis after one week of inpatient investigation).
were used in diagnosis FUO. Patient demographics, etiology of
FUO that could be detected, clinical symptoms and signs were
recorded.
Results: A total of 154 patients fulﬁlling the criteria of FUO
were determined. Mean age was 42.95 ± 17.76 (17–75) and 56.5%
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of the patients were males. A total of 154 immunocompetent
patients with FUO were followed up of whom 53 (34.4%) had
infections, 47 (30.5%) had non-infectious inﬂammatory diseases
(NIID), 22 (14.2%) had malignant diseases, 8 (5.2%) had
miscelleneous diseases. In 15.6% (24) of the cases, the reason
for high fever could not be explained despite every effort. The
most common infectious etiologies were tuberculosis [20
(37.7%)] and brucellosis [8 (15.1%)]. On the contrary, Adult
Still Disease was the most common NIID [22 (46.8%)], and
haematologic malignancy was the most common malignant
diseases [8 (36.4%)]. For the 130 patients with diagnosis, a
diagnosis was established after a median of 32.12 ± 18.53 days
from the onset of fever (range, 4–90). In patients with NIID, the
median duration of reaching a diagnosis (37.76 ± 23.77) was
signiﬁcantly longer, compared with the patients with infection
(25.56 ± 12.78) (p = 0.007). The median duration of fever in the
group of 130 patients in whom a diagnosis was made was
35.95 ± 32.62 days (range, 3–180). In patients with malignancy,
the median duration of fever (51.38 ± 35.55) was longer, com-
pared with the patients with infection (37.58 ± 38.97)
(p = 0.052).
Conclusions: Several reports have been reported a changing
pattern in the prevalence of the three main categories of the FUO
in Turkey since 1985: infections, malignancies and NIIS. Our
multicentre study showed that a decrease in the prevalence of
infectious diseases in favor of the other two groups compared
with the previous Turkish studies.
Catheter-related infections
P1710
Retrospective study to evaluate differential time
to positivity for diagnosing catheter-related
bloodstream infections
C. Venturelli, A. La Regina, A. Alai, F. Rumpianesi (Modena, I)
An accurate diagnosis, an adequate antimicrobial therapy and a
rational decision concerning catheter removal are the main steps
in the management of catheter-related infections(CRI). There is
no established gold standard for diagnosing CRI. A newly
developed method which compares the differential time to
positivity (DTP) of qualitative cultures of blood samples drawn
from the catheter and a peripheral vein has been proposed to
avoid unjustiﬁed removal of the catheter and potential risks
associated with the placement of a new catheter.
Objective: To evaluate DTP as a method for diagnosing
catheter-related bacteremias (CRB) in patients with catheteriza-
tion.
Methods: Patients with suspected CRI who had blood cultures
drawn simultaneously through the catheter and a peripheral
vein, according to the local guidelines, from January 2003 to
June 2004 at Policlinico of Modena were included in a retro-
spective study. The blood-culture system used was the
Bactec9240 and the growth times of peripheral and catheter
blood cultures were recorded and expressed in min. The criteria
of deﬁnite or likely CRB were clinical and/or microbiological in
patients with isolation of the same microrganism from the
catheter and peripheral blood cultures.
Results: During of this preliminary study, 146 episodes
occurred, 23 of which were excluded (15 for incompleteness of
data and 8 for different microrganisms in each paired bottles).
Finally, 123 episodes of suspected CRI were analysed: in 75 the
DTP was greater than 120 min. and CRB was conﬁrmed in 90%;
in 48 the DTP was less than 120 min. and in 95% of them the
bacteraemia wasn’t related to the catheter. The main microrgan-
isms involved in CRB were CONS (46.3%), S.aureus (20.9%),
P.aeruginosa (13.4%);theCRBwaspolymicrobial in three episodes.
Conclusions: The diagnostic reliability of semi and quantitative
catheter cultures is dimininuished by the fact that catheter
removal and subsequent culture are often performed several
days after the simultaneous blood cultures are drawn, a period
during which antibiotics are often given through the central
venous catheter. Hence DTP introduces a useful,simple labor-
atory method that can be proposed for routine clinical practice
in hospital using automatic devices for detection of positive
blood cultures in patients with possible CRB. The accuracy of
this methods requires accurate tracking of the source of blood
cultures, as well as simultaneous placement of the cultures in
the automated machine.
P1711
Results of active surveillance of nosocomial
central venous catheter-associated bloodstream
infections in a tertiary care hospital
M. Wroblewska, J. Wojkowska-Mach, A. Domagala-Krzewniak,
A. Radomyski (Warsaw, Cracow, PL)
Objectives: The analysis of the results of active surveillance
system of nosocomial bloodstream infections associated with
central venous catheters (CVC) in patients hospitalised on
intensive care units and surgical wards of a tertiary care
pulmonological hospital (280 beds).
Methods: The surveillance was based on a system of the Polish
Society of Hospital Infection. The study comprised patients
hospitalised in 2003 in two surgical wards (S-A and S-B) and
two intensive care units: surgical ICU (ICU-S) and cardio-
pulmonary ICU (ICU-CP). The mean stay in each ward was 10.8,
12.4, 1.6 and 10.0 days, respectively.
Results: In the analysed period there were 4086 patient admis-
sions, comprising 29805 patient-days (including 2816 central
venous catheter-days). The CVC utilisation rate was 9% for the
whole hospital, while in the analysed units it amounted to 51%
in ICU-S, 22% in ICU-CP, 3% in S-A and 4% in S-B. The highest
number of cases of CVC-associated bloodstream infections was
recorded in the ICU-S (6 cases), corresponding to the highest
incidence rate/1000 patient-days (2.2&), in comparison to other
wards (1.9& in ICU-CP, 0.1& in S-A and 0.2& in S-B). However,
the highest incidence rate/100 admissions (1.9%) and the
highest incidence rate/1000 CVC patient-days (8.8&) was
recorded in the ICU-CP, comparing to 0.4% and 4.2& in ICU-
S, 0.1% and 2.3& in S-A and 0.2% and 4.0& in S-B, respectively.
Conclusions: The results show that the highest frequency of a
CVC-associated bloodstream infection was in ICU-S. However, a
high incidence rate of CVC-associated infections/100 admis-
sions in ICU-CP, combined with a lower CVC utilisation rate (in
comparison to ICU-S), indicate a need for improvement of
compliance with infection control procedures in ICU-CP. There-
fore active surveillance system allows a detailed epidemiological
analysis of frequency and dynamics of different forms of
nosocomial infections, as well as assessment and need for
modiﬁcation of infection control procedures.
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P1712
Assessment of the potential infection risk
associated with the Q-Syte needleless connector
D. Adams, T. Karpanen, T. Worthington, P. Lambert,
T.S.J. Elliott (Birmingham, UK)
Objectives: To determine the potential infection risk associated
with the Q-Syte needleless connector. To determine if multiple
activations of the Q-Syte needleless connector increases the
potential risk of infection.
Method: Fifty Q-Syte needleless connectors were inoculated
with a suspension containing 25% (v/v) blood and 6.5 x105
colony forming units of S. epidermidis. Suspensions were allowed
to dry and each device was subsequently decontaminated with
70% isopropyl alcohol as per standard practice. Needleless
connectors were then ﬂushed with a pre-ﬁlled sterile syringe
containing 10 ml of 0.9% (v/v) sterile saline. Each ﬂush solution
was collected and the number of colony forming units present
determined by standard laboratory techniques. A further 50
needleless connectors were activated up to a total of 70 times to
simulate routine clinical practice. After a deﬁned number of
activations each needleless connector was inoculated with
S. epidermidis, decontaminated and ﬂushed with 0.9% (v/v)
sterile saline as described previously. The number of colony
forming units present in each ﬂush solution was determined.
Results: None of the saline solutions ﬂushed through Q-SyteTM
needleless connectors which had been activated up to a total of
70 times, contained detectable numbers of microorganisms.
Conclusion: If appropriately disinfected, the Q-Syte needle-
less connector is a needle safe barrier to microbial contamination
of ﬂush solutions even following multiple activations. These
devices may have the potential for reducing the incidence of
catheter contamination, colonisation and sepsis acquired via the
intraluminal route.
P1713
Evaluation of RAPD for the epidemiological
typing of coagulase-negative staphylococci
implicated in catheter-related bloodstream
infection on a bone marrow transplant unit
A.L. Casey, T. Worthington, J.M. Caddick, A.C. Hilton,
P.A. Lambert, T.S.J. Elliott (Birmingham, UK)
Objectives: Coagulase-negative staphylococci (CoNS) are the
most common aetiological agents implicated in central venous
catheter (CVC)-related bloodstream infection. Phenotypic mark-
ers have been widely used for typing CoNS however, genotypic
methods such as pulsed-ﬁeld gel electrophoresis (PFGE) are
more discriminative. PFGE is a time-consuming method there-
fore epidemiological results achieved are often retrospective. In
this study, the ability of a rapid random ampliﬁcation of
polymorphic DNA (RAPD) technique to discriminate CoNS
implicated in CVC-related bloodstream infection in stem cell
transplantation (SCT) patients was compared to PFGE.
Methods: Patients at the University Hospital Birmingham NHS
Foundation Trust, UK who underwent SCT and were diagnosed
with CVC-related bloodstream infection due to CoNS whilst on
the bone marrow transplant (BMT) unit were studied. Isolates of
CoNS were genotyped by PFGE and RAPD. The RAPD
technique evaluated employed a single primer and simple
DNA extraction method. The discriminatory power of the RAPD
technique and PFGE was determined.
Results: Thirty-three SCT patients on the BMT unit were
diagnosed with CVC-related bloodstream infection from which
49 pure cultures of CoNS were obtained from blood cultures.
Both RAPD and PFGE were highly discriminatory (Simpson’s
diversity index, 0.96 and 0.99, respectively). Within the isolates
obtained from the 33 patients, 20 distinct strains were identiﬁed
by PFGE (using the Tenover criteria for bacterial strain typing)
and 25 by RAPD. Of the 25 strains identiﬁed by RAPD, there
were 9 distinct clusters of CoNS which contained isolates from
multiple patients, suggesting limited nosocomial spread and not
a common source. However, there was no signiﬁcant association
between time of inpatient stay and infection due to any one
strain of CoNS.
Conclusion: Genotypic analysis of CoNS isolates demonstrated
clusters of CVC-related bloodstream infection caused by
common strains, suggesting nosocomial cross-transmission.
However, no single strain was associated with a signiﬁcant
number of CVC-related bloodstream infections during the study
period. The expensive, time-consuming nature of PFGE indi-
cates that it is currently unlikely to be incorporated into the
routine microbiology laboratory. By contrast, the RAPD tech-
nique allows CoNS strains to be genotyped with high discrim-
ination within 4 hours, thus facilitating real-time
epidemiological investigations.
P1714
Central venous catheter related sepsis due to
Chryseobacterium meningosepticum: a case report
P. Carfagna, M. Galie`, F. Taglietti, A. Rocchi, C. Santini (Rome, I)
Objective: C. meningosepticum is cause of severe infections in
premature and newborn infants. Infections due to this oppor-
tunistic pathogen in adult immunocompetent patients are
uncommon.
Methods: We describe a cvc-related sepsis in an immunocom-
petent elderly patient.
Results: On July 2004, a 84-year-old man was admitted to
hospital for acute onset of epigastric pain and fever. He had an
history of hypertension, chronic bronchitis and peptic ulcer.
Physical examination revealed a severely ill patient with marked
tenderness to palpation and diffuse rigidity of the abdominal
wall. Abdominal radiographs showed pneumoperitoneum.
Clinical diagnosis of perforated peptic ulcer was done and
patient underwent gastrectomy. He was transferred in the ICU
for postoperatory monitoring: he was mechanically ventilated,
had a cvc and a urinary catheter. Broad-spectrum antibiotics
were administered. Tracheal tube was removed in a few days
and clinical conditions recovered. After 2 weeks, fever with
chills occurred, WBC count was 18000/mm3 (90% neutrophils).
Blood cultures from a peripheral vein and cvc were drawn and a
meropenem-based empiric therapy was started, without clinical
improvement. After 2 days, blood cultures yielded Gram-
negative rods. Cvc was removed and the tip cultured. The
isolate was further identiﬁed as C. meningosepticum resistant to
aztreonam, amikacin, tobramicin, netilmicin, piperacillin, pip-
eracillin/tazobactam, ceftazidime, meropenem and susceptible
to levoﬂoxacin. Also culture of catheter tip yielded C. meningo-
septicum. Therapy was changed to intravenous levoﬂoxacin
500 mg daily. Fever subsided after 2 days and a six-day-course
therapy was completed. The patient died one month later for
A. baumannii cvc related sepsis.
Conclusions: C. meningosepticum has been reported to cause
pneumonia, sepsis, wound infection, peritonitis in adult patients
with severe underlying diseases. In a recent series, it has been
described as cause of cvc-related bacteraemia in a cancer patient.
Our patient had no evident causes of immunodepression but the
advanced age, the severe underlying disease, and the presence
of an indwelling catheter might have played a role in the
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acquisition of infection. Furthermore, this pathogen has a
peculiar resistance to antibiotics usually prescribed for Gram-
negative bacterial infections, such as beta-lactam agents and
aminoglycosides, thus representing a clinical concern in the
choice of adequate antimicrobial therapy.
Molecular bacteriology and mycology
P1715
DNA microarrays for environmental, clinical
microbiology, and microbial taxonomy
D. Volokhov, J. George, C. Anderson, N. Sergeev, Y. Zhang,
A.D. Hitchins, A. Rasooly, V. Chizhikov (Rockville, Silver Spring,
Baltimore, College Park, Bethesda, USA)
DNA microarrays have the potential to be excellent tools for
environmental, clinical microbiology, and microbial taxonomy
due to the capability to signiﬁcantly improve identiﬁcation and
multilocus typing of target pathogens in a bacterial community.
We have developed and evaluated several microarray-based
assays for the reliable detection, discrimination, and multilocus
typing of the all Listeria species, four Campylobacter species
(C. jejuni, C. coli, C. lari, and C. upsaliensis), Bacillus anthracis,
most of the Mycoplasma species, and enterotoxins of Staphilococ-
cus spp.; many of which are know as either outbreak related or
clinically relevant pathogens for humans and animals. The assay
can also detect the presence of bacterial genes responsible for
drug resistance in Staphylococcus and Streptococcus spp., as well
as those genes related to drug resistance in Mycobacterium
tuberculosis. The approach used in this study included: (i)
simultaneous PCR ampliﬁcation of several target bacterial
genes; (ii) high-yield synthesis of single-stranded RNA driven
by T7 polymerase from the promoter-tagged PCR amplicons;
(iii) incorporation of appropriate ﬂuorescent dye into ssRNA;
(iv) hybridization of ﬂuorescently labeled sample with the
microarray containing multiple individual oligonucleotide
probes, and (v) microarray scanning and image data analysis.
Microarray analysis of large numbers of bacterial samples from
environmental and clinical sources demonstrated that this
method enabled unambiguous detection and identiﬁcation of
all target pathogens. The microarray approach is also a prom-
ising application in the microbial taxonomy ﬁeld due to the
ability to correctly identify species by a multilocus probing.
During this study we found that the occurrence of weak
hemolytic or non-hemolytic isolates of Listeria spp. (L. seeligeri),
and atypical hemolytic activity of typical non-hemolytic Listeria
spp. (L. innocua) can result in false biochemical species differen-
tiation of Listeria as a taxon. How can amicroarray improve this?
We found seven isolates that initially identiﬁed as L. welshimeri
has discrepancies with our microarray data. All seven isolates
were identiﬁed bymicroarray as L. seeligeri, but lost several genes
due to a deletion in the central virulence gene cluster. Thus, our
data suggests that microarray technology might be a valuable
tool for the identiﬁcation and accurate characterization of
bacterial pathogens and microbial community in general.
P1716
Atypical non-haemolytic Listeria seeligeri
isolated in the USA
D. Volokhov, J. George, V. Chizhikov, C. Anderson, R.E. Duvall,
A.D. Hitchins (Rockville, College Park, USA)
We found that seven Listeria isolates, initially identiﬁed as Xyl+,
Rha- biotypes of L. welshimeri by phenotypic tests, exhibited
discrepant genotypic properties using a well validated species
identiﬁcation oligonucleotide microarray. All seven isolates
were identiﬁed with the microarray as L. seeligeri (L.s.) based
on hybridization patterns with general iap- and hly-speciﬁc
oligonucleotide probes. However, these isolates did not hybrid-
ize with special L.s hly-speciﬁc oligonucleotide probes. Based on
the microarray result, these seven isolates were identiﬁed as
atypical hly-negative L.s. isolates, not L. welshimeri isolates. The
aberrant L.s. isolates are D-xylose fermentation positive and
L-rhamnose fermentation negative (Xyl+, Rha)); non-hemolytic
on BBL Columbia Agar supplemented with sheep blood, and
also are negative in the CAMP test with both S. aureus, and
R. equi. Since, the aberrant L.s. isolates are genetically and phe-
notypically hly-negative other structural alterations within the
PrfA regulated virulence-gene cluster of L.s. were suspected. All
genes of the PrfA cluster of L.s., located in the prs-ldh region,
including orfA2, orfD, prfA, orfE, plcA, hly, orfK, mpl, actA,
dplcB, plcB, orfH, orfX, orfI, orfP, orfB, and orfA genes were
checked by PCR and direct sequencing for evidence of their
presence in the atypical isolates. The PCR-based data and direct
sequencing of prs-ldh region suggested that the organization of
the genes of the virulence gene cluster of the aberrant isolates is
different from that in the reference strain L.s. ATCC 35967. The
PrfA clusters of the L.s. isolates are approximately three-fold
shorter, due to loss of orfD, prfA, orfE, plcA, hly, orfK, mpl,
actA, dplcB, plcB, orfH, orfX, and orfI. The genetic map order of
the cluster genes of all the atypical L.s. isolates is: prs-orfA2-
orfP-orfB-orfA-ldh. Direct sequencing showed that all of these
genes are L.s. speciﬁc. DNA sequencing and phylogenetic
analysis of housekeeping genes (iap, 16S rRNA gene, the16S-
23S rRNA inter-genic spacer region, prs, comK, groEL, cat, sigB,
recA, hsp60, and ldh) indicate a L.s. genomic background in all
seven of the atypical hly-negative L.s. isolates. Thus, Xyl+, Rha)
Hly+ L. seeligeri can only be distinguished from Xyl+, Rha)
L. welshimeri genotypically and not phenotypically. In contrast to
this case, the Rha+, Xyl+ biotype of L. welshimeri would not
present an identiﬁcation issue.
P1717
Species identiﬁcation of nocardial infections in
Denmark
K. Schønning, M. Kemp, K. Andresen, J.J. Christensen on behalf of
the Danish Nocardia Study Group
Objectives: To implement and validate DNA sequencing meth-
ods for species identiﬁcation of Nocardia isolates submitted to
the Danish Reference Laboratory for Bacterial Identiﬁcation and
to establish phenotypic criteria for correct identiﬁcation.
Methods: 29 clinical isolates presumed to be Nocardia and 9
type strains purchased from CCUG were subjected to almost
complete (>1400bp) sequencing of th 16S RNA gene and partial
sequencing (app. 500 bp) of the heat shock protein gene (hsp60).
Strains were tested for partially acid fast staining and resistance
against lysozyme to identify the genus. Phenotypic test for
species identiﬁcation included equivalent growth at 35C and
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45C, opaciﬁcation of Middlebrook 7H11 agar and carbohydrate
assimilation using the API 20C AUX test strip. Finally, strains
were tested for susceptibility to penicillin, cefoxitine, colistine,
gentamicin, erythromycin, rifampicin, fusidic acid, and vanco-
mycin using disk diffusion test on Muller-Hinton agar.
Results: 16S sequencing and BLAST searching in GenBank
correctly identiﬁed all type strains. 22 out of 29 clinical isolates
belonged either to N. farcinica (9 isolates), N. abscessus/asiatica (9
isolates) or N. cyriacigeorgica (4 isolates). To faithfully discern
between N. abscessus and N.asiatica at aleast a 1000 bp 16S RNA
sequence had to be analysed. Phenotypic identiﬁcation of these
three groups was possible using carbohydrate assimilation tests,
opaciﬁcation og 7H11 agar and gorwth at 45C. Deistinction
between the groups was further aided by colony morphology.
Other species could also be identiﬁed by phenotypic tests and
antibiotic susceptibility patterns could further aid diagnosis.
Phylogenetic analysis of hsp60 gene sequences indicated that
this gene carried phylogenetic information comparable to the
16S RNA gene.
Conclusions: Three phenotypic species of Nocardia constituted
more than 75% of danish clinical isolates submitted for identi-
ﬁcation. These were readily identiﬁed by 16S sequencing and
could also be identiﬁed by simple phenotypic tests.
P1718
Nocardia and nocardiosis in recent years:
different micro-organisms in different patients
C. Radice, P. Mun˜oz, M. Marı´n, E. Bouza (Madrid, E)
Background: Nocardia infections have traditionally been repor-
ted in severely immunocompromised patients. The majority of
the Nocardia isolates were identiﬁed as N. asteroides, and
cotrimoxazole prophylaxis was considered protective.
Methods: Between 1995 and 2003, there were 37 episodes of
nocardiosis in our center; 10 were excluded from the study due
to incomplete records (6) and colonization (4). Identiﬁcation to
species level was performed both by classic procedures and by
hsp65 PCR-RFLP in 27 cases.
Results: 89% of the patients were men and mean age was
54 ± 59 years. The most common underlying condition was HIV
infection (9 pts, 33.3%), followed by 5 (19%) immunological
diseases (2 rheumatic arthritis, 1 idiopathic thrombocytopenic
purpura, 1 temporal arteritis, 1 sarcoidosis), solid organ trans-
plantation (6 pts, 22%), COPD (4 pts, 14.7%) and neoplasm (3
pts, 11%). Among all patients (14 pts, 52%) were receiving
corticosteroids therapy due to different diseases and 9/27
(33.3%) were receiving prophylaxis with cotrimoxazole. The
infection was disseminated in 2 cases (7%), or involved the lung
(70%), skin and soft tissues (4 pts, 15%), CNS (1 pt, 4%), or
caused otomastoiditis (1 pt, 4%). The species of Nocardia were
as follows: N. asteroides VI 48%, N. farcinica 33%, N. nova 8% and
N. otitidiscaviarum 11%. Antimicrobial resistance rates were:
cotrimoxazole 15%, ceftriaxone 41% and imipenem 11%. Nocar-
diosis occurred while the patients were on cotrimoxazole
prophylaxis in 9 cases (33.3%) and the strains isolated in those
patients were susceptible (7) or resistant (2) to cotrimoxazole. Six
patients died (22%), but we could not detect a higher death rate
in HIV-infected patients with species other than asteroides or in
cases with prior cotrimoxazole prophylaxis. The outcome of
Nocardia farcinica infection was 3/9 (33.3%) related deaths and
6/9 (66.7%) were cured. For Nocardia asteroides VI the outcome
was favourable in 10/13 (77%), 1/13 related death, 1/13
unknown and 1/13 non-related death.
Conclusion: Our results show important changes in Nocardia
spp and nocardiosis in recent years. HIV infection is the most
common underlying condition, new species are emerging and
cotrimoxazole prophylaxis should not be relied upon as univer-
sally protective.
P1719
Detection and identiﬁcation of Ochrobactrum
anthropi strains from environmental samples
using 16S rRNA-speciﬁc PCR and sequence
analysis
N. Siafakas, D. Papavntsis, P. Markoulatos, S. Levidiotou-
Stefanou, C. Oikonomou (Larissa, Ioannina, Athens, GR)
Objectives: There was an attempt to further characterize an
Ochrobactrum anthropi isolate using molecular methods and
speciﬁcally, sequence analysis of the 16S rRNA gene. The strain
was isolated from cell culture material obtained after the
application of VIRADEN (VIRus ADsorption and ENumeration)
on incompletely decontaminated sewage samples for enterovi-
rus detection. It was initially phenotypically identiﬁed by the
API 20NE system, on the basis of its biochemical proﬁle.
Methods: Genetic material was extracted from the enterovirus-
positive VIRADEN material and a 16S rRNA-speciﬁc PCR was
applied using universal primers for the 16S rRNA gene. The
strain was successfully detected and the sequence of the largest
part of the gene was obtained. Identiﬁcation of the bacterial
strain was then attempted using the BLAST alignment software
for the comparison of its 16S rRNA-derived sequence with the
respective sequences of all bacterial species and strains available
in GenBank database.
Results: The results interestingly showed a 98% similarity with
the 16S rRNA sequences of other O. anthropi strains, as well as
with O. tritici and O. lupini strains. Although there is no clear
consensus deﬁnition of bacterial species and genus by 16S rRNA
gene sequence comparisons, it is generally believed that intra-
species 16S rRNA sequence variability may not be greater than
1%. In the present study, therefore, there was a phenotypic
similarity with other O. anthropi strains that allowed identiﬁca-
tion of the isolate, but genotypically on the basis of 16S rRNA
sequence the isolate was divergent to be categorized to the same
species.
Conclusion: The observed genotypic variability in the strain
presented here provides further support to the fact that some
wastewater treatment plants constitute reservoirs for a wide
range of diverse pathogens or even novel microorganisms with
possible important consequences for public health, as shown by
previous studies. More 16S rRNA sequences from environmen-
tal isolates could contribute to the observed variability but,
nevertheless, detection and identiﬁcation of bacteria on the basis
of 16S rRNA from the environment still proved to be an
invaluable asset for further epidemiological surveys. This study
was co-funded by 75% from the European Union and 25% from
the Greek Government under the Framework of the Education &
Initial Vocational Training Program – Archimedes.
P1720
Enigmatic Leuconostoc and Lactobacillus
infections
W. Kulwichit, S. Nilgate, S. Krajiw, N. Srisawat, C. Unhasuta,
A. Chongthaleong (Bangkok, TH)
Objectives: Leuconostoc and Lactobacillus are gram positive
coccobacilli of low virulence. Human infections are commonly
misdiagnosed. This report is to provide interesting diagnostic
and clinical features of these organisms.
Methods: 26 clinical isolates identiﬁed as Leuconostoc by API
20 STREP (Biome´rieux, Inc.) in our hospital during 1997–2004
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were reevaluated by repeated API 20 STREP, API 50 CHL,
conventional phenotypic assays including gas production in
MRS broth and vancomycin MIC, and two genus-speciﬁc PCRs
for Leuconostoc and Lactobacillus as previously described (Lett
Appl Microbiol 2000;31:129–33 and FEMS Microbiol Lett
2002;214:271–5, respectively). Four ATCC strains of Leuconostoc,
Lactobacillus, and Pediococcus were used as controls in all
experiments. A review of medical records was performed only
in cases with conﬁrmed both phenotypic and PCR assays to be
Leuconostoc or Lactobacillus.
Results: Only 3 isolates initially identiﬁed as Leuconostoc were
conﬁrmed by both manual phenotypic and PCR assays. Another
two turned out to be Lactobacillus spp. The rest were mostly
Streptococci or closely related bacteria. API 50 CHL identiﬁed 16
isolates as Lactobacillus spp., only 2 of which were conﬁrmed by
genus-speciﬁc PCR. Lactobacillus pentosus ATCC 8041 and
Pediococcus pentosaceus ATCC 33316 were both identiﬁed by
API 20 STREP as Leuconostoc and by API 50 CHL as Lactococcus
lactis ssp lactis 1 and Lactobacillus pentosus, respectively. Clinical
features are diverse and include both community and hospital
acquired infections in normal and compromised hosts without
antibiotic pressure, and with various outcomes (Table).
Conclusions: These bacteria are underrecognized emerging
pathogens which are frequently misidentiﬁed. Without conﬁr-
mation by manual phenotypic and genotypic assays, widely-
used commercial could potentially mislead clinical management
and reports in medical literature.
P1721
PCR-based detection of Klebsiella pneumoniae in
blood cultures
T. Kotlovsky, L. Austin, R. Shalginov, H. Sprecher (Haifa, IL)
Objective: K. pneumonia infections are a major source of
morbidity and mortality among hospitalized adult and paedi-
atric patients. They rank second as cause of gram negative sepsis
in our medical centre and 45% of them are caused by extended
spectrum b-lactamase producers. Early detection is a key factor
in determining the outcome of K. pneumoniae infections and
numerous attempts have therefore been made during the last
years to develop more rapid and accurate detection systems. The
aim of the present study was to establish rapid and reliable PCR-
based assays aimed at detecting gram negative bacterial DNA
and K. pneumoniae nucleic acid sequences in blood cultures
obtained from patients with suspected sepsis.
Methods: DNA was extracted from positive blood culture
bottles using the benzyl alcohol-guanidine hydrochloride
method. Two sets of oligonucleotide primers were designed:
the ﬁrst one identiﬁes a nucleotide sequence of the 16S rRNA
gene that is speciﬁc for gram negative bacteria; the second one
targets K. pneumoniae haemolysin gene.
Results: The sensitivity of gram negative speciﬁc PCR targeted
to the 3-end of the 16S rRNA gene and to the haemolysin gene
of K. pneumoniae was optimized to 100fg/ml and 200pg/ml,
respectively, using DNA extracted from a standard isolate of
K. pneumoniae. The speciﬁcity of the assay was established using
100 different bacterial isolates and found to be 100%. The assay
performance was assessed using 108 consecutive positive blood
cultures identiﬁed as part of the routine work-up of hospitalized
patients. Gram staining was performed on positive blood
cultures and DNA was extracted from these cultures bottles
and PCR-ampliﬁed using the assay described above. The results
were compared to the ﬁnal microbiological diagnosis as deter-
mined using standard methodology. 108 out of 108 positive
blood culture bottles were correctly identiﬁed using the PCR
based assay with 100% speciﬁcity and 100% sensitivity. The
turnaround time for the molecular identiﬁcation was 4 hours.
Conclusions: PCR-based detection of K. pneumoniae directly
from blood culture bottles is rapid (4h), and highly speciﬁc
(100%) and sensitive (100%). Implementation of this and similar
assays targeted to common bacterial pathogens should allow for
earlier treatment to be provided and for a more rationale and
cost-effective use of antibiotic treatment, thus cutting down
costs while at the same time preventing the emergence of
resistant strains.
P1722
Diagnosis of human brucellosis by PCR assay
E. Alepopoulou, K. Ritis, M. Kantzanou, E. Maltezos,
M. Panopoulou, G. Kartalis, S. Kartali (Alexandroupolis, GR)
Introduction: Brucellosis is a world-wide re-emerging zoonosis
causing severe disease in humans with unspeciﬁc clinical signs
affecting numerous organs. Therefore, clinical diagnosis is
difﬁcult to establish but effective therapy requires an early
diagnosis. Laboratory diagnosis of chronic brucellosis is gener-
ally difﬁcult because conventional methods (blood culture,
serological tests) lack sensitivity and speciﬁcity. PCR has offered
a new dimension in the diagnosis of Brucella spp.
Methods: Blood specimens were collected from 18 patients with
suspected brucellosis. All patients had two or more blood
cultures and a serological battery of tests, including the Rose
Bengal plate agglutination test, Wright’s seroagglutination, and
Coombs antibrucella test. Blood specimens were also tested by
PCR technique. PCR assay consists of ampliﬁcation of a 223-bp
fragment from the gene coding for the synthesis of an immu-
nogenic protein on the external membrane of Brucella abortus
(BCSP31). All amplicons had the expected size of 223 bp. DNA
exctracted from blood taken from healthy individuals did not
show any ampliﬁcation with the primers used. All PCRs were
carried out in duplicate.
Results: The sensitivities of the serological tests range from 17%
to 44.5%. Brucella was isolated in blood cultures from 3 of 18
(16.7%) cases. In all 18 cases diagnosis of Brucella was estab-
lished by PCR, conﬁrming the clinical suspicion. Post-treatment
blood samples examined by PCR proved to be negative for
brucellosis. The sensitivity of our PCR assay was 100%, since it
correctly identiﬁed all 18 cases of brucellosis, regardless of the
duration of the disease, the positivity of the blood culture, or the
presence of focal forms.
Conclusions: In this study PCR has been shown to be a
valuable molecular technique, higly sensitive and speciﬁc for
the diagnosis of human brucellosis. Culture sampling sensitivity
Organism Specimen
C
or H*
Host
status
Antibiotic
pressure
Foreign
body
or device
Co-
pathogen
isolated
Treatment
& outcome
Leuconostoc Corneal
discharge
C Normal No Tiny piece
of wood
no Topical
antibiotic
recovered
Leuconostoc Ascitic
ﬂuid
C suspected
chronic
liver
disease
No No No Cefotaxime
expired
Leuconostoc blood H Stroke No Peripheral
IV line
no Co-
amoxiclav
expired
Lactobacillus Ascitic
ﬂuid
C HIV No no E. coli
Candida
Ciproﬂoxacin
matendazole
recovered
Lactobacillus Duodenal
content
C Pancreatic
carcinoma
No No No Ciproﬂoxacin
recovered
* ¼ community or hospital acquired
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is often low, depending on the disease stage, quantity of
circulating bacteria and blood culture technique employed.
P1723
Rapid molecular detection of clinically relevant
yeasts by PCR-based denaturing high
performance liquid chromatography
O. Goldenberg, B. Graf, S. Herrmann, T. Adam, G. Marjoram,
A. Fischer, G. Hong, S. Bereswill, U. Go¨bel (Berlin, D; Omaha,
USA)
Objectives: The detection and identiﬁcation of clinically relevant
yeast species by cultivation and biochemical testing is costly and
time consuming. Thus, we established a rapid culture-independ-
ent molecular approach allowing both sensitive detection, as well
as identiﬁcation of individual yeast species.
Methods: Yeast DNA was detected in total DNA samples
isolated from stool and from blood cultures, respectively, by
ampliﬁcation of the intergenic regions between ribosomal genes.
Amplicons were separated by denaturing high-performance
liquid chromatography (DHPLC) with the WAVE system
(Transgenomics Inc.). Cultivation and biochemical testing of
yeasts was performed in our diagnostics laboratory according to
standard procedures.
Results: The analysis of yeast reference strains showed that a
set of 13 different species could be identiﬁed by their DHPLC
peak proﬁles and the corresponding retention times. The
applicability of the method was evaluated by detection and
identiﬁcation of yeasts in clinical samples taken from complex
matrices such as stool and blood. The peak-proﬁles and
retention times obtained by DHPLC corresponded with the
dominant yeast species in the samples, as conﬁrmed by
sequence analysis, cultivation and biochemical testing. If the
retention times of amplicons from the samples were compared
to standard strains in each run, the technique was reproducible,
and valid data were obtained from blood cultures as well as
from stool samples.
Conclusions: Detection and identiﬁcation of yeast species in
clinical specimens by PCR-based DHPLC complements the
conventinal techniques available for yeast diagnostics.
P1724
Culture-independent identiﬁcation of fungal and
bacterial species using one convenient automated
platform
T. McKenzie, L. Bunnell, G. Hong (Omaha, USA)
Objectives: In most clinical settings, detection of bacterial or
fungal species has been focused on conventional culture-based
approaches. However, these traditional methods can lead to
unreliable results. Broad range molecular detection, using PCR
to target the ribosomal RNA gene of microorganisms from
clinical specimens is an approach that can provide a much more
rapid and accurate identiﬁcation of organisms, especially from
the so-called non-culturable or slow growing organisms.
Indeed, this method is only applicable to the direct diagnosis
of mixed infections when the mixed rRNA gene amplication
products can be separated and sequenced for conﬁrmation. We
applied this approach for separation of mixed rRNA gene
ampliﬁcation products prior to sequencing using the WAVE
Microbial Analysis System.
Methods: Genomic DNA was extracted individually from 15
bacterial and 19 fungal species, derived from clinically signiﬁ-
cant specimens. Broad range primers speciﬁc for either fungal
(5.8S-28S) or bacterial (16S) rRNA genes were developed, and
the regions of interest were ampliﬁed. The ampliﬁed PCR
products from different species were either mixed in different
combinations or unmixed and analysed.
Results: The WAVE System detected Enterococcus, Staphylo-
coccus, Streptococcus, Bacillus, Escherichia, Klebsiella, Pseudomonas,
Serratia, Citrobacter, Salmonella, and Proteus species either as
single or mixed species. Every individual species from a mixture
of 12 bacteria can be resolved and detected simultaneously in 20
minutes. The separated and collected ampliﬁcation PCR prod-
ucts provided clean sequences for the identiﬁcation of each of
the unique species. Six commonly seen candidosis causative
agents – krusei, glabrata, albicans, tropicalis, parapsilosis, and
lusitania – can all be resolved and detected at one time, as well
as four major aspergillosis causative agents of fumigatus, niger,
terreus, and ﬂavus. Furthermore, the same system also resolved
and detected Rhizopus, Mucor, Fusarium, Absidia, and Pseudalle-
scheria species of either single or mixed species.
Conclusions: We conclude that the WAVEMicrobial Analysis
System is a powerful single platform capable of detecting
bacterial and fungal microorganisms without culturing. This
technique can be applied to the monitoring of microﬂora from
complex samples such as stool or sputum, as well as identiﬁ-
cation of the important individual species from either complex
or sterile samples.
P1725
Stability of the bacterial ﬂora composition
in chronic wounds
K. Gjødsbøl, J.J. Christensen, M.K. Sonnested, T. Karlsmark,
B. Jørgensen, K.A. Krogfelt (Copenhagen, DK)
Objectives: Longitudinal investigation of the bacterial compo-
sition in chronic venous leg ulcers, by culturing and molecular
typing.
Methods: Forty-six patients were included in the study. All had
persisting ulcers for more than three months. The size and the
healing of the ulcers were followed for 8 weeks or until the
ulcers healed. Every second week biopsies and ﬁlter paper pads
were collected. Bacteria were isolated and identiﬁed at species
level by standard methods. Molecular typing was performed by
RiboPrinterMicrobial Characterisation system (Qualicon).
Results: During the study 5 of the 46 ulcers healed. The
remaining ulcers had a relatively stable ulcer size during the 8
weeks. More than one bacterial species was detected in close to
all the samples (94.4%). None of the patients’ chronic wounds
were colonized by a single bacterial species. Between four and
six bacterial species were detected in 50% of the ulcers. 39% of
the patient ulcers were colonized with more than six species.
The most common species found in the ulcers were Staphylo-
coccus aureus (isolated at least once during the study period in
95.7% of the patients), E. faecalis (71.7%), Pseudomonas species
(58.7%, mainly P. aeruginosa), coagulase-negative staphylococci
(45.7%), Proteus species (41.3%), anaerobic bacteria (39.1%),
E. cloacae (37.0%) and E. coli (32.6%). A comparison of the
microbial ﬁndings from the same ulcer showed that one or more
of the same species were re-isolated from all the samples from
41 out of 46 ulcers. In the remaining 5 ulcers one or more of the
same species were present in all but one of the samples. The
most common resident bacteria species were S. aureus, re-
isolated in 32 ulcers and P. aeruginosa re-isolated in 17 ulcers.
RiboPrint analyzes were performed on S. aureus and P. aerugi-
nosa isolates, the results revealed that bacteria isolated from the
same patient always belonged to the same ribogroup. None of
the patients belonged to the same ribogroup showing that the
infection was not hospital-acquired. Furthermore were ulcers
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with P. aeruginosa found to be signiﬁcant larger than ulcers
without the presence of P. aeruginosa (p = 0.006). No signiﬁcant
correlations were found between ulcer size and other bacteria
species.
Conclusion: The results showed that chronic wounds are
colonized by a community-acquired resident bacteria ﬂora,
and once a bacteria species is established in the wound no re-
infections occur.
P1726
EMM-typing of invasive T28 group A
streptococci, 1995–2002, Finland
T. Siljander, M. Toropainen, A. Muotiala, J.M. Musser,
J. Vuopio-Varkila (Helsinki, FIN; Houston, USA)
Objectives: Surveillance of invasive group A streptococcal (GAS)
disease in Finland is based on mandatory laboratory notiﬁca-
tions to the National Infectious Disease Register at National
Public Health Institute (KTL) and typing of corresponding GAS
isolates referred to the reference laboratory at KTL. During years
1995 to 2002, serotype T28 remained amongst the most common
T serotypes in isolates causing bacteremic GAS cases, together
with serotypes T1 and B3264. In order to study the clonality of
T28 strains, M protein genotyping (emm-sequencing) was
introduced.
Methods: All blood GAS isolates referred to the Hospital
Bacteriology Laboratory at KTL in 1995 to 2002 were included.
The GAS strains were T serotyped and their emm genes
sequenced. emm-types were compared with the CDC Strepto-
coccus pyogenes emm sequence database.
Results: A total of 735 bacteremic GAS cases were referred to
KTL in 1995–2002; annual numbers varied from 43 to 139. The
T28 strains (a total of 229 isolates) represented 25–40% of annual
GAS isolates with 14 strains in 1995 to 56 strains in 2002. The T28
strains distributed to 6 distinct emm-types: emm28 (125 isolates,
55% of all), emm77 (55 isolates, 24%) and emm53 (34 isolates,
15%), emm87 (3 isolates, 1%), emm2 (7 isolates, 3%) and emm4
(2 isolates, (1%). For three strains (1%) emm-typing is in
progress. The proportion of T28/emm28 strains was highest in
1995–97 (86–44% of all), declined in 1998–2000 (26–29%) and
showed an increase again in 2001–2002 (80–79%). During 1998–
2000, the most prominent type was T28/emm77 (31–40% of all).
T28/emm53 was uncommon during the three ﬁrst study years,
peaked sharply in 1998 (30% of all) and became again rare by
2001. T28/emm2 strains were only identiﬁed in 1997–2000.
Conclusion: This study shows that T-serotyping alone is not a
sufﬁcient method for epidemiological surveillance of invasive
GAS disease caused by T28 isolates. Analysis of M-proteins by
emm-sequencing showed that several T/M-types circulated
during the eight year study period. Overall, T28/emm28 strains
were amongst the most common GAS types, but they showed a
cycling prevalence pattern. During periods of low T28/emm28
prevalence, other T28/emm combinations seemed to emerge
and partially replace them.
P1727
Genome-based ampliﬁed fragment length
polymorphism for typing of Francisella tularensis
strains
I. Ivanov, S. Panaiotov, V. Levterova, T. Kantardjiev,
P. Padeshki, B. Popov, R. Nenova (Soﬁa, BG)
Francisella tularensis is facultative inracellular bacterium spread
mainly in the Northern hemisphere. It causes a disease in
mammals known as tularemia and due to its high level of
virulence and infectivity is considered a potential biological
weapon (CDC list, Category A). Tularemia is a major problem in
Bulgaria since 1998 when an outbreak occurred. Every year
about 40 new cases are registered and the increasing number of
isolated strains raised the need for their typing.
Objectives: The objective of the study was the development of a
genome based AFLP approach that detects good level of
polymorphism among F. tularensis strains.
Methods: The pDraw32 (Acaclone) software was applied for
genomic screening. 150 different restriction enzymes were tested
for generating a sufﬁcient number of fragments. HindIII, XbaI
and MboI were selected as working enzymes. DNA isolated
from 30 F. tularensis strains, 24 originating from all over the
world and 6 Bulgarian isolates were submitted to digestion with
XbaI/HindIII and HindIII/MboI enzyme combinations. Double
stranded DNA adaptors were designed and ligated to the ends
of the obtained fragments. Several PCR primer combinations
were tested. The PCR products were run on an automated
electrophoresis system and the patterns were submitted to
cluster analysis with GelComparII (Applied-Maths) software.
Dendrograms were generated using Pearson correlation and
UPGMA.
Results: The AFLP approach was applied for the typing of 30
F. tularensis strains. The best results were obtained with HindIII/
MboI restriction enzyme and Hind/Mbo(C primer combina-
tions. In general, it was found little variability (up to 30%)
among the strains which is in consistence with previously
published data. Bulgarian isolates are more closely related and
form a separate cluster.
Conclusion: The AFLP method proved to be a powerful
technique for typing of various types of organisms. With its
high discriminatory power and type ability it is capable of
distinguishing very closely related strains. However, AFLP is
necessary to be properly designed for a particular organismwith
respect to the relevant genomic characteristics. Some critical
parameters (e.g. enzyme selection, primer design and concen-
tration) have to be taken into account.
P1728
A comparison of Listeria monocytogenes serovar
4b isolates of clinical and food origin in Austria
by automated ribotyping and pulsed-ﬁeld gel
electrophoresis
I. Heller, K. Grif, M.P. Dierich, R. Wuerzner (Innsbruck, A)
Objectives: In this study, automated ribotyping and pulsed-
ﬁeld gel electrophoresis (PFGE) were evaluated in an epide-
miological study of Listeria monocytogenes serotype 4b strains
from patients and food samples collected in Austria. These
isolates were compared with isolates from foodborne incidents
which have occurred in other European countries and North
America.
Methods: The L. monocytogenes serovar 4b isolated were com-
prised of isolates from listeriosis patients in Austria, isolates
from food and environmental samples in Austria as well as
isolates from foodborne listeriosis in other European countries
and North America. Automated ribotyping was performed
using the RiboPrinter microbial characterisation system accord-
ing to manufacturer’s instructions using EcoRI as restriction
enzyme. PFGE was performed according to the standardized
protocol for molecular subtyping of L. monocytogenes by Pulse-
Net USA using restriction enzymes AscI and ApaI.
Results: Two PFGE subtypes dominated among human iso-
lates, and these PFGE subtypes were also found among food
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isolates. Some ribotypes contained different PFGE types, but
PFGE types were also assigned to different ribotypes. The
largest group of Austrian clinical isolates was of the same PFGE
subtype as those isolated from foodborne outbreaks in the
United Kingdom and in the USA. Another subtype of clinical
isolates from Austria was indistinguishable to that obtained
from isolates responsible for foodborne outbreaks in Canada,
Switzerland, the USA and France.
Conclusion: Although the discriminatory power of PFGE is
believed to be higher than that of ribotyping, some PFGE types
included several ribotypes. Thus, combining data obtained by
ribotyping and PFGE increases the likelihood of strains dis-
crimination. Nevertheless, many of the Austrian strains remain
indistinguishable from strains of foodborne outbreaks in other
countries. This complies to previous results which show the
highly clonal nature of the serotype 4b clonal group.
P1729
Multi-locus sequence typing of MNR loci for the
typing of bacterial pathogens
Y. Kashi, Y. Danin-Poleg, L. Somer, L. Cohen, E. Diamant,
J. Epstein, D. Walt (Haifa, IL; Medford, USA)
Background and Objectives: Mononucleotide repeats (MNR)
are major component of the Simple Sequence Repeat (SSR)
tandem genomic sequences that are highly mutable. Variation in
MNR tracts may affect the bacterial phenotype, thereby allowing
it to adapt to changing environments. Being highly mutable,
MNR loci can be used as genomic markers for phylogenetics and
typing. Here, we evaluate the potential of multi-locus sequence
typing (MLST) analysis of loci harbouring MNR (MNR-MLST)
for bacterial typing, and for inferring phylogenetic relationship
among strains.
Methods: Our analysis was performed by the following order:
(i) in silico genome-wide screen for MNR-containing sequences
and selection of candidate loci (ii) characterization of the
variation at the chosen MNR loci by sequencing these loci in
several bacterial strains (iii) phylogenetic and statistical analyzes
for,discrimination between given strains (iv) typing by allele
speciﬁc oligonucleotide (ASO) hybridization.
Results: Genome-wide MNR search in published bacterial
genomes showed that the majority of the SSRs (88–90%) were
found to be MNRs, 4 to 9bp in length. MNRs are evenly
distributed throughout the bacterial genomes with an average
appearance of an MNR tract every 241 bp, 225 bp, 110 bp, and
224 bp in E. coli K12, E. coli O157:H7, L. monocytogenes and
V. cholerae genomes, respectively. Among strains of each of these
species, a high level of MNR polymorphism was found,
however low enough to allow discrimination between strains.
Sequence analysis of the MNR-containing loci, showed an
average variation of 1 to 4 bp, either as polymorphism in the
MNR itself or as single nucleotide polymorphisms (SNPs) in
their ﬂaking sequences. These MNR sequences were further
used as probes for a custom-made allele speciﬁc oligonucleotide
optic ﬁber microarray, dedicated to rapid high-throughput
typing of bacterial strains based on their MNR-MLST signature.
Ampliﬁed MNR-containing loci of E. coli strains that were
hybridized to the array, clearly showed discrimination between
all strains, and, moreover, were able to classify different O157
serotypes.
Conclusion: DNA sequences of MNR loci are a ready source of
high variation content, which can be utilized for rapid strain
identiﬁcation. Using the MNR-MLST method, we can assign an
identity card to any given strain. Also, we show that MNR-
MLST approach can be integrated in a high-throughput method
for bacterial typing.
P1730
Bacteroides fragilis enterotoxin gene isoforms (bft
1, bft 2 and bft 3) among strains isolated in the
Netherlands, France and Poland
P. Obuch-Woszczatynski, A. van Belkum, L. Dubreuil, D. Kreft,
H.P. Endtz, R. Wintermans, H. Pituch, F. Meisel-Mikolajczyk,
M. Luczak (Warsaw, PL; Rotterdam, NL; Lille, F; Roosendaal, NL)
Bacteroides fragilis Gram-negative anaerobic rods were isolated
from intestinal and extraintestinal sources: in France 53 strains,
in The Netherlands 78 strains and in Poland 82 strains. The
identiﬁcation of bacterial strains was done on the basis of Gram
staining, growth on selective BBE (Bacteroides Bile Esculine)
medium, and biochemical characteristics determined by the API
20 A test (bioMe´rieux, France). For assessment of the presence of
the enterotoxin (fragilysin) gene PCR was used. Ampliﬁcation
was performed with primers 404 and 407. For isoform identi-
ﬁcation PCR-RFLP was performed. PCR product was digested
using restriction endonuclease Mse I. After DNA digestion we
received fragments: for bft 1 263 bp and 165 bp, for bft 2 263 bp,
83 bp and 82 bp, for bft 3 211 bp, 110 bp, 82 bp and 18 bp.
Among the 78 Dutch strains 12 contained the fragilysin gene (bft
1 – 8 strains, bft 2 – 1 strain, bft 3 – 1 strain and 2 strains were not
identiﬁed). Between the 53 French strains 10 contained the
fragilysin gene (bft 1 – 5 strains, bft 2 – 4 strains and bft 3 – 1
strain). Between 82 Polish strains 14 contained the fragilysin
gene (bft 1 – 9 strains, bft 2 – 2 strains and 3 strains were not
identiﬁed). In conclusion prevalence of the ETBF strains in The
Netherlands, France and Poland is similar (15, 18, and 17%).
Among the ETBF strains bft 1 isoform dominate (50–64%). bft 2
isoform were isolated most frequently in France (40%), in
Poland only (14%) and in The Netherlands (8%). The ﬁrst bft 3
isoform isolated in Europe was described by Scotto DAbusco
(2000). We found new bft 3 strains: one (isolated from ascites)
among Dutch strains and one (isolated from peritoneal ﬂuid)
among French strains. We did not observe the bft 3 isoform
among Polish ETBF strains.
P1731
Phenotypic and genotypic detection of 3 Mex
efﬂux pumps in P. aeruginosa
N. Mesaros, F. Van Bambeke, M.P. Mingeot-Leclercq,
P.M. Tulkens (Brussels, B)
Objectives: Infections by P. aeruginosa are difﬁcult to manage
because of its frequent multiresistance. This multidrug resist-
ance is often associated with active efﬂux by several transport-
ers, among which MexAB-OprM, MexCD-OprJ, MexXY-OprM
appear the more prevalent. Precocious detection of this mech-
anism of resistance by the clinical microbiologist appears
worthwhile in this context. We have thus developed a combined
phenotypic and genotypic methodology for the detection of
these pumps.
Methods: We use 3 P. aeruginosa strains previously published as
presenting resistance associated to 1 of these 3 Mex pumps and
compared them to a wild type strain. MIC were determined by
microdilution for 3 antibiotics selected for differential recogni-
tion by the 3 Mex pumps. Expression of inducible pump (MexD)
was assessed by RT-PCR and overexpression of constitutive
pumps (MexB, MexY), by QC-RT-PCR.
Results: RT-PCR conﬁrmed the expression of MexD; QC-RT-
PCR demonstrated overexpression of MexB (6-fold) and of
MexY (8-fold). The table shows the MIC measured in the
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absence or in the presence of 50 mg/L Phe-Ala-beta-Naphtyl-
amide (inhibitor of Mex transporters). Thus, overexpression of
MexAB-OprM increased mainly the MIC of carbenicillin, of
MexCD-OprJ, that of erythromycin, and of MexXY-OprM, that
of gentamicin.
Conclusions: Resistance due to active efﬂux by Mex pumps can
be easily detected by a simple phenotypic characterization and
further conﬁrmed by molecular biology approaches.
Antifungal susceptibility studies
P1732
Susceptibility pattern analysis to determine the
in vitro susceptibility to ﬂuconazole,
voriconazole, itraconazole, and ﬂucytosine in
1404 clinical yeast isolates (Candida spp.)
W. Fegeler, K. Becker, A. Schmalreck for the Working Group
"Clinical Mycology" of German Speaking Mycological Society
(DMykG)
Objectives: Resistance to azoles has become an emerging
problem in Candida spp. In order to determine the frequency
and type of resistance to different azoles, clinical yeast isolates
collected in a multicentre study (2001–2002, performed by the
DMykG antifungal study group) were tested and analysed using
susceptibility pattern analysis (SPA).
Methods: A total of 1404 clinical isolates comprising C. albicans
(47.6%), C. glabrata (23.3%), C. tropicalis (10.6%), C. parapsilosis
(6.1%), and C. krusei (5.5%) were included. MICs were deter-
mined by microdilution according to the German reference
method DIN-58940–84 in YST medium (Siﬁn, FRG). In order to
achieve standardized results, susceptibility of each isolate to
four antifungal agents (VOR, FLC, ITR, 5FC) was evaluated in a
microdilution plate (Merlin Diagnostics, FRG) using one inocu-
lum. SPA was performed for each isolate on a basis of the MICs
read after 24 hours of incubation at 36C. An isolate was
classiﬁed as susceptible (S) or resistant (R) by applying the
following breakpoints (R: FLC ‡ 64 mg/l, ITR ‡1 mg/l, VOR
‡4 mg/l (arbitrary), 5FC ‡ 32 mg/l). A susceptibility pattern
(SP) was generated for each isolate by ranking the susceptibility
class (S or R) of each antifungal agent in a speciﬁed order (FLC-
VOR-ITR-5FC). The SP characterized the individual isolate and
is mathematically an element of a set. Theoretically, 16 different
sets of susceptibility patterns may occur here.
Results: Among 1404 isolates, only oneC. krusei strainwas found
to be resistant to all four antifungals (SP: RRRR). Resistance to the
three azoles (FLC-VOR-ITR) tested (SP: RRR) was found in 0.9%
distributed as follows: C. albicans, 1% (n=7/669); C. glabrata, 1.2%
(n=4/327), and C. krusei, 1.3% (n=1/77). Except one C. krusei
isolate, all isolateswere susceptible to 5FC. The SPA revealed that
multi-resistant isolates were distributed as single spots in indi-
vidual centers of different geographic origin. The percentage of
isolates which were susceptible to all of the azoles tested varied
between 95.7% (C. albicans) and 36.4% (C. krusei). Depending on
theCandida species, SPs to azolesdiffered in a signiﬁcantmanner.
Conclusion: Multi-resistant Candida isolates to the antifungal
agents tested are still rare, however, there is an obvious need for
surveillance of resistance in yeasts. For this purpose, suscepti-
bility pattern analysis offers a reliable tool.
P1733
Inhibitory effect of the Penicillium chrysogenum
antifungal protein on different zygomycetes
L. Galgoczy, T. Papp, E. Leiter, I. Pocsi, C. Vagvolgyi (Szeged,
Debrecen, HUN)
Objectives: Cases of zygomycosis (the opportunistic fungal
infection caused by the members of Zygomycetes) increased
dramatically over the past several years. Therefore, there is a
substantial demand for new-type compounds with antifungal
activity against the pathogenic species of Zygomycetes. The
ﬁlamentous fungus Penicillium chrysogenum secretes a small,
highly basic and cysteine-rich antifungal protein named PAF.
This protein inhibits the growth of some ﬁlamentous fungi,
including opportunistic human pathogens and phytopathogens.
PAF induces a typical hyphal tip branching, oxidative stress and
K+-efﬂux in the sensitive strains.
Methods: The effect of PAF on 21 fungal isolates representing
16 different genera has been investigated. Aspergillus niger and
A. terreus were used as control for a PAF sensitive and a PAF
insensitive strain, respectively. The effect of PAF on germination
efﬁciency of sporangiospores was examined in different culture
media. Untreated sporangiospores were plated as controls. An
agar diffusion technique was used to estimate the size of
inhibition of hyphal extension by PAF.
Results: The Mucor, Actinomucor, Cokeromyces, Gilbertella,
Rhizopus, Saksanea and Syncephalastrum strains tested were
practically insensitive to PAF independently of the culture
conditions and inhibition tests applied. On the other hand,
Absidia, Micromucor, Mortierella, Mycotypha, Rhizomucor,
Rhizopus, Thamnostylum and Umbellopsis were sensitive to
PAF. The PAF-sensitivity of some of the zygomycetes depended
on the culture medium and the inhibition test selected, e.g. in
the case of M. africana, R. pusillus and U. isabellina, the inhibitory
effect was usually weaker on hyphal growth than on sporan-
giospore germination.
Conclusion: Among the zygomycetes considered as opportun-
istic human and/or animal pathogens, PAF was effective
against Absidia, Mortierella, Rhizomucor and Rhizopus. These
results support the assumption that PAF and similar low
molecular mass basic antifungal proteins produced by ﬁlamen-
tous fungi should be considered as promising candidates in
future antifungal drug research.
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P1734
Fungicidal activity of caspofungin and
amphotericin B against Candida guilliermondii
determined by time-killing studies
M. Sastre, J. Pema´n, E. Canto´n, M. Romero,
M. Gobernado (Valencia, E)
Introduction: C. guilliermondii is isolated with a low frequency
from blood culture, but treatment of infections produced by this
species may present problems, specially in immunocompro-
mised patients since a high percentage of strains have dimin-
ished susceptibility to ﬂuconazole (MIC90, 16 mg/L) and
itraconazole (MIC90, 0.5 mg/L), furthermore, a fungicidal
agent is preferred for treatment of these patients. Amphotericin
B and caspofungin have fungicidal activity against yeasts,
however, most studies have focused on C. albicans.
Objective: To determine the killing kinetics of caspofungin and
amphotericin B against C. guilliermondii.
Methods: Three strains of C. guilliermondii isolated from blood
cultures were tested. MICs were determinate following M27-A2
method, but using an inoculum of 0.5–2.5·104 CFU/mL.
Caspofungin MIC2 and MIC0 (minimum concentration of
drug that produces a growth reduction 50% and 100% respect
to growth control, respectively) were determinate; and for
amphotericin B the MIC0 and the MFC (minimum fungicidal
concentration). The MFC was obtained by transferring 0.1 mL
from all clear MIC wells onto Sabouraud dextrose agar. The
MFC was the lowest drug concentration that killed ‡99.9%
(<5 colonies) from the starting inoculum. Time-killing studies
were performed in RMPI 1640 medium (5 mL) by using an
inoculum size from 1–7·105 CFU/mL. Concentrations tested
were: 0.12, 0.5, 8, 2 and 32 mg/L. Aliquots were removed to
determine CFUs at 0, 2, 4, 6, 12, 24 and 48h. Time-killing data
were ﬁtted to a lineal equation (log Nt = log N0 + Kt, where
N = CFU, t = time, K = killing rate) to determine the time
(hours) to achieve 50, 90, 99 and 99.9% (T50, T90, T99 and T99.9,
respectively) of growth reductions from the starting inoculum at
each concentration tested.
Results: Amphotericin B MICs were 0.06 and 0.5 mg/mL and
MFCs were equal to MICs. Caspofungin MIC2 were 1 mg/L for
the three strains and the MIC0 1–4 mg/L. The kinetics of
amphotericin B fungicidal activity against C. guilliermondii was
fast. With 2 mg/L, the T50 ranged was 6–35 minutes, depending
on the strain, and the T99.9 between 1.5–5.9 hours. Caspofungin
just produced growth inhibition, without fungicidal activity.
Conclusions: Amphotericin B and caspofungin were active
against C. guilliermondii but only amphotericin B showed
fungicidal activity.
P1735
Susceptibility testing of amphotericin B and
caspofungin-resistant Candida glabrata isolates
M. Krogh-Madsen, M.C. Arendrup, J.D. Knudsen (Hvidovre,
Copenhagen, DK)
Objectives: C. glabrata isolates recovered from an ICU patient
with invasive candidiasis, were found to be resistant to either
amphotericin B (AmB), caspofungin (Caspo), or both. The aim of
this study was to determine and compare the MICs by various
in vitro methods.
Methods: The MIC for 4 C. glabrata isolates (labelled A–D) were
determined by two broth microdilution methods: NCCLS (M27–
A2) and EUCAST (discussion document E.dis 7.1). The MICs of
AmB were also determined using the E-test. Time-kill studies
were performed using both RPMI-1640 medium and Antibiotic
Medium 3 (AM3). The criterion for determining MIC in the
time-kill studies was the lowest concentration giving minimum
1-log reduction in cfu/mL after 24 hours.
Results: Three of the 4 isolates were clearly AmB resistant
according to the E-test results with MICs ranging between 6 and
>32 mg/mL. Microdilution endpoints ranged between 1 and
4 mg/mL and time-kill endpoints between 2 and 4 mg/mL.
Two isolates were proven to be resistant to Caspo in the
microdilution methods, a ﬁnding that was conﬁrmed by time-
kill studies. The MIC values for Caspo were found to be reduced
in all methods in AM3 medium compared to RPMI1640. For
both Caspo and AmB the MICs determined by the NCCLS
method and the EUCAST method were all within ±1 dilutions.
Table 1 shows the MICs for all four isolates.
Table 1. MIC values (lg/mL) obtained by various methods
Conclusion: The MIC values of AmB depend on the method.
The E-test showed the highest, and the broth microdilutions
methods the lowest values. The MIC values of Caspo depend on
the medium used. Values obtained using AM3 were lower than
values obtained using RPMI–1640. The NCCLS and EUCAST
broth microdilution methods were equally useful in determin-
ing MICs of AmB and Caspo for C. glabrata.
P1736
Correlation of neo-sensitabs on three media with
NCCLS reference disk diffusion and broth
microdilution methods for testing the
susceptibility of Candida spp. and Cryptococcus
neoformans to ﬂuconazole and voriconazole
A. Espinel-Ingroff, E. Canto´n, D.L. Gibbs, A. Wang (Richmond,
USA; Valencia, E; Santa Barbara, USA)
Objective: The purpose of this study was to compare both
NCCLS reference agar disk diffusion (M44-A document) and
broth microdilution (M27-A2 document) methods with the Neo-
Sensitabs method (Rosco, Taastrup, Denmark) for determination
of the susceptibility of 10 to 20 isolates each of Candida spp. (8
species) and C. neoformans to ﬂuconazole and voriconazole.
Methods: NCCLS agar disk diffusion and broth microdilution
methods were performed according to NCCLS standard condi-
tions. The Neo-sensitabs method was performed according to
the manufacturer’s instructions on three different media:
Mueller-Hinton + 2% glucose and 0.5 mg/L methylene blue
[MHGM, M44 agar], RPMI-1640 [Remel, RPMI] and Shadomy
[E&O laboratories, SHAD] agars), 25-mcg ﬂuconazole and
1-mcg voriconazole tablets and the same inoculum size as for
M44-A method. Plates were incubated for 24 to 72 h.
Results: The performance of Neo-sensitabs was similar to that
of the M44-A disk diffusion method as demonstrated by
comparison of zone diameters and M27-A MIC values. The
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regression statistics by the M44-A method for ﬂuconazole and
voriconazole provided R values of 0.877 and .759, respectively.
The R values for the Neo-sensitabs ﬂuconazole tablets (24 h
results for Candida spp. and 48 h for C. neoformans) were: .892
(MHGM), .929 (RPMI) and .874 (SHAD) and for voriconazole
tablets: .790 (MHGM), .757 (RPMI), and .736 (SHAD). The
overall categorical agreement (>90%) was also similar to that
obtained between M44-A zone diameters and M27-AMICs; both
ﬂuconazole and voriconazole tablets were able to identify
ﬂuconazole-resistant strains (MICs >64 mg/L) as well as those
with decreased susceptibility to voriconazole (MICs >2 mg/L).
Conclusions: The tablets had suitable and similar performance
on the three media evaluated with both antifungal agents.
Therefore, the Neo-sensitabs tablet method is a potential alter-
native to theM44-Amethod for testing the susceptibility of yeasts
to ﬂuconazole and voriconazole using the standardMHGMagar.
P1737
Candida strains with decreased susceptibility to
ﬂuconazole. Cross-resistance to other azoles and
activity of other antimycotic agents
P. Gaustad, P. Sandven (Oslo, N)
Objective: Decreased susceptibility to azoles has been reported
in Candida species and in particular in C. glabrata. Selection
pressure due to the continuous exposure to azoles seems
essential in the development of resistance in Candida spp. The
aim of the study was to look for cross-resistance between
antimycotics. Strains with decreased susceptibility to ﬂuconaz-
ole were chosen and tested for resistance to other azoles and to
other groups of antimycotics.
Methods: The study included 101 yeasts isolates from patients
with various fungal infections. Strains with varying susceptibil-
ity to ﬂuconazole (range MIC‡ 0.25–256 mg/l) were included:
C. albicans (n = 35), C. dubliniensisis (n = 1), C. glabrata (n = 24),
C. guilliermondii (n = 3), C. krusei (n = 10), C. norvegensis (n = 11),
C. parapsilosis (n = 2), C. tropicalis (n = 13) and Saccharomyces
cerevisiae (n = 2). The yeast strains were tested for susceptibility
to ﬂuconazole, itraconazole, ketoconazole, voriconazole, 5-ﬂu-
cytosin, amphotericin B and caspofungin using Etest. When
available the NCCLS breakpoints were used (resistant (R) MIC
‡64 mg/l; itraconazole R MIC ‡1 mg/l; 5-ﬂucytosin R MIC ‡
32 mg/l), otherwise the breakpoints were chosen from recom-
mendations in the literature (voriconazole R MIC ‡ 1 mg/l;
ketoconazole R MIC ‡0.125 mg/l; amphotericin B R MIC ‡1;
caspofungin R MIC ‡1 mg/l).
Results: All the strains were susceptible to caspofungin (MIC <
1 mg/l) and to amphotericin B (MIC < 1 mg/l) except 7 strains
(MIC = 1–3 mg/l). 24% of the strains were resistant to 5
ﬂucytosin (MIC ‡ 32 mg/l).For the azoles the results indicated
cross-resistance. The 23 strains of the species C. krusei,
S. cerevisiae and C. norvegensis, species known for resistance to
ﬂuconazole, were all resistant to ketoconazole and itraconazole
(MIC‡ 1 mg/l) and had decreased susceptibility to voriconazole
(MIC = 0,5 mg/l 8 strains) or were resistant (MIC‡1 mg/l 15
strains) (Table 1). In the other species included in the study
decreased susceptibility to ﬂuconazole was linked to decreased
susceptibility or resistance to other azoles.
Conclusions: Strains with decreased ﬂuconazole susceptibility
frequently showed cross-resistance to other azoles. Treatment
with non-azole antimycotics should be considered in serious
infections caused by yeasts with decreased ﬂuconazole suscep-
tibility. All the isolates were fully susceptible to caspofungin, the
majority to amphotericin B and 76% to 5-ﬂucytosin.
P1738
In vitro activities of voriconazole, ﬂuconazole,
itraconazole and ketoconazole against
non-albicans Candida strains
A.I. Aller, J.L. De Francisco, J.C. Alados Arboledas,
C. De Miguel, L. Calbo (Jerez de la Frontera, E)
Objective: The aim of this study was to evaluate the in vitro
activity of voriconazole (VZ) compared with those of ﬂuconaz-
ole (FZ), itraconazole (IZ) and ketoconazole (KZ) against non-
albicans Candida strains.
Material and methods: All 253 non-albicans Candida species
(132 C. glabrata, 67 C. parapsilosis, 40 C. tropicalis and 14 C. krusei)
were recovered from clinical samples isolated between June
2002 and September 2004. The minimal inhibitory concentra-
tions (MICs) were determined by Sensititre YeastOne colori-
metric method in accordance with the manufacturer’s
instructions. C. parapsilosis ATCC 22019 and C. tropicalis ATCC
200956 were used as control strains.
Results: Table I shows the MIC 90 to FZ, IZ, KZ and VZ of the
253 non-albicans Candida species. VZ demonstrated excellent
activity in all studied species. All of the C. krusei isolates tested
were susceptible to VZ (MIC £ 1 mg/L). All of the isolates of
C. glabrata susceptible-dose-dependent (MIC from 16 to 32 mg/
L) to FZ (78 strains) showed a MIC to VZ £ 1 mg/L. Among the
FZ resistant C. glabrata isolates (38 strains), all but one were also
resistant to IZ (RR phenotype). The MIC to VZ was ‡2 mg/L in
24 out of the 37 (65%) C. glabrata with RR phenotype.
Conclusions: Voriconazole showed good activity against all
Candida non-albicans strains, including C. krusei. Cross-resist-
ance was observed at the strains of C. glabrata with RR
phenotype.
P1739
In vitro activity of voriconazole and ﬂuconazole
against Candida species: a report from the
ARTEMIS global surveillance program
D.L. Gibbs, D.J. Sheehan on behalf of the ARTEMIS Global
Antifungal Study Group
Objective: To compare the susceptibility of 140,767 yeasts
collected worldwide over a six-year period to voriconazole
Table 1. Cross distribution of ﬂuconazole and voriconazole
MICs
CMI 90 (mg/L).
Species (n) Fluconazole Itraconazole Ketoconazole Voriconazole
C. glabrata (132) 256 ‡16 8 2
C. parapsilosis (65) 8 0.25 0.25 0.25
C. tropicalis (40) 8 0.5 0.125 0.25
C. krusei (14) 128 0.5 1 0.5
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and ﬂuconazole by disk diffusion and analysed by the BIOMIC
Vision System.
Methods: Fluconazole disk susceptibility test results were
collected from 127 investigators in 39 countries from 1997
through 2003. Data was collected on voriconazole from 2001–3.
All investigators tested yeast isolates by NCCLS M44-A disk
method. Test plates were read and results recorded with the
BIOMIC Vision System. Species, drug, zone diameter, suscep-
tibility category, MIC, and Quality Control results were collec-
ted quarterly via email. Duplicate (same: patient, species, and
sensitive-resistant biotype proﬁle during any 7-day period) and
uncontrolled test results were not analysed. MICs were auto-
matically determined through the BIOMIC Vision System from
the agar gradient around each disk calibrated with MICs by
NCCLS M27-A.
Results: Fluconazole and voriconazole disk diffusion test
results were obtained on 140,767 and 79,343 yeast isolates,
respectively. The cumulative susceptibility of >79,000 Candida
spp tested from 2001–2003 showed approximately 1.5 log lower
MIC values for voriconazole versus ﬂuconazole. The 10 most
common Candida species showed less resistance to voriconazole
than to ﬂuconazole. C. krusei and C. rugosa showed the greatest
difference with >50% resistance to ﬂuconazole and <2% to
voriconazole. All species were more susceptible to voriconazole
than ﬂuconazole assuming proposed voriconazole interpretive
breakpoints of 1 (susceptible) and 4 mcg/ml (resistant).
Conclusion: Susceptibility of Candida spp (collected world-
wide) to voriconazole and ﬂuconazole have changed minimally
over the study period. Both agents show stable susceptibility
patterns under the selection pressure of increased hospital
usage. Voriconazole appears to be a promising new agent for the
treatment of Candida spp based on its extended spectrum in
vitro activity.
P1740
In vitro activity of voriconazole and ﬂuconazole
vs >8000 C. glabrata isolates
D.J. Sheehan, D.L. Gibbs on behalf of the ARTEMIS Global
Antifungal Study Group
Objective: To compare the activity of voriconazole and ﬂucon-
azole against >8000 isolates of C. glabrata determined by disk
diffusion and analysed by the BIOMIC Vision System.
Methods: 115 investigators in 35 countries participated in the
ARTEMIS global surveillance program from 2001 through 2003.
C. glabrata isolates were tested by the NCCLS standard M44-A
disk diffusion method. Test plates were read and results
recorded with the BIOMIC Image Analysis System. Species,
drug, zone diameter, susceptibility category, MIC, and Quality
Control results were collected quarterly via email. Duplicate
(same: patient, species, and sensitive-resistant biotype proﬁle
during any 7 day period) and uncontrolled results were not
analysed. MICs were automatically determined through
BIOMIC Image Analysis System by balance weight regression
from the agar gradient around each disk calibrated with MICs
by NCCLS M27-A.
Results: Voriconazole and ﬂuconazole disk diffusion test
results were obtained on 8719 and 9040 Candida glabrata isolates,
respectively. Voriconazole demonstrated approximately 1.5 log
lower MICs than ﬂuconazole. MIC 50 and 90 values for
voriconazole were 0.36 and 2 mcg/ml, respectively versus 10
and 128 mcg/ml for ﬂuconazole. Assuming interpretive break-
points of 1 (susceptible), 2 (susceptible-dose dependent) and
4 mcg/ml (resistant) for voriconazole, 5.8% of isolates were
resistant to voriconazole, versus 16.6% resistant to ﬂuconazole at
Voriconazole MICs and Interpretation by Organism (1-2-4*)
Organism %S %SDD %R MIC 50 MIC 90 N
Candida albicans 99.0 0.4 0.7 0.02 0.09 47,584
Candida glabrata 78.6 15 6 5.8 0.36 2.08 8,719
Candida tropicalis 93.3 4.3 2.4 0.11 0.86 5,643
Candida parapsilosis 98.2 1.0 0.8 0.02 0.16 5,233
Candida species 95.3 2.0 2.8 0.03 0.41 4,094
Candida krusel 92.5 5.8 1.7 0.24 0.95 1,996
Cryptococcus neoformans 98.3 0.6 1.1 0.01 0.14 1,266
Other Yeast 95.2 1.9 2.9 0.04 0.41 1,103
Candida guilliermondii 95.1 3.2 1.7 0.09 0.60 633
Candida lusitaniae 98.0 0.4 1.6 0.01 0.12 445
Saccharomyces cerevisiae 96.8 1.2 2.0 0.03 0.24 401
Candida rugosa 73.6 25.1 1.3 0.34 1.81 394
Candida kefyr 99.4 0.3 0.3 0.01 0.06 331
Trichosporon sp. 97.3 1.9 0.8 0.06 0.60 264
Candida famata 94.5 3.8 1.7 0.04 0.72 238
Candida inconspicua 94.6 2.7 2.7 0.14 0.72 186
Candida norvegensis 98.9 1.1 0.11 0.54 91
Rhodotorula sp. 51.7 15.7 32.6 0.86 >4.5 89
Trich. beigelii / cutaneum 84.6 6.4 9.0 0.08 2.88 78
Crypto neo var. neoformans 98.5 1.5 0.08 0.34 67
Candida dubllniensis 100.0 0.01 0.05 63
Blastoschizomyces capitatus 94.5 3.6 1.8 0.09 0.95 55
Candida lipolytica 80.8 19.2 0.11 1.25 52
115 Sites in 35 Countries. All Specimen Types, All Locations in Hospital.
Breakpoints based on MIC of 1/2/4 ¼ S/SDD/R.
The Correlation of Broth Microdilution and Disk Diffusion Test Results
with Non-glabrata Yeast Species and Voriconazole
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‡64 mcg/ml. C. glabrata isolates were plotted separately from
other species which resulted in a high correlation (R = 0.96)
between disk diffusion and reference broth dilution MIC.
Conclusion: This investigation demonstrated that 94.2% of 8719
Candida glabrata isolates were susceptible (S + S-DD) to voric-
onazole. Based on in vitro data, voriconazole is a promising new
agent for treating C. glabrata. Disk diffusion testing correlated
well with the reference broth dilution MIC.
P1741
Potential for a natural anticandidal combination
comprising garlic, cinnamon and Lactobacillus
acidophilus
I. Garaiova, T.S. Sarvotham, K.M. Lemar, J.C. Harris,
M.A. Weaver, S. Plummer (Swansea, Cardiff, UK)
Objectives: Increasingly, Candida spp. are developing resist-
ance to standard antimicrobial therapies and recurrent candidal
infections are becoming a major problem. In order to express its
pathogenicity, a yeast cell must attach to epithelial tissue
(particularly oral and vaginal tissues). In this study, the efﬁcacy
of garlic and cinnamon, two plant materials with anticandidal
activity, but no known resistance susceptibility, were investi-
gated. The ability of these materials individually, and in
combination with Lactobacillus acidophilus, to inhibit attachment
of C. albicans to human buccal epithelial cells (BEC) was studied.
Methods: The in vitro attachment of the yeast to the BEC of 18
healthy volunteers (14 females, 4 males, mean age 33.3 ± 2.8
years) was assessed using a modiﬁcation of Kimura and Pearsall
(1978). The minimum inhibitory concentration (MIC) of garlic
and cinnamon powders with C. albicans and L. acidophilus were
evaluated using a broth bioassay procedure. Electron microsco-
py was used to visualise structural damage to the yeast in the
presence of garlic.
Results: The MIC for garlic with C. albicans is 2–3 mg/ml and
with L. acidophilus is 17.5 mg/ml. The MIC for cinnamon with
C. albicans is 1–2 mg/ml and with L. acidophilus is 4 mg/ml.
Candidal attachment to the BEC was inhibited with greatest
effects observed at 5 mg/ml garlic or 5–10 mg/ml cinnamon or
in the presence of 1x108 CFU/ml L. acidophilus. Structural
damage to the yeast cells occurred at 1.5 mg/ml garlic with
severe disruption of the cellular integrity at 20 mg/ml garlic.
When garlic and L. acidophiluswere added to the BEC together, a
synergistic effect on the inhibition of candidal attachment
occurred but if cinnamon was combined with L. acidophilus
(which had been shown to have an inhibitory effect on the
growth of this bacteria) the opposite effect was observed.
Conclusion: From these in vitro studies it appears that the
combination of L. acidophilus and garlic should provide a preven-
tative/treatment regime to address the growing problem with
candidal infections. The next stage will involve setting up a
randomised, double blind, placebo controlled trial with a product
comprising the combination of L. acidophilus and garlic.
P1742
The effect of subinhibitory concentrations of
antifungal agents on variation of cell surface
hydrophobicity and bioﬁlm formation with
relation to genotype of Candida albicans and
Candida dubliniensis
S. Melkusova´, H. Bujda´kova´, A. Vollekova´,
M. Lisalova´ (Bratislava, SVK)
Objectives: This work studied the variation of cell surface
hydrophobicity (CSH), the bioﬁlm formation and their
relationship to genotype in clinical isolates of C. albicans and
C. dubliniensis. Next objective was aimed at the effect of sub
inhibitory concentrations of the conventional azole derivates
ﬂuconazole and itraconazole, the new azole voriconazole,
polyene amphotericin B and the experimental antifungal agent
6-amino-2-n-pentylthiobenzothiazole (APB) on both CSH and
bioﬁlm formation.
Methods: For this study, 50 C. albicans and C. dubliniensis
clinical isolates from immunocompromised patients were col-
lected. Genotyping of Candida isolates was performed by PCR
assay using set primer pair: Ca-INT-L and Ca-INT-R. The CSH
was measured by biphasic separation method in YNB medium/
octane overlay. Bioﬁlm formation was quantiﬁed as the ability to
adhere to polystyrene plastic surfaces and the formation of
bioﬁlm was measured by the XTT reduction assay. The MIC95
values for tested antifungal agents were established by broth
microdilution method according to NCCLS M27-A reference
method and these values were used to calculate sub inhibitory
concentrations in subsequent experiments.
Results: All C. albicans isolates were separated into three
genotype groups: genotype A (12), genotype B (13), genotype
C (12). Thirteen isolates represented genotype D (C. dubliniensis).
In the XTT assay, the mean A490 values for the 50 strains were
0.359 ± 0.130, for the genotype A 0.42 ± 0.154, for the genotype
B 0.262 ± 0.072, for the genotype C 0.281167± 0.059 and for
genotype D 0,.471231 ± 0.07. The relative hydrophobicity of cells
was established: 11.48% for the genotype A, 18.32% for the
genotype B, 18.44% for the genotype C and 71.55% for genotype
D. Although, no signiﬁcant difference was detected among
bioﬁlm formation in genotype A and genotype D, the CSH
calculated for genotype D was 6.2-fold highest in comparison
with genotype A. The difference between genotype B and C was
determined neither in bioﬁlm formation nor in CSH. The
inﬂuence of sub inhibitory concentrations of tested antifungal
agents on CSH and bioﬁlm formation was observed as well.
Moreover, sub inhibitory concentration of ﬂuconazole decreased
the ability to form bioﬁlm, but increased the CSH in ﬂuconazole-
resistant isolates.
Conclusion: Results suggested the association between geno-
type and bioﬁlm formation, as well as conﬁrmed the effect of
antifungal agents on both bioﬁlm and CSH.
P1743
Can we accurately assess antifungal cidality in
vitro? Cidality studies of voriconazole and
caspofungin against Candida species
M. Ghannoum, N. Isham, D.J. Sheehan (Cleveland, New York,
USA)
Objectives: A perception exists among many that antifungal
agents exhibit either fungicidal or fungistatic activity. For
example, caspofungin (CAS) is perceived to exhibit fungicidal
activity and voriconazole (VOR) fungistatic activity against
Candida spp. However, standard methods to accurately assess
these phenomena are currently lacking. In this study, we
employed the suggested standard method of Canton et al.
(Diag Microbiol Infect Dis 2003) to determine the fungicidal
activity of an antifungal agent against Candida species.
Methods: MIC testing was performed according to the standard
NCCLS M27-A2 method except that the inoculum size was
increased to 104 colony-forming units (CFU)/ml. The total
content (200 microliters) of each clear well in the broth micro-
dilution assay was subcultured onto two potato dextrose agar
plates (100 microliters onto each). To minimize antifungal
carryover, the 100 microliter aliquots were allowed to soak into
the agar before streaking for isolation. Plates were incubated for
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48 hours at 35C. Fungicidal activity was deﬁned as > 99.9%
reduction in the number of CFU/ml. Ten Candida albicans and
eighty non-albicans isolates, including C. dubliniensis (3), C.
glabrata (20), C. tropicalis (20), C. krusei (20), C. lusitaniae (7), and C.
parapsilosis (10) were tested.
Results: As expected, VOR exhibited fungistatic activity and
CAS fungicidal activity against all C. albicans isolates. However,
VOR demonstrated cidal activity against 10% of the non-
albicans strains tested while CAS was cidal against only 81%
of these same non-albicans isolates. Of note, VOR was cidal
versus 40% of C. parapsilosis isolates tested while CAS exhibited
fungistatic activity against 20% of these strains.
Conclusion: Using a method that limits drug carryover when
assessing cidality, we found that CAS lacked complete cidality
against non-albicans spp and especially, C. parapsilosis. This
ﬁnding may provide an explanation why CAS MICs are
elevated for this particular Candida species. Importantly, until
methods are standardized to accurately assess the cidal nature
of an antifungal agent, we should be wary of preconceived
antifungal characterizations.
P1744
Susceptibility of itraconazole and voriconazole
using ﬂow cytometry
S. Costa-de-Oliveira, C. Pina-Vaz,
A. Gonc¸alves-Rodrigues (Porto, P)
The need of antifungals susceptibility tests is now a reality to aid
empiric selection of antimicrobials, specially on candidemia,
deep infections or on isolates from recurrent mucosal disease.
NCCLS methods are standardized and reproductive but labor
intensive, time consuming and takes at least 48 hours to give
results. Flow cytometry analysis, has been repeatedly used by
our team to evaluate susceptibility of Candida to different
drugs, with considerable advantages (1).
Objective: To optimize conditions to study the susceptibility to
voriconazole and itraconazole.
Methods: Ten Candida strains (9 clinical isolates and one ATCC
type strain) with different susceptibility patterns were studied.
Itraconazole was a kind gift by Jansen Pharmaceutic and
voriconazole by Pﬁzer. Minimal Inhibitory Concentrations
(MIC) were determined using the NCCLS protocol M27-A. For
ﬂow cytometry analysis 106 cells/ml were incubated with MIC
values, MIC/2 and 2xMIC in PBS (Sigma) during 1, 2 and 3
hours. The yeasts were washed and stained both with 0.5 lM of
FUN-1 (Molecular Probes) an indicator of metabolic activity and
with 1 lg/ml of propidium iodide (PI; Sigma) a marker of cell
death. The cell suspension was analysed on a ﬂow cytometer
(Beckman Coulter XL-MCL): the morphology (scattergram) and
the intensity of ﬂuorescence of the stained cells were evaluated.
Results: No obvious morphologic cell changes were observed
under the described experimental conditions. FUN-1 staining
increased on susceptible strains, after 1 hour incubation with
MIC or with higher concentrations, meaning a metabolic
impairment; resistant strains, at MIC concentrations, didn’t
present any increase on the staining. PI was unable to stain the
cells, even at the highest concentrations of the drug and
following the longest incubation periods.
Conclusions: Flow cytometry analysis and FUN-1 staining
allowed the determination of the susceptibility proﬁle to
itraconazole and voriconazole, soon after 1 hour of incubation,
contrasting with the 48 hours needed on classical methods. PI
was not a good marker to study the effect of these azoles, which
is in accordance with the fungistatic mechanism of action. (1)
Pina-Vaz C, et al. J Med Microbiol 49: 831–840, 2000
P1745
Antifungal resistance and production of
virulence factors in Candida spp. isolated in Italy
during the period 2002–2004 from paediatric and
adult patients
A. Marchese, L. Gualco, R. Bandettini, C. Peri, L. Pescetto,
A. Cavallero, M.C. Ossi, G.C. Schito (Genoa, Milan, I)
Objectives: 1 - to assess the rates of antifungal resistance and of
phospholipase and proteinase production in Candida spp.
recently isolated form clinical specimens in adult and paediatric
patients and 2 - to establish whether a correlation exists between
virulence factors, resistance, site of infection and age of patients.
Methods: 505 Candida spp. including 337 C. albicans , 68
C. glabrata, 40 C. parapsilosis, 34 C. tropicalis, 11 C. krusei and 15
other species have been studied. Susceptibility to ﬂuconazole,
amphotericinB and ﬂucytosine was determined by the broth
dilution method (M27-A2, NCCLS). Strains producing protein-
ases and phospholipases were identiﬁed using plates containing
media supplemented with BSA and egg yolk respectively.
Results: Susceptibility to ﬂuconazole, amphotericinB and ﬂuc-
ytosine was more common among C. albicans (97.6%, 99.1%,
99.4% respectively) than among non-albicans species (83.3%,
85.7%., 92.2.%). Production of proteinases and phospholipases
was signiﬁcantly more common among C. albicans (91.1% and
92.6% respectively) than among non-albicans strains (38.1% and
35.1%). There were no important differences in the patterns of
resistance and production of exoenzymes when grouping the
strains according to the patient’s age (resistance from 95.4 to
99.1% in 348 adults vs 93.1–98.7% in 157 children and synthesis
of exoenzymes from 71.5–79.5 vs 77.4–81.8). Strains from vaginal
swabs were slightly more resistant to ﬂuconazole (3.2%) than
isolates from other specimens (urine, respiratory secretions,
blood and wound/skin/soft tissues: 0.8–1.9%). Concerning
production of exoenzymes, no signiﬁcant differences were
observed among C. albicans isolates from different specimens,
while isolates of C. glabrata originating from blood produced
more frequently proteinases (23.1%) and less frequently phos-
pholipases (23.1%) than isolates obtained from urine, vaginal
swabs and wound/skin/soft tissues (13.6%, 6.7%, 0% and
59.1%, 53.3%, 50% respectively). Similar results were obtained
for C. tropicalis.
Conclusions: C.albicans and non-albicans isolates originated
from paediatric and adult patients possess similar characteristics
in terms of antifungal susceptibility and exoenzyme production.
However, rates of antifungal resistance and synthesis of viru-
lence factors are different among different Candida species and
may vary among strains belonging to the same species depend-
ing on the site of infection.
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Pathogenesis of respiratory tract and other infections
P1746
Reduced effect of penicillin treatment against a
penicillin susceptible Streptococcus pneumoniae
serotype 3 as compared to serotypes 2 and 6A in a
murine pneumonia model
R.L. Fischer, N. Frimodt-Møller (Copenhagen, DK)
Objectives: The effect of a single day treatment with penicillin
was tested against three penicillin susceptible Streptococcus
pneumoniae strains with different serotypes in immunocompe-
tent mice.
Methods: Pneumonia was induced in outbred, immunocompe-
tent mice by inoculation of a S. pneumoniae intranasally. Three
penicillin susceptible strains were tested; D39: serotype 2, 68034:
serotype 3 and strain 6A from Iceland. In addition, three
different 68034 inoculi of 1e8, 1e7 and 1e6 cfu/ml, respectively,
were tested in the pneumonia model to investigate the corre-
lation between inoculum size and effect of penicillin. The mice
were treated with penicillin BID 3 or 15 mg/kg at 24 and 30
hours after inoculation. Colony counts from lung homogenates
were determined at start of treatment and 24 hours after start of
treatment. MIC’s were determined by Etest, and in vitro time-
kill curves were performed for 1, 2, 4 and 8 times MIC according
to the NCCLS guideline.
Results: All 3 strains had a penicillin MIC of 0.016–
0.032 lg/mL. The in vivo results showed a 3–4 log reduction
in cfu/lungs for the S. pneumoniae strains serotype 2 and 6A after
treatment with 6–30 mg penicillin/kg, compared to colony
counts at start of treatment (see Fig). The opposite effect was
observed for the S. pneumoniae serotype 3 strain, as a one log
increase in growth was detected after treatment with 6 mg
penicillin/kg compared to colony counts at start of treatment.
The lack of effect after the 6 mg/kg penicillin treatment was
observed for all three tested serotype 3 inoculi (see Fig). A static
effect on serotype 3 was observed for the higher penicillin dose
of 30 mg/kg. The in vitro time-kill curves, however, showed
equal non-concentration dependent killing of all three strains.
Conclusion: The effect of penicillin on the penicillin susceptible
S. pneumoniae serotype 3 strain was greatly reduced compared to
two other tested serotypes. No difference in penicillin activity
was observed for the three strains in vitro. Serotype 3 has a huge
polysaccharide capsule giving it a typical mucoid appearance of
the colonies on blood agar, which from the present data
apparently impedes the effect of penicillin in vivo.
P1747
Interaction between penicillin and erythromycin
treatment on Streptococcus pneumoniae in a
murine pneumonia model
R.L. Fischer, N. Frimodt-Møller (Copenhagen, DK)
Objectives: The antimicrobial response after treatment with
penicillin (P) and erythromycin (E) in combination was inves-
tigated against S. pneumoniae in a murine pneumonia model.
Methods: Pneumonia was induced in outbred, immunocompe-
tent mice by inoculation of a S. pneumoniae intranasally. Two
strains were used, D39 (serotype 2) and serotype 6A from
Iceland, both P and E susceptible. All mice were treated BID in
groups of 6 mice at 24 and 30 hours after inoculation. The
following ﬁve BID dose regimens were tested: P 3 mg/kg, E 3 or
13 mg/kg, P 3 mg/kg in combination with E 3 mg/kg and
ﬁnally P 3 mg/kg in combination with E 13 mg/kg. In addition,
the combination of the two compounds was either dosed
simultaneous or P was given a half hour later than the
E treatment. Colony counts from lung homogenates were
determined at start of treatment and 24 hours after start of
treatment. Time-kill curves with P and E alone and in combi-
nation against the two strains were performed in addition.
Results: In vitro antagonism was shown for the combination of
P and E, i.e. same killing effect as for E alone but less so than for
P alone. Not only P, but also E had a cidal effect on both strains
in vivo when tested individually. The E mean log reduction in
colony counts compared to start of treatment was 1.6 for BID
3 mg/kg and 3 for BID 13 mg/kg, similar for both strains. The P
and E combination did not increase the effect on the tested
pneumococci compared to the effect of P alone (see Fig). The
colony counts for strain 6A after P treatment was not signiﬁ-
cantly different to the treatment with E 3 mg/kg ( P 3 mg/kg,
whereas, E had an antagonistic effect on P for the D39 strain
(P = 0.04, Mann–Whitney test). No difference in effect was
observed between dosing simultaneous and using half hour
separation of the two compounds.
Conclusion: Combination treatment with a beta-lactam and a
macrolide is commonly recommended for empiric treatment of
community acquired pneumonia. Testing such a combination in
the experimental mouse pneumonia model showed no additive
effect on the pneumococci, and a signiﬁcant antagonistic effect
was observed for one strain. We recommend that the combina-
tion of P and E should not be administered if a pneumococcal
etiology is suspected.
11
serotype 2
Single day penicillin treatment
against S. pneumoniae
serotype 6A
serotype 3, ino 1E8
serotype 3, ino 1E7
serotype 3, ino 1E6
10
9
8
7
6
5
4lo
g 
(C
FU
/lu
ng
s)
3
2
1
0 6 12
Penicillin total mg/kg
Start of treatment
18 24 30
9
8
7
6
5
4
3lo
g 
cf
u/
lu
ng
s
2
1
Detection level
0
6A
, s
tar
t o
f tr
ea
tm
en
t
D3
9, 
sta
rt o
f tr
ea
tm
en
t
6A
, p
en
 3
D3
9, 
pe
n 3
6A
, e
ry 
3 +
 pe
n 3
D3
9, 
ery
 3 
+ p
en
 3
P = NS
BID, one day treatment of S. pneumoniae
in a murine pneumonia model
P = 0.04
Clinical Microbiology and Infection, Volume 11, Supplement 2, 2005
575
P1748
Efﬁcacy of moxiﬂoxacin signiﬁcantly more
effective than levoﬂoxacin against a ﬁrst-step
ParC mutant of Streptococcus pneumoniae in a
murine model of pneumonia
D.J. Bast, L. Dresser, C.L. Duncan, X. Chen, R. Goren,
L.A. Mandell, D.E. Low, J.C.S. de Azavedo (Toronto, CAN)
Objective: Fluoroquinolone (FQ) resistance in Streptococcus
pneumoniae (SPN) occurs by stepwise selection of mutations in
genes encoding type II topoisomerases. Clinical isolates with
single-step ParC mutations are increasing & their subsequent
exposure to a less active FQ could render them resistant. In a bid
to reduce numbers of resistant bacteria the use of more potent
agents like MOX to treat pneumonia has been advocated. We
tested this by comparing moxiﬂoxacin (MOX) & levoﬂoxacin
(LEV) efﬁcacy against pneumonia caused by a ParC mutant in
mice.
Methods: Pneumonia in Swiss Webster mice was induced by
endotracheal inoculation with a susceptible (LEV MIC 2 mg/L;
MOX MIC 0.06 mg/L) serotype 3 SPN that harbours an D83Y
substitution in ParC. At 24 h, surface-temperature (ST) was
measured for assessment of disease severity prior to treatment.
We have shown that moderately (MOD)-ill mice have a ST of
‡32C & 6–log10 CFU in their lungs. By comparison, severely
(SEV)-ill (>30C but <32C) & gravely-ill (£30C) mice have 7- &
8-log10CFU, respectively. Drug was administered subcuta-
neously to all mice (50 mg/kg q12) at 24 h & for up to 5 days.
Since we have shown death to be imminent at a ST £30C, mice
were euthanized during treatment if their ST dropped to 30C or
less & continued to drop over the next 24 h. Bacterial counts
from lungs of all mice were determined using an automated
spiral plating system. Resistant isolates (LEV MIC ‡4 lg/ml)
recovered from mice were detected similarly on a LEV concen-
tration gradient & characterized for resistance mechanisms.
Results: Among MOD-ill mice, 21 of 23 (91%) survived MOX
treatment & 5 of 37 (14%) survived LEV treatment (P < 0.001).
Among SEV-ill mice, 7 of 7 (100%) survived MOX & 1 of 4 (25%)
survived LEV (P = 0.02). Among MOD-ill mice, bacterial counts
in 3 of 23 (13%) mice treated with MOX & 36 of 37 (97%) treated
with LEV were noted (P < 0.0001). Among SEV-ill mice, none
treated with MOX but all treated with LEV had counts (mean,
7.3log10CFU) (P = 0.003). Resistant isolates (LEV MIC ‡4 mg/L)
were recovered from 11 of 41 mice treated with LEV but only 1
of 30 mice treated with MOX.
Conclusions: MOX is signiﬁcantly more effective than LEV for
treatment of pneumonia caused by a ParC mutant. Its ability to
minimize selection of high-level FQ resistance compared with
LEV further supports the notion that a more potent FQ should
be used as a means to reduce FQ resistance among SPN.
P1749
Effect of porins and AmpC betalactamases in the
treatment of experimental pneumonia due to
Klebsiella pneumoniae
E. Padilla, D. Alonso, A. Dome´nech-Sa´nchez, J.L. Pe´rez,
N. Borrell (Palma de Mallorca, E)
Objectives: Enterobacterial strains with decreased outer mem-
brane permeability in combination with plasmid-mediated class
C betalactamases (such AmpC) show an increased in vitro levels
of resistance to betalactams, including carbapenems. The aim of
this study was to evaluate the in vivo efﬁcacy of human
regimens of imipenem (IMP), meropenem (MEM) and cefepime
(FEP) in the experimental pneumonia due to AmpC producing
Klebsiella pneumoniae (Kp) and one of its in vitro-porin-deﬁcient
mutant by using an animal model with immunocompetent rats.
Methods: Strain Kp12 is a derivative of Kp52145 (clinical
isolate) containing an AmpC betalactamase, which contains
the plasmid coding for the ampC gene. Kp12dp is a Kp12 porin
deﬁcient strain. Each strain used to induce pneumonia was
studied separately. A total of 162 animals (81 animals for each
strain group) were intratracheally inoculated with 1.3E + 06
CFU of Kp12 or 1E + 07 CFU of Kp12dp to reproduce pneu-
monia. In turn, each group was divided in three subgroups
according to the antibiotic used. Moreover, 9 extra control rats
were used for each strain. After 3 days of treatment rats were
sacriﬁced and their lungs were analysed. A reduction in
bacterial counts measured in Log CFU/g of lung was used as
the parameter of efﬁcacy. The nonparametric Kruskal–Wallis
and Mann–Whitney statistical tests were used.
Results: MICs obtained for Kp12 and Kp12dp were the follow-
ing: IMP, 1.5 and 16 lg/ml, MEM, 0.03 and 8 lg/ml, and FEP,
0.25 and 2 lg/ml respectively. Mean Log CFU/g of lung for
Kp12 were: 8.0 for controls, 1.8 IMP, 1.7 MEM and 2.0 FEP. The
corresponding results for Kp12dp were: 9.6 for controls, 2.9 IMP,
2.4 MEM and 2.7 FEP. All therapeutic groups showed signiﬁcant
statistical differences in comparison with controls (p < 0.01). In
terms of efﬁcacy, comparison within the three antibiotics tested
showed MEM slightly better bacterial counts than IMP, but only
with Kp12dp strain (p < 0.05).
Conclusion: IMP, MEM and FEP showed in vivo efﬁcacy in
decreasing bacterial count lungs in Kp AmpC producing strains
regardless of the presence of porins. However with Kp12dp,
MEM seems to be more active than IMP.
P1750
Effect of dehydroepiandrosterone in an
experimental pneumonia model caused by
Klebsiella pneumoniae
J. Ortiz-Moyano, M.E. Pacho´n-Iba´n˜ez, M. Jime´nez-Barros,
F. Docobo-Pe´rez, C. Ortiz-Leyba, J. Iba´n˜ez-Martı´nez,
J. Garnacho, J.A. Ma´rquez-Va´caro, J. Pacho´n (Seville, E)
Objectives: A relationship has been referred between dehyd-
roepiandrosterone (DHEA) levels and survival in sepsis in
human beings, and in a murine model of cecal ligation and
puncture DHEA administration results in an increase of survi-
val. The aim of this study was to evaluate the effect of
administration of DHEA in a severe experimental model of
pneumonia of Klebsiella pneumoniae.
Methods: First, a toxicity study was made in 3 groups of
uninfected male C57BL/6 mice (16–20 g) using different subcu-
taneous doses of DHEA (30, 15, and 7.5 mg/kg/24 h, during
48 h), with mortality rates of 90%, 33%, and 0%, respectively;
then, a dose of 7.5 mg/kg was used in the in the pneumonia
model. An experimental pneumonia model in male C57BL/6
mice was developed, using the modiﬁed method of Esposito and
Pennington (Rodrı´guez-Hernandez MJ et al. JAC 2000); an intra-
tracheal inoculum size of 8 log10 CFU/ml was used. The animals
were grouped in CON (controls, no treatment) and DHEA
(7.5 mg/kg/24h) during 48 h. The results are expressed as
percentages in qualitative variables and as mean ± SD of log
CFU/g of tissues. Statistical analysis: Chi-square and Fisher test,
ANOVA, and the t-student test were performed; a P < 0.05 was
considered signiﬁcant.
Results: The mortality rates (92% and 100%), the bacterial
concentration in lungs (10.6 ± 0.9 and 10.1 ± 0.8), liver (6.8 ± 1.7
and 6.3 ± 1.2), spleen (6.8 ± 1.5 and 5.9 ± 0.8), and the sterile
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blood cultures (8% and 17%) were not different between CON
and DHEA groups, respectively.
Conclusion: In the model of experimental pneumonia caused
by K. pneumoniae the administration of DHEA did not protect
from mortality nor reduce the bacterial concentration in tissues.
P1751
Efﬁcacy of rifampin, imipenem, and sulbactam in
monotherapy and combination, in the
experimental pneumonia caused by panresistant
Acinetobacter baumannii
M.E. Pacho´n-Iba´n˜ez, F. Docobo-Pe´rez, M.E. Jime´nez-Mejı´as,
C. Pichardo, A. Garcı´a-Curiel, J. Pacho´n (Seville, E)
Objectives: There is not efﬁcacious treatment for infections
caused by panresistant A. baumannii. The aim of this study was
to evaluate the efﬁcacy of rifampin (RF), imipenem (IMP), and
sulbactam (SB), in monotherapy and in combination, in an
experimental murine pneumonia model caused by panresistant
A. baumannii.
Methods: In vitro studies: MIC and MBC were determined in
two different panresistant clinical strains. The bactericidal
activity and the synergy (time-kill curves) of the combinations
were evaluated in these strains. Cmax in animal serum of each
antimicrobial was also determined. In vivo studies: Both in vitro
analysed strains were used. An experimental pneumonia model
in C57BL/6 mice with an intratracheal inoculum of approxi-
mately 8 log10 CFU/ml was used. The animals were grouped in
CON (controls, no treatment), IMP (120 mg/kg/d), SB
(240 mg/kg/d), RF (100 mg/kg/d), IMP+SB, IMP+RF, and
SB + RF, receiving treatment during 72 h. The mortality rate,
the bacterial clearance from lungs, and the sterilization of blood
cultures were analysed. Statistical analysis: Chi-square and
Fisher test, ANOVA, and post-hoc Tukey and Dunnett tests.
Results: MIC/MBC (mg/l): strain A: IMP 128/>256, SB >256/
>256, RF 128/>128, and colistin (COL) 32/>32; strain B: IMP
256/>256, SB >256/>256, RF 128/>128, and COL 32/>32. Cmax
(mg/l) were: 16.9, 81.5, and 13.39 for IMP, SB, and RF,
respectively. RF and SB were bactericidal against two and one
strains, respectively. According to time-kill curves, synergy was
found using the following combinations: SB+RF and IMP+RF
against the two strains. RF, IMP+RF, and SB+RF decreased the
mortality respect to CON (p < 0.05) in both strains; in the strain
A, RF and IMP(RF were better than IMP+SB (p < 0.05). In regard
with the bacterial clearance from lungs, RF and the all combi-
nations cleared the lungs respect to CON (p < 0.05) in both
strains. Respect to sterilization of blood cultures, RF and the
three combinations improved the results of CON (p < 0.05).
Conclusions: In vitro and in vivo, RF alone or associated to SB
or IMP were effective against panresistant A. baumannii. The
association of imipenem plus sulbactam was also effective.
P1752
Effects of ﬂavonoids quercetin and luteolin on
acute Chlamydia pneumoniae infection in a mouse
model
L. To¨rma¨kangas, P. Vuorela, E. Saario, M. Leinonen, H. Vuorela,
P. Saikku (Oulu, Helsinki, FIN)
Objectives: Dietary ﬂavonoids, found in almost all foods of plant
origin, are receiving increasing attention as potential protectors
against a variety of humandiseases. These compounds are shown
to prevent lipid peroxidation and inhibit LPS-inducedproduction
of cytokines and NO both in vitro and in animal models.
Antimicrobial properties of the ﬂavonoids are well known and
we have found earlier that some of the compounds are strongly
chlamydiacidal in cell cultures. Our aim was to ﬁnd out if two
common ﬂavonoids, quercetin and luteolin, would have an effect
on acute C. pneumoniae (Cpn) infection in vivo in mice.
Methods: C57BL/6J mice were given quercetin and luteolin
intraperitoneally once daily for three days prior to inoculation.
The treatment was continued for ten days post infection (p.i).
Three groups of 8 mice, inoculated intranasally with Cpn isolate
K7, were treated either with 20 mg/kg quercetin, 2 mg/kg
luteolin or given diluent (infected controls). Fourth group was
inoculated with SPG instead of Cpn (uninfected controls).
Samples were taken on days 3, 6, 10, 13 and 20 p.i. Lung tissue
was analysed for the presence of viable Cpn by culture and Cpn
DNAbyquantitativePCR.Lung inﬂammationwas analysed from
haematoxylin eosin-stainedparafﬁn sections. Expression levels of
cyclooxygenases (COX-1, COX-2) and nitric oxide synthases
(eNOS, iNOS) in the lung tissue were determined by quantitative
RT-PCR from different set of samples collected at 4 days p.i.
Results: Quercetin signiﬁcantly increased the presence of infec-
tiouschlamydia in the lung tissueonday6p.i. compared to infected
controlmice (468 000 IFU vs. 57 000 IFU, respectively). The number
of infectious chlamydia in the luteolin-treated group was lower
than in the control group at every time point. Signiﬁcant reduction
in the lung mononuclear cell inﬁltrates as a response to infection
was seen in luteolin-treated mice as well. Infection had no
statistically signiﬁcant effect on NOS and COX expression levels
but luteolin suppressedboth eNOSandCOX-1 levels andquercetin
increased iNOS levels when compared to infected controls.
Conclusions: Luteolin treatment was found to have signiﬁcant
attenuating effects both on the presence of chlamydia and on the
inﬂammatory response in vivo. Further studies are needed to
clarify the surprising worsening effect of quercetin, which might
be due to the higher treatment dose compared to luteolin or
inappropriate administration route.
P1753
Effect of the delay of antibiotic treatment on the
therapeutic outcome of an experimental acute
otitis media (AOM) caused by an erythromycin-
susceptible Streptococcus pneumoniae
C. Ponte, C. Cenjor, C. Martinez-Marin, L. Huelves, M. Gracia,
G. del Prado, F. Soriano (Madrid, E)
Objective: To evaluate the effect of delayed administration of
erythromycin in the course of an experimental acute otitis media
(AOM) in gerbils caused by an erythromycin- susceptible
Streptococcus pneumoniae.
Methods: The organism was inoculated by transbullar chal-
lenge in the middle ear (ME) and antibiotic treatment (2.5, 5 and
50 mg/kg) was administered at various times thereafter. Trea-
ted and control animals were studied longitudinally for the
presence of otorrhea, changes in weight, otoscopical aspects, and
composition of ME samples. Bacterial counts in ME washing
ﬂuids were also determined.
Results: The bacteriological efﬁcacy of erythromycin adminis-
tered in a single dose at different intervals after bacterial
inoculation was as follows: A further experiment was carried
out administering the antibiotic at standard and high doses in
one and three shots administered in early and delayed regimen
obtaining the following results: Table 2 Erythromycin was able
to signiﬁcantly diminish the number of organisms in the ME if
the drug is administered early, even in a single dose. However
the delayed administration of the antibiotic was associated with
bacteriological failure even when the drug was given at a higher
and repetitive dose.
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Conclusion: The delayed erythromycin treatment in an experi-
mental AOM caused by an erythromycin-susceptible S.pneumo-
niae strain is associated with bacteriological failure as also has
been described with amoxicillin.
P1754
Clinical analysis of anti neutrophil cytoplasmic
antibody against bactericidal/permeability
increasing protein (BPI-ANCA) in chronic
Pseudomonas aeruginosa lung infections
O. Kobayashi, S. Ohtami, E. Tadokoro, H. Kobayashi,
S. Kamiya (Tokyo, JP)
Objectives: It is well known that persistently colonization of
Mucoid Pseudomonas aeruginosa on lung in patients with diffuse
panbronchiolitis (DPB), bronchiectasis (BE) and Cystic ﬁbrosis
(CF) induce immunological modiﬁcation to the host side. Our
previous basic studies have indicated that the phagocytic
activity of neutrophil was signiﬁcantly inhibited by anti neu-
trophil cytoplasmic antibody against bactericidal/permeability
increasing protein (BPI-ANCA) in a dose dependent manner in
vitro (P < 0.01), and in clinical studies, high titres of serum BPI-
ANCA played an important role in the clinical course of disease
such in patients with DPB, BE and CF. However, the inﬂuence of
BPI-ANCA on the clinical picture and prognosis of in patients of
these disease has not been clariﬁed in detail. In this time, we are
going to make discussion with the clinical role of such auto
antibody in chronic P. aeruginosa lung infections.
Materials and Methods: Sixteen patients of DPB and 34
patients with BE are sampled. Relationship between serum
BPI-ANCA titres and clinical symptoms, respiratory function,
chest X-ray ﬁndings, and bacteria detected were evaluated.
Serum BPI-ANCA was tested with ELISA testing kit (BPI IgG
kit, GENESIS diagnosis, Cambridge, UK).
Results: Serum BPI-ANCA titre was 1) correlated with the
severity of clinical symptoms, in patients with chronic
P. aeruginosa lung infections (P < 0.01), 2) decreased with the
improvement of the clinical picture (P < 0.05), 3) signiﬁcantly
higher in patients with in patients with far-advanced lesions on
chest X-rays than with milder lesions (P < 0.05) and in patients
with reduced pulmonary function (P < 0.05), 4) signiﬁcantly
higher in the patients with poor prognosis (P < 0.05).
Conclusion: The above results suggests that BPI-ANCA, an
autoimmune factor, appears during the course of chronic
P. aeruginosa lung infections, and that this autoimmune factor
may make chronic lung infections more intractable, by inhibit-
ing the phagocytic activity of neutrophil for P. aeruginosa.
P1755
Prevalence of the internalisation-associated
PRTFf1gene in a bacterial population of
Streptococcus pyogenes isolated from patients
with acute pharyngotonsillitis in Greece before
and after antibiotic therapy
M. Maniati, C. Skulakis, Z. Bersos, E. Petinaki,
A.N. Maniatis (Larissa, Volos, GR)
Objectives: The ﬁnding that some isolates of Streptococcus
pyogenes can enter respiratory epithelial cells by means of
ﬁbronectin –binding proteins, becoming in this way inaccessible
to antibiotics unable to reach high intracellular concentrations,
such as penicillins, has been proposed as an attractive explan-
ation for treatment failure conferring a selective advantage to
these organisms. Purpose of this study was to determine the
prevalence of the internalization-associated prtf1 gene, that
codes the ﬁbronectin–binding protein, in 100 isolates of Strep-
tococcus pyogenes obtained from Greek patients with acute
pharyngotonsillitis and to investigate the correlation between
the presence of this gene with the b-lactam therapy failure.
Methods: A hundred of Streptococcus pyogenes isolates were
collected during 2001–2004 in Central Greece from pharyngeal
swabs of patients presenting with acute pharyngotonsillitis.
b-lactam therapy (penicillin, ampicillin, amoxicillin and clavul-
anic acid, cefaclor, ceﬁxime, cefuroxime axetil, and ceftibuten)
was administered to all patients and cultures were obtained
before and after therapy. Thirty patients remained carriers of
S. pyogenes after therapy. In order to avoid a new re-colonization,
isolates (before andafter therapy) fromeachof thesepatientswere
compared by PFGE,. The presence of prtf1 was detected by PCR.
Results: All isolates recovered from patients, that remained
positive after therapy, carried the prtf1-gene(100%), while, only
ten of the 70 patients, that were successfully treated by b-lactam
antibiotics, were prtf1-positive (14%).
Conclusions: The isolation of prtf1-positive S. pyogenes was
signiﬁcantly higher in patients that remained carriers after
therapy than in patients successfully treated (p: 0.0001). We
believe it reasonable to hypothesize that the capacity of some S.
pyogenes isolates to resist to b-lactam antibiotic therapy is related
in part to prtf1-mediated enhanced colonization. Additional
studies are under to test this idea.
P1756
Effect of three different treatment methods on
probing pocket depth in the management of
chronic periodontitis
S.P. Rajapakse, S. Kandegedara, L.S. Ekanayake (Peradeniya, LK)
Objectives: The objective of the present study was to evaluate
the effects of three modalities of non surgical periodontal
therapy on probing pocket depth (PD)in a group of patients with
chronic periodontitis.
Methods: The study sample was selected from the patients
attending the Periodontal Screening clinic at the Faculty of
Dental Sciences. Each subject was assigned to a severity category
(S1 ‡ 3mm -£ 5mm, S2 ‡ 5mm - £ 7mm, or S3 ‡ 7mm) depend-
ing on the maximum PD in any site at baseline. The subjects in
each severity category were then randomly assigned into three
treatment groups; T1 = oral health instruction (OHI)+ scaling
and root planing (SRP), T2 = OHI + SRP+0.2% Chlorhexidine
mouthwash (CHX) for two weeks, or T3 = OHI + SRP+ antibi-
Table 1.
Dose (mg/kg)
Time (h) from challenge
to treatment
% of culture-positive
ME samples
Mean bacterial count
(log10CFU/20 micro L)
Control - 100 3.18 ± 0.55
2.5 2 50 0.97 ± 0.67
5 60 2.55 ± 1.96
18 100 3.25 ± 0.66
21 100 3.27 ± 0.94
5 2 37.5 0.97 ± 0.59
5 56.2 1.52 ± 0.98
18 100 2.78 ± 0.79
21 100 3.04 ± 0.67
Table 2.
Dose (mg/kg)
Time (h) from challenge
to treatment
% of culture-positive
ME samples
Mean bacterial count
(log10CFU/20microL)
Control - 100 3.44 ± 0.44
5 2 37.5 0.97 ± 0.59
2,5,8 0 <0.6
21 100 3.04 ± 0.67
21,24,27 93.7 2. 67 ± 0.79
50 21,24,27 75 1. 84 ± 0.84
Abstracts
578
otic therapy +Amoxycilin+Metranidazole combination for one
week). PD was recorded for all teeth at six sites at baseline and 6
weeks after treatment. Florida Probe-FP32 was used for record-
ing of data. The differences in probing pocket depth before and
after treatment was assessed. One way ANOVA was used to
compare the differences in PD between the three treatment
categories in each severity group. If ANOVA revealed a
signiﬁcant difference(p < 0.05), Scheffe’s test was performed to
ascertain where the differences occurred.
Results: In all severity categories, ANOVA revealed signiﬁcant
differences in the mean PD in the three treatment groups. The
mean reduction in PD in the S1 category after T1, T2 and T3
treatments were 1.47 mm, 1.45 mm and 1.69 mm respectively. In
S2 category they were 2.50 mm, 3.10 mm and 3.21 mm whereas
in S3 category the ﬁgures were 3.92mm, 4.32 mm and 7.02 mm
respectively. In the severity category-S1 there was a signiﬁcant
difference between T2 and T3 treatment groups (p < 0.05).
However the actual differences in reduction of PD was marginal
(0.22 mm). In severity category-S2 there was a signiﬁcant
differences between treatment groups T1 and T2 and also
between T1 and T3 (p < 0.005 and p < 0.001 respectively).
Conclusion: The use of systemic antibiotics as an adjunct to oral
health instruction, scaling and root planing has proven to be
signiﬁcantly beneﬁcial over treatments carried out using oral
health instruction, scaling and root planing with or without
Chlorhexidine in the treatment of periodontal disease sites with
probing pocket depths exceeding 7 mm.
P1757
Oral lactobacilli in chronic periodontitis and
periodontal health: species composition and
antimicrobial activity
P. Ko˜ll-Klais, R. Ma¨ndar, H. Marcotte, E. Leibur, M. Mikelsaar,
L. Hammarstro¨m (Tartu, EST; Stockholm, S)
Chronic periodontitis (CP) is characterised by the imbalance of
indigenous microﬂora and resulting in the overgrowth of
putative periodontal pathogens. Although lactobacilli play an
important role in the maintenance of health by stimulating
natural immunity and contributing to the balance of microﬂora,
their role in CP is less clear.
Objectives: To identify Lactobacillus species isolated from oral
cavity in periodontally healthy subjects and in patients with CP,
and to characterize their antimicrobial activity against oral
pathogens.
Methods: The saliva and two subgingival sites of 12 CP and 11
healthy subjects were cultured for lactobacilli. Species were
identiﬁed using rapid ampliﬁed ribosomal DNA restriction
analysis. Antimicrobial activity against Streptococcus mutans
(Sm), Actinobacillus actinomycetemcomitans (Aa) and Candida
albicans (Ca) was assessed using deferred antagonism method
(115 Lactobacillus strains tested), and against Porphyromonas
gingivalis (Pg) and Prevotella intermedia (Pi) using a streak line
procedure (63 Lactobacillus strains tested).
Results: A total of 115 strains (48 from CP and 67 from healthy
patients) of lactobacilli were identiﬁed as L. acidophilus,
L. crispatus, L. delbrueckii, L. gasseri, L. salivarius, L. paracasei,
L. plantarum, L. rhamnosus, L. fermentum and L. oris. L. fermentum
(52%) and L. plantarum (48%) were the most prevalent. In
comparison to healthy subjects, in CP patients obligately
homofermentative lactobacilli, particularly L. gasseri, were less
prevalent (73% vs 17% for homofermentatives, p = 0.012, and
64% vs 8% for L. gasseri, p = 0.009). 69% of tested lactobacilli
inhibited Sm, 88% Aa, 82% Pg and 65% Pi but none inhibited Ca.
The strongest antimicrobial activity was associated with
L. paracasei, L. plantarum, L. rhamnosus and L. salivarius. Strains
from CP patients expressed stronger antimicrobial activity
against Sm than strains from healthy persons (mean growth-
free zone 2.3 vs. 1.2 mm; p < 0.001).Conclusions: the composi-
tion of oral lactoﬂora between healthy subjects and patients with
CP differs by the higher prevalence of homofermentative
lactobacilli, particularly L. gasseri, in former group. The antimi-
crobial properties of oral lactobacilli are related to their
fermentation type and species. These ﬁndings indicate that
lactobacilli may play a crucial role in the maintenance of
microecological balance in oral cavity.
P1758
Identiﬁcation of Streptococcus mutans
bacteriocins in children with and without dental
caries
F. Gamboa, M. Chaves (Bogota, COL)
Streptococcus mutans is the main microorganism implied in
dental caries. Different researches suggest that bacteriocins
produced by this bacterium may be very important in the ability
to exclude or preempt S. mutans establishment in the oral
cavity.
Objectives: The aim of this study was to identify S. mutans
strains which produce bacteriocins.
Methods: Thirty three S. mutans strains, previously isolated in
patients with and without dental caries, were taken for the
bacteriocin detection. The 33 strains were biotypiﬁed with the
Api-ZYM (bioMe´rieux; Marcy-ltoile, France) enzimatic system.
In order to determine the bacteriocins production, the strains
were inoculated onto brain heart infusion agar (BHI). After a
24-hour CO2 incubation, the plates were overlaid with 5 ml of
0.75% BHI agar containing 0.5 ml of an overnight BHI culture of
the indicator strain. After an additional CO2 overnight incuba-
tion at 37C the width of the inhibition zone was measured.
Results: In the 33 strains of S. mutans 10 biotypes were found.
The most frequent biotypes were the 10, 15 and the 11 with 9, 8
and 4 strains, respectively. Eight (24%) of the 33 evaluated strains
produced bacteriocins, 6 of these strains came from patients with
dental caries and the other two from patients with no caries. The
8 strains which produced bacteriocins presented 5 different
biotypes: 3 strains with biotype 10, 2 strains with biotype 14, and
the last three ones were biotypes 11, 15, and 17, respectively.
Conclusion: The obtained results in this study are in agreement
with the information reported in other works done with
S. mutans. In the 33 strains of S. mutans evaluated, 8 strains
(24%) which produced bacteriocins with 5 different biotypes
were identiﬁed, which after accomplishing other requirements
have a great option to be used in oral infections control in which
S. mutans is involved.
P1759
Bacterial electroporation using an endox
endodontic system derived instrument
C. Cassanelli, S. Roveta, A. Marchese, E.A. Debbia (Genoa, I)
Objectives: Endox Endodontic System is used for the treat-
ment of bacterial infections in the root canal by application of a
high frequency alternating current (HFAC). The generated
electromagnetic ﬁeld (which lasts 140 msec) results bactericidal.
The aim of this study was to investigate the mechanism of action
of this instrument. It was hypothesised that this apparatus
produces pores on the cell membrane leading to bacterial death.
In order to demonstrated this assumption some parameters
were adjusted, in particular frequency, voltage and time-pulse.
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Methods: The instrument was setted as follows: frequency 300
kHz, power 600 kV, time-pulse 60 msec. Electroporation was
veriﬁed using E. coli K-12 strains C600 carrying the amikacin
(AK) resistant pBP517(gyrA+) non conjugative plasmid as donor
and C600 rifampicin (RIF) and nalidixic acid (NAL) resistant as
recipient. Cells were prepared for electroporation according to
standard method. Donor (0.1 ml) and recipient (0.1 ml)
strains were mixed in 1.8 ml of saline solution and 0.2 ml of
mixture were exposed to the electromagnetic ﬁeld. Untreated
coltures were used as controls. After incubation the recombi-
nants were counted on selective plates (RIF and AK) and then
tested for NAL susceptibility.
Results: In a ﬁrst experiment 60 recombinants were obtained,
they also resulted NAL susceptible. Plasmid stability was
veriﬁed growing bacteria in non selective broth for 48 hours.
The culture was then plated in rich medium. The singles
colonies obtained were tested for AK, RIF and NAL suscepti-
bility. The results showed that among 60 recombinants, 15
clones maintained the plasmid while the others revealed that
original phenotypes of the recipient C600 strain.
Conclusion: The present ﬁndings indicated that non conjuga-
tive plasmid pBP517 can be transferred from a donor to a
recipient via an exposure to the electromagnetic ﬁeld generated
by Endox. The recombinants resulted stable in 15/60 isolates.
The mechanism of plasmid transfer is reminiscent with that
occurs in electroporation. The great difference between the
setting instrument used for clinic treatment and that used in this
study is the time-pulse: probably a time-pulse of 140 msec
produces pores formation for too long time so the bacterial cells
are killed for osmotic-lysis, while a time-pulse of 60 msec
produces pores-formation for a time that allows the electropo-
ration process. Further studies are in progress to conﬁrm the
present result.
P1760
Oral linezolid as an adequate therapy of
experimental endocarditis by methicillin-
resistant Staphylococcus aureus
T. Tsaganos, L. Sabracos, T. Adamis, I. Skiadas,
M. Mouktaroudi, H. Giamarellou, E.J. Giamarellos-
Bourboulis (Athens, GR)
Objective: Linezolid is a new antimicrobial agent with excellent
oral bioavailability and well documented in vitro activity
against gram positive cocci when resistance to other anti-
staphylococcal agents is present. Little is known on its potential
use in endocarditis. The efﬁcacy of oral linezolid on experimen-
tal endocarditis by MRSA was studied.
Methods: Left sided endocarditis was induced by the insertion
of a catheter in the aortic valves of 19 white male rabbits.
Twenty-four hours after catheter insertion, animals were chal-
lenged by a 7log10 inoculum of an MRSA clinical isolate, with
MIC of linezolid equal to 4 lg/ml. Eleven animals were
administered linezolid at a dose of 75mg/kg q8h per os for
ﬁve days. Eight served as controls. Blood samples were drawn
16, 32, 48, 72, 96 and 120h post therapy, immediately before drug
administration, for the determination of trough levels. At the
end of treatment animals were sacriﬁced and valves were
quantitavely cultured. Concentration of linezolid was deter-
mined by an HPLC method with UV detection.
Results: Mean ± survival was 133.27 ± 10.23 hours and
66.00 ± 13.75 hours animals treated with linezolid and controls
respectively. Mean log10 (±SE) bacterial counts of valves was
3.9 ± 0.86 CFU/g and 7.93 ± 1.21 CFU/g (p 0.019) for animals
treated with linezolid and controls respectively. Mean ± SE
trough linezolid concentrations were 5.22 ± 1.96 mg/l at 16 h,
5.52 ± 1.57 mg/l at 32 h, 8.29 ± 1.62 mg/ml at 48 h, 17.94 ±
8.65 mg/l at 72 h, 27.58 ± 8.67 mg/l at 96 h and 8.78 ±
1.36 mg/l at the end of therapy.
Conclusion: Therapy of experimental endocarditis by MRSA
with oral linezolid results in increased survival and in lower
bacterial counts of valve vegetations. Trough blood concentra-
tions of linezolid are above the MIC of the MRSA isolate even
reaching 7 times the MIC at the 4th day of therapy. The results
are promising for the therapy of serious staphylococcal infec-
tions when resistance to other antistaphylococcal agents is
present.
P1761
Assessment of Staphylococcus aureus
pathogenicity using the nematode Caenorhabditis
elegans
L.E. Thomsen, H. Ingmer (Frederiksberg, DK)
Several bacterial pathogens, both Gram-positive and Gram-
negative, kill the nematode Caenorhabditis elegans when supplied
as a food source, and a variety of bacterial virulence factors,
known to play a role in mouse-models, have been shown also to
play a role in nematode pathogenesis. The Gram-positive
bacterium Staphylococcus aureus is an opportunistic human
pathogen, which is implicated in a wide range of diseases
including septicaemia, meningitis and toxic-shock syndrome.
Objectives: With the aim of investigating the virulence of
various S. aureus genes, we have used C. elegans as a model.
Methods: Mutants in S. aureus genes involved in the bacterial
stress-response were tested in the killing-assay. To follow the
fate of the bacteria upon ingestion, we used strains of S. aureus
that expresses the green ﬂuorescent protein (GFP) which is
visible in the transparent nematode. We analysed both the
ability of the bacteria to kill the nematode and the effect of
the bacteria on nematode propagation, but also how well the
bacteria adhere to the intestine.
Results and Conclusions: A difference in virulence was obser-
ved when the wild-type bacteria were compared with various
mutants, which conﬁrms the importance of the stress genes on
virulence. In addition, a difference on nematode propagation
was seen when C. eleganswhere feed the wild-type- and mutant-
strains.
P1762
Whole genome expression proﬁling of
intracellular Staphylococcus aureus in human
lung epithelial cells
C. Garzoni, P. Francois, S. Couzinet, C. Tapparel, A. Renzoni,
D. Lew, P. Vaudaux, W. Kelley, J. Schrenzel (Geneva, CH)
S. aureus is classically considered as an extracellular pathogen,
although recent reports from several laboratories, including our,
suggest that it can invade and persist intracellularly in a variety
of non-professional (non-myeloid) phagocytes. The intracellular
environment is thought to constitute a protected niche against
immunological defenses or pharmacologic treatments. Intracel-
lular survival might also explain the frequent relapses observed
in osteomyelitis, foreign body infections, and poorly successful
attempts to eradicate nasal carriage. In gene expression proﬁle
studies of host-pathogen models, pathogen RNA is often present
in low abundance and constitutes a major limiting factor for
global gene expression analysis. We successfully developed a
procedure to stabilize and amplify bacterial RNA. Using a
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custom-designed S. aureus microarray, we monitored S. aureus
gene expression following host cell internalisation. A549 human
lung epithelial cells were infected with S. aureus strain 6850 and
bacterial RNA was extracted at different time points. A panel of
control experiments revealed no signiﬁcant changes in bacterial
gene expression following host cell contact, exposure to secreted
cellular products in the culture medium, or when internalization
was blocked by cytochalasin D. In contrast, we detected
signiﬁcant alterations in bacterial gene expression at 2 and 6
hours post-infection. At 2 hours post-infection, we observed a
substantial down-regulation of genes involved in general meta-
bolism. A signiﬁcant number of regulatory proteins, virulence
factors, components of mobile genetic elements, and genes
involved in iron metabolism and defence against oxidative
stress were upregulated. At six hours post-infection, we
observed clear evidence of metabolic restart that was consistent
with bacterial survival and adaptation to the intracellular
growth. We conclude that S.aureus rapidly undergoes changes
in its genetic program upon contact with the intracellular
environment and that global gene expression analysis improves
our understanding of events contributing to intracellular patho-
gen survival. Finally, this study has revealed strategies that
might lead to new therapeutic targets.
P1763
Persistence of Staphylococcus aureus capsular
polysaccharides during infections in a passively-
immunised mouse challenge model
K. Taylor, J. Sarwar, A. Kale, A. Fattom (Rockville, USA)
Objectives: Staphylococcus aureus (SA) infection isolates possess
capsular polysaccharides (CP) that help the organism evade
immunological mechanisms of clearance by the host. Our goal
was to evaluate the role of CP in protecting bacteria from being
killed during in vitro opsonophagocytosis and the persistence of
CP in an in vivo challenge model in the presence of CP-speciﬁc
antibodies.
Methods: A Type 5 SA strain was cultured to log and stationary
phase to yield both partially capsulated and fully capsulated
forms, respectively. Bacterial counts were measured at time 0
and 1 hour after incubation in a whole blood killing assay in the
presence or absence of CP-speciﬁc IgG. To determine the
persistence of CP during infection, a mouse survival model
(a passively-immunized mouse challenge model) was used.
Mice were passively immunized with CP-speciﬁc IgG prepared
from StaphVAX (a SA-CP conjugate vaccine) immunized sub-
jects, challenged 48 hours later with capsulated Type 5 SA and
then bled 24 hours later. Blood samples were evaluated for
bacterial counts and for persistence of capsulation by a colony
lift/blotting technique.
Results: Upon incubation of partially capsulated form of a Type
5 SA strain for 1 hour in freshly drawn whole blood >90% of the
bacteria were killed in the absence or presence of CP-speciﬁc
antibodies. When fully capsulated bacteria was used <10% of
the organism was killed after 1 hour incubation in the absence of
CP-speciﬁc antibody. Only when CP-speciﬁc antibody was
added a >90% reduction in bacterial counts was observed.
Sequential transfer of the SA challenge through animals 5 times
showed consistently that 100% of the colonies retrieved from
bacteremic animals were capsulated after each passage. None of
the lifted colonies showed a loss of capsulation through the ﬁfth
transfer.
Conclusions: Our data show that CP promotes survival of SA
in the presence of complement and phagocytes in the blood.
CP-speciﬁc antibodies are required for clearance of those
organisms and that immunotherapy mediated by CP-speciﬁc
antibody did not constitute a selective pressure towards parti-
ally capsulated SA. This indicates that protective immunity is
conferred by CP-speciﬁc antibody, which is essential for
combating infections caused by SA.
P1764
Characterisation of haem-deﬁcient mutants in
Staphylococcus aureus displaying the small
colony variant phenotype using a full-genome
DNA-microarray
C. von Eiff, M.R. Khoschkhoi Yazdi, G. Peters,
K. Becker (Munster, D)
Background: Staphylococcus aureus small colony variants (SCVs)
are found in patients with persistent, antibiotic-resistant, and
recurrent infections. The SCVs from clinical infections are
commonly auxotrophic for menadione and hemin, which are
used for the formation of menaquinone and cytochromes,
respectively, and are thus important components of the electron
transport chain. The alterations in electron transport in such
SCVs result in multiple phenotypic changes, including slow
growth, increased MIC’s to several antibiotics, and reduced
alpha-toxin production.
Method: In order to analyze the SCV phenotype, a S. aureus full-
genome DNA-microarray was used for transcriptional proﬁling
of heme-deﬁcient mutants in comparison to their parent strains.
This microarray is based on the recently published genome
sequence of S. aureus N315. Copy-DNA (c-DNA) was generated
by reverse transcription from total bacterial RNA harvested from
cells at different stages of growth and was used in competitive
hybridization experiments with ﬂuorescently labeled c-DNAs.
Results: Monitoring the relative expression levels of the heme-
deﬁcient mutants mimicking the S. aureus SCV phenotype, about
60 out of 2334 annotated genes were found to be up-regulated
compared to those of the parent strains. The most prominent
genes up-regulated encode for enzymes involved in energy
metabolism (e.g. L-lactate dehydrogenase, glyceraldehyde-
3-phosphate dehydrogenase, phosphoglycerate kinase, and
triose phosphate isomerase). Furthermore, genes encoding
enzymes of the arginine metabolic pathway were found to be
up-regulated in the mutants generated by interrupting the
electron transport.
Conclusions: Applying a S. aureus full-genome DNA-microar-
ray to site-directed mutants displaying the SCV phenotype, it
was found that genes involved in glycolytic and related as well
as in fermentation pathways were up-regulated. These tran-
scriptional data are in agreement with data obtained by
biochemical studies and proteomic approaches.
P1765
An animal model of staphylococcal graft
infection without mortality
C. Agalar, O. Saygun, K. Aydinuraz, F. Pehlivanli, S. Ceken,
C. Daphan, F. Agalar (Kirikkale, TR)
Objective: To constitute a valid and reproducible graft infection
model without mortality in Wistar rats.
Method: In the ﬁrst group of the study, 2 · 1 cm2 polypropilen
grafts were incubated in Brain Heart Broth containing slime
positive S. epidermidis 2 · 108 cfu /ml for 24 hours at 37C.
Incubated grafts, were then washed with physiologic saline.
Under general anaesthesia, these grafts were placed subfascially
to the groins of rats. In the second group naive polypropilen
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grafts were placed to the groins of rats. Before closing the fascia
and skin 1 ml of slime positive S.epidermidis (3 · 109 cfu/ml)
containing sample were placed inside of the wounds. At the end
of day 8, rats were killed; wounds were assessed with macro-
scopic evaluation and microscopic cultures in both groups.
Results: In the ﬁrst group of the study, wound infection rate
was 100%. No mortality occurred in this group. In one blood
culture slime positive S. epidermidiswas cultivated. In the second
group, graft infection rate was only 20%. No mortality was seen
in this group.
Conclusion: Incubation of polypropilen grafts in Brain Heart
Broth containing slime positive S. epidermidis for 24 hours in pre
application period enhances occurrence of graft infection with-
out generating mortality. We propose to use this reproducible
and valid animal model of staphylococcal graft infection in
future studies.
P1766
Fusidic acid impregnation inhibits adherence of
S. epidermidis to peripheric venous catheters
C. Agalar, D. Kilic, S. Ceken, E. Ozturk, E. Denkbas,
S. Kaygusuz (Kirikkale, Ankara, TR)
Objective: To evaluate the effect of impregnation of fusidic acid
on adherence of slime poisitive S. epidermidis to peripheral
catheters in an in vitro model.
Methods: Segments of 0.5 cm of uncoated catheters were cut.
Both internal and external surfaces of these catheters were
coated with fusidic acid dispersed in polylactic acid/dichloro-
methane solution. Fusidic acid release experiments were per-
formed under unstirred conditions at pH 7.4 as a physiological
buffer. Fusidic acid-impregnated catheters were added to the
release medium. At predecided intervals, samples were with-
drawn and the release of fusidic acid in the buffer solution was
followed by UV spectrophotometer at 250 nm. The cumulative
fusidic acid released into the medium from catheters was
measured as a function of time. Fusidic acid impregnated and
naive cahteters were incubated in Brain Heart Broth containing
104 cfu/ml slime positive S. epidermidis. At intervals of 12, 24,
48, 72 hours catheters were washed and vortexed for two
minutes in 1 ml of physiologic saline. 100 microliter of samples
of vortexed material and Brain Heart Broth were incubated in
blood agar. 24 hours later colony numbers were assessed.
Results: Growths at 12, 24, 48, 72 hours were, 104, 105, 105, 105
colony/ml, and 10, 0, 0, 0 colony/ml, in naive catheters and
impregnated catheters, respectively. No bacteria was cultivated
from the Brain Heart Broth containing fusidic acid impregnated
catheters 24 hours afterward.
Conclusion: Adherence of slime positive S. epidermidis to
catheter in in vitro conditions was restricted with fusidic acid
impregnation.
P1767
Impregnation of polypropilen graft with gold-
palladium decreases staphylococcal graft
infection in vivo and in vitro
O. Saygun, C. Agalar, K. Aydinuraz, S. Ceken, A. Akkus,
C. Daphan, F. Agalar (Kirikkale, TR)
Objective: To evaluate the local anti staphylococcal activity of
gold and gold-palladium in an established in vitro and in vivo
model.
Method: In vitro: Naive, gold and gold-palladium coated
polypropilen grafts of 2 · 1 cm2 were incubated in physiologic
saline buffered, 0.5 McFarland slime positive S. epidermidis. At
intervals of 6, 12, 24, 48, 72 hours grafts were washed with saline
and vortexed for two minutes in 2 ml of physiologic saline.
100 l litres of samples of vortexed material were incubated in
blood agar. 24 hours later colony numbers were assessed.
In vivo: Naı¨ve polypropylene, gold coated and gold and
palladium coated grafts were incubated with slime positive S.
epidermidis. 24 hours later grafts were inserted subfascially to the
groins of Wistar rats under general anesthesia. 8 days after
inoculation of grafts, rats were killed and macroscopic and
microbiologic examinations were performed.
Results: In vitro: The least bacterial growth was detected in the
samples obtained from gold-palladium coated grafts, where as
the highest rate of growth was found in samples of naive grafts.
In vivo: 8 days after inoculation, in naive polypropylene group,
all groin incisions were infected with staphylococcus. The graft
infection rate was 100%. This ﬁnding was shown by microbi-
ologic cultures and macroscopic examination of the wounds. No
mortality occurred in this group. In palladium- gold impregna-
ted group wound infection rate was 0%, where as this ﬁgure was
30% for gold plated group.
Conclusion: Impregnation of polypropylene graft with gold-
palladium reduces the wound infection rate in vivo and in vitro.
P1768
There is no correlation between the minimal
inhibitory concentration of teicoplanin against
Staphylococcus epidermidis and efﬁcacy in the
mouse sepsis/peritonitis model
E. Batard, M.E. Juvin, C. Jacqueline, G. Potel,
H. Drugeon (Nantes, F)
Objectives: The predictive value of teicoplanin Minimal Inhib-
itory Concentration (MIC) for clinical efﬁcacy in the treatment of
Staphylococcus epidermidis infections has been questioned. We
aimed to assess the relation between the MIC and experimental
in vivo efﬁcacy of teicoplanin against Staphylococcus epidermidis.
Methods: We selected 7 clinical strains of Staphylococcus epider-
midis with MICs of teicoplanin ranging from 0.25 to 32 mg/L.
Two ciproﬂoxacin-resistant mutants (strains 15657 and A1894)
were respectively obtained from wild-type strains 7453 and
7318. MICs were determined by agar dilution. Cyclophospha-
mide pre-treated female 20-gram Swiss mice were inoculated
intraperitoneally with 2 107 CFU. Antibiotics (teicoplanin or
ciproﬂoxacin, used as a control antibiotic) were administered
subcutaneously at increasing concentrations immediately and
4 h after inoculation. Median effective doses (ED50) were
calculated from mortality at day 6. Correlation was tested
between log2 transformed MIC and ED50.
Results: MICs and ED50s are reported in the table. There was a
signiﬁcant positive correlation between log2 MIC and ED50 for
ciproﬂoxacin (r2 = 0.79, p = 0.005), but not for teicoplanin
(r2 = 0.35, p = 0.18).
Strain
Ciproﬂoxacin
MIC (mg/L)
Ciproﬂoxacin
ED50 (mg/kg)
Teicoplanin
MIC (mg/L)
Teicoplanin
ED50 (mg/kg)
7453 0.125 14.5 0.25 45.6
7318 0.125 2.3 0.5 2.3
7026 1 18 4 23.2
7418 2 >50 32 4.8
7371 4 >50 16 1.9
15657 8 >50 Nd nd
A1894 8 >50 Nd nd
5331 32 >50 4 5.3
5056 Nd nd 4 1.5
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Conclusion: Our data suggest a lack of correlation between
MIC of teicoplanin and in vivo activity in the mouse sepsis/
peritonitis model. Further experimental and clinical studies are
needed to determine the impact of elevated MICs of teicoplanin
against Staphylococcus epidermidis.
Adverse drug reactions, probiotics
P1769
Impact of adverse drug events on resource
consumption: amoxicillin-clavulanate vs
gemiﬂoxacin
S.M. Bhavnani, G.L. Drusano, P. Ambrose (Albany, USA)
Background: Morbidity and mortality associated with ADEs
cost > $136 billion annually in the US (Arch Intern Med 1995;
155:1949). Major contributors to these costs are increased
hospital admissions and lengths of stay, medical procedures,
and medicinal therapy related to the ADE. Despite these
observations, speciﬁc cost data associated with a given ADE
category are limited.
Methods: Data, including the nature and body system of the
ADE, clinical actions, and associated medical procedures and
therapy, were obtained from a double-blind Phase 3 clinical trial
comparing AC to GEM for the treatment of community-acquired
pneumonia. Only those ADEs with probable or suspected
associations with study drug and requiring treatment were
evaluated. Medical procedure fees and drug costs, based on the
2004 US Medicare database and Red Book, respectively, were
used to construct speciﬁc ADE cost ($US) distributions, which
were then compared across body systems and between study
drugs within a body system.
Results: Of the 320 patients who received at least 1 dose of
study drug, 246 had 1 or more ADEs (totaling 712 ADEs). Of
these, 43 ADEs from 34 patients were associated with study
drug and required a medical procedure (AC, 2; GEM, 4) and/or
medicinal therapy (AC, 29; GEM, 12) (AC, 29/336; GEM, 14/376;
p = 0.006). None required prolonged hospitalization. ADEs
commonly involved the gastrointestinal (GI) tract (44%) and
skin (19%). Across all ADEs, the median cost/event was $8.80
(range 0.24–1077.09) (Figure). For GI ADEs, the median cost/
event for AC was $3.04 (range 0.24–24.30) and for GEM was
$3.43 (range 0.88–454.26) (NS). For skin ADEs, the median cost/
event for AC was $12.63 (range 2.00–178.74) and for GEM was
$4.92 (range 1.51–7.62) (p = 0.1). Assuming a standard course of
AC or GEM costs $65/patient, ADEs added 12% ($8.01) to
antibiotic treatment costs.
Conclusions: A greater proportion of ADEs associated with
drug and requiring treatment were observed for AC than GEM.
While no difference existed in treatment costs of GI ADEs
between agents, a trend toward lower median treatment cost for
skin reactions was apparent for GEM. Analysis of larger
databases will allow for better resolution of speciﬁc ADE cost
distributions. Given that the cost of treating ADEs is an
important economic determinant, such data will allow for
improved pharmacoeconomic models for health maintenance
organizations, governmental agencies, formulary-decision
makers, and clinicians.
P1770
Fluoroquinolone-associated anaphylaxis in
spontaneous adverse drug reports
A. Barger, S. Riegel, H. Merck, J. Beckmann, B. Sachs (Bonn,
Aachen, D)
Objectives: Anaphylaxis has been reported associated with the
intake of ﬂuoroquinolone (FQ) antibiotics. According to patho-
physiology such reactions may be immune-mediated (anaphy-
lactic) or result from direct stimulation of effector cells
(anaphylactoid). Both mechanisms produce the same clinical
picture of anaphylaxis, however, anaphylactoid reactions may
occur after ﬁrst intake since no sensitization phase is necessary.
In Germany, numerous cases of suspected ADRs are reported
spontaneously to the Federal Institute for Drugs and Medical
Devices and registered in a large ADR data base. The aim of the
study was to analyze all cases of FQ-associated anaphylaxis
contained in the BfArM database with respect to previous
exposition, time to onset and other determinants.
Methods: All FQ-associated cases of anaphylaxis, anaphylactic
shock, anaphylactic/anaphylactoid reaction reported to the
BfArM between 1993 and 2004 were identiﬁed and assessed
with regard to correctness of diagnosis and causal relation.
Further analyses were performed in deﬁned subgroups.
Results: 172 cases reporting the aforementioned terms were
identiﬁed. In 152 cases correctness of diagnosis and causal
relation was considered at least as possible and further analyses
were restricted to this subgroup. Administration of moxiﬂoxacin
was reported in 75/152 cases (49%), and this ﬁgure did not seem
to be matched by a comparable high number of exposed
patients. Levo-, cipro-, and oﬂoxacin accounted for 25 (16%), 21
(14%) and 17 (11%) of the 152 cases, respectively. Intake of other
FQs was reported in 14/152 cases (9%). Occurence of the ADR
after the ﬁrst dose or within the ﬁrst three days was reported in
63/152 cases (41%), but no information on pre-exposure with
this or any other FQ was provided with these reports. In 20/152
cases (13%) the reaction occurred within the ﬁrst three days and
it was stated, that the respective FQ has never been taken before,
although previous administration of a different FQ was not
explicitly excluded. In 1/152 cases (0.7%) it was stated explicitly,
that no FQ has ever been taken before.
Conclusions: Anaphylaxis appears to be an ADR of the class of
FQs. Time to onset is compatible with an underlying anaphy-
lactoid mechanism in a relevant number of cases. Differences in
reported frequencies constitute a signal for the true differences
and should be further investigated.
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P1771
Amoxicillin and Co-amoxiclav
(amoxicillin + clavulanic acid): differences in
adverse drug reactions type and seriousness
extrapolated from an Italian inter-regional
database
M.A. Catania, F. Salvo, G. Polimeni, I. Meneghelli, L. Magro,
S. Colcera, A.P. Caputi (Messina, Verona, I)
Objectives: Amoxicillin (4.0 DDD/1000 inhabitants/die) and
co-amoxiclav (5.3 DDD/1000 inhabitants/die) are antibiotic
drugs largely prescribed for the same indications in Italian
medical practice (year 2003). The co-amoxiclav is also the ﬁfth
drug for public health spending and alone represents the 71%
on the total amount of expenses for penicillin class. Aim of the
present study was to investigate adverse events caused by
them and reported through the Italian spontaneous reporting
system.
Methods: The Pharmacovigilance Inter-regional Group (GIF)
database contains 31.000 reports of adverse drug reactions
(ADRs), related to ~25,000,000 inhabitants (43% of Italian
population), collected from 1988 to now. From this database,
amoxicillin and co-amoxiclav reports were extrapolated. Partic-
ularly, ADRs seriousness was estimated, comparing adverse
reactions reported for both antibiotics.
Results: The number of reports relating to amoxicillin and co-
amoxiclav is almost the same (986 vs 923, respectively). In the
ADRs reported, the mean age of patients is similar (amoxicillin:
42.3 ± 22.9; co-amociclav: 42.8 ± 22.8). Co-amoxiclav caused
haematologic, hepatic and gastroenteric ADRs more often than
amoxicillin (2.3% vs 0.9%, 3.6% vs 0.6%, 13.7% vs 7.8%,
respectively). Serious haematologic and hepatic ADRs were
signiﬁcantly higher following co-amoxclav than following
amoxicillin (2.2% vs 0.9%, 2.5% vs 0.4%, respectively). Examples
of difference between co-amoxiclav and amoxicillin are the
following: hepatitis (15:1), cholestatic hepatitis (7:2), jaundice
(4:10), purpura (13:5) and Stevens-Johnson Syndrome (10:2).
Conclusion: These data indicate a different safety proﬁle
between amoxicillin and co-amoxi-clav. The latter was respon-
sible for more serious adverse reactions. Thus, in therapeutic
choice, this difference should be borne in mind.
P1772
The genotoxic effect of ribavirin in the patients
with Crimean-Congo haemorrhagic fever
A. Tatar, Z. Ozkurt (Erzurum, TR)
Objectives: Ribavirin (RBV) is a synthetic purine nucleoside
analogue with a broad spectrum. RBV is used to therapy of viral
infections because it prevents replication of a large variety of
viruses. It has a lot of adverse effect such as haematologyc
toxicity, mitochondrial toxicity, liver toxicity and teratogenicity.
Since it has not been studied enough, the genotoxicity of RBV
has not been known exactly. We aimed to seek the genotoxicity
of RBV.
Methods: Three patients with Crimean-Congo hemorrhagic
fever diagnosed clinically, laboratory and microbiologically
were included in this study. The diagnosis was conﬁrmed by
ELISA. RBV was used for therapy at high dose (after 2000 mg
initially dose, 1000 mg per 6 hours at ﬁrst 4 days, and 500 mg
per 6 hours 6 days). In these patient, we studied the mutagenic
effects of RBV with 2 methods; the MN assay and the SCE
method. In the 9th day of the therapy and after one month
following the therapy, 2 ml perypheral blood was taken from
these patients and two different blood culture for each patient
carried out for 3 days. The ﬁrst culture used to SCE studies and
the second culture used to micronuclei studies. For SCE studies;
1ml perypheral blood and 5-BromodeoxyUridine were added to
15 ml falcon tupe including 5 ml culture medium. After 72
hours, the cultures were stopped and harvested. And then SCE
method was applied. For each patient, 20 metaphase sample was
examined and SCE rate was detected. For MN study, 1 ml
perypheral blood was added to 15 ml falcon tupe including 5 ml
culture medium. After 44 hours, cytochalasine-B was added to
the cultures and then the cultures was harvested at 72nd hour.
For each patient, 1000 binucleate cells were examined to
establish the frequency of micronuclei.Results: The results of
this study is shown as table.
Conclusion: We used two different methods to indicate the in
vivo genotoxicity of RBV. In all patients, the SCE rates at 9th day
of therapy were higher than the rates after one month following
therapy. In the same way, the MN amounts increased at 9th day
of therapy but they were regress to normal levels after one
month. The results of this two studies were appeared the in vivo
toxicity of RBV. Although the number of patient was inad-
equate, the presence of in vivo genotoxicity was supported by
concordance between the results of MN method and of SCE
method.
P1773
Safety of probiotics – a surveillance study of
lactobacilli induced bacteraemia
A˚. Sullivan, C.E. Nord (Stockholm, S)
Objectives: To determine the incidence of bacteraemia caused
by lactobacilli in Stockholm, Sweden, between January 1998 and
March 2004, and to identify the possible presence of the
probiotic strains most commonly used in Sweden.
Methods: Strains of lactobacilli isolated at the two microbiolo-
gical laboratories of Karolinska University Hospital in Huddin-
ge and Solna, Stockholm, Sweden have been analysed. All
isolates were checked initially for growth on Rogosa- and MRS-
agar with and without vancomycin (20 mg/l). The plates were
incubated for 72 hours at 37C in anaerobic jars. Isolates growing
on Rogosa- and MRS-agar were further characterized biochem-
ically by API 50 CHL test kit. Strains of lactobacilli belonging to
the groups Lactobacillus paracasei, Lactobacillus acidophilus or
Lactobacillus rhamnosus according to the API test were further
analysed with molecular methodologies (randomly ampliﬁed
polymorphic DNA, RAPD-PCR or species-speciﬁc PCR fol-
lowed by pulsed-ﬁeld gel electrophoresis, PFGE) to ascertain
eventual similarities with the probiotic strains L. paracasei subsp.
paracasei F19, L. acidophilus NCFB 1748 and L. rhamnosus GG
(ATCC 53103). To secure an unbiased identiﬁcation of the
strains, positive and negative controls were randomly included
in the sample series.
Results: Lactobacilli were isolated in blood samples from 74
patients during the period January 1998 to March 2004. The
incidence remained at the same level during the period and
patients with lactobacilli induced bacteraemia constituted <1%
of the total numbers of patients with bacteraemia. Isolates from
59 of the patients were available for identiﬁcation. The majority
of strains belonged to L. paracasei ssp. paracasei (n = 14),
L. rhamnosus (n = 12), L. plantarum (n = 8) and L. acidophilus
(n = 5). L. paracasei subsp. paracasei F19 and L. acidophilus NCFB
1748 were not identiﬁed in any of the samples. The identiﬁcation
of possible L. rhamnosus GG strains is under investigation.
Conclusion: The introduction of probiotic strains in food is
Sweden has not led to an increased incidence of lactobacilli
induced bacteraemia in Stockholm.
Abstracts
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P1774
Effects of oral Bifﬁdobacterium lactis on the
faecal ﬂora and the growth of preterm infants
A. Giakoumatou, E. Stratiki, K. Kouirouxis, S. Sevastiadou,
H. Prifti, V. Petrocheilou, C. Costalos (Athens, GR)
Objectives: The aim of this study was to evaluate the effect of
Bifﬁdobacterium lactis (BL) supplementation on the intestinal
microﬂora balance of preterm infants and its contribution to
maintaining health.
Methods: In a prospective randomized study 35 healthy infants
of less than 2080 g birth weight, with gestational age 28–35
weeks were included. Eighteen infants received a preterm milk
formula to which BL was added (group A), whereas the other 17
infants were fed an unsupplemented formula (controls, group
B). Feacal ﬂora was examined three times a) before treatment, b)
on day 7 and c) on day 21 after the onset of enteral feeding, for
quantitative aerobic and anaerobic cultures. BL tolerance and
growth rates were also evaluated.
Results: Enterobacteria and enterococci were the ﬁrst genera to
appear on stools after birth. Both persisted as the predominant
organisms in the feacal ﬂora of both groups. An increase in
species number was noted in infants of group A by day 7 and
became signiﬁcant by day 21, being mainly the result of
increased Gram (+) and anaerobic species. More speciﬁcly, by
the third week, infants in this group attained signiﬁcantly higher
mean log colony forming units (CFU) for biﬁdobacteria and
lactobacilli compared to group B (9.7 ± 0.402 vs 8.9 ± 1.152
(P < 0.05) and 9.6 ± 0.413 vs 8.5 ± 0.901 (P < 0.05) respectively).
In addition, the number of staphylococci in stools was
signiﬁcantly lower in BL group compared to controls
(42 ± 1.658 vs 8.1 ± 1.493) (P < 0.05). No yeasts were found in
the BL group, whereas in group B candida spp. were recovered at
a rate of 11.7% of infants studied. There was no remarkable
difference in weekly weight, length and arm circumference gain.
Head circumference was signiﬁcantly higher in infants treated
with BL formula than controls by day 21(mean ± SD, 33 ± 1.6 vs
32.5 ± 1.3 P < 0.05). Moreover, BL was well tolerated in all
infants included.
Conclusions: A BL supplemented milk formula appeared to
affect neonatal intestinal colonization patterns, increasing anaer-
obic ﬂora and decreasing staphylococci and yeasts. It was also
well tolerated in preterm infants.
Antibiotic-resistant community-acquired pathogens – II
P1775
Antimicrobial susceptibility of bacterial enteric
pathogens isolated in humans from 2002 to 2004
in the Province of South-Kivu, Democratic
Republic of Congo
N. Zozo, O. Vandenberg, P. Mitangala, P. Donnen, M. Wouafo,
A. Aı¨dara-Kane, J. Butzler (Bukavu, CD; Brussels, B; Goma, CD;
Yaounde, CMR; Geneva, CH)
Objectives: Diarrheal diseases represent a major health prob-
lem in Africa where they account for 15% of all deaths in
children. However, little data’s are available on the antibiotic
resistance of bacterial enteric pathogens in African countries. To
develop guidelines for the management of gastroenteritis in the
province of South-Kivu, Democratic Republic of Congo, a
provincial survey was conducted to determine the antimicrobial
susceptibility patterns of enteric pathogens isolated between
2002 and 2004.
Methods: During the study period, all bacterial enteric patho-
gens isolated from blood or stool specimens received at the
Provincial Public Health Reference laboratory were identiﬁed
using conventional laboratory methods. Antimicrobial suscep-
tibility tests were performed by disk diffusion method following
the recommendations of the NCCLS. The antimicrobial drugs
tested were ampicillin (AM), ceftriaxone (CTX), chloramphen-
icol (CL), ciproﬂoxacin (CI), co-trimoxazole (SXT), tetracycline
(TC), erythromycin (EM) and amikacin (AK).
Results: Among the 182 bacterial enteric pathogens studied,
Salmonella spp. (53.3%) were the most commonly identiﬁed,
followed by Vibrio cholerae (20.9% ), Campylobacter spp. (20.3%),
and Shigella spp. (5.5%). Eighty-nine per cent of salmonellae
isolates were multidrug resistant with the following proportion
of resistant strains to: AMP (92.5%), CL (94.0%), SXT (93.8%),
and TC (60.0%). Resistance to CI was uncommon in Salmonella
spp. (1.2%) but detected in 16.2% of Campylobacter. All Campy-
lobacter strains were susceptible to EM but 21.6% and 5% of them
were resistant to AM and TC respectively. Most of Vibrio cholerae
isolates were resistant to CL and SXT but sensitive to AM, CI, TC
and AK. Resistance to CI, AK and CTX was not detected in
Shigella isolates but all of them were resistant to SXT.
Conclusions: Due to the high prevalence of multidrug resist-
ance, third generation cephalosporins or ﬂuoroquinolones are
now the drug of choice to treat severe Salmonella infection in the
province of South-Kivu. Quinolones should be used with
caution as empirical therapy for dysentery because of the
increasing incidence of ciproﬂoxacin resistance in Campylobacter.
Erythromycin remains the agent of choice for campylobacter
infection.
P1776
Surveillance of antibacterial resistance in major
pathogens of community-acquired respiratory
tract infections in Moscow, Russia, 2004
S.A. Grudinina, O.Y. Filimonova, S.V. Sidorenko (Moscow, RUS)
Objectives: Streptococcus pneumoniae, Haemophilus inﬂuenzae and
Streptococcus pyogenes a are key pathogens of community-
acquired respiratory tract infections. The objective of the study
was to determine the prevalence of resistance against commonly
used antibiotics.
Methods: From January to November 2004 clinically signiﬁcant
isolates of respiratorypathogens from8hospital laboratorieswere
sent to a central laboratory for re-identiﬁcation and susceptibility
testing using the microdilution method according to NCCLS
recommendations. Antibiotics tested were: penicillin G (Pen),
amoxicillin (Amx), amoxicillin/clavulanic acid (Amc), ampicillin
(Amp), cefotaxime (Ctx), cefuroxime (Cef), erythromycin (Ery),
clindamycin (Cli), levoﬂoxacin (Lev), ciproﬂoxacin, trimetho-
prim/sulfamethoxazole (Stx), tetracycline (Tet). The ermA, ermB
and mefA genes were ampliﬁed using speciﬁc primers. Produc-
tion of beta-lactamase was detected by nitroceﬁn.
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Results: Susceptibility rates of S. pneumoniae (n = 225) were
as follows: Pen 89.5%, Amx 100%, Ctx 100%, Ery 94.8%, Cli
95.6%, Lev 100%, Tet 80.3%, and Stx 65.5%. Among 6 high-
level Pen-resistant strains all were Ery and Tet-resistant, and
4 were Stx-resistant. In 9 of 11 Ery-resistant strains ermB and
mefA genes were detected simultaneously, in one strain only
mefA was detected and in one – only ermB. 23F and 19F
serotypes were prevalent among resistant strains. H. inﬂuen-
zae isolates (n = 155) showed the following susceptibility
rates: Amp 95.6%, Amk 100%, Ctx 100%, Cip 100%, Tet
99.4% and Stx 69.8%. Beta-lactamase production was detected
in 2 of 5 Amp-resistant isolates. One isolate demonstrated
Cip MIC = 1.0 mg/l. Susceptibility rates of S. pyogenes
(n = 89) were as follows: Pen 100% Ery 93.3%, Cli 98.9%,
Tet 44.9% and Lev 100%. One isolate demonstrated Lev
MIC = 2.0 mg/l.
Conclusions: With the exception of Tet and Stx the prevalence
of resistance among major respiratory pathogens in Moscow
remains relatively low in comparison with other parts of the
world.
P1777
Community-acquired pneumococcal pneumonia
in Germany: ﬁrst results of the CAPNETZ study
M. van der Linden, A. Al-Lahham, N. Neuberger, S. Barbosa,
C. Heeg, R.R. Reinert (Aachen, D)
Introduction: Streptococcus pneumoniae is considered to be one
of the major causative agents of community acquired pneu-
monia (CAP) infections. CAPNETZ was conducted in 2003 to
collect and analyze all possible clinical and microbiological
data of patients with CAP. These are the ﬁrst data on the
pneumococcal pneumonia patients showing the resistance
and clonal relatedness of the pneumococcal isolates using
MLST.
Methods: Isolates of S. pneumoniae were sent to the NRCS in
Aachen-Germany for conﬁrmation of species diagnosis by
optochin testing, bile solubility and for serotyping by the
Neufeld Quellung reaction. MICs of penicillin G (PEN), cefo-
taxime (CEF), erythromycin A (ERY), clindamycin (CLI), tetra-
cycline (TET), telithromycin (TELI), and ciproﬂoxacin (CIP)
were determined using the microdilution method according to
the latest NCCLS guidelines. All included strains of S. pneumo-
niae were analysed for clonal relatedness using the multilocus
sequence typing methodology. Isolates resistant to macrolides,
tetracycline and ﬂuoroquinolones were checked for mechanisms
of resistance and resistance phenotypes.
Results: Between June 2003 and August 2004, 75 isolates were
included in the study. Resistance to antibiotics was as follows:
PEN (6.7%), CEF (0%), ERY (33.3%), CLI (9.3%), TET (10.7%),
TELI (0%), and CIP (0%). The predominant serotypes were: 14
(20%), 3 (13.3%), 19F (9.3%) and 11A (6.7%). 19 macrolide
resistant isolates were M-phenotypes and possessed the efﬂux
mechanism of resistance (mefE) and 6 were cMLSB with ermB.
Among macrolide resistant isolates, MLST 9 (England macrolide
R clone) was the most prevalent (60%) and was directly followed
by the Taiwan resistant clone MLST 242 (4%). The British
sensitive serotype 3 clone (ST 180) was the predominant MLST-
clone among sensitive pneumococcal isolates (10.7%).
Conclusions: Macrolide resistance is increasing drastically
in Germany and the most prevalent clone is the England clone
ST 9.
P1778
A comparison of trends in antibiotic resistance in
Staphylococcus aureus and Streptococcus
pneumoniae in the UK
L.A. Bishop, N. Alhaddad, T.L. Lamagni, A.P. Johnson (London,
UK)
Objectives: To compare the trends in methicillin resistance in
S. aureus and reduced susceptibility to penicillin and erythro-
mycin in S. pneumoniae in the UK between 1999 and 2004, using
the UK EARSS (European Antimicrobial Resistance Surveillance
System) dataset.
Methods: The UK has participated in EARSS since it began in
1999. Under the scheme, a network of sentinel laboratories
across the country sends information on all S. aureus blood-
stream infections and S. pneumoniae isolates from blood or
cerebrospinal ﬂuid to the Health Protection Agency Centre for
Infections. Data collected include the age and sex of the patient,
hospital department and antimicrobial susceptibilities of the
isolate. Laboratories may also include clinical information.
Results: The percentage of S. aureus isolates reported as
resistant to methicillin increased from 33.2% in 1999 to 44.9%
in the ﬁrst quarter of 2004, an average increase of 1.96% per
annum (p = 0.047, 95% CI 0.05–3.88%). The UK has one of the
highest proportions of methicillin resistant S. aureus (MRSA) in
Europe, ranking among the top ﬁve countries participating in
EARSS between 1999 and 2004. By contrast, the percentage of S.
pneumoniae isolates reported as non-susceptible (either resistant
or intermediate) to penicillin decreased from 7.1% in 1999 to
3.9% in the ﬁrst quarter of 2004, a signiﬁcant average annual
decrease of 0.61% (p = 0.012, 95% CI )(1.00% to )0.22%). For
each of the years 1999–2004, the UK percentage of penicillin non-
susceptible S. pneumoniae (PNSP) was ranked in the lower half
among countries participating in EARSS. There was no trend in
the percentage of S. pneumoniae isolates reported as resistant to
erythromycin (p = 0.53). In 1999, 14.8% of isolates were reported
as resistant to erythromycin with little ﬂuctuation in the
following years (15.2% resistant in the ﬁrst quarter of 2004).
Conclusion: In the UK very different trends have been seen in
two important antibiotic-resistant pathogens, MRSA and PNSP,
since 1999. While the percentage of S. aureus isolates resistant to
methicillin has increased, the percentage of PNSP has decreased,
with the proportion of erythromycin-resistant pneumococci
remaining stable. These trends may be related to differential
antibiotic prescribing between hospital and community envi-
ronments. The differences between these contrasting trends
merit further epidemiological investigation and analysis.
P1779
Evaluation of tet genes distribution in bacteria
isolated from milk samples of ovine herds
S. Lollai, M. Ziccheddu, D. Manunta, P. Zara, G. Marogna,
G. Leori (Sassari, I)
Objectives: The use of tetracycline, a broad-spectrum antimi-
crobial for animals and human therapy, can induce antimicro-
bial resistance (AR) in bacteria. AR genes, carried by mobile
elements, e.g. plasmids, transposons or integrons (Robert et al.,
2003), can be transmitted among different species and genera of
bacteria. Our work is an evaluation of the distribution of
tetracycline resistance genes in strains of Staphylococcus aureus,
Coagulase Negative Staphylococci (CNS), Streptococcus uberis
and Escherichia coli found in milk samples of sheep belonging to
extensive breeding where Somatic Cell Count was >1,000,000.
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Methods: 115 S. aureus, 146 CNS, 58 S. uberis and 10 E. coli,
identiﬁed by biochemical miniaturized system (API System) and
also coagulase test for staphylococci, have been screened for
tetracycline resistance by Kirby-Bauer method, according to
NCCLS Documents. Since several genes for tetracycline resist-
ance had already been detected (Chopra et al., 2001), resistant
strains were checked by PCR to evaluate the presence of the
following resistance genes: tetM, tetK, tetO and tetL in Gram
positive bacteria and tetA, tetB, tetC e tetE in E. coli, by using
primers proposed by Ng et al. (2001)
Results: 5 strains of S. aureus out of 115 (4.3%), 18 strains of CNS
out of 146 (12.3%), 4 strains of S. uberis out of 58 (6.9%), 3 strains
of E. coli out of 10, were resistant to tetracycline. All the
staphylococcus strains harboured the tetK gene (100%) while tetL,
tetO and tet M determinants were not detected; 3 strains of S.
uberis were positive for tetM gene and 1 strain harboured both
tetK and tetO; no one streptococcus harboured the tetL. In E. coli
resistance genes detected were tetA (2 strains out of 3) and tetB
(1 strain out of 3). tetC and tetE were not detected.
Conclusion: The tetK is the most representative plasmid har-
bouring gene in our Staphylococcus strains. It has been found
more in CNS than in S. aureus, suggesting that environmental
microbes, causing subclinical mastitis, may transfer easily
resistance genes more than microbes causing acute diseases.
Antibiotics in extensive sheep breeding are utilized in acute
disease only, other than in intensive breeding; it may explain the
lower diffusion of chromosomal resistance genes, as tetM.
P1780
Establishment of a network of laboratories
participating in the European Antimicrobial
Resistance Surveillance Scheme in Northern
Ireland
J. McCarroll on behalf of Northern Ireland EARSS participating
laboratories
In 2002, the Department of Health, Social Services & Public
Safety for Northern Ireland (DHSSPSNI) published its Antimi-
crobial Resistance Action Plan (AMRAP). This document out-
lined a three-year action plan with practical application over a
range of pertinent areas, including surveillance. Recommenda-
tion 6.6 stated that all Northern Ireland (NI) clinical laboratories
should be invited by CDSC (NI) to participate in the European
Antimicrobial Resistance Surveillance Scheme (EARSS).
Objectives: To recruit NI laboratories to EARSS, through
promotion of the beneﬁts of participation. To agree, in conjunc-
tion with key stakeholders, a minimum reporting dataset and
establish reporting arrangements. To develop, in conjunction
with key stakeholders, appropriate feedback material. To devise
a means of data collection, storage and analysis which would
facilitate all other objectives.
Methods: Consultant microbiologists were approached in wri-
ting, regarding the possible participation of their laboratories in
EARSS. They were given a copy of the EARSS newsletter and
Annual Report, provided by EARSS management team. Scien-
tists were identiﬁed as contacts for data collection issues in each
laboratory. The core dataset was agreed with each laboratory,
and a Microsoft Access database was developed to allow
transfer, storage and analyses of data. Feedback arrangements
are currently being developed with individual laboratories, to
suit their speciﬁc needs.
Results: All laboratories have agreed to join EARSS. To date, six
of nine (67%) laboratories are regularly reporting data to CDSC
(NI). It is anticipated that the remaining three laboratories will
have commenced reporting by January 2005. Most laboratories
report an enhanced dataset which permits more detailed
analyses to be performed and utilised at ward level. Data is
collected at NI level before being included in the United
Kingdom database for submission to EARSS.
Conclusions: Contribution to EARSS has led to a greater level
of discussion and harmonisation amongst microbiologists, and
has had a generally positive impact on Northern Ireland
laboratories. Regional management of the data in this way has
lead to a greater sense of ownership at local level, and had
permitted adaptation of outputs to suit local needs. Collection of
an enhanced dataset has allowed health Trusts to provide
clinicians with locally relevant, clinically-focused information
which can be used to effect change and improve practice.
P1781
Frequency and susceptibility to antimicrobial
agents of the Proteus genus strains isolated in
chronic middle ear disease
W. Amhis, M. Nain (Algiers, DZ)
Objectives: To evaluate the frequency of the species of Proteus
isolated in the chronic middle ear disease and their susceptibil-
ity to the antimicrobial agents.
Methods: From June 1997 to February 1998, all the patients
addressed to our laboratory for chronic middle ear were
questioned and a sample taken by a physician microbiologist.
The specimen was already seeded on different speciﬁc medium.
The strains isolated were identiﬁed with the biochemical
galleries (API 20E –Biomerieux) and their susceptibility to the
antimicrobial agents was evaluated by the disk diffusion
method according to the NCCLS.
Results: 130 patients have been addressed to our laboratory
during this period and 140 specimens analysed. The sex ratio
was: 1.18 (96/58). The infection rates were 84.61% (110/130
patients). 111 specimens out of 140 were positive (79%). In 5
specimens we isolated more then 3 bacterial species so they have
been done again. 125 strains were isolated 81 out of 125 strains
(64.8%) were represented by the most frequent which were:
Pseudomonas aeruginosa 46(56.79%) Proteus: 22(27.16%) and Sta-
phylococcus aureus 13(16%). These strains have been isolated
either alone or associated: Pseudomonas aeruginosa alone: 74%,
associated to another species:35%.Proteus alone: 65% associ-
ated:35%. Proteus was associated to Pseudomonas aeruginosa in 5
cases out of 7, once to Klebsiella pneumonia and once to Alkali
genes. Among the 22 strains of the Proteus Genus, 20 belonged to
the species mirabilis, 1 to vulgaris and 1 to penneri. The
susceptibility test of the Proteus mirabilis strains showed that:
20% of the strains were sensitive to all antimicrobial agents
tested. 35% were resistant to Ampicillin, 25% to Piperacillin, 20%
to Cefalotine and 10% to chloramphenicol. Moreover 100% of
Proteus mirabilis strains were sensitive to Cefotaxim, Gentamy-
cin, Amikacin and Peﬂoxacin, 70% to amoxicillin/clavulanic
acid, 75% to Cefoxitin and 95% to Cotrimoxazol.
Conclusion: The Proteus Genus and especially the species
mirabilis are frequently isolated in the chronic middle ear
disease. It occupies the second place just behind Pseudomonas
aeruginosa, with which he is often associated. Besides Proteus
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mirabilis remains relatively susceptible to the majority of the
antimicrobial agents tested.
P1782
Determination of ciproﬂoxacin resistance in non-
typhoidal Salmonellae in Scotland: 1993–2004
A. Murray, D.J. Brown, J. Taylor, H. Mather, J.E. Coia (Glasgow,
UK)
Objectives: To determine the levels of resistance to ciproﬂoxa-
cin among non-typhoidal salmonellae in Scotland.
Methods: E-test strips were used to determine the minimum
inhibitory concentrations (MICs) of ciproﬂoxacin for nalidixic
acid resistant salmonellae isolated from human, veterinary and
environmental sources between 1993 and 2004.
Results: Of 911 strains of Salmonella tested, 24 were resistant to
ciproﬂoxacin at the NCCLS breakpoint of 4 mg/L. A further 14
were resistant at the SSRL breakpoint of 0.5 mg/L, while 784
isolates had reduced susceptibility with MICs of greater than or
equal to 0.125 mg/L and less than to 0.5 mg/L.
Conclusions: These results show that very few non-typhoidal
strains of Salmonella in Scotland are resistant at the current
recommended breakpoint of 4 mg/L. The majority of strains
examined however, do show reduced susceptibility at
0.125 mg/L. This conﬁrms the necessity for continuing antimi-
crobial surveillance of resistance to this important antibiotic.
P1783
Combined resistance to penicillin and gentamicin
in community-acquired bacteraemia in
Copenhagen County, 1991–2000
J.M. Bangsborg, J.O. Jarløv, J. Scheibel (Herlev, DK)
Objectives: For several years, a combination of penicillin and
gentamicin has been our recommendation for the initial treat-
ment of community-acquired septicemia with an unknown
focus, supplemented with metronidazole if an abdominal or
genital focus is suspected. We sought to verify if this regime is
still valid according to resistance patterns and mortality over a
recent period of ten years.
Methods: From results registered in our laboratory database
(ADBakt), we analysed 6476 cases of community-acquired
bacteraemia (CAB), excluding contaminants, during Jan 1,
1991 to Dec 31, 2000 from the County of Copenhagen (three
hospitals, 2400 beds) for resistance patterns and clinical infor-
mation (initial antibiotic treatment given, follow-up treatment
and patient survival).
Results: Resistance to both penicillin and gentamicin were
found in 239 isolates, of which 191 were anaerobes sensitive to
metronidazol, and 48 isolates from 46 patients were facultative
or aerobic bacteria [Enterobacteriaceae (23), enterococci (8),
Staphylococcus aureus (1), coagulase-negative staphylococci (10),
Pseudomonas spp (2), Stenotrophomonas maltophilia (1), Streptococ-
cus pneumoniae (1), Mycobacterium fortuitum (1), and Haemophilus
inﬂuenzae (1)]. There was no increase in the occurrence of
microorganisms with resistance to both penicillin and gentam-
icin over the years. Most notably, the incidence of gentamicin-
resistant Enterobacteriaceae remained low (0–5/year). Forty-two
of the 46 patients survived, 31 receiving irrelevant or no
antibiotic treatment until diagnosis. Treatment according to
our recommendations was relevant in 99% of cases if strict
adherence to the guidelines, also with respect to the addition of
metronidazole, is presumed.
Conclusion: The incidence of CAB with aerobic and facultative
bacteria resistant to both penicillin and gentamicin remains low
in our county. Our recommendations for the initial antibiotic
treatment of community-acquired sepsis will remain
unchanged.
P1784
Macrolide resistance associated with chronic
azithromycin use in cystic ﬁbrosis
A. Ott, S.J. Phaff, H.A.W.M. Tiddens, H.A. Verbrugh (Rotterdam,
NL)
Objectives: To study the effects of chronic azithromycin use on
change over time in macrolide susceptibility of S. aureus and
Haemophilus spp in CF patients.
Methods:
Setting: Erasmus MC - Sophia Children’s Hospital. Materials:
All sputum cultures from CF-patients, obtained at routine visits
and at time of pulmonary exacerbations, cultured between
January 1999 and March 2004. The study period was divided in
octiles of 240 days. S. aureus and Haemophilus were cultured on
selective media. Antibiotic susceptibility was tested routinely. A
random set of S. aureus and Haemophilus strains from non-CF
patients, cultured during the same period, was used as controls.
Azitromycin use in CF started in January 1999 and increased
gradually. In March 2004 one-third of patients was on mainten-
ance therapy. Cultures were classiﬁed as from non-azitro (NA),
azitro (AZ), or post-azitro (PA) user. Cultures were classiﬁed AZ
until one month after azitro was stopped.
Results: During the study period 2522 sputum cultures were
received from 155 patients (mean 16.3, range 1–111 cultures). In
699 (27.7%) of these cultures we grew S. aureus (713 isolates) and
in 524 (20.8%) Haemophilus spp (537 isolates). Erythromycin
resistant S. aureus was found in 2.8% of NA, 8.7% of AZ, and
15.4% of PA cultures. Among all strains resistance increased
from 8% (octile 1) to 52% (octile 8). Clarithromycin resistant
Haemophilus spp were found in 2.4% of NA, 2.4% of AZ, and
7.7% of PA cultures. Clarithromycin resistance increased from
5% of the strains (octile 1) to 40% (octile 8). Both of 2140 non-CF
S. aureus and of 3015 non-CF Haemophilus control strains 8% was
resistant. No increase in resistance was observed in these strains.
Not only in AZ strains, but also in NA strains resistance
increased signiﬁcantly over time (Chi square for trend
p < 0.0001 for both S. aureus and Haemophilus).
Conclusion: Over a 4-year period we noticed a 6–7 fold increase
in macrolide resistance in CF pulmonary pathogens, associated
with chronic use of azithromycin. Increasing resistance in strains
from patients not using azitro could only partly be explained by
former use.
P1785
Trends in antimicrobial resistance among
Escherichia coli in Europe reported via the
European Antimicrobial Resistance Surveillance
System (EARSS)
E. Tiemersma, N. Bruinsma, J.C.M. Monen, J.E. Degener,
H. Grundmann and EARSS participants
Objectives: The prevalence of ﬂuoroquinolone resistant Escheri-
chia coli has been increasing in Europe in recent years. This trend
might have led to the use of newer antimicrobial drugs and thus,
increasing resistance to e.g. third generation cephalosporins and
possibly, multiple drug resistance. We explored trends of
antimicrobial resistance among invasive E. coli isolates reported
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through the European Antimicrobial Resistance Surveillance
System (EARSS), focusing on resistance to third generation
cephalosporins and on multiple drug resistance.
Methods: Participating laboratories carry out routine antimi-
crobial susceptibility testing for invasive E. coli isolates. Data are
collected at national level and forwarded to the EARSS database.
Between 2001 and 2003, 502 laboratories from 25 countries
reported susceptibility results for 58,061 E. coli isolates. Test
results were available for aminopenicillins (92% of the isolates),
3rd generation cephalosporins (95%), ﬂuoroquinolones (91%)
and aminoglycosides (97%). Multiple drug resistance was
deﬁned as resistance to at least 3 drugs. Trends in resistance
were calculated using the Cochran Armitage test (two-sided
p < 0.05).
Results: From 2001 to 2003, 7 countries (Austria, Bulgaria,
Spain, Finland, Croatia, the Netherlands and Portugal) wit-
nessed a signiﬁcant increase in resistance to third generation
cephalosporins, whereas resistance decreased in Czech Republic
and Slovakia. Eighty-one per cent of the isolates was tested for
all 4 antibiotics included in the EARSS protocol, of which 50%
were susceptible to all antibiotics. Multiple drug resistance
occurred in 4% of these isolates and increased in most countries.
Statistically signiﬁcant increases were reported from Bulgaria,
Finland, Hungary, the Netherlands and Sweden. Fluoroquino-
lone resistance continued to increase in 15 countries and reached
statistical signiﬁcance in 7 (Austria, Bulgaria, Czech Republic,
Germany, Spain, Hungary and Sweden). No country showed a
signiﬁcant decrease in resistance proportion.
Conclusions: E. coli is rapidly becoming a difﬁcult-to-treat
organism in many countries. Next to common resistance to
aminopenicillins, resistance rates to ﬂuoroquinolones and to
third generation cephalosporins are increasing. Furthermore,
co-resistance to several drugs apparently becomes more
common in many European countries, including countries
with low resistance rates.
P1786
Multi-resistance in E. coli – an underestimated
therapeutic problem? Epidemiological results
from the GENARS Project
I. Noll, J. Beer, K. Huppertz, W. Pﬁster, T. Pietzcker, S. Schubert,
T.A. Wichelhaus, S. Ziesing, B. Wiedemann (Bonn, Leipzig, Jena,
Ulm, Kiel, Frankfurt a.M., Hannover, D)
Objectives: E. coli strains are naturally sensitive for most
clinically used antibiotics, except for those used only for
infections with gram positive bacteria. Statistics on bacterial
resistance usually focus only on the percentage of resistance of a
species to single drugs. In these statistics resistance to ampicillin,
tetracyclin and cotrimoxazole is usually high but resistance to
3rd generation cephalosporins, aminoglycosides and even ﬂuor-
inated quinolones are usually rather low, suggesting that E. coli
does not cause therapeutic problems due to the development of
resistance. However, multi-resistant strains become more and
more common, causing severe therapeutic problems. Therefore
we wanted to analyze the datapool of the GENARS project for
the incidence of multi-resistant E. coli strains.
Methods: Analysis was based on ﬁrst isolates of E. coli from six
laboratories, collected from January 2002 to June 2004. Minimal
inhibitory concentrations (MICs) were determined by broth
microdilution method for ceftazidime (CAZ), cefotaxime (CTX),
ciproﬂoxacin (CIP), gentamicin (GEN), meropenem (MER) and
piperacillin (PIP). Resistance patterns were evaluated by using
breakpoints according to DIN, grouping resistant and interme-
diate as non-susceptible; multi-drug resistance was deﬁned as
non-susceptibility to at least four of the six agents.
Results: A total of 13,544 isolates was analysed. 45.5% of these
isolates were non-susceptible to at least one agent. The ranking
of the ﬁve most frequent resistance patterns was: PIP (26.7%),
PIP/CIP (6.0%), GEN (3.2%), PIP/CIP/GEN (3.0%) and PIP/
GEN (2.6%). 0.9% of the strains were classiﬁed as multi-
resistant; 3 strains were resistant to all six antibiotics. There
were no signiﬁcant differences in multi-drug resistance rates
neither between ward types nor between the centers involved.
Conclusions: Multi-resistant, untreatable E. coli strains are still
not too common. In the hospitals under investigation, no
outbreaks with multi-resistant strains could be observed.
These strains seem to be developed by individual patients
with severe underlying diseases. However it cannot be exclu-
ded, that such strains become a commensal of more patients in
their gut ﬂora and then can be selected during any antibiotic
treatment. Therefore these strains need signiﬁcant attention in
order to prevent their spread.
P1787
Sustained in vitro activity of telithromycin in
Germany: the PROTEKT study (Years 1–4)
R.R. Reinert, D. Felmingham, D.J. Farrell on behalf of the EU
PROTEKT Study Group
Objectives: PROTEKT – a global, longitudinal, international
surveillance programme established in 1999 to study the
antimicrobial susceptibility of common bacterial pathogens
associated with community-acquired respiratory tract infections
(RTIs) – has now completed its fourth year. This analysis of
PROTEKT Year (Y) 1 to 4 data from Germany was undertaken to
assess the susceptibility of key community-acquired RTI isolates
to the ketolide antibacterial, telithromycin, which was ﬁrst
introduced in Germany in October 2001.
Methods: Minimum inhibitory concentrations (MICs) of com-
munity-acquired RTI isolates collected within Germany as part
of the PROTEKT study over 4 consecutive respiratory seasons
(Y1: 1999–2000; Y2: 2000–2001; Y3: 2001–2002; Y4: 2002–2003)
were determined centrally using the NCCLS broth microdilu-
tion method and interpreted using NCCLS breakpoints.
Results: In total, 2139 isolates of Streptococcus pneumoniae (Y1:
325; Y2: 693; Y3: 623; Y4: 498), 1711 isolates of Haemophilus
inﬂuenzae (Y1: 284; Y2: 508; Y3: 512; Y4: 407) and 432 isolates of
Streptococcus pyogenes (Y1: 87; Y2: 119; Y3: 122; Y4: 104) were
collected from a total of 11 centres in Germany (7 centres in Y1;
11 in Y2 and Y3; 10 centres in Y4). Over the 4 years of the study,
(99% of pathogens were susceptible to telithromycin (Y1: 99.7%;
Y2: 99.7%; Y3: 100%; Y4: 99.6%). The mode MIC for telithromy-
cin against S. pneumoniae was 0.008–0.015 mg/L, while the
MIC90 ranged between 0.03 mg/L and 0.12 mg/L; in total,
99.95% (2138/2139) of isolates were susceptible to telithromycin
(MIC £ 1 mg/L). The mode MIC and MIC90 for telithromycin
against H. inﬂuenzae were 1 and 2 mg/L, respectively, for all 4
respiratory seasons. The mode MIC for telithromycin against
S. pyogeneswas 0.015 mg/L for all 4 years, with MIC90 values of
0.015–0.12 mg/L.
Conclusions: The ketolide telithromycin is highly active in vitro
against isolates of S. pneumoniae, H. inﬂuenzae and S. pyogenes
collected from 11 centres in Germany as part of the PROTEKT
study. Since its introduction in Germany in the third respiratory
season of the PROTEKT study (October 2001), the in vitro
activity of telithromycin against community-acquired RTI path-
ogens appears unchanged.
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P1788
Fluoroquinolone resistance in invasive
Escherichia coli in Europe is related to age and
gender
N. Bruinsma, G. Cornaglia, F. Baquero, G. Kahlmeter,
E. Tiemersma, H. Grundmann on behalf of EARSS participants
Objectives: For years ﬂuoroquinolones (FQs) have constituted
effective treatment of invasive Escherichia coli infections. E. coli is
the most common cause of both hospital and community-
acquired urinary tract infections, and the most frequent cause of
gram negative bacteraemia. However, in the data reported to the
European Antimicrobial Resistance Surveillance System
(EARSS), FQ resistance increases in all parts of Europe.
Methods: EARSS has collected routine FQ susceptibility results
of primary invasive E. coli isolates from blood or cerebrospinal
ﬂuid (CSF) since 1999. In the present study we related FQ
resistance to gender and age (chi-square test, 2-sided, p < 0.05).
The patients were divided into the following age groups:
<1 year, 1–14, 15–44, 45–64, and ‡65 years.
Results: For the period 2001–2003, FQ susceptibility test data
was reported for 51,001 E. coli isolates from 500 laboratories in 25
European countries. The overall proportion of FQ resistance was
11%, and was signiﬁcantly higher for men (13% of 22,515 E. coli
isolates) than for women (10% of 28,486 E. coli isolates). No
signiﬁcant differences were found between men and women
under the age of 15. The age groups <1 (3%), and 1–14 years
(7%) had a signiﬁcant lower proportion of FQ resistance
compared to the older patients (11%).
Conclusion: The signiﬁcant lower proportions of FQ resistance
in patients under the age of 15 ﬁts the limited use of FQ in this
age group. The signiﬁcantly higher proportion of FQ resistance
in men could be related to the higher likelihood of men being
infected with hospital strains, as women are more prone to
ascending urinary tract infections originating from the more
sensitive E. coli strains from normal gut ﬂora.
P1789
Increasing prevalence of beta-lactam resistant
Haemophilus inﬂuenzae in Japan: in vitro activity
of telithromycin and beta-lactam antimicrobials
over 4 years
H. Baba, M. Inoue, D.J. Farrell (Nagoya, Aichi, Kanagawa, JP;
London, UK)
Objectives: There has been a steady increase in the prevalence
of beta-lactam-resistant Haemophilus inﬂuenzae strains world-
wide. This increase is of particular concern in Japan, where beta-
lactams are commonly used for the empiric treatment of
community-acquired respiratory tract infections (CARTIs).
This analysis — part of the PROTEKT global surveillance
programme — assesses the in vitro activity of the ketolide,
telithromycin (TEL), against beta-lactamase-positive (BL+) and
BL-nonproducing ampicillin-resistant/intermediate (BLNAR/I)
H. inﬂuenzae strains isolated from patients in Japan.
Methods: H. inﬂuenzae isolates were collected over 4 years
(between 1999 [Year (Y) 1] and 2003 [Y4]) from adult and
paediatric patients with CARTIs at 12 centres in Japan (6 in Y1;
12 in Y2–Y4). Isolates were tested for BL production (by the
chromagenic nitroceﬁn method) and for nonsusceptibility to
ampicillin (AMP; MIC ‡2 mg/L). MICs for a panel of antibacte-
rials were determined centrally using the NCCLS broth microdi-
lution method and interpreted using NCCLS breakpoints.
Results: A total of 1833 H. inﬂuenzae isolates were collected over
4 years (Y1: 281; Y2: 442; Y3: 546; Y4: 564). The proportion of BL+
isolateswas8.5%,8.8%,9.7%and5.5%forY1,2, 3and4, respectively.
From Y1–Y4, isolates that were BLNAI (MIC 2 mg/L) increased
from 3.5% to 16.0%, and those that were BLNAR (MIC ‡ 4 mg/L)
increased from0.4% to2.5%.TheMIC50 for amoxicillin–clavulanate
(AMC) against all isolates increased from0.5 mg/L inY1 to 1 mg/L
inY4.Overall, 0.7%ofallH. inﬂuenzae isolateswere resistant toAMC
in Y1 (MIC ‡ 8 mg/L), increasing to 1.8% in Y4. Non-susceptibility
to cefdinir increased from 8.2% in Y1 to 20.4% in Y4. TEL showed
sustained invitroactivityagainstH. inﬂuenzae (MIC50 = 1 mg/Lfor
BL+ isolates) over the 4 years. Overall susceptibility for all isolates
was >99%, regardless of BL status.
Conclusions: The proportion of H. inﬂuenzae isolates from
patients in Japan thatwere BLNAI, BLNARor BL+ (and therefore
co-resistant to a number of other beta-lactams, including AMC
and cephalosporins) increased from ~12% in Y1 to 25% in Y4,
indicating that the empiric use of beta-lactams to treat CARTIs in
Japanmay be compromised. TELdemonstrated sustained in vitro
activity against H. inﬂuenzae, including BL+ strains (>99% of
isolates susceptible), and may be an option for empiric treatment
in areas with an increasing prevalence of BLNAR isolates.
P1790
TARGET Surveillance, a part of the LIBRA
initiative: comparative activity of moxiﬂoxacin
against respiratory pathogens isolated during
2003
I. Morrissey, M. McKeon, K. Dowling, A. Colclough, L. Viljoen,
T. Veltman (London, UK)
Objectives: To assess the antibiotic (ABX) susceptibility of H.
inﬂuenzae (HI) & S. pneumoniae (SP) isolates causing community-
acquired respiratory-tract infections (CARTI) in 2003.
Methods: 51 centres in 7 countries submitted 2925 HI and 3233
SP. MICs for penicillin G (PEN, SP only), ampicillin (AMP, HI
only), amoxycillin–clavulanate (AMX/C), azithromycin (AZI),
ceftriaxone (CTX), levoﬂoxacin (LEV), gatiﬂoxacin (GATI) &
moxiﬂoxacin (MXF) were determined by microbroth dilution.
Results: All HI were susceptible to AMX/C, CTX, LEV, GATI &
MXF. Beta-lactamase prevalence in HI was: France (32.8%), USA
(30.6%), Mexico (21.6%), Spain (15.2%), Germany (8.6%), Italy
(6.6%), & South Africa (7.8%). Fourteen AZI non-susceptible HI
were also found (0.5%). SP resistance (number of centres,
isolates per country) is shown below:
Conclusion: Full ABX susceptibility was seen with HI except
AMP due to beta-lactamase. However, universal susceptibility to
AZI is no longer guaranteed.With SP,AZI and/or PEN resistance
was high in many countries. Relatively high AMX/C & CTX
resistance was also found in South Africa. SP from Germany had
very low ABX resistance but resistance to AZI was observed.
Althoughﬂuoroquinolone resistancewas low, therewas evidence
of a gap emerging betweenLEV orGATI andMXF. Thiswasmost
% res
PDD subset (N) PEN AZI AMX/C CTX LEV GATI MXF
- Tot pop (3233) 22.1 34 0 5 0 1.8 1.3 1.1 0 3
Age 0-1 years (424) 38.4 49.8 12.5 4.5 0.2 0.2 0
2-5 years (317) 30.0 40.7 8.5 4.4 0.3 0 0
6-17 years (224) (21.0) 28.6 6.7 (2.7) (0.9) (0.9) (0.5)
18-64 years (1359) 18.0 (30.6) 2.9 (0.8) (1.8) (1.5) (0.3)
>64 years (884) 17.8 (30.2) 2.8 (0.9) (1.4) (1.2) (0.5)
Source Ear (330) 30.0 43.0 10.6 (3.6) (1.2) (1.2) (0.3)
Sinus aspirate (176) 30.0 44.9 9.7 (2.8) (0.6) (0.6) 0
Infection Acute otitis
media (306)
28.8 44.8 10.5 NS NS NS NS
Chronic ottis
media (63)
36.5 (36.5) 12.7 4.8 0 0 0
Acute sinusitis (217) (21.2) (35.5) (5 1) (3.2) 0 0 0
Acute tonsillitis (119) (20.2) (31.1) (8.0) (4.0) (0.8) 0 0
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prominent in Italy where LEV & GATI resistance was highest.
MXF is therefore an important option for the treatment of CARTI
especially where resistance to other ABX is high.
P1791
TARGET Surveillance, a part of the LIBRA
initiative: the comparative activity of
ciproﬂoxacin against urinary tract pathogens
isolated during 2003
I. Morrissey, K. Dowling, A. Colclough, M. McKeon, L. Viljoen,
T. Veltman (London, UK)
Objectives: To assess the prevalence of species and antibiotic
(ABX) susceptibility of pathogens causing outpatient (out) &
inpatient (in) urinary tract infections (UTIs) worldwide.
Methods: 41 centres in 7 countries submitted 6203 isolates (2518
in and 3677 out): France (6 centres, 922 isolates), Germany (5,
707), Italy (12, 1051), Mexico (3, 143), South Africa (2, 146), Spain
(3, 502) & USA (20, 2732). These were re-identiﬁed & MICs for
common oral and parenteral ABX were determined using
NCCLS broth microdilution assays.
Results: The most common species associated with UTIs (where
N > 100) was Escherichia coli (3743 isolates, 60.3%), followed by
Klebsiella pneumoniae (508, 8.2%), Proteus mirabilis (400, 6.4%),
Enterococcus faecalis (395, 6.4%), Pseudomonas aeruginosa (250,
4.0%), Enterobacter cloacae (144, 2.3%) & Klebsiella oxytoca (104,
1.7%). Generally lower antibacterial susceptibility was found with
inpatients compared with outpatients. Lower susceptibility was
also found tomanyAMs inMexico, SouthAfrica& Italy compared
with other countries. The most signiﬁcant difference was overall
TSXsusceptibility that reduced to 29.4%&34.9% inMexico&South
Africa respectively. Susceptibilities (in vs out) for orally available
ABXwere: ciproﬂoxacin (CIP, 79.8%vs 85.6%), ampicillin (43.9%vs
50.0%), amoxycillin–clavulanate (59.0% vs 65.4%), nitrofurantoin
(72.4% vs 78.6%), & trimethoprim/sulphamethoxazole (TMP/
SMX,65.1%vs68.8%). Susceptibilities forparenteral administration
only ABX were: piperacillin/tazobactam (82.2% vs 85.4%), gen-
tamicin (82.8% vs 86.8%), ceftriaxone (80.1% vs 88.1%), ceftazidime
(84.6% vs 88.4%) & imipenem (89.6% vs 91.9%).
Conclusion: CIP was the most active orally available ABX
against the total population of pathogens associated with UTIs
from 7 countries worldwide. CIP also showed good activity
compared to parenteral only ABX. This is important because CIP
is available in parenteral as well as oral formulation, thus
avoiding any oral-switch concerns that may be associated with
parenteral only antibacterial agents.
P1792
TARGET Surveillance, a part of the LIBRA
initiative: the effect of patient demography on the
antibiotic susceptibility of Streptococcus
pneumoniae from community-acquired
respiratory-tract infections
I. Morrissey, A. Colclough, K. Dowling, M. McKeon, L. Viljoen,
T. Veltman (London, UK)
Objectives: To assess antibiotic (ABX) resistance (res) in
S. pneumoniae (SP) collected in 2003 based on patient demogra-
phic data (PDD).
Methods: 512 centres in 7 countries submitted 3233 SP. Peni-
cillin G (PEN), amoxycillin–clavulanate (AMX/C), azithromycin
(AZI), ceftriaxone (CTX), levoﬂoxacin (LEV), gatiﬂoxacin (GATI)
and moxiﬂoxacin (MXF) MICs were determined. Specimen
source, infection type, age and gender PDD were collected and
res compared based on 95% conﬁdence intervals.
Results: Most PDD subset data was not statistically different
(NS) to that of the total SPpopulation (Tot pop). Results are shown
below (bold > Tot pop; italic > Tot pop; parenthesis = NS). Age
had themost signiﬁcant effect onABX res. PEN,AZI,AMX/Cand
CTXreswashighest in children<6 yearsold.AMX/Creswasalso
raised in children 6–17 years old but AZI res was NS. Res to PEN
or AMX/Cdecreasedwith adult patients. PEN, AZI andAMX/C
res was > the Tot pop in ear specimens and acute otitis media
(both associatedwith age) and sinus aspirate (not associatedwith
age). Res to PEN, AMX/C or CTX, but not AZI, increased in
chronic otitis media infection (associated with age). In contrast,
ﬂuoroquinolone (FQ) res, esp. MXF, was very low in the Tot pop
and even lower or zero in children <6 years old, sinus source/
infection, chronic otitis media or tonsillitis. None of these PDD
data was linked to country of origin.
Conclusion: Some patient subsets such as children <6 years or
all sinusitis patients (i.e. sinus aspirate source) have a greater
chance of harbouring PEN, AZI or AMX/C res SP than the Tot
pop. This was not the case with MXF or other FQ. This should be
taken into account when empirical ABX therapy is being
considered.
P1793
Antimicrobial susceptibility among invasive
Gram-negative bacteria in the UK and Ireland:
the BSAC Bacteraemia Resistance Surveillance
Programme 2003
R. Reynolds, R. Hope on behalf of the BSAC Working Party on
Bacteraemia Resistance Surveillance
Objective: To monitor prevalence of established forms of
resistance, detect emerging forms, and assess the activity of
newer antimicrobial agents.
Methods: Bacteraemia isolates were collected from 25 laborat-
ories in the UK and Ireland in 2003, excluding duplicates isolated
within one week. MICs were determined centrally using the
BSAC agar dilution method and interpreted by BSAC criteria.
Isolates with MICs on or above the susceptibility breakpoint for
ceftazidime (CAZ) or cefotaxime (CTX) were tested for ESBLs by
clavulanate synergy tests (potentiation of 8-fold or more) with
CAZ, CTX and cefepime. Results were compared with those
from similar surveillance in 2001 and 2002.
Results: Table 1 shows resistance rates to important antimicro-
bials (excluding tetracyclines and glycylcyclines, for which
breakpoints are not currently deﬁned). There were no statis-
tically signiﬁcant trends over the three-year period. The one
imipenem-resistant Enterobacter (MIC > 16 mg/L) produced a
novel KPC enzyme, KPC-4. Among Enterobacter spp., 32% were
CTX-resistant without producing ESBLs and were presumed to
be AmpC producers. Multi-resistant isolates with CTX-M
% res
PDD subset (N) PEN AZI AMX/C CTX LEV GATI MXF
- Tot pop (3233) 22.1 34 0 5 0 1.8 1.3 1.1 0 3
Age 0-1 years (424) 38.4 49.8 12.5 4.5 0.2 0.2 0
2-5 years (317) 30.0 40.7 8.5 4.4 0.3 0 0
6-17 years (224) (21.0) 28.6 6.7 (2.7) (0.9) (0.9) (0.5)
18-64 years (1359) 18.0 (30.6) 2.9 (0.8) (1.8) (1.5) (0.3)
>64 years (884) 17.8 (30.2) 2.8 (0.9) (1.4) (1.2) (0.5)
Source Ear (330) 30.0 43.0 10.6 (3.6) (1.2) (1.2) (0.3)
Sinus aspirate (176) 30.0 44.9 9.7 (2.8) (0.6) (0.6) 0
Infection Acute otitis
media (306)
28.8 44.8 10.5 NS NS NS NS
Chronic ottis
media (63)
36.5 (36.5) 12.7 4.8 0 0 0
Acute sinusitis (217) (21.2) (35.5) (5 1) (3.2) 0 0 0
Acute tonsillitis (119) (20.2) (31.1) (8.0) (4.0) (0.8) 0 0
Clinical Microbiology and Infection, Volume 11, Supplement 2, 2005
591
ESBLs were noted ﬁrst in this surveillance in 2002 and
persisted in 2003; all remained susceptible to imipenem and
ertapenem, and were inhibited by tigecycline at or below
2 mg/L.
Conclusion: Although there was no clear increase in preval-
ence of resistance in these major Gram-negative agents of
bacteraemia, beta-lactamases have continued to evolve and
spread, and are often associated with multi-resistance. Imipe-
nem, ertapenem and tigecycline retained good activity against
ESBL-producers.
Table 1: Percentage of isolates resistant at MIC level shown (mg/L)
resistance
E. coli
N=248
Klebsiella
N=245
Enterobacter
N=217
P. mirabilis
N=186 resistance
P. aeruginosa
N=205
CIP >1 10.5 7.3 9.2 8.1 CIP >4 8.8
GEN >1 5.2 7.3 11.5 5.4 GEN >4 4.9
AMX >16 58.9 97.1 Amp C 29.0
AMC >16 6.5 3.3 Amp C 1.1 TZP >16 4.4
CAZ >2 3.2 10.2 37.3 0.0 CAZ >8 1.5
CTX >1 2.0 9.0 38.2 0.0
ESBL + 2.8 9.8 6.0 0.0
IPM >4 0.0 0.0 0.5 0.0 IPM >4 5.9
CIP cipro ﬂoxacin GEN gentamicin, AMX amoxicillin, AMC amoxicillin-clavulanate. CAZ ceftazidime,
CTX cofotasume, ESBL - extended spectrum beta-lactamase, IPM imipenem.
Pathogenesis of infections
P1794
magA, a previously assigned virulence gene of
Klebsiella pneumoniae, is a part of the capsular
polysaccharide gene cluster of serotype K1
M. Bojer, C. Struve, D.S. Hansen, E.M. Nielsen,
K.A. Krogfelt (Copenhagen, DK)
Objectives: K. pneumoniae is a commonpathogen associatedwith
nosocomial infections such as bacteraemia and pneumonia. In
recent years, an emerging community-acquired disease with a
high mortality rate has arisen. More than 900 episodes of
bacteremic liver infections and associated complications due to
K. pneumoniae have been reported in Taiwan during the last
decade. The pathogenic mechanism of this infectious disease is
not well understood. A virulence gene, magA (mucoviscosity-
associatedgene), has recently been identiﬁed, but not functionally
characterized, in invasive strains from Taiwan. Furthermore, a
high prevalence of serotypeK1 in clinical cases has been reported.
The purpose of this study was to investigate the prevalence of
magA in different clinical isolates of K. pneumoniae.
Methods: 499 isolates of K. pneumoniae were screened for the
presence of magA using a colony-blot hybridization technique.
Isolates included test strains of all serotypes as well as isolates of
different clinical origin. Results were compared to capsular
serotype previously determined by countercurrent immuno-
electrophoresis. A part of the CPS gene cluster of a K1 test strain
was ampliﬁed by PCR using primers ﬂanking conserved regions
of the CPS operon along with primers matching magA.
Results: 40 strains were positive in hybridization, all of them
belonging to the K1 serotype. One strain of K1 serotype was
negative in hybridization but the presence of magA in this
remaining strain was conﬁrmed by PCR. No strains of serotype
other than K1 possessed magA. Ampliﬁcation products through
PCR of the CPS gene cluster of serotype K1 demonstrated the
location of magA to be in this region.
Conclusions: The results of this study showed that the pro-
posed virulence gene, magA, is restricted to capsular serotype
K1 of K. pneumoniae and is situated in the capsular polysaccha-
ride gene cluster. Therefore, this gene might not contribute to
virulence itself but its presence indicating a strain of serotype
K1, which is more likely to be virulent in certain clinical cases.
Thus, hybridization of magA could serve as a stable diagnostic
method in clinical and epidemiological research.
P1795
Identiﬁcation of genes conferring cytotoxicity in
Serratia marcescens
L.-H. Su, C. Chu, C.-H. Chiu, T.-L. Wu, J.T. Ou, T.V. Riley,
B.J. Chang (Taoyuan, Chiayi, TW; Perth, AUS)
Objectives: To identify genes associated with cytotoxicity in
Serratia marcescens.
Methods: Random insertion mutagenesis by an EZ::TN<R6-
Kagmmaori/KAN-2>Tnp Transposome system was used to
generate isogenic insertional derivatives of a bacteremic isolate
of S. marcescens NB36, which has previously been shown
cytotoxic to MDCK cells. Recombinant plasmids were construc-
ted by self-ligation of BamH I- or Sac I-digested genomic DNA
of non-cytotoxic insertional mutants and then transformed into
the TransforMax EC100D pir-116 electrocompetent Escherichia
coli. The transposon-containing plasmid was rescue-cloned and
sequenced. The genes associated with cytotoxicity were pheno-
typically examined by the production of gluconic acid among 40
isolates of S. marcescens using a reverse-phase, ion-pairing high-
performance liquid chromatography (HPLC) method.
Results: A non-cytotoxic mutant was ﬁrstly obtained during the
screening of 1784 insertional clones obtained by random
mutagenesis. Sequence analysis of a 7814-bp DNA fragment
showed four open reading frames with high homology to
pyrroloquinoline quinone biosynthesis protein F (PQQF), cyto-
sine/purine/uracil/thiamine/allantoin permease family pro-
tein, aldehyde dehydrogenase, and glucose-6-phosphate
dehydrogenase, respectively. A partial gene homologous to the
pyrroloquinoline quinone biosynthesis protein E gene was
found 6-bp upstream of the pqqF. Both PQQ genes were
cotranscribed at the same direction, while the remaining three
genes at the opposite direction. The transposon insertion site
was on pqqF and close to the end of the gene. Because PQQ acts
as the cofactor of glucose-6-phosphate dehydrogenase to form a
holoenzyme essential for the periplasmic oxidation of glucose to
gluconic acid, it was hypothesized that the transposon-inserted
pqqF gene may lose its function and the production of gluconic
acid may be reduced and thereby decreased the cytotoxicity.
Through HPLC analysis, the production of gluconic acid was
conﬁrmed in 29 cytotoxic isolates of S. marcescens, while another
11 non-cytotoxic isolates produced no gluconic acid. The
insertional mutant did not produce gluconic acid, whereas the
parent strain, NB36, did.
Conclusions: PQQ genes are associated with the cytotoxicity of
S. marcescens, and the cytotoxicity may be due to the production
of gluconic acid. Restoration of the function of pqqF by comple-
mentation experiments is ongoing to verify these ﬁndings.
P1796
In vitro effect of subMICs of antibiotics on the
adherence ability and morphology of
Pseudomonas aeruginosa strains isolated from
patients with urinary tract infection
J. Vranes, B. Bedenic, B. Turkovic (Zagreb, HR)
Objectives: The ability of Pseudomonas aeruginosa to adhere to
the surface of mucous membranes of the human body is
considered the initial step in its colonization and subsequent
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infection. The aim of this study was to examine the inﬂuence of
subminimal inhibitory concentrations (subMICs) of ceftazidime
and ciproﬂoxacin on the morphology and adherence ability of
wild-type P. aeruginosa strains to Buffalo green monkey kidney
(BGMK) cell line.
Methods: A total of 14 strains isolated from urine of patients
with urinary tract infection (UTI) were used. Bacterial adherence
to the BGMK cell line was tested before and after treatment with
antibiotics and detected by means of an immunoﬂuorescence
staining. Comparisons were made between the morphology
before and that after exposure of strains to 1/2, 1/4, 1/8, 1/16
and 1/32 MIC of antibiotics, as well as between the number of
bacteria attached to the BGMK cells before and the number after
their exposure to the same concentrations of antibiotics.
Results: Signiﬁcant dose dependent reduction of P. aeruginosa
adherence ability was observed, wich correlated with the
alterations in bacterial cell morphology. After exposure of
strains to subMICs of antibiotics, normal shapes and ﬁlaments
were noted. The greatest ﬁlamentation and the greatest loos of
adherence ability occurred at 1/2 MIC of ceftazidime. The
lenght of ﬁlaments decreased as the concentration of this
antibiotic was being reduced, and at the concentration of 1/32
MIC normal bacterial morphology was detected. Treatment with
subMICs of ciproﬂoxacin resulted in shorter ﬁlaments. Using the
paired t test to compare the number of adhered bacteria before
and after exposure to subMICs of antibiotics, a statistically
signiﬁcant difference was determined after exposure of strains
to 1/2, 1/4, 1/8 and 1/16 MIC of ceftazidime, and to 1/2, 1/4
and 1/8 of ciproﬂoxacin.
Conclusion: The results of this study have shown that the
adherence capacity of P. aeruginosa strains isolated from urine of
patients with UTI was signiﬁcantly decreased after exposure to
subMICs of ceftazidime and ciproﬂoxacin. SubMICs of antibi-
otics affected not only the adherence ability of bacteria, but also
their morphology.
P1797
In vivo selection of resistant subpopulations from
rats infected with high inocula of Pseudomonas
aeruginosa and treated with ﬂuoroquinolones
J. Blondeau, G. Hansen, E. Rubenstein (Saskatoon, Winnipeg,
CAN)
Objective: Mutant prevention concentration (MPC) deﬁnes anti-
microbial (AM) drug concentration threshold that would require
an organism to simultaneous possess 2 resistance mutations for
growth in the presence of drug. Todate,MPCmeasurements have
been determined in vitro and we report the selection of resistant
subpopulations – fromstrainsdetermined tobe susceptible to FQs
by minimal inhibitory concentration (MIC) testing – following
infection in rats and treatment with FQs.
Methods: Sprague Dawley white rats (250–300 grams) were
infected with PA following implant of PA saturated foreign
objects. Pre- and post-infection MICs and MPCs were deter-
mined utilizing 100,000 cfu/ml or 10 billion organisms by
microbroth or agar dilution respectively. Isolates were tested
following recovery from infected rats that did not receive AM
therapy and those treated with ciproﬂoxacin (Cpx)or levoﬂoxa-
cin (Lfx) based on dosages utilized in humans (400 mg tid IV,
750 mg OD respectively).
Results: PA strains with MICs to Cpx and Lfx of 0.25 and
0.5 lg/ml respectively were used to infect rats (n = 22) without
drug and following sacriﬁce (48–72 hr), recovered PA strains
had MICs equal to pre-infections values for 33–35 strains and 2
strains had MICs one dilution higher to each drug. For infected
and treated rats (n = 38–19 Cpx, 19 Lfx), organism recovered
had MICs to Cpx 2–4 lg/ml and for Lfx 8–16 lg/ml. Corres-
ponding MPC values were also elevated from pre-infection
values. Pre-treatment and recovered PA strains were the same
based on pulsed ﬁeld gel electrophoresis analysis.
Conclusion: Exposure of high bacterial PA inoculums to drug
in vivo resulted in recovery of organisms with elevated MICs
when compared to pre-infection values. MIC values were lower
for Cpx than for Lfx. This data shows dosing to prevent selection
of resistant subpopulations is necessary and this could slow the
rates at which resistance occurs and possibly prevent therapeu-
tic failure.
P1798
The effect of hyperbaric oxygen treatment on the
in vitro and in vivo activity of Borrelia burgdorferi
C. Pavia, G. Butler, S. Bittker (Old Westbury, Valhalla, USA)
Objectives: To evaluate the use of hyperbaric oxygen treatment
(hbot) for its ability to inhibit the growth of Borrelia burgdorferi
(Bb) in vitro, and in vivo, in a murine model of Lyme disease.
Methods: Several North American tick-derived and recently
obtained patient isolates of Bb were studied for their sensitivity
to hbot. To test for in vitro susceptibility, one million Bb were
cultured in 0.2 ml of BSK growth medium using small snap-cap
test tubes. With the tubes loosely capped, these cultures were
then exposed, daily for one continuous hour (for 2 consecutive
days), to pure, ﬁltered oxygen pressurized to 2–3 times normal
atmospheric conditions. This was achieved using a specially
constructed, miniaturized cylindrical chamber (length = 25 cm;
diameter = 17 cm), equipped to accept any pressurized gas
mixture through one portal opening. After the ﬁnal HBOT was
given, all culture tubes were snapped shut. Matching control
tubes received no HBOT. All cultures were incubated at 33 C for
2–3 days and were then examined microscopically for live,
motile Bb at the end of the incubation period. For the in vivo
studies, separate groups of C3H or CD1 mice were infected
intradermally with 100.000 Bb. Two to 4 weeks later, one group
of infected mice received a 1.0–1.5 hour(s) of continuous hbo
exposure, for 2 consecutive or alternating days. The treated
mice, along with untreated controls, were sacriﬁced one day
after the last hbot, and extract cultures of their urinary bladders
were prepared in BSK culture media. All cultures were mon-
itored periodically for the presence of motile Bb, using darkﬁeld
or phase-contrast microscopy.
Results: Following hbot, it was found 14 of 17 different strains
of Bb had their growth inhibited by 33–94%, while there was
little or no growth inhibition of 3 Bb strains. For the Bb-
infectivity experiments in hbot-treated mice, it was found that
borrelial spirochetes grew out in only 20% of the matching
extract cultures, whereas live Borrelia were recoverable from
90% of the extract cultures prepared from the matching set of
infected control mice not given and hbot.
Conclusions: These data show that hbot exerts a selective
antiborrelial effect which suggest that it might possibly be
considered as a clinically useful form of adjunct therapy in the
treatment of Lyme disease.
P1799
Monocyte apoptosis in experimental sepsis by
multidrug-resistant species
A. Antonopoulou, T. Poukoulidou, T. Adamis, V. Tziortzioti,
T. Tsaganos, H. Giamarellou, E.J. Giamarellos-
Bourboulis (Athens, GR)
Objectives: There is little evidence regarding monocyte apop-
tosis during the course of sepsis. This study aims to investigate
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changes in cytokine release by peripheral blood monocytes and
their correlation to monocyte apoptosis.
Methods: Acute pyelonephritis was induced in 20 New Zea-
land rabbits after ligation of the right pyelo-ureteral junction; all
were inoculated of an 8log10 cfu/ml inoculum in the renal
pelvis, 10 of a multidrug-resistant clinical isolate of Pseudomonas
aeruginosa and 10 of a multidrug-resistant isolate of Klebsiella
pneumonia. Blood was sampled for estimation of tumor necrosis
factor-alpha (TNFa) and for isolation of monocytes. Mononu-
clear cells were isolated after centrifugation over Ficoll and
incubated for one hour at 37C under 5% CO2 in RPMI with 10%
FBS and 2 mM glutamine. Non-adherent cells were removed
and after trypsinization monocytes were lyzed. TNF-alpha was
estimated by a bioassay on L929 ﬁbrosarcoma cell line; caspase-3
activity was estimated in the cytosolic extract by a kinetic
chromogenic assay.
Results: Mean ± SE values for serum TNF-alpha at 4 and 24
hours after challenge by P.aeruginosa were 37.97 ± 28.07, and
16.19 ± 10.62 pg/ml respectively. At the same intervals, mean
values for caspase-3 activity were 6472.74 ± 4850.7 and
1129.48 ± 863.35 pmol/min.10000cells respectively. Mean ± SE
values for serum TNF-alpha at 4 and 24 hours after challenge by
K. pneumoniae were 253.97 ± 170.15, and 83.77 ± 62.30 pg/ml
respectively. At the same intervals, mean values for caspase-3
activity were 8.95 ± 4.40 and 10.47 ± 5.87 pmol/min.10000 cells
respectively.
Conclusion: Experimental acute pyelonephritis by multidrug-
resistant Pseudomonas aeruginosa is accompanied by enhanced
activity of monocyte caspase-3 over the ﬁrst hours following
bacterial challenge revealing an early initiation of the apoptotic
process. Contrary ﬁndings are noted for K. pneumoniae. Results
merit clinical relevance.
P1800
Critical assessment of factors affecting adhesion
properties of lactic acid bacteria to human cell
lines
V. Vankerckhoven, T. Van Autgaerden, B. Ooms, K. Van Herck,
H. Goossens (Wilrijk, B)
Objectives: To critically evaluate factors affecting adhesion of
lactic acid bacteria to three human cell lines; Caco-2, HT-29MTX
and GIRARDI heart cells.
Methods: A total of 64 [23 faecal (F), 19 clinical (C) and 22
probiotic (P)] lactobacilli and 17 [5 F, 6 C and 6 P] biﬁdobacteria
were tested for their adhesion to Caco-2 (CC2L, CC2B) and
HT-29MTX (MTXL, MTXB) cells and a total of 24 [5 F, 8
endocarditis (E) and 11 P] lactobacilli were tested using
GIRARDI heart cells (GIR). Two negative (NC1, NC2) and one
positive control (PC) strain were used in each assay. Adherent
bacteria were counted by plating serial dilutions on MRS. All
assays were performed in triplicate. Adhesion was expressed as
the percentage of bacteria recovered after adhesion relative to
the number of bacteria added. Statistical analysis was performed
using one-way ANOVA, Tukey’s test (P < 0.05 was considered
statistically signiﬁcant) and Pearson’s correlations.
Results: Adhesion results of the same strain varied when done
in triplicate. A longer plate incubation time resulted in signiﬁ-
cantly better adhesion of PC for CC2L. The number of weeks of
postconﬂuency of the cells did not signiﬁcantly affect adhesion.
Automatic plating produced signiﬁcantly higher adhesion for
MTXL, while a signiﬁcantly higher adhesion was only noticed
for PC for CC2L. A signiﬁcantly higher adhesion in relation to
the incubation time (23–25 h) for PC was seen for CC2L, CC2B
and MTXB. The researcher (R) performing the experiments also
affected assay results. R3 generated signiﬁcantly higher adhe-
sion values compared to R1 and R2, while R2 generated
signiﬁcantly lower adhesion values for PC. Experiments per-
formed on later dates generated signiﬁcantly higher and lower
adhesion for PC and NC, respectively, probably due to
increased experience of the researcher, however; signiﬁcantly
higher adhesion for NC1 and NC2 generated for MTXL might be
correlated to automated plating. Adhesion of PC to HT-29MTX
was signiﬁcantly improved by B. longum and to Caco-2 by both
B. longum and L. sakei. Also, L. gasseri signiﬁcantly increased the
adhesion of NC1 to HT-29MTX.
Conclusions: Many confounding factors affect adhesion of
bacteria to human cell lines. These results question the relevance
of adhesion studies widely reported in the literature. The effect
of variables should be validated on cell culture test systems
before setting up experiments.
P1801
Inﬂuence of subinhibitory concentrations
of metronidazole, vancomycin, clindamycin and
linezolid on toxin production in Clostridium
difﬁcile
C. Walch, M. Gerber, G. Ackermann, A.C. Rodloff (Leipzig, D)
Objective: Clostridium difﬁcile is the major cause of hospital-
acquired infectious diarrhoea. Several antimicrobials are known
to induce and promote C. difﬁcile-associated diarrhoea (CDAD).
The impact of metronidazole (MET), vancomycin (VAN), clin-
damycin (CLI) and linezolid (LIN) on toxin-production in
C. difﬁcile was investigated in this study. Metronidzole and
vancomycin are ﬁrst line therapy drugs of CDAD. Clindamycin
is strongly associated with the induction of CDAD. Linezolid is
a new antimicrobial exhibiting activity mainly against gram-
positive bacteria. A previous study showed enhanced and
earlier toxin detection in the presence of vancomycin and
metronidazole. This study intends to differentiate between toxin
release and enhanced production.
Methods: C. difﬁcile strain VPI10463 and three strains recovered
from patients were tested for their susceptibility to MET, VAN,
CLI and LIN using Etest. Toxigenicity was determined by PCR.
Growth curves with and without subinhibitory concentrations of
MET, VAN, CLI and LIN (0.5 · MIC) were determined for the
C. difﬁcile isolates. Growth wasmeasured spectrophotometrically
and by counting of plated cells. Toxin production was detected
with ELISA (toxin A) and cytotoxicity assay (toxin B) from
culture supernatant and from sonicated cell pellet also. Using
real-time PCR mRNA for toxin A and B gene sequences was
measured. Toxin production and mRNA copies were calculated
in relation to the number of bacterial cells.
Results: The four strains showed very different growth and
level of toxin production in the absence of antibiotics. Metroni-
dazole and vancomycin stimulated toxin production in three of
the four strains tested. Clindamycin did not stimulate and in
some cases inhibited toxin production in all strains. Linezolid
had variable effects on toxin A and B production in the four
strains.Conclusion: The ﬁnding that our established drugs of
choice for CDAD, MET and VAN, are able to enhance toxin-
production in C. difﬁcile indicates the nessicity to renew the
discussion of the pathogenesis of severe CDAD, pseudomembr-
anoese colitis and toxic megacolon, where MET and VAN
cannot always change the clinical course. Animal studies are
needed to conﬁrm the in vitro results.
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P1802
In vivo toxin expression is increased by proton
pump inhibitor (PPI) in the dominant strain of
the 2003–4 Montreal Clostridium difﬁcile
epidemic
T.J. Louie, D.R. MacCannell, V. Loo, W. Krulicki,
L. Ward, R. Louie, J. Emery (Calgary,
Montreal, CAN)
The recently publicized massive outbreak of C. difﬁcile associ-
ated disease (CDAD) in Montreal is largely clonal in nature,
with a single, binary-toxin (CDT) positive strain accounting for a
major proportion of clinical cases, with attendant morbidity and
mortality. A recent epidemiologic study showed that concurrent
use of proton pump inhibitor (PPI) was associated with a 2.1–2.7
fold increased risk of infection. The Calgary region experienced
a large ermB + clonal outbreak in 2000–2001, also with
associated increased disease severity.
Objectives: We examined the impact of pantoprazole on
C. difﬁcile toxin expression of cytotoxin B in a Sprague-Dawley
animal model simulating human intestinal ecology and antibi-
otic selection pressure.
Methods: In two parallel experiments, 73 rats were infectedwith
either the dominant, binary toxin-positive (M13) from the Mon-
treal CDAD outbreak, a less-prevalent, binary toxin negative
(M18) Montreal strain or the binary toxin-negative Calgary
outbreak strain (C2007). Animals (200 g) were individually
housed in wire mesh cages; barrier/contact precautions were
maintainedbetweengroups toprevent cross infection.Culturesof
all rats conﬁrmed no initial colonization. After 7 days of
conditioning on a mixed meat/grain diet (maintained for 20
days), the animals were given 103 CFU of CD spores on days 8–9,
followed by Cefotaxime (15 mg q8h) with or without pantopraz-
ole (2 mg IP/day) from days 10–20. The animals were sacriﬁced
on day 21, and vegetative and spore counts were quantitatively
assessed. Toxin titres were determined by standard cell culture
methods, and pH of cecal contents was measured ex-vivo.
Results: The increase in toxin titre upon exposure to pantoprazole
was statistically signiﬁcant (p < 0.01) in the pooled M13 group
(Montreal dominant clone). Conversely, toxin titres in C2007 and
M18bothdecreaseduponexposure to thePPI, butwhile thedecrease
in C2007 was signiﬁcant (p < 0.05), the change in M18 was not.
Conclusion: In this animal model, the dominant strain of the
2003–4 Montreal CDAD epidemic demonstrated a 2 to 2.5 fold
increase in-vivo toxigenicity in the presence of pantoprazole. It
is unclear if the function of colonic Na + /K + ATPase pumps
accounts for this difference. The effect appears to be strain
speciﬁc. Since toxigenicity is variably linked to disease severity,
these observations support of the possibility that PPIs could
increase disease severity.
P1803
Ciproﬂoxacin impregnated
carboxymethylcellulose membrane reduces
adherence and intra-abdominal abscess
formation and mortality rate in a lethal intra-
abdominal sepsis model in mouse
K. Aydinuraz, C. Agalar, O. Saygun, E. Denkbas, E. Ozturk,
A. Cime, C. Daphan, F. Agalar (Kirikkale, Ankara, TR)
Objective: To assess the efﬁcacy of ciproﬂoxacin impregnation
to carboxymethylcellulose membrane in reduction of adherence,
intraabdominal abscess formation and mortality rates in a lethal
intraabdominal sepsis model in mouse.
Methods: A midline laparotomy was performed under general
anesthesia and 0.8 ml of 3 · 108 cfu/ml E. coli and 0.2 ml of
sterile homogenated mouse faeces as an adjuvant were inocu-
lated after caecal abrasion in mouse. This model was found to be
100% lethal in 24 hours. Sepraﬁlm was dissolved in 0.05 M
NaOH solution by sonication for 4 hours. Ciproﬂoxacin and
0.05 M HCl solution were added to this solution and mixed for 2
hours. Different drug concentrations were used in the prepar-
ation of membranes. At predecided intervals, samples were
withdrawn and the release of ciproﬂoxacin in the buffer solution
was followed by UV spectrophotometer at 275 nm. The cumu-
lative drug released into the medium from membranes was
measured as a function of time.Afterwards the study was
conveyed in four groups. In the ﬁrst group this newly synthe-
tised carboxymethylcellulose membrane was placed after mid-
line laparotomy and caecal abrasion without any
microbiological intervention. Three ciproﬂoxacin impregnated
carboxymethylcellulose sheets differing in ciproﬂoxacin doses
were used in groups 2, 3 and 4. The mice were sacriﬁced on day
7 and the presence of intraabdominal abscesses and adhesions
were evaluated
Results: The newly synthetised carboxymethylcellulose was
found to be similar to the original with respect to intraabdom-
inal adhesions. There was no mortality in groups 2, 3 and 4. The
rate of intraabdominal abscess formation and adherence were
signiﬁcantly reduced in study groups 2, 3 and 4. The rate of
intraabdominal adhesion and abscess formation were reduced
as the amount of impregnated ciproﬂoxacin was increased.
Conclusion: The impregnation of ciproﬂoxacin to newly syn-
thetised carboxymethylcellulose reduces mortality rate, intraab-
dominal abscess and adhesion formation in a lethal
intraabdominal sepsis model in mice.
P1804
Pharmacokinetics of IV or IM ceftazidime
in relation to cytokines in septic neutropenic mice
J. Buijs, A.S.M. Dofferhoff, J.W. Mouton, J.W.M. van der
Meer (Heerlen, Nijmegen, NL)
Objectives: A sudden high cytokine release has been reported
after the ﬁrst dose of beta-lactam antibiotics during treatment of
Gram-negative infections. This cytokine response is a result of
antibiotic-induced bacterial endotoxin release and this cascade
probably worsens the infection outcome. We hypothesized that
different routes of antibiotic administration have signiﬁcant
inﬂuence on kinetics of endotoxin- and cytokine-release patterns
during the ﬁrst hours of infection.
Aim: To compare cytokine-release patterns and kinetics of
plasma antibiotic levels during initial treatment of Gram-
negative sepsis in neutropenic mice, applying different routes
of antibiotic administration.
TOXIN TITER VEG. COUNT SPORE COUNT CECALpH
Exp #1
M13 Cefotasxime (n=8) 4000 (±645 6) 1.1E9 (±2.6E8) 3.4E7 (±1.5E7)
M13 Cefotaxime +
Pantoprazole (n=8)
10625 (±2652.0) 4.8E8 (±1 0E8) 7.8E6 (±3 4E6)
C2007 Cefotaxime (n=8) 6500 (±2665 9) 5.3E8 (±1 0E8) 1.1E7 (±2.1E6)
C2007 Cefotaxime +
Pantoprazole (n=8)
3750 (±700.7) 5.1E8 (±1 0E8) 1.1E7 (±2.1E6)
Exp #2
M13Cefotaxime (n=8) 4125 (±934.2) 3.4E8 (±8.4E7) 5.1E3 (±1.1E3) 6.08 (±0.04)
M13 Cefotaxime +
Pantoprazole (n=8)
8000 (±1851.6) 4.0E8 (±1.4E8) 8.5E6 (±7.4E6) 6.93 (±0.33)
M18 Cefotaxime (n=8) 6375 (±3741.4) 5.5E8 (±2.2E8) 9.3E3 (±3.8E3) 7.04 (±0.11)
MI8 Cefotaxime +
Pantoprazole (n=8)
2625 (±532 4) 4 1E8 (±7.2E7) 2.8E4 (±)1.2E4 6.98 (±0.12)
Control
C2007 Untreated
Control (n=9)
Nil Nil Nil 6.33 (±0.07)
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Methods: Fifty neutropenic Swiss mice were divided into two
groups with infection and one without. Two hours after
inoculation of 107 CFU E.coli in the thigh muscle, mice were
treated with either ceftazidime 2 mg (80 mg/kg) intravenously
(IV) or intramuscularly (IM). Mice were sacriﬁced at
T = 0,1,5,10,20,30,40,60 and 90 minutes for plasma-sample col-
lection to determine TNF-alfa, IL-6, and antibiotic-concentra-
tions. Bacterial counts and morphology were also assessed. In
mice without infection, ceftazidime was administered IV to
study healthy in-vivo kinetics of ceftazidime.
Results: Peak serum levels of ceftazidime (T = 1) in mice
without sepsis were 486 mg/l. At t = 90, antibiotic concentration
had decreased to 9.3 mg/l. Elimination half-life was 10 minutes.
TNF-alfa levels showed a short peak, declining to undectectable
valueswithin 40minutes in both the IV and the IM group. Plasma
IL-6 levels did demonstrate a fast peak at T = 5 during IV
treatment, but not after IM administration. In the latter case, a
stable plateau-phase was encountered lasting the entire experi-
ment. At T = 90, IL-6 levels were signiﬁcantly higher in IM
treatedmice compared to IV treatedmice (2595 vs 1504, p < 0.05)
Conclusion: In the initial treatment of Gram-negative sepsis,
antibiotic route of administration signiﬁcantly inﬂuences cyto-
kine release patterns. IV treatment causes short and high peak
levels, whereas IM treatment leads prolonged elevations. These
differences probably indicate faster killing of bacteria after start
of IV treatment with concomittant higher endotoxin release.
P1805
Effect of melatonin on Candida sepsis
in experimental rat models
M.T. Yavuz, D. Kaya, E. Ozturk, N. Ustundag,
M. Behcet (Duzce, TR)
Objectives: The aim of the present study was the evaulation of
possible protective effects of melatonin against experimental
Candida sepsis in rats.
Methods: Total 50 rats included to study at 5 different groups,
as control, sepsis, melatonin-control, melatonin-sepsis without
treatment and melatonin-sepsis with treatment. Melatonin (200
microgram/kg/day) was injected introperitonally (one a.day-
during 3 days) three days prior to sepsis application. for sepsis
Candida albicans ATCC 10259 strain was used intraperitonally.
For treatment Amphoterisin B was used 1 mg/day intraperi-
tonally. Plasma concentrations of cytokines and adhesion
molecules were compared between rats with sepsis due to
Candida albicans and control groups. Experimental data during
candidaemia are controversial. On day 1 and day 15 of sepsis,
plasma levels of IL-6, TNF-alpha, V-CAM, E- selectin were
determined. All rats were investigated for physiopathologic
differences in liver and spleen by using immunhistochemical
dying.
Results: On day 1; IL-6, TNF-alpha, V-CAM levels were ﬁnd
higher in sepsis groups compared to controls(p<0.05), while E-
selectin levels were not shown signiﬁcant difference. On
melatonin groups, Il-6 and V-CAM plasma levels were detected
signiﬁcantly greater than others (p < 0.05). On day 15; All
measurements were higher than initial levels. Plasma levels of
cytokines and adhesion molecules of survivor in sepsis groups
were signiﬁcant higher than control groups(p < 0.05). On
melatonin groups; there was no signiﬁcant difference according
to day 1 plasma levels. On the treatment taken groups; 1t has
been detected mean of improving time of melatonin taken group
was 2.25 day shorter than normal treatment group.
Conclusions: In view of the current results; we conclude that
adhesion molecule levels may use a diagnostic marker for yeast
sepsis with cytokine level measurements and melatonin treat-
ment may have therapeutic beneﬁts in candidal sepsis in
addition to classic antimycotic treatment due its capacity to
reduce oxidative stress.
P1806
Effect of Saccharomyces boulardii on the
re-establishment of hamster gut microﬂora
perturbed by vancomycin treatment
H. Goiot, G. Philippe-Taine, E. Bayart, T. Cecile, J.-M. Gillardin,
L. Coroler (Compiegne, F)
Studies of the intestinal microbial ecosystem by classical culture
techniques suggest that only 30% of the microbiota can be
cultured. PCR procedures based on 16 S ribosomal RNA gene
speciﬁc for bacteria were developed to detect bacterial popula-
tions in hamster feces. 33 populations of bacteria were charac-
terised by their genomic DNA sequences and targeted by PCR
probes: Actinomyces group, Bacteroides distasonis, B.fragilis,
Biﬁdobacterium group and 5 Biﬁdobacterium species, Campylo-
bacter group, Citrobacter group, C.freundii, Clostridium group
and 5 Clostridium species, Enterobacteriaceae group, Enterobacter
cloacae, Escherichia group, Faecalibacterium prausnitzii, Lactobacil-
lus group, Morganella morganii, Peptostreptococcus productus,
Porphyromonas gulae, Propionibacterium group, Proteus mirabilis,
Pseudomonas aeruginosa, Ruminococcus bromii, R. obeum, Salmon-
ella group and Staphylococcus group.After oral antibio-therapy,
with 200 mg/kg vancomycin (ATB) daily for 2 days, some
bacterial groups were partially or totally eradicated. Qualitative
variations were observed for 4 or 5 days: Bacteroides distasonis,
B. fragilis, Biﬁdobacterium angulatum, Clostridium coccoides,
C. clostridiiforme, C. leptum, C. perfringens, Faecalibacterium pra-
usnitzii, Peptostreptococcus productus, Staphylococcus group. No
antibiotic effect was observed on levels of dominant faecal
groups: Biﬁdobacterium group, Citrobacter group, Enterobacte-
riaceae group, Escherichia group, Proteus mirabilis. In order to
better understand the Saccharomyces boulardii (S.b.) mechanism
of action in prevention of antibiotic-associated diarrhoea, 4.109
CFU/kg daily for 5 days of S.b. were administered to hamsters
during oral ATB treatment. The results showed that populations
eradicated with ATB treatment remained expressed and stabi-
lised with concomitant S.b. treatment. More effective protection
were showed for 2 or 3 days with S.b and ATB groups than with
ATB only treatment on the following fecal microbiota: Bactero-
ides fragilis, Clostridium coccoides, C.clostridiiforme, C.leptum,
C.perfringens, Staphylococcus group. These observations are in
agreement with the well accepted notion of an equilibrium of
the total fecal microbiota. S.b. induces a functional resilience
(re-establishment) among the main groups of the ﬂora: the
Bacteroides, the C. coccoides and the C. leptum subgroup. These
PCR results will be used to quantify the effects of S.b. on the
intestinal microﬂora by DNA microarray analysis.
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Non-fermenter Gram-negative bacilli: epidemiology and resistance
P1807
Characterisation of a hospital outbreak of multi-
resistant Acinetobacter baumannii and prevalence
of class 1 integrons
E. Kraniotaki, R. Manganelli, A. Grossato, M. Erdenizmenli,
E. Platsouka, O. Paniara, G. Palu` (Padua, I; Izmir, TR; Athens, GR)
Objectives: The aim of this study was to investigate the
possibility of nosocomial transmission of one or more epidemic
strain(s) using phenotypic and genotypic typing methods and to
detect the presence of class 1 integrons in these strains.
Methods: Nine multi-resistant Acinetobacter baumannii isolates
were recovered from patients over a two-month period between
May and June 2003, in an intensive care unit (ICU) of a Greek
tertiary hospital. The strains were identiﬁed by commercial ID
panels and susceptibility to a broad panel of antimicrobial
agents was determined by broth micro dilution method (MIC
panels) according to NCCLS guidelines. Plasmid DNA ﬁnger-
printing, REP-PCR and PFGE analysis were used for molecular
typing. Class 1 integrons were detected and molecularly
characterized by sequencing.
Results: All isolates were resistant to beta-lactam/beta-lacta-
mase inhibitor combinations, cephalosporins, aztreonam,
imipenem, meropenem, aminoglycosides, ciproﬂoxacin, trimeth-
oprim-sulfamethoxazole and chloramphenicol. Both REP-PCR
and PFGE techniques revealed identical or similar banding
patterns classiﬁed as subtypes of the same clone. Plasmids were
found in all isolates and two different plasmid proﬁles were
observed with sizes in the range of 2 to >30 kb. All isolates bore
class 1 integrons. An integron of 2.2 kb was the predominant,
with only one isolate bearing an integron of 3 kb.
Conclusions: The molecular typing results showed that the
outbreak was caused by a single strain, indicating a common
sourse of transmission. The differences in the plasmid proﬁles
reﬂect the exchange of genetic elements in a higly selective
environment during the outbreak. The presence of integrons in
all isolates proves their importance for the dissemination of
antibiotic resistant genes and nosocomial spread of Acinetobacter
baumannii.
P1808
Multi-drug resistant Acinetobacter baumannii:
susceptibility patterns (including tigecycline) and
ribotyping
E. Carretto, D. Barbarini, O. Bargiacchi, S. Garazzino, C. Rebuffa,
F.G. De Rosa, G. Di Perri (Pavia, Turin, I)
Acinetobacter baumannii is an important cause of nosocomial
infections in many hospitals, most often isolated from critically
ill patients admitted in intensive care units (ICUs). After the ﬁrst
isolation of an A. baumanni strain with a high-resistance proﬁle
(only susceptible to colistin) in a big hospital of Northern Italy
we collected in a four-year period 44 strains from 22 different
patients. In this report we present the results of the susceptibility
and the molecular typing of the A. baumannii strains collected.
Susceptibility testing was performed on the collected isolates
using the standardized disk-diffusion method following the
criteria of NCCLS. We evaluated the susceptibility of our
isolates to beta-lactams, ﬂuoroquinolones, aminoglycosides,
tetracyclines and to the new agent tigecycline (GAR-936)
[WAY-156936]. All the strains showed a proﬁle of multi-drug
resistance except for a strain resistant only to beta-lactams. In
particular, 43 out of all 44 isolates were resistant to carbapenems
and all strains were resistant to tetracyclines but susceptible to
tigecycline. It is noteworthy that 6 strains (isolated from two
different patients) were resistant to colistin. We are currently
evaluating the mechanism of resistance to this drug, since this
kind of resistance is rarely reported in A. baumannii.
Strains typing: We performed automated ribotyping using
EcoRI as restriction enzyme on 24 strains isolated from 20
different patients. We obtained two distinct patterns: all the
carbapenem-resistant strains showed the same proﬁle, whereas
the carbapenem-susceptible strain had a different pattern. Both
the patterns obtained were quite different from those obtained
from isolates collected in the Hospital of Pavia (data presented at
the 6th International Symposium on Acinetobacter, Dublin 2004).
Conclusions: Our report conﬁrms the wide circulation of a
carbapenem-resistant clone of A. baumannii, that was different
from those isolated in a different hospital of the same geo-
graphical area. We reported also an unusual high number of
colistin-resistant strains. The only 100% effective drug was the
new compound tygecicline, that is not yet used in clinical
practice in our country.
P1809
Molecular epidemiology and beta-lactamase
production of multidrug resistant Acinetobacter
baumannii clinical isolates from Italian hospitals
R. Migliavacca, M. Spalla, M.M. D’Andrea, M. Quatela, T. Giani,
A. Navarra, F. Luzzaro, M. Labonia, M. Perilli, G.M. Rossolini,
L. Pagani (Pavia, Siena, Varese, San Giovanni Rotondo, L’aquila, I)
Objectives: A. baumannii is an opportunistic pathogen respon-
sible for a variety of nosocomial infections in intensive-care-
units (ICUs) and in immunocompromised patients exposed to
elevated risk factors. Nosocomial infections caused by multi-
drug-resistant (MDR) acinetobacters are difﬁcult to treat. Carb-
apenems remain active in many centres, but reports of
carbapenem resistance have accumulated worldwide. In this
work we studied MDR A. baumannii clinical isolates from
different Italian Hospitals to evaluate clonal relationships and
beta-lactamase determinants.
Methods: From 2002 to 2004, 44 nonreplicate MDR isolates
were collected from different wards (ICUs, surgical and reha-
bilitative units) of 3-Italian Hospitals, and studied for clonal
diversity and beta-lactamase production. All the isolates were
identiﬁed and tested for antimicrobial susceptibility using the
GNI card (Vitek System, BioMe´rieux) and panels NMIC/ID4
(Phoenix System, BD). The blaVIM, blaIMP, blaTEM, blaSHV,
blaCTX-M, blaVEB, and blaOXA determinants presence and
nature were investigated by colony hybridization method, DNA
microarray analysis, PCR and sequencing. AmpC production
was determined by spectrophotometric assay. The clonal rela-
tions were analysed by REP-PCR and conﬁrmed by PFGE after
digestion with SmaI enzyme.
Results: The 44 isolates belonged in 5 different clones, of which
3 were more prevalent and were detected in more than one
hospital. One dominant clone (14 of 26 isolates from Varese
hospital and 1 of 13 from S. Maugeri IRCCS in Pavia), resistant
to cefotaxime (CTX), cefepime (FEP), ceftazidime (CAZ) and
susceptible to piperacillin/tazobactam (TZP), was found to
produce the TEM-92 extended-spectrum beta-lactamase.
Another dominant clone including isolates closely related (8 of
26 isolates from Varese hospital and 11 of 13 from S.Maugeri
IRCCS), resistant to CTX, CAZ, FEP and intermediate to TZP,
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produced high levels of the AmpC chromosomal beta-lactamase.
The third dominant clone (5 of 5 isolates from San Giovanni
Rotondo hospital and 1 of 13 from S. Maugeri IRCCS), resistant
also to TZP and imipenem (MIC > 32 mg/l), produced an OXA-
type beta-lactamase.
Conclusions: The results showed inter-hospital spread of mul-
tiple MDR clones of A. baumannii, which carried different beta-
lactamase determinants. This is the ﬁrst report on production of
the TEM-92 ESBL in A. baumannii.
P1810
Acinetobacter baumanii: evolution of the
antimicrobial resistance of strains isolated at a
central military hospital
W. Amhis, M. Naim, D. Tiouit, A. Chabani (Algiers, DZ)
Objectives: To evaluate the frequency and the antimicrobial
resistance evolution of Acinetobacter baumanii isolated from
different specimens in our laboratory from September 1st 2002
to august 31 2004.
Methods: From September 1st 2002 to august 31 2004 strains of
Acinetobacter baumanii were isolated from different clinical
samples coming from inpatients hospitalised in different depart-
ments of our hospital. The strains were identiﬁed with the
biochemical galleries (API NE–Biomerieux) and their suscepti-
bility to the antimicrobial agents evaluated by the disk diffusion
method according to the NCCLS.
Results: 121 strains of Acinetobacter baumanii were isolated
during the 3 years: 11 in 2002, 85 in 2003(during this period
we observed an epidemy in the ICU) and 25 in 2004.These
results shown that the susceptibility to Ticarcillin, Piperacillin,
Imipenem, Amikacin, and Gentamycin decreased noticeably
during these 3 years, when it increased to Ceftazidim and
Peﬂoxacine. The resistance was respectively during 2002–2004:
Ticarcillin 60% 68% 95%
Piperacillin 80% 82% 91%
Ceftazidim 100% 64% 65%
Imipenem 0 47% 46%
Amikacin 70% 64% 87%
Gentamycin 64% 60% 90%
Peﬂoxacin 56% 56% 46%
Conclusion: The strains of Acinetobacter baumanii isolated in our
hospital during the period 2002–2004 in our hospital presented a
high level of antimicrobial resistance which was often associated
to a resistance to at least 3 antimicrobial agents. In some cases
the strains were totally resistant and the treatment became
problematical. The most notable resistance was to Imipenem
which increased from 0% to 47% in 3 years. In front of this
situation, hygiene measures have been taken in the ICU with the
collaboration of the physicians and the director in the purpose to
limit the diffusion of these strains. Moreover the use of the
antimicrobial agents and especially Imipenem is controlled in
our hospital and in the majority cases the prescription is based
on the results of the susceptibility test.
P1811
Acinetobacter species and strains in a university
hospital during a four-year period
L. Dijkshoorn, A.T. Bernards, T. van der Reijden, P.H. van den
Broek (Leiden, NL)
Objectives: Despite the numerous reports of outbreaks by
acinetobacters, relatively little is known about the general
incidence of Acinetobacter species in hospitals. The aim of the
present study was to investigate the species and strain distri-
bution of Acinetobacter during a four-years period in the Leiden
University Medical Center using validated genotypic methods
for species and strain identiﬁcation.
Methods: Isolates were identiﬁed to species by the use of AFLP
analysis and/or ampliﬁed ribosomal DNA analysis (ARDRA).
AFLP was also used to identify isolates at the strain level using a
grouping level of ‡90% as a threshold above which organisms
were considered to belong to the same strain.
Results: In total, the investigated number of isolates of the
period of study were 37 out of 25 patients (1999), 79 out of 47
patients (2000), 126 out of 53 patients (2001) and 39 out of 25
patients (2002). Isolates were identiﬁed to 15 named and
unnamed species with Acinetobacter baumannii (62 patients)
and the unnamed genomic species 3 (39 patients) being the most
prevalent. Isolates of 11 patients could not be identiﬁed to any of
the described species of Acinetobacter. Cross-infection was noted
for A. baumannii (4 strains, 35 patients), genomic species 3
(3 patients), yet unclassiﬁed strain (2 patients), and gen.sp. 10
(2 patients). In 1999–2000 one A. baumannii strain was epidemic
in the hospital, affecting 29 patients. Exclusion of this epidemic
strain from the study, revealed the more endemic level of
occurrence of Acinetobacter species.
Conclusion: The current study provided insight in the preval-
ence of different Acinetobacter species in the hospital of study.
Apart from A. baumannii, many other species can be found in
clinical specimens, some of which may also spread among
patients and may be of clinical signiﬁcance.
P1812
Appearance of a pandrug-resistant Acinetobacter
baumannii causing nosocomial infections in a
Portuguese university hospital
G.J. Da Silva, L. Boaventura, C. Vital, C. Vieira, F. Cardoso,
C. Pontes, R. Tome´, A. Duarte, G. Ribeiro (Coimbra, Lisbon, P)
Since 1999, sporadic and clusters of multidrug resistant Acine-
tobacter baumannii isolates (MDRAb) have been found in patients
infected or colonized by these bacteria throughout the Univer-
sity Hospital of Coimbra (HUC), Portugal, a 1600-bed hospital.
Recently, there was an increase in the isolation of these
organisms, disseminated in several wards.
Objective: The main objective of this work was to determine the
clonal relatedness of MDRAb isolates and to document the ﬁrst
appearance of a pandrug-resistant isolate in Portugal (isolates
resistant to almost all commercially available and tested antibi-
otics).
Methods: Between November 2003 and March 2004, thirty eight
MDRAb isolates were recovered from 35 inpatients of HUC.
Susceptibility was determined by disc-diffusion method and
VITEK 2 System (BioMe´rieux). Random ampliﬁed polymorphic
DNA analysis (RAPD) was used to assess the genetic relatedness
among the isolates.
Results: The isolates were recovered from: hemocultures
(44.4%), catheters (19.4%), urine (14%), bronchial aspirates
(11.1%), wounds (8.3%) and sputum (2.7%). The majority of
the samples were taken from inpatients of Medicine Intensive
(SMI) (43%) and Burn Unit (BU) (20%) wards. All but one isolate
showed an identical resistance proﬁle to amoxicillin, amoxicil-
lin/clavulanate, piperacillin/tazobactam, ampicillin/sulbactam,
cefalotin, ceftazidime, cefotaxime, cefepime, aztreonam, imipe-
nem, meropenem, ciproﬂoxacin, doxiciclin, SXT, gentamicin and
netilmicin, and variable susceptibility to tobramycin (Tob) and
amikacin (Amk). Thirty isolates were susceptible to Tob and
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Amk (TobSAmkS). The other phenotypes observed were:
TobRAmkS (n = 1), TobRAmkI (n = 3) and TobRAmkR
(n = 3). Analysis of RAPD patterns suggested that the isolates
were genetically related. Comparing the antibiotype and RAPD
ﬁngerprints of outbreak isolates, occurred in 1999 and 2002,
suggested the persistence and dissemination of a clone, that has
been acquiring more resistance determinants. It is noteworthy
that isolates resistant to all antibiotics typically tested, pandrug-
resistant isolates (TobRAmkR phenotype) emerged only
recently.
Conclusion: The results showed that a multi-resistant A. bau-
mannii clone is endemic for several years in this hospital, despite
the infection control measures taken by the institution. The
emergence of a pandrug resistant isolate may augur the
appearance of untreatable infection by this organism.
P1813
Bacteraemia due to Acinetobacter baumannii
in an intensive care unit
P. Carfagna, M. Galie`, F. Taglietti, G. Battisti, G. Testa,
C. Santini (Rome, I)
Objectives: To analyze clinical and microbiological features
bacteremias due to A. baumannii (ABB) acquired in an ICU.
Methods: All clinically signiﬁcant bacteremias in a 8-bed ICU,
from Jan 2003 to Aug 2004 were evaluated.
Results: Eighteen cases of ABB occurred in 16 patients (3.7
episodes per 1000 patients-days). All cases were hospital-
acquired and occurred after a mean hospitalisation of
37.1 days. Nine cases (50%) were observed from July to
September. The mean age was 72.3 years and 11 patients
were males. All cases underwent invasive procedures: 4
(22.2%) surgery, 16 (88%) mechanical ventilation, 18 (100%)
intravascular catheterisation (cvc), 18 (100%) urinary catheter-
isation. Sixteen cases (88.8%) previously received antimicrobial
therapy. The sources of ABB were cvc in 10 (55.6%) cases,
respiratory tract in 6 (33.3%) and unknown in 4 (22.2%). Six
cases (33.3%) were polymicrobial bacteremias. All strains were
resistant to piperacillin, piperacillin/tazobactam, ceftazidime,
amikacin, gentamicin, ciproﬂoxacin and aztreonam, 37.5% were
susceptible to tobramicin and 60% to imipenem. Sepsis
occurred in 11 cases (61.1%), severe sepsis in 1 (5.6%) and
septic shock in 6 (33.3%). Nine patients died (56.5%) and
deaths were related to ABB in 8 (50%). One patient died for
severe respiratory failure after 4 months. Seven patients sur-
vived. The 8 deaths directly related to ABB occurred after a
mean time of 7.1 days from the onset of sepsis, in 50% of cases
the source was the respiratory tract and 62.5% of isolates were
resistant to carbapenems; 7 (87.5%) patients received inad-
equate therapy (in 5 cases the strains were multi-drug
resistant), the remaining patient died for septic shock despite
adequate therapy. In the group of patients who recovered from
ABB the rate of carbapenem resistance was 42.8%, and the
source was respiratory tract in 2 cases (28.6%): 4 patients
received adequate therapy (51.1%), 3 patients had a cvc-related
ABB due to a multi-drug resistant strain, but removal of
intravascular catheter was effective.
Conclusions: Our study conﬁrm that ABB has a high rate of
related mortality in ICU patients. Pneumonia as source of
bacteraemia and resistance to carbapenems are associated with a
higher mortality. Moreover a prompt adequate antimicrobial
therapy and removal of infected devices are associated with a
better prognosis.
P1814
An epidemic with multiresistant Acinetobacter
baumanii: a chain of horror?
A. Antoniadou, M. Souli, A. Ghika, S. Athanasia, I. Galani,
R. Vorou, L. Zerva, F. Kontopidou, G. Poulakou, D. Katsala,
H. Giamarellou (Athens, GR)
Objective: To investigate a cluster of MDR A.baumanii bacte-
remic infections (3) in a newly built and operating for the last
10 months, tertiary, university, general hospital.
Methods: In September 2004 two patients with acute leukaemia
died of perineum soft tissue bacteremic infections due to
A.baumanii sensitive only to colimycin and despite appropriate
treatment. A third patient in the surgical ward presented
concurrently with CVC-related bacteraemia. A survey of all
A. baumanii strains isolated in the hospital since November 2003
revealed two clusters of MDR A.baumanii cases (colonization or
infection) : one in April–May (5 pts, 2 bacteremias considered at
that time imported) and the other in August–September (10
cases, 3 bacteremias). None had been in the ICU and all were in
the surgical ward and the one of the 2 medical wards, admitting
hematology–oncology patients.
Results: Study of the strains by REP-PCR showed 2 distinct
clones crossing over between the above mentioned wards.
Interestingly these clones were harboured by 2 patients previ-
ously in the ICU and subsequently transferred to the surgical
and hematology unit respectively more than 4 months earlier.
The same strains were found on the hands of a nurse in the
medical ward and the hands of the personnel and the inanimate
environment of the ICU, where MDR A. baumanii is endemic.
They were not found on the surfaces of the wards, but thorough
cleaning and disinfection had already been performed before
sampling. Strict infection control and hand hygiene measures
regarding also in-hospital transportation of patients are now
being applied. No new case has been reported in October 2004
from the wards but A. baumanii is still endemic in the ICU.
Probably the hands of health-care workers-HCW (surgeons and
ICU doctors consulting in the medical wards) served as the
vehicle spreading the pathogen from a reservoir in the ICU.
Conclusion: A. baumanii can be preserved in reservoirs in the
hospital and cross transferred by the hands of HCW. Infection
control measures must be constant and intense to eliminate this
sometimes deadly chain.
P1815
The incidence and risk factors for Acinetobacter
baumannii bacteraemia in ICU patients with
A. baumannii respiratory tract colonisation
M. Pratikaki, E. Platsouka, C. Routsi, C. Sotiropoulou,
K. Kritikos, H. Belessiotou, O. Paniara, C. Roussos (Athens, GR)
Objectives: The aim of the study was to determine the impact
of Acinetobacter baumannii respiratory tract colonization in
patients admitted to the ICU, and the incidence and the risk
factors for the development of A. baumannii bacteraemia in this
group of patients.
Methods: During a 4-month period all patients with ICU stay
more than 48 hours, in the 30-bed multidisciplinary ICU of
Evangelismos hospital, were studied. Clinical, laboratory, and
demographic characteristics, the time of respiratory tract colon-
ization with A. baumanni, the development of A. baumannii
bacteraemia, and the susceptibility proﬁles were recorded.
Results: During the study period 63 (44 male, 19 female), of the
152 ICU patients, (41%), became respiratory tract colonized with
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A. baumannii. Admission diagnosis was surgical in 35 of
them and medical in the remaining 28. Subsequently, 20 of
the above group of patients (32%) developed A. baumannii
bacteraemia. The time between admission and colonization
or bacteraemia was 6.5 days and 10.5 days respectively
(median value). All A. baumannii strains were resistant to
aminoglycosides and 20.6% of them were resistant to
ampicillin plus sulbactam. Patients with A. baumannii res-
piratory tract colonization who developed A. baumannii
bacteraemia had signiﬁcantly a higher Apache II score on
admission than those with A. baumannii respiratory tract
colonization who didn’t developed A. baumannii bacteraemia
(22.2 + 1.7 vs. 17.2 + 1.0, p = 0.014). Multiple logistic regres-
sion analysis showed that independent risk factors for A.
baumannii bacteraemia in the respiratory track colonized
patients with A. baumannii, were Apache II score (OR = 1.1,
p < 0.05), and admission albumin (OR = 0.3, p = 0.03).
Conclusion: The incidence of A. baumannii bacteraemia in the
ICU patients with A. baumannii respiratory tract colonization is
high (32%). The severity of the disease and the degree of
hypoalbuminaemia on admission are independent risk factors
for the development of A. baumannii bacteraemia in ICU patients
with A. baumannii respiratory tract colonization.
P1816
Nosocomial bacteraemia due to
Acinetobacter baumannii in a university
hospital
A. Inal, Y. Tasova, N. Saltoglu, F. Firinciogullari,
N. Aksoy, I.H. Du¨ndar (Adana, TR)
Objectives: To determine clinical features, risk factors, and
outcome of bacteraemia due to Acinetobacter species detected in
a university hospital.
Methods: For a 12-month period during year 2003, 44 bacterae-
mia episodes due to Acinetobacter baumannii detected as a part of
nosocomial infection surveillance study of C¸ukurova University
Hospital, a 1100-bed tertiary health care institution, investigated
retrospectively.
Results: Of all patients whose mean age was 35 ± 25 (min 1,
max 85) 63.6% (n:28) were male and 36.4% (n:16) female. Mean
growth time was 24 days after admission. Thirty eight patients
(86.4%) were hospitalized in intensive care units. Of bacteraemia
episodes 59.1% (n:26) were polymicrobial. No focus of infection
was detected in 65.9%. Of the remainders (34.1%), infection
focus determined as follows: pneumonia 20.5%, urinary tract
infection 4.5%, burn infection 4.5%, and catheter related blood-
stream infection 4.5%. None of the patients had endocarditis.
Fifteen patients (34.1%) were colonized previously by Acinetob-
acter baumannii. All of the patients have at least one risk factor
described in the literature. Risk factors detected were previous
antibiotic use 79.5%, central venous catheter 54.5%, mechanical
ventilation 50.0%, surgery 43.2%, trauma 25.0%, neurological
disorder 20.5%, burn 11.4%, solid organ transplantation 9.1%,
haemodialysis 11.0%. Despite appropriate therapy%61.4 (n:27)
of patients were died.
Conclusions: In recent years, bloodstream infections due to
Acinetobacter baumannii became an important cause of mortality
in patients who requires intensive care and hospitalized long
period. Besides strict infection control procedures to prevent
acquisition of this pathogen, payin attention for early determin-
ation of patients with high risk and appropriate therapy would
reduce mortality.
P1817
Genotyping analysis of Acinetobacter isolated
from bloodstream infections in a Turkish
university hospital
E. Alp, D. Esel, O. Yildiz, A. Voss, W. Melchers,
M. Doganay (Kayseri, TR; Nijmegen, NL)
Objectives: To evaluate the genetic relatedness of Acinetobacter
spp. isolated from blood cultures.
Methods: This prospective study was conducted from March
2002 to March 2003 in a University Hospital in Turkey. During
this period, all patients with BSI caused by Acinetobacter spp.
were included in the study. Blood cultures were processed by
using the BACTEC 9240 blood culture system (Becton Dickinson,
Sparks, MD, USA). Acinetobacter spp. isolates were identiﬁed
according to their gram-negative morphology, based on stand-
ard biochemical reactions (API ID 32E system; bio-Merieux). For
susceptibility testing and genetic analysis, only the ﬁrst isolate of
a bacteremic period was included. Antimicrobial susceptibility
testing was determined by Kirby–Bauer disk diffusion testing
according to NCCLS recommendations. The genetic analysis of
isolates was performed by RAPD-PCR and pulsed-ﬁeld gel
electrophoresis (PFGE) at the University Medical Centre, Nijme-
gen. Eric 1 and d8635 primers were used in RAPD-PCR and SmaI
was used in PFGE.
Results: During a one-year period, 41 patients acquired a
nosocomial bloodstream infection caused by A. baumanii. More
than 80% of these infections (36 of 41) occurred while the
patients were treated in the intensive care unit. Nearly 80% of
the isolates belonged to three genotypes, suggesting cross-
transmission in ICU settings where infection control practices
are poor. Most Acinetobacter isolates were multi-resistant. The
crude mortality of patients infected with A. baumanii was 80.5%.
Conclusion: BSIs due to A.baumannii are mostly ICU-acquired.
Moreover nosocomial transmission may lead to the spread of
one or more epidemic strains. Early detection and strict
compliance with standard precautions and contact isolation,
are essential components of infection control programmes to
prevent nosocomial transmission of A. baumannii.
P1818
Attributable mortality of Acinetobacter
baumannii bacteraemia
M. Grupper, R. Finkelstein (Haifa, IL)
Objective: This study was designed to determine the attribut-
able mortality resulting from A. baumannii bloodstream infection
(BSI).
Methods: The Rambam medical Center is a 900-bed teaching
hospital providing tertiary care for persons in the Northern of
Israel. A matched, retrospective, case-control study was per-
formed. A case patient was deﬁned as any adult patient
developing signs and symptoms of BSI > 48 hours after admis-
sion to the hospital, and for whom 1 or more blood culture
yielded A. baumannii between January 1, 2001 and December 31,
2003. Patients with polymicrobial bacteraemia were excluded. A
control was deﬁned as a patient similar to a case but without
evidence of A. baumannii BSI during hospitalization. We care-
fully matched each case patient to a control patient using a
3-stage stepwise procedure. First, using a computerized data-
base cases were matched by period of hospitalization (±3 years),
age (±10 years), sex, length of time at risk (length of stay for each
control equal or greater than the time of onset of A. baumannii
BSI for the matched case), and primary diagnosis at admission.
Second, the ICD-9 diagnostic codes and medical records were
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reviewed to match for underlying diseases(s), primary and
secondary diagnosis, and surgical procedure(s). Finally, candi-
date records were reviewed to identify the best possible match
based on the severity and duration of illness, without know-
ledge of outcome for either case or control.
Results: 52 patients fulﬁlled our inclusion criteria for A.
baumannii BSI. We matched the 52 case patients with 52 control
patients. All case and controls patients were correctly matched
for major underlying disease, age, sex, period of hospitalization
and median duration of hospital stay before the onset of BSI.
Most blood culture isolates were multiple-drug resistant. Of the
52 cases, only 18 (34.7%) and 34 (65.4%) were susceptible to
imipenem and ampicillin-sulbactam, respectively. Of the 52
cases, 29 died during hospitalization, for a crude mortality of
55.7%. The mortality rate found in the control group was of
19.2% (10 of 52 patients). Therefore, the attributable mortality
was 36.5% (95% CI, 27%–46%) and the mortality risk-ratio was
2.9 (95% CI, 1.58–5.32).
Conclusion: A. baumannii is a multiple drug resistant pathogen
commonly isolated from nosocomial BSI and is associated with
mortality in excess of that due to the underlying diseases alone.
P1819
Cure of multidrug-resistant Acinetobacter
baumannii prosthetic material-related
orthopaedic infections with intravenous colistin
S. Kasiakou, K. Fragoulis, G. Tzagarakis, P. Mistidis,
A. Kapaskelis, M. Falagas (Athens, GR)
Background: Multidrug-resistant (MDR) Gram-negative bac-
teria, including Pseudomonas and Acinetobacter spp., are frequent
causes of osteomyelitis, and septic arthritis now-a-days. For such
infections, colistin has not been considered as an alternative to the
conventional therapeutic intervention, mainly due to its reported
in the old literature inadequate penetration in these tissues.
Methods: We describe two cases of MDR Acinetobacter bauman-
nii prosthetic material-related orthopaedic infections which
where successfully treated with intravenous colistin.
Results: A 53-year-old male was admitted with complicated left
proximal femur fracture. He underwent surgical debridement of
the necrotic tissues and external ﬁxation of the femur. However,
during the ensuing days his clinical condition worsened and he
became febrile. A specimen culture obtained during consecutive
surgical debridement grew anAcinetobacter baumannii strain. This
strain exhibited sensitivity only to colistin (MIC 0.5 mg/l) and
intermediate sensitivity to gentamicin, tobramycin, and merope-
nem. The patient received a bolus intravenous injection of colistin
1million IU followed by 6million IU per day continuous infusion
for 36 days. His clinical condition gradually improved. The
second casewas a 37-year-oldmale whowas admitted because of
fractures of both left tibial condyles. He underwent surgical
treatment, which consisted of an open reduction and internal
ﬁxation. However, he became febrile 7 days after his discharge
and 5 days later he was readmitted to our hospital. Physical
examination showed erythema and tenderness at the region of the
left knee. The patient underwent surgical debridement of the
affected area. A specimen obtained from the surgical site grew an
Acinetobacter baumanii strain and a Staphylococcus lugdunensis
strain. The Acinetobacter baumanii strain exhibited sensitivity to
colistin and gentamicin and intermediate sensitivity to merope-
nem and tobramycin. Subsequently, the patient was given
intravenous treatment with colistin 2 million IU q8h for 22 days,
andvancomycin 1grq12h for 13 days. Thepatient becameafebrile
and was discharged after 29 days of hospitalization. No serious
colistin associated toxicity developed and no recurrence of the
infection occurred on follow up in both patients.
Conclusion: Colistin may consider as a valuable therapeutic
option in cases of prosthetic material-related orthopaedic infec-
tions due to MDR Acinetobacter baumannii strains.
P1820
Colonisation with vancomycin-resistant
enterococci and methicillin-resistant
Staphylococcus aureus increases the risk for
multidrug-resistant Pseudomonas aeruginosa
colonisation
E. Tacconelli, K. de Gaetano Donati, R. Citton, F. Magnano San
Lio, A. Cambieri, T. Spanu, G. Fadda, R. Cauda (Rome, I)
Background: Vancomycin-resistant Enterococci (VRE) and meth-
icillin-resistant S aureus (MRSA) have emerged as major infec-
tions control problem worldwide. Recently, a dramatic increase
in multi-drug resistant gram-negative bacteria, mainly P. aeru-
ginosa (MDR-PA), has been reported. No data are available on
the prevalence and risk factors for MDR-PA colonisation.
Design: A rectal swab culture survey was conducted during a
1-week period (March 2004) to determine the point-prevalence
of stool colonization with VRE and MDR-PA in hospitalized
patients. Two case-control studies were designed to identify risk
factors for colonisation. Patients colonised with VRE (group-1)
and with MDR-PA (i.e. resistance to >2 drug classes; group-2)
were compared to patients with negative rectal screening
(group-3) using a logistic regression analysis.
Patients: All patients hospitalised in a 700-bed University
Hospital.
Results: Of the 1,036 patients screened (581 inmedical and 414 in
surgicalwards, 41 in ICU), 26 (point-prevalence: 25/1,000hospital
admissions) were colonised with VRE and 16 patients (15/1,000
hospital admissions) with MDR-PA. One-hundred and sixty-ﬁve
controls, randomly selected among patientswith negative screen-
ing cultures, were compared to VRE+ and MDR-PA+ patients.
Themean age ±SDwas 55 ± 15 in group-1 and 65 ± 15 in group-2
(P = ns vs group-3). The mean Charlson score was 2.1 ± 2.2
(P = ns vs group-3) and 3.7 ± 3.1 in group-2 (P < 0.001 vs group-
3). Five (8%) patients were co-colonised with VRE and MDR-PA
and 12 (29%) had VRE or MRSA isolated within 6 months (6 in
group-1 and 6 in group-2, P < 0.01 vs group-3). Risk factors for
both VRE andMDR-PA colonisations were: (1) antibiotic therapy
within 30 days (P < 0.01 group-1; P=.01 group-2); (2)previous
MRSA isolation (P < 0.001 both groups), and (3) previous VRE
isolationwithin 30 days (P < 0.001 both groups).Wheel-chair and
bed-bound status was independently associated with MDR-PA
colonisation (P < 0.001) while hospital admission from long-term
care facility, nursing home, or other hospitals to VRE colonisation
(P = 0.001).
Conclusion: The prevalence of MDR-PA colonisation is high in
hospitalised patients. Previous antibiotic therapy and colonisa-
tion or infection with VRE and/or MRSA increase the risk for
MDR-PA colonisation. This data suggests that alert systems and
isolation measures necessary to control VRE and MRSA may
provide other beneﬁt in controlling the spreading of MDR gram-
negative bacteria into the hospital.
P1821
A seven-year review of neonatal sepsis due to
multidrug resistant Pseudomonas aeruginosa in a
regional NICU
B. Sadownik, J. Behrendt, J. Karpe, M. Wasek-Buko,
U. Godula-Stuglik (Zabrze, PL)
Objectives and methods: Analysis of epidemiology, clinical
symptoms, laboratory ﬁndings and outcome of neonatal
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septicemia due to Pseudomonas aeruginosa in tertiary regional
NICU. Retrospective chart review of preterm and full-term
neonates diagnosed with this sepsis between January 1997 and
December 2003.
Material: Among 549 septic neonates 47 ( 8.6%) had Pseudo-
monas aeruginosa in blood culture. Early-onset septicemia (£3 day
of life) in 4 (8.5%) and late-onset in 43 (91.5%) neonates were
diagnosed. Prematurity in 87%, intrauterine hypotrophy in 21%,
severe birth asphyxia in 24%, very low birth weight (£1500g) in
58%, extremely low birth weight (£1000g) in 30% and male sex
in 51% of cases were found. In all neonates with late-onset
Pseudomonas aeruginosa sepsis the endotracheal intubation and
total parenteral nutrition in ﬁrst week of life were applied.
Results: Most frequent clinical symptoms included bilateral
pneumonia (96%), septic shock (66%), urinary tract infection
(43%), DIC (40%), purulent meningitis (21%) and necrotizing
enterocolitis (21%). Metabolic acidosis (83%) and signiﬁcant
increase of serum CRP concentration (92%) as biochemical
disorders were most often stated. Thrombocytopenia in 58%,
marked decrease of AT III activity in 51% and neutropenia in
19% of cases were found. Pseudomonas aeruginosa isolated from
blood were resistant to gentamycin in 100%, to amikacin,
tobramycin, ciproﬂoxacin, imipenem/clastatin, meropenem
and cefepim in 75%, to ceftazidim, piperacillin, ticarcillin/
clavulanic acid in 50%. All strains were sensitive to colimycin
and piperacillin/tazobactam. In 36% septic mechanically venti-
lated neonates Pseudomonas aeruginosa in tracheobronchial aspir-
ates were also isolated. Mortality rate was 34%. All 16 neonates
who died had low birth weight (including 9 with birthweight
less than 1000g) and late-onset sepsis. Nine of them suffered
from others signiﬁcant diseases such as bronchopulmonary
dysplasia, necrotizing enterocolitis, congenital defects and/or
severe intracranial hemorrhages.
Conclusion: Multidrug resistant Pseudomonas aeruginosa is
potentially important pathogen in the etiology of severe neona-
tal sepsis, especially late-onset with bad prognosis.
P1822
Carbapenem-resistant Pseudomonas aeruginosa
from clinical specimens over two years
L. Naumiuk, E. Naumiuk, A. Sledzinska, M. Bronk,
A. Samet (Gdansk, PL)
Objectives: To analyze occurence and susceptibility of carb-
apenem-resistant Pseudomonas aeruginosa (CRPA) in a university
hospital.
Methods: The analysis of microbiological records with
P. aeruginosa resistant to imipenem or meropenem from 2002
to 2003 was done. We used abbreviated methods for identiﬁca-
tion (NCCLS) and disk-diffusion technique (NCCLS) to deter-
mine susceptibility to selected antipseudomonal drugs.
Results: There were 515 and 584 one-per-patient P. aeruginosa
isolates in 2002 and 2003, respectively. CRPA was isolated from
190 (102-2002 and 88 - 2003) patients. They were hospitalised in
surgery departments (58), ICU (51), general medicine (36),
haematology (15) and other units (30). Majority of CRPA were
from respiratory tract specimens 29%, wound and urine, each
28%. The most active antibiotics against CRPA were caftazidime
73%, amikacine 67%, cefepime 62%, piperacilline/tazobactam
59%, and piperacilline 46%.
Conclusion: CRPA were isolated from about 20% patients with
P.aeruginosa infection/colonisation. Patients from surgery and
ICU are at the greatest risk of acquiring CRPA during their
hospitalisation. Ceftazidime retains high activity against this
resistant group of Pseudomonas isolates which makes it the drug
of choice in those kind of infections.
P1823
Three-year resistance trend among P. aeruginosa
isolated from Brazilian intensive care units:
results from the MYSTIC Program
S. Andrade, C.R. Kiffer, P. Tuner, A.C. Pignatari, A.C. Arruda,
P.C. Koga, C. Oplustil, J.L. Sampaio, C.M. Mendes on behalf of
the MYSTIC Group Brazil
Objective: To evaluate the resistance trends for P. aeruginosa
responsible for nosocomial infections in intensive care units
(ICUs) participating in 2001, 2002, and 2003 editions of the
MYSTIC Program in Brazil.
Methods: Four hundred and ninety-four P. aeruginosa clinical
isolates were collected by the six ICUs participating in each of
the three yearly editions of the MYSTC Program (217 were
collected in 2001, 131 in 2002, and 146 in 2003). Minimum
inhibitory concentrations (MICs) were determined at a central
laboratory by E-test methodology according to manufacturer’s
instructions to: cefepime, ceftazidime, piperacillin/tazobactam,
imipenem, meropenem, tobramycin, gentamicin, and ciproﬂ-
oxacin. Interpretations followed the NCCLS document M100-
S14. A chi-square for trend test (Altman, 1999) was applied to
identify ordered differences in the rates along the 3 years
studied. P values below 0.05 were considered signiﬁcant.
Results: The table presents susceptibility rates of all P. aerugi-
nosa clinical isolates collected from Brazilian ICUs according to
the year of isolation and their respective p value for the chi-
square for trend test. Piperacillin/tazobactam and meropenem
presented the higher susceptibility rates at all years. However,
the chi-square for trend test yielded a p value of 0.04 for both,
meropenem (59.9%/2001, 56%/2002, 49.3%/2003) and pipera-
cillin/tazobactam (63.1%/2001, 62.5%/2002, 52%/2003). All
other yearly comparisons showed a p value above 0.05, although
ciproﬂoxacin (46%/2001, 45%/2002, 38.4%/2003) presented a p
value close to the cut-off (0.07).
Conclusions: Decreasing susceptibility rates were observed
among all antimicrobials evaluated in each year, but only
meropenem and piperacillin/tazobactam presented a signiﬁcant
ordered decline in their rates. Although resistance for these
antimicrobials seems to be increasing, they were still the most
active drugs for P. aeruginosa in this setting. Nevertheless, it
should be noted that previous editions of the program detected
P. aeruginosa clonal spread among these centres. Thus, biased
samples cannot be ruled out, due to either possible clonal spread
or overvalued resistant clinical isolates.
Percentage of antimicrobial susceptibility of 494 clinical isolates
of P. aeruginosa collected from Brazilian ICUs according to the
year of isolation MYSTIC Program 2001–2003
Year of isolation/ Susceptibility %
Antimicrobial class/agent 2001 (N-217) 2002 (N = 131) 2003 (N = 146) P valuea
b lactams
Cefepime 52.0 52.6 48.6 0.54
Ceftazidime 45.1 48.8 45.2 0.93
Piperacillin/tazobactam 63.1 62.5 52.0 0.04
Imipenem 43.7 52.6 43.1 0.94
Meropenem 59.9 54.1 49.3 0.04
Aminoglycosides
Gentamycin 35.9 47.3 42.4 0.15
Tobramycin 38.7 43.5 41.7 0.51
Fluomquiaaloaei
Ciproﬂoxacin 46.0 45.0 38.3 0.07
aP values calculated through chi-square for trend test.
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P1824
Carbapenem- and pandrug-resistant
Pseudomonas aeruginosa causing nosocomial
infection at a university hospital in Taiwan
P.R. Hsueh, L. Teng, S. Ho (Taipei, TW)
Objectives: To investigate the epidemiology of carbapenem-
and pandrug-resistant Pseudomonas aeruginosa (resistant to all
cephalosporins, piperacillin-tazobactam, aztreonam, carbapen-
ems, ciproﬂoxacin, and aminoglycosides) (CRPA and PDRPA)
in a university hospital in Taiwan.
Methods: Data on the routine disk diffusion susceptibilities of
P. aeruginosa recovered from 1993 to 2002 were evaluated to
determine the secular trend of resistance. Time-kill study was
used to evaluate the synergy of antibiotic combinations for two
PDRPA isolates. Genotypes of PDRPA isolates were determined
by pulsed-ﬁeld gel electrophoresis (PFGE).
Results: The rapid emergence of CRPA isolates (from 8.1% in
1999 to 13.0% in 2002) causing nosocomial infections was
associated with the increased use of carbapenems and extended-
spectrum cephalosporins. PDRPA was ﬁrst found in 1996 and
reemerged thereafter (1.4% in 1999 to 2.7% in 2002). Among the
26 PDRPA isolates recovered from 16 patients, 50%, 27%, 12%
and 8% were intermediate to amikacin, aztreonam, cefepime,
and ceftazidime, respectively. Time-kill curve study at one-
fourth the minimum inhibitory concentrations (MICs) for two
PDRPA isolates demonstrated synergism for cefepime-amikacin
combination at 24 hours. Nineteen (73%) of the isolates pos-
sessed blaVIM-3 and 25 (96%) had class I integrons (intI).
Pulsed-ﬁeld gel electrophoresis analysis of the 26 isolates
disclosed 12 pulsotypes. Several isolates from different patients
had identical pulsotypes or were closely related indicating the
presence of clonal spreading.
Conclusions: Selective pressure due to increasing consumption
of carbapenems and extended-spectrum cephalosporins as well
as clonal dissemination contributed to the spread of CRPA and
PDRPA in the hospital.
P1825
Epidemiology and surveillance of MDR P.
aeruginosa in an Italian hospital
G. Gattuso, D. Tomasoni, C. Chiarelli, L. Palvarini, P. Costa,
G. Fibbia, B. Morandini, G. Perboni, A. Scalzini (Mantua, I)
The spread of MDR-PA is a serious emergency causing
nosocomial infections, unfortunately this problem may be
observed also in small hospitals.
Objectives: To evaluate the prevalence of the MDR-PA isolates
through the monitoring of laboratory data. To determine the
resistance rates of PA isolates againts commonly used antibiot-
ics. To compare the obtained data with national and interna-
tional database.
Methods: The Hospital is a 510-bed tertiary care teaching
hospital in Mantua with 30,000 patient admissions per year.
The study has been conducted from January 2002 to June 2004.
All data reported refer to non-duplicate isolates. MDR-PA was
deﬁned as resistance at least three of the following four drugs:
imipenem, ceftazidime, ciproﬂoxacin and gentamycin. Statistical
analysis were performed using Mercurio (Dianoema) software.
The rates of resistance to individual or combination anti-
pseudomonal agents were compared using Chi-square test.
Results: 790 PA were isolated from every site; 85/790 (10.7%)
were considered MDR-PA. The principal wards involved were:
IntensiveCareUnit (ICU),Neonatal-ICU (NICU) andRespiratory
diseases, respectively in 36.4%, 21,1% and 14.1% of MDR-PA
isolates.The microbiological materials predominately involved
were: pus, blind endotracheal suctioning and sputum respect-
ively in 22.3%, 21.1% and 15.3% of cases. The resistance rates to
anti-pseudomonal agents increased substantially over the con-
sidered period for the ciproﬂoxacin, aztreonam and imipenem.
Resistance to ciproﬂoxacin increased from 11.7% to 40.0%
(p < 0.001); to imipenem from 35.3% to 40% (p = n.s.) and to
aztreonam from 23.5% to 56.2% (p < 0.001). The agents with the
lowest rates of MDR-PA were amikacin and piperacillin/
tazobactam. Empiric drugs combinations were considered to
valuate the frequency of the resistance to both agents. The cross-
resistance rates between ciproﬂoxacin and the beta-lactam
antibiotics (aztreonam, imipenem) increased signiﬁcantly; also
for regimen with cefepime plus gentamicin. A combination that
included piperacillin/tazobactam and amikacin resulted in the
lowest resistance.
Conclusion: The rates of resistance using antipseudomonal
agents increased in period considered and reﬂected the results
of the international studies. The surveillance based on the
laboratory data indicates the true magnitude of local resistance
problems and let the selection of an appropriate empiric
therapy.
P1826
Emergence of multi-drug resistant Pseudomonas
aeruginosa isolates in neonatal septicaemia
R. Moniri, Z. Mosayebi, A.H. Movahedian,
G.A. Mousavi (Kashan, IR)
The emergence of multi-drug resistant (MDR) strains of Pseudo-
monas aeruginosa has complicated decision for treatment andmay
lead to failure in treatment. In this study, we evaluated the
prevalence of resistance to Amikacin, Ampicillin, Carbenicillin,
Ceﬁxime, Cefotaxime, Ceftazidime, Ceftizoxime, Ceftriaxone,
Gentamicin, Imipenem, and Trimethoprim/ Sulfamethoxazole in
sixty-nine strains of P. aeruginosa isolates from neonates with
septicemia in Kashan, Iran from April, 2000 to June 2004. In
assessment of the current breadth of multi-drug resistance in
P. aeruginosa isolated from neonates with septicemia, 4.3% were
susceptible to all studied agents, 10.1% were resistant to a single
agent, MDR isolates accounted for 73.9% (51 out of 69) of isolates.
The majority MDR isolates (41.2%) were resistant to three
antimicrobial agents, which accounted for 30.4% of all isolates.
Nineteen MDR isolates from ﬁfty-one (37.3%) were resistant to
four agents (19 out of 69; 27.5% of all isolates) and 21.6% of MDR
isolates to ﬁve agents (15.9% of all isolates). Statistical analysis
conﬁrmed that there were no signiﬁcant differences between
multi-drug resistance phenotypes of isolates with age, gender,
gestational age, outcome of septicemia, and application of
respirator in neonates. Continued local surveillance studies are
urged to monitor emerging antimicrobial resistance and to guide
interventions to minimize its occurrence.
P1827
Determination of drug resistance in Pseudomonas
aeruginosa isolated from burn patients in Sari,
Iran 2004
M. Ahanjan, M. Vahedi, M. Nasrollahie (Sari, IR)
Objectives: Pseudomonas aeruginosa is the main opportunist
pathogen One of the features of this organism is resistance to
most of the current antibiotics, as a result creates problems in
tratmentent . This sudy is on the determination of MIC of
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currently used antibiotics to Pseudomonas .Therefore, it is
necessary to have study on this phenomenon. We tried to
have a regional on the drug resistance in the pseudomonas
isolated in burn patients referring to burn treatment centre of
zareh hospital ,in order to the patients be beneﬁted from the
more effective antibiotic treatment.
Methods: With the help of sterile swab, sample from the burn
was collected, kept in tube containing sterile saline and
transported to the laboratory .cultured on blood agar and
EMBagar,incubated at 37(D.C) centigrade for 24 hours. Gram
staining was done from the.colonies belonging to the gram
negative and oxidas positive bacilli were selected and cultured
on simmon citrate and TSI, incubated at 37 D.C for 24 hours. The
conﬁrmed P. aeruginosa colonies were inoculated in sterile saline,
suspension was prepared and compared with 0.5 standard of
Mac Farland . Then cultured by streak method on Muller–
Hinton. Antibiogram was done using disk of antibiotic prepared
from Padten Teb company ,Iran. Kept at 37DC for 24 hours.
The resistance and sensitivity to different antibiotics were
determined in millimeters comparing with the chart provided
from the manufacture.
Results: In this study samples were collected from 250 patients
admitted in burn unit of zareh hospital. 60% of the patients
under study had Pseudomonas infection, There was signiﬁcant
difference between prevalence sex, Geographic condition hos-
pital stay period. It was shown that resistance to Amikacin,
Gentamycin, trimethoprim sulfo methoxazole, cephoxidim,
ceftazidim. Ciproﬂoxazin, cephipenem, emipenem, and cephri-
axon, 72.9% , 63% , 41.6% , 33.3% , 30% , 29.1% , 27% , 25% , and
15% respectively.
Conclusion: Result of the studies on resistance of the organisms
to antibiotics differs in different countries. These are as follow:
To Amikacin 11%( in spain ), 1% in Germany , 67% Tehran (Iran)
and in this study 72.9%. Also resistance to Gentamicin 65.5% in
zimbabveh, Tarbiat modarres university (Iran)78%, and in this
study 63%. Considering the obtained results on the resistance of
this organism to antibiotics, regional study on determination of
drug resistance is necessary.
P1828
Antimicrobial susceptibility among Pseudomonas
aeruginosa isolates in Centro Hospitalar de
Coimbra, central Portugal
A. Pena, A. Alves, R. Leita˜o, O. Cardoso (Coimbra, P)
Objective: Pseudomonas aeruginosa (PA) infections are of great
concern for hospitalized patients, particularly those in intensive-
care units. This bacterium is the leading cause of nosocomial
respiratory infections. The aim of this study was to determine
antimicrobial susceptibility of PA clinical isolates obtained from
Centro Hospitalar de Coimbra to ascertain resistance patterns.
Methods: Bacterial isolates (n = 416) were collected during
April 2003 to April 2004 (one year). They were identiﬁed with
VITEK (BioMe´rieux) and MicroScan WalkAway (Dadebehring)
and susceptibility patterns were determined with these panels.
Susceptibilities to Piperacillin (PIP), Piperacillin plus Tazobac-
tam (TZP), Aztreonam (AZT), Ceftazidime (CAZ), Imipenem
(IP), Meropenem (MP), Amikacin (AMK), Tobramicin (NN),
Gentamicin (GN), and Ciproﬂoxacin (CIP) were guideline by
NCCLS.
Results: In the set of 416 clinical isolates two hundred and
seventy three were obtained from nosocomial infections and one
hundred and forty three from community acquired infections of
different clinical specimens, including urine (16.5%, 39.8%,
respectively), sputum (44.3%, 27.3%), exudates (13.6%, 16.1%),
blood (6.6%, 4.9%), and others sources (19.0%, 11.9%). Among
all isolates MP was the most potent antibiotic (91.6% suscept-
ible), GN and CIP were the worst agents (66.8% and 69.2% of
susceptibility, respectively). Susceptibilities rates varied signiﬁ-
cantly between nosocomial and community acquired infections.
PIP and IP had same susceptibility in hospital infections (80.2%),
but CAZ and TZP had better activities (82.8%, 81.7%, respect-
ively), MP was the best agent (88.3%), and AZT was a weak one
(71.1%). Aminoglycosides presented light activities, 78.4% for
AMK and 61.5% for GN. The quinolone, CIP, inhibited only
64.1% of these isolates. Ambulatory isolates were more suscept-
ible to these antibiotics. MP was the best agent (97.9%) followed
by IP (96.5%), CAZ and TZP (95.8%), PIP (94.4%) and AMK
(94.4%). GN and CIP presented sensibilities like 76.9% and
79.9%, respectively.
Conclusions: Considering the results and the high prevalence
of multidrug resistant strains (9.6%) (resistance to three or four
of these agents: PIP, CAZ, IP and CIP) in this hospital
environment, it is obviously necessary to detect and follow
sources of infection, in order to prevent the spreading of these
strains and its transmission. Susceptibility rates should be
determined and effective antibiotics usage policy should be
performed.
P1829
Antibiotic resistance of Pseudomonas aeruginosa
strains isolated from patients in intensive care
unit
A. Budak, P. Nowak, P. Wodzinski , E. Karczewska, E. Tokarska,
M. Skalkowska (Cracow, PL)
Objective: The aim of the paper was the epidemiological
investigations of multidrug resistance among P. aeruginosa
strains isolated from patients hospitalized in AICU of Rydy-
gier’s Hospital in Krako´w between 2000–2004.
Materials: The subject of the analysis was 1008 P. aeruginosa
strains isolated from blood, respiratory tract, urine and wounds.
Methods: The isolates were identiﬁed in the ATB system
(bioMerieux) using ID 32 GN strips. The sensitivity of strains to
selected antibiotics (piperacillin/tazobactam, ceftazidime, imi-
penem, meropenem, gentamicin, tobramycin and ciproﬂoxacin)
was performed with disc diffusion method and with interpret-
ation according to NCCLS. The E-tests MBL (AB BIODISK,
Sweden) for detection ofmetallo-beta-lactamaseswere used. PCR
analysis was performed for the estimation of genotypes of chosen
P. aeruginosa strains isolated from patients of AICU, which
represented different and changing patterns of sensitivity during
hospitalization and applied therapy and for comparison strains
isolated from persons from other hospital wards. Analysis for the
detection of genotypes of strains was carried out with primers
PAL-2 (5¢-CTTCTTCAGCTCGACGCGACG-3¢) and ERIC-2
(5¢-AAGTAAGTGACTGGGGTGAGCG-3¢).
Results: P. aeruginosa strains isolated in the period of ﬁve years
showed the resistance to piperacillin/tazobactam and ceftazy-
dime in the range respectively about 11% and 21%. The
resistance to carbapenems was very similar among strains
every year and was estimated in the range 22% to 29%. The
decrease of resistance to aminoglicosides : gentamycin and
tobramycin in the range 21% to 2% was notiﬁed. The resistance
to carbapenems and/ or to ceftazidime in some strains was
metallo-beta-lactamase dependent. Multidrug resistant strains
were also identiﬁed. Genotyping of 20 selected phenotypes of
P. aeruginosa conﬁrmed the big heterogenicity of strains.
Conclusions: The E-test MBL can be used in microbiological
laboratory to monitor the emergence of metallo-beta-lactamases.
Estimation phenotypes of resistance and genotypes among the
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most frequently isolated in ICU P.aeruginosa strains is very
important in epidemiological surveillance of hospital infections.
P1830
Worldwide antimicrobial susceptibility patterns
of Pseudomonas aeruginosa causing intra-
abdominal infections: results from SMART 2003
F. Baquero, V. Satishchandran, C. Harvey, H. Teppler,
M. DiNubile (Madrid, E; West Point, USA)
Background: SMART (Study for Monitoring Antimicrobial
Resistance Trends) is an ongoing global antimicrobial surveil-
lance program focused on clinical isolates from intraabdominal
infections (IAI). The aim of this interim analysis was to assess
antimicrobial susceptibility patterns among P. aeruginosa from 4
different regions of the world during 2003.
Methods: A total of 71 hospitals in North America (NA), Latin
American (LA), Europe (EU), & Asia/Paciﬁc (A/P) tested the in
vitro activity of 9 antipseudomonal antibiotics commonly used
to treat IAI against consecutive unique P. aeruginosa isolates
from IAI using microdilution techniques according to NCCLS
guidelines & breakpoints. Isolates recovered within 48 hr of
hospitalization were considered community-acquired (CA).
Results: 559 isolates of P. aeruginosa were recovered from 4478
patients (12%). 188 of these isolates (34%) were CA. The%
susceptible are displayed by region:
Conclusion: P. aeruginosa appears to be a relatively infrequent
pathogen in IAI. Resistance rates among P. aeruginosa causing
IAI exceeded 10% for many antibiotics. In NA & LA, ﬂuoroqu-
inolone resistance was more prevalent than resistance to
antipseudomonal cephalosporins, Group II carbapenems, pip-
eracillin-tazobactam, & aminoglycosides.
P1831
Multi-resistance in P. aeruginosa :
epidemiological results from the GENARS
Project
I. Noll, J. Beer, K. Huppertz, W. Pﬁster, T. Pietzcker, S. Schuster,
T.A. Wichelhaus, S. Ziesing, B. Wiedemann (Bonn, Leipzig, Jena,
Ulm, Kiel, Frankfurt a.M., Hannover, D)
Objectives: Natural resistance of P. aeruginosa to many antibi-
otics reduces the usefulness of many drugs for treatment of
infection with P. aeruginosa . Most statistics on resistance report
only resistance to speciﬁc drugs. However, more important is
the knowledge of the epidemiology of multi-resistant strains,
because these usually cause difﬁculties in antibiotic treatment.
The GENARS-project (German Network for Antimicrobial
Resistance Surveillance) is designed to provide epidemiological
data for German university hospitals. Since 2002 resistance data
are collected for all clinical relevant pathogens.
Methods: Analysis was based on ﬁrst isolates of P. aeruginosa
from six laboratories, collected from January 2002 to June 2004.
Minimal inhibitory concentrations (MICs) were determined by
broth micro dilution method (DIN) for ceftazidime (CAZ),
ciproﬂoxacin (CIP), gentamicin (GEN), meropenem (MER) and
piperacillin (PIP). Resistance patterns were evaluated by using
breakpoints according to DIN, grouping resistant and interme-
diate as non-susceptible; multi-drug resistance was deﬁned as
non-susceptibility to at least four of the ﬁve agents.
Results: A total of 6,150 isolates was analysed. 82% of these
isolates were non-susceptible to at least one agent: The most
common pattern was a mono-drug resistance to GEN (34.5%)
followed by co-resistance to GEN and PIP (14.3%). 9.8% of the
isolates were classiﬁed as multi-resistant, 3.2% were resistant to
all ﬁve class representatives. Signiﬁcant differences in multi-
drug resistance rates were associated with ward type with
highest rates for ICU-patients (16.9%). Higher-than-average
rates of multi-resistant strains were observed in departments
for cystic ﬁbrosis (14.2%) as well as in surgical departments
(12.1%). Furthermore, multi-resistance rates varied signiﬁcantly
between the centers involved with a range from 6.1% to 14.9%.
For one centre the distribution of resistance patterns over time
revealed an outbreak for one phenotype (GEN/PIP/CIP/
MER).
Conclusions: The relevance of multi-resistance in P. aeruginosa
as a major clinical problem is proved by an overall rate of almost
ten per cent for German university hospitals and an even higher
proportion for ICU-patients. Among the agents tested gentam-
icin plays an eminent role in regard to its mono-resistant rate as
well as a component of the most frequent resistance patterns.
P1832
Occurrence of meropenem-resistant Pseudomonas
aeruginosa in a university hospital
R. Vatcheva-Dobrevsky, J. Doncheva, E. Savov (Soﬁa, BG)
Objectives: The aim of this study is to asses the antimicrobial
susceptibility of Pseudomonas aeruginosa clinical isolates and to
determine carbapenemases producing strains in MMA, Soﬁa.
Methods: A total of 346 Gram negative nonfermentors isolates
was investigated by Mini API System (BioMerieux, France).
Sixty ﬁve multidrug resistant Pseudomonas aeruginosa from
hospitalised patients during the last one year were analysed.
The MICs of meropenem (MP) and eight antimicrobials were
determined by E-test (AB, Biodisk, Sweden) as follow: cefepime,
cefpirome, ceftazidime, ciproﬂoxacin, piperacillin/tazobactam,
gentamicin, tobramycin, cefoperazone/sulbactam. Detection of
metallo-beta lactamases (MBL) was performed using E-test
double-ended strip, loaded with imipenem (IMP) and IMP/
EDTA.
Results: MICs of MP were ranged from 0.25–32 mg/l. In
Pseudomonas aeruginosa isolates 18 (5.2%) of total 65 showed
positive result of E-test MBL. The majority of them originated
from ICU. The MBL-producers were more resistant than non-
producers to gentamicin, piperacillin/tazobactam and ciproﬂ-
oxacin: 89%, 72%, 97,2% and 67%, 38,6%, 56,3%. Both groups
showed similar low resistant rate to cefoperazone/sulbactam.
Isolates were most often recovered from respiratory tract
(47.9%), urine (31.6%) and blood culture (5.1%).
Conclusions: This ﬁrst in our country prevalence study conﬁrm
the appearance and increasing occurrence if carbapenem resist-
ant Pseudomonas aeruginosa and suggests the further investiga-
tions of type and epidemiology of isolates.
NA
(N = 139)
LA
(N = 64)
EU
(N = 209)
A/T
(N = 147)
Imipenem 37 88 78 81
Mercpenern 39 91 83 85
Ceftazidime 33 89 79 75
Cefepime 34 89 80 79
Tiperacillin-Taxobactam 38 98 91 89
Tooramycin 39 38 82 80
Amikacin 98 94 83 85
Letroﬂoxacin 76 59 78 83
Ciproﬂoxacin 77 57 77 82
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P1833
Pseudomonas aeruginosa resistance: audit in a
tertiary intensive care unit
L. Pejakov, N. Vucinic (Podgorica, CS)
Objectives: To determine the rate of antibiotic resistant
Pseudomonas aeruginosa from various isolates, and to ﬁnd possible
relationship between duration of hospital stay and development
of multidrug resistant (MDR) Pseudomonas aeruginosa.
Methods: Prospective analyses of all microbiological isolates
from 61 adult patients hospitalized in tertiary intensive care unit
more than 10 days. Following samples have been taken: endo-
tracheal tube/tracheal cannula aspirate, BAL samples, blood
culture, wound isolate, urine and intravenous line *central and
peripheral samples. Forty two (68.8%) patients were intubated/
tracheostomized more than two weeks. Data of previous
antibiotic therapies were noted as well.
Results: 61 patient ages from 19 to 79 years (41 male, 20 female)
hospitalized more than 10 days in intensive care unit were
followed regarding incidence of Pseudomonas aeruginosa isola-
tion, and its sensitivity/resistance to antibiotics, considering
length of stay in ICU (average stay: 22.4 days). Pseudomonas
aeruginosa was isolated in 31(50.8%) patients, most of them from
tracheal aspirate (28 patients). In 10 patients (6.1%) Pseudomonas
aeruginosa was isolated from both, tracheal aspirate and wound
samples. Resistance during appropriate antibiotic therapy (gen-
tamycin, cephtriaxon) developed in 14 patients (45%) after
10 days of treatment. In 9 patients (29%) after 20 days of
hospitalization in ICU resistance to amikacin therapy devel-
oped. Multiresistant Pseudomonas aeruginosa (MDR) has been
isolated in 5 patients (16.1%), after 20 days of stay, where
resistance developed during therapy (cephalosporines I,II,III
generation, aminoglycosides, chynolones, cephtazidim). They
were only sensitive to carbapenemes. Overall mortality in a
study group was 47.5%.
Conclusions: Development of multidrug resistance (MDR
Pseudomonas aeruginosa) during therapy in intensive care unit
is a real possibility. Appropriate microbiological monitoring and
changes of antibiotics regime are suggested in order to prevent
serious complications caused by this germ.
P1834
The risk factors for imipenem-resistant
Pseudomonas aeruginosa in the burn unit
Z. Ozkurt, M. Ertek, S. Erol, U. Altoparlak,
M.N. Akcay (Erzurum, TR)
Objective: This study was conducted to determine the risk
factors for acquisition of imipenem-resistant Pseudomonas
aeruginosa in the burn unit.
Methods: The patients hospitalized in the burn unit from July
2003 to November 2004 were included in this study. The features
of the patients with isolated imipenem-resistant P.aeruginosa
(IRPA) were compared with those of patients with isolated
imipenem-susceptible P. aeruginosa (ISPA). Demographic fea-
tures, greatness of burn surface, burn deepness, antimicrobials
used previously and presence of other microoorganism included
risk factors analysis. T test, chi-square test and logistic regression
analysis were used for statistics.
Results: ISPA was recovered from 137 patients, and IRPA was
recovered from 40 patients in this period. There were no relation
between age, gender, greatness of burn surface, burn depthness
with aquisition of IRPA. Hospitalization time before isolation
(p = 0.12), previous carbapenem use (p = 0.000), broad-spectra
antibiotics use (p = 0.000), and previous presence of ISPA
(p = 0.002) were associated with aquistion of IRPA.
Conclusion: Long hospitalization time, previous imipenem/
meropenemuse, previous broad-spectra antibiotics use and pres-
ence of ISPA previous were associated with aquistion of IRPA in
theburnunit. Fordecresing incidence of IRPA infections theusage
of broad-spectra antibiotics and especially carbapenem should be
restricted, and if possible hospitalization time should be short.
P1835
Genotypic diversity and virulence parameters
variation within samples of nosocomial
populations of Pseudomonas aeruginosa
A.P. Fonseca, P. Correia, A.F. Fonseca, R. Tenreiro,
J.C. Sousa (Porto, Lisbon, P)
Objectives: The objective of this study was to evaluate the
differences in genotypic diversity between sources and among
several virulence parameters, namely adhesion to polystyrene,
hexadecane and silicone, initial bioﬁlm formation and motility.
A total of 96 strains of P. aeruginosa collected at a Portuguese
Central Hospital and isolated from 5 different sources were
examined: Urine (U), Bronchial Secretion (BS), Catheter (C),
Exudate (E) and Reference Strains (R).
Methods: A combination of two genomic typing systems, the
minisatellite-primed PCR (MSP-PCR) and the enterobacterial
repetitive consensus sequence PCR (ERIC-PCR), was used to
discriminate the 96 strains. The data were analysed using
BioNumerics software. Bacterial adhesion (2 h) and initial
bioﬁlm formation (6 h) were studied by growing bacteria in
LB in a modiﬁed microtiter-plate assay. Strains were screened
for their capacity to adhere to hydrophobic biomaterials such as
silicone and hexadecane using a biphasic separation method.
The opportunistic P.aeruginosa were also screened for their
capacity to swim (ﬂagella) and twitch (pili). All tests were run in
triplicate. For quantitative comparisons of genotypic diversity
among samples, Stoddart’s and Simpson’s indices were used.
Results: Our results show that genotypic groups including
several sources and clusters of source-speciﬁc genotypes are
dispersed throughout the phenogram, regardless of isolation
source. In 96 strains, 59 (61%) correspond to genotypic groups
that include strains from all 5 sources; the other genotype
groups were shared by strains from 2 to 4 of the 5 sources and
accounted for a total of 28 isolates (29%); the remaining 9 isolates
(9%) were included in genotypes with only one source (BS or U
or R). Both diversity measures yielded similar results; the
population from R and BS had the highest diversity. In general,
all the pairwise differences in genotypic diversity between
sources were not statistically signiﬁcant (P > 0.05), except the
pairwise difference between BS and C sources. None of the
pairwise differences in all the parameters tested between
sources were statistically signiﬁcant (P > 0.05).
Conclusions: There were no signiﬁcant differences in genotypic
diversity among samples from the 5 different sources. Strains from
each of the 5 sources exhibited wide variations in the virulence
parameters tested.
Acknowledgments: This study was supported by a research
grant from Fundac¸a˜o Calouste Gulbenkian.
P1836
Inter-laboratory comparison of the results of
RAPD typing of Pseudomonas aeruginosa,
Acinetobacter baumannii, and Stenotrophomonas
maltophilia
K.Grif,F.Daxboeck,W.Koller,C.Lass-Florl (Innsbruck,Vienna,A)
Objectives: Macrorestriction (i.e. PFGE) is still the gold-stand-
ard in molecular typing, and sequencing-based methods are
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applied increasingly. Nevertheless, due to the ease and speed of
performance, PCR-based typing methods (e.g. random ampliﬁ-
cation of polymorphic DNA, RAPD) are widely used. However,
the value RAPD is thought to be limited by a lack of
reproducibility. The aim of this study was to assess the inter-
laboratory concordance of RAPD results.
Methods: Each participating laboratory colleted 30 clinical
isolates of P. aeruginosa , A. baumannii, (including 18 outbreak-
isolates from Vienna), and S. maltophilia, respectively. For DNA
extraction, colonies were suspended in lysis buffer containing
0.05 M NaOH and 0.25% (vol./vol.) SDS and incubated at 95C
for 15 min. The isolates were subjected to RAPD using the
previously described primers P15 (5¢-AAT GGC GCA G-3¢) and
272 (5¢-AGC GGG CCA A-3¢) according to a standardized
protocol (using Ready-to-Go PCR beads; Amersham) in the
collecting laboratory. Subsequently, the sets of isolates were
exchanged and typed in the other laboratory (and vice versa).
Finally, the results of RAPD typing were analysed by the Bio
Numerics software (Bio-Maths) by the use of dendrograms
derived from the Dice coefﬁcient-unweighted pair group
method with arithmetic averages (UPGMA). Automated ribo-
typing was performed as reference method.
Results: In none of the six series of isolates the RAPD results
were completely concordant. The median difference in the
strains identiﬁed as unique genotypes was 3.5 isolates. Overall
there was no difference regarding the discriminatory power of
the assays performed in the different laboratories (median
Simpson’s index of diversity: 0.647 vs. 0.64) or using the
different primers (median SID: 0.604 vs. 0.641).
Conclusion: These results are not in favour of the use of RAPD
for large-scale epidemiological investigations. Several parame-
ters in addition to those which were standardized in the present
study have to be optimized in order to achieve stable RAPD
results in different laboratories. With regard to the strict
adherence to the predeﬁned protocol in this study, we speculate
that the quality of DNA extraction (i.e. the concentration of the
DNA solution subjected to PCR) and the processing of the
electronic version of the gels (with regard to brightness and
contrast), which were essentially dependent on the individual
researchers, are most important in this context.
P1837
Outbreak of nosocomial bacteraemia due to
Burkholderia cepacia associated with contamined
soap
A.T. Tresoldi, L.G.O. Cardoso, P. Trabasso, M.C.S. Carvalho,
S.R.P.E. Dantas, M.L. Leichsenring, R. Fagnani,
M.L. Moretti (Campinas, BR)
Objectives: To describe an outbreak of nosocomial bacteremias
due to Burkholderia cepacia among low risk patients, in a 400 bed
teaching hospital, associated with contaminated soap.
Methods: Recovery of historical incidence of blood culture
positivity due to B. cepacia, retrospective analysis of medical and
nursery charts, and a review of literature were done. In
agreement to these ﬁndings, samples of antiseptic solutions
were cultured, and a pulsed-ﬁeld gel electrophoresis (PFGE)
was done.
Results: The analysis of historical endemicity curve of bac-
teraemia due to B. cepacia revealed an outbreak scenario, with 5
cases per month between June and July-2004, comparing with a
incidence of 0.8 cases/month in the last six months of 2003.
Patients didn’t have any known risk factor for B. cepacia
infection, like cystic ﬁbrosis, use of broad-spectrum antimicro-
bials or central venous catheter. Furthermore, the outbreak
occurred in low risk clinical, surgical and paediatric wards, all of
them using soap for hand hygiene; but not in high risk wards
like bone marrow transplantation unit, that routinely uses
chlorhexidine for this purpose. B. cepacia grew in cultures of
soap dispenser for health care workers use from several units,
but not in cultures of others antiseptic solutions, like alcohol and
iodine. Genotypically identical strains of B. cepacia were iden-
tiﬁed from blood samples and soap dispenser by PFGE. Only
one blood isolate from a patient with pulmonary neoplasm, and
another sample of maxilar sinus puncture in an allogeneic bone
marrow transplantation recipient with community acquired
sinusitis were genotypically distincts. Prompt cleansing and
disinfecting of all soap dispensers and continuous education of
health care workers provided no new cases of B. cepacia
bacteraemia in the further 3 months.
Conclusion: It’s known that B. cepacia can degrade parabens,
the stabilizing agents of a variety of soaps. Soap contamination
was the source of this outbreak, probably by association with
poor adherence of health care workers to standard precautions
and by absence of routine cleansing and disinfecting of soap
dispensers, emphasizing the importance of continuous educa-
tion of these professionals.
P1838
The virulent properties of nosocomial strains of
Burkholderia cepacia complex, isolated from
patients of Moscow hospitals
M.U. Chernukha, G.V. Alekseeva, I.A. Shaginyan,
A.L. Ginzburg (Moscow, RUS)
Objective: The development of the complex microbiological
approach for the indication of the source of hospital infection,
caused by Burkholderia cepacia complex strains.
Materials and methods: We have studied hospital strains from
Moscow clinics. Different phenotypic and genotypic methods
were used. We used Burkholderia cepacia selective agar, commer-
cial bacterial identiﬁcation systems (Biomerje, Crystal). Anti-
biotic resistance was studied by method of series dilutions.
Genotypic methods included speciﬁc PCR for various genom-
ovars (I-IX), RAPD-PCR, PCR for the identiﬁcation of epidemic
markers: cbl-gene, Burkholderia cepacia epidemic strain marker
(BCESM), IS-hybrid marker, and the PCR for the indication cepI
and cepR genes, the components of Quorum sensing system,
which regulated the production of pathogen factors.
Results: Phenotypic methods allowed us to differentiate
Russian strains and to determine these strains to the group of
three genomovars (I, III, IV). The comparison of the results of
determination of antibiotic resistance did not show the clonal
character of examined strains, but permitted to discover the
growth of antibiotic resistance during last years. The application
of molecular methods permitted to discriminate exactly Russian
strains of genomovar III to the group IIIA. We revealed by
typing strains with RAPD-PCR, that strains, which circulated in
Moscow hospitals, divided into nature strains in concrete
hospital and strains common for all Moscow hospitals. The
epidemic signiﬁcance of strains was conﬁrmed by positive PCR
for epidemic markers. The isolates of strains had different
combinations of epidemic markers, which were speciﬁc for each
hospital. Identiﬁcation of cepI and cepR genes in strains of our
collection permitted us to acknowledge the epidemic signiﬁ-
cance of strains, which had a potential ability due to regulatory
system Quorum sensing to source the infection and to persist in
organs of patients. The presence of cepR gene in all strains and
the absence of cepI gene among 33% of strains allowed us to
suggest, that for some strains it was necessary to exist in the
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presence of another bacteria , which had a full Quorum sensing
system. In conclusion, the complex microbiological approach
with the using of the set of phenotypic and molecular methods
will give the opportunity to identify more exact the source of
hospital infection, caused by bacteria of Burkholderia cepacia
complex.
P1839
Epidemiological features of nosocomial
Stenotrophomonas maltophilia
pseudobacteraemia
A. Xanthaki, M. Toutouza, S. Vourli, A.C. Vatopoulos,
A. Tsiringa, C. Kontou-Castellanou (Athens, GR)
Objectives: Stenotrophomonas maltophilia is an important
nosocomial pathogen responsible for serious infections. It is
associated with high morbidity and mortality especially in
immunocompromised patients. It can also be a contaminant or
member of the endogenous ﬂora of hospitalized patients. In our
hospital, S.maltophiliawas recovered from the blood cultures of 7
patients hospitalized in the same Internal Medicine Ward,
during a period of 40 days. We present here the clinical,
microbiological and epidemiological characteristics of this out-
break.
Methods: Identiﬁcation of the microorganisms was performed
by the VITEK II system (Biomerieux-France). Susceptibility to
antibiotics was assessed by both the disk diffusion method and
MIC breakpoints determination by the VITEK II system.
Molecular typing was done by the ERIC-II PCR method. The
epidemiological investigation included the review of the med-
ical records of the respective patients, as well as of the medical
and nursing practices in the ward. Surveillance cultures from
surfaces and also from hospital personnel (hand and throat
swabs) working in the speciﬁc ward were also performed.
Results: All strains were multiresistant and shared the same
phenotype being sensitive to quinolones, ticarcillin-clavulanate
and piperacillin-tazobactam and resistant to all other groups of
antibiotics tested. Molecular analysis showed that all S.malto-
philia strains had identical patterns. None of the 7 patients had
fever or other signs of infection during the respective period.
Moreover clearance of bacteraemia occured spontaneously and
without any speciﬁc treatment in all cases. All surveillance
cultures were negative. The epidemiological investigation
revealed that a particular povidone-iodine solution was used
on all infected patients used during the process of blood
culturing. Although the solution was not available for culturing,
it was concluded that all data are indicative not of a real
outbreak but of a pseudo outbreak, due to the contamination of
blood cultures from the solution.
Conclusions: Pseudo outbreaks due to contaminated antiseptic
solutions should be suspected in the event of clustering
of positive cultures without the respective clinical signs of
infection.
P1840
Increasing incidence of S. maltophilia in
bacteraemic patients
S. Kanavaki, H. Moraitou, I. Galani, M. Makarona, M. Panagi, S.
Triantafyllou, J. Natsios, S. Pentea, S. Karabela (Athens, GR)
Objectives: S. maltophilia has been recognized as a serious
bacteraemia-associated microorganism. The predisposing fac-
tors include prolonged hospitalization, use of broad-spectrum
antimicrobial chemotherapy, central iv catheters, neutropenia
and malignancies. The mortality rate is high, rising up to
21%–69%. The aim of our study was to investigate the increasing
incidence of S. maltophilia in blood cultures, of Sotiria Hospital
patients.
Methods: In the period 1998–2004, 88 S. maltophilia strains were
isolated from blood cultures of patients hospitalized in Sotiria
Chest Diseases Hospital of Athens. Blood cultures were per-
formed using the automated system Bactec 9240 (Becton–
Dickinson). The automated system Vitek2 (Biomerieux) and
Api20NE were used for identiﬁcation, while susceptibility
testing was performed by the disk diffusion method, following
standard guidelines. Molecular typing was performed by PFGE.
Results: In total of all Gram(-) bacteria isolated from blood
cultures, S. maltophilia isolation frequency increased from 2.5%
in 1998, up to 11.0% in 2004. Most effective antibiotics proved to
be co-trimoxazole (95.8%), ciproﬂoxacin (85.2%) and ticarcillin/
clavulanic acid (61.4%). PFGE showed some variability in
molecular proﬁles among strains, although in the total number
of isolates, a particular clone was predominating.
Conclusions: The increasing incidence of S. maltophilia in
systemic hospital acquired infections, should be alerting for
both microbiologists and clinicians.
P1841
Stenotrophomonas maltophilia and antibiotic use
in German intensive care units: data from project
SARI (Surveillance of antimicrobial use and
antimicrobial resistance in German ICUs)
E. Meyer, F. Schwab, D. Jonas, P. Gastmeier, H. Ru¨den,
F.D. Daschner (Freiburg, Berlin, Hannover, D)
Objectives: To analyze antimicrobial use as a risk factor for the
selection of an emerging multidrug-resistant nosocomial patho-
gen, by correlation of antimicrobial use and the percentage of
S. maltophilia isolated in intensive care units.
Methods: SARI is a prospective unit and laboratory based
surveillance system which collects data on the 13 most import-
ant pathogens responsible for nosocomial infections. Isolates are
non duplicate and are not differentiated according to whether
they have caused infection or colonisation. The percentage of
S. maltophilia among these 13 pathogens was calculated if ICUs
reported more than 50 isolates per year; the data was subse-
quently correlated with antibiotic use density (AD) calculated in
DDDs/1000 patient days.
Results: From 2/2000–06/2004, 38 out of 40 ICUs providing
more than 50 isolates per annum were included in the analysis.
The data cover a total of 52.864 isolates (the number of isolates
reported yearly ranged from 51–1098, with a mean of 341) and
697,976 DDDs (yearly AD ranges from 496.8–2764.0 with a mean
of 1274.1). Of the total number of pathogens reported yearly, the
proportion of S. maltophilia ranged from 0.0% to 13.1% with a
mean of 2.5%. Calculation of yearly antibiotic use and the yearly
proportion of S. maltophilia among the total number of isolates
reported showed a signiﬁcant positive correlation with the use
of carbapenems (correlation coefﬁcient (cc) 0.23; p = 0.004),
quinolones (cc = 0.24; p = 0.003), ceftazidime (cc = 0.44; p =
0.000), glycopeptides (cc = 0.26; p = 0.001) and aminoglycosides
(cc = 0.20; p = 0.012).
Conclusion: S. maltophilia displays intrinsic resistance to many
antibiotics. Thus, prudence should be exercised in the use of
broad spectrum and reserve antibiotics because a signiﬁcant
association and a cc > 0.2 are observed between the use of
carbapenems, quinolones, ceftazidime and glycopeptides and
isolation of S. maltophilia in ICUs.
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P1842
Comamonas testosteroni: an emerging
nosocomial pathogen?
H. Moraitou, M. Makarona, I. Galani, S. Karabela,
A. Gerogianni, S. Solomon, S. Kanavaki (Athens, GR)
Objectives: Comamonas testosteroni, formerly known as
Pseudomonas testosteroni, is a non-fermenting, gram(-), oxidase(+)
bacterium with a wide geographic distribution in water and soil,
and a little apparent capacity of causing human infections. We
present two cases of Com. testosteroni bacteraemia, occurred to
our hospital within a month’s period.
Methods: Patient (A) was a 76-years old lady, admitted to
’Sotiria’ Chest Diseases Hospital of Athens, in a poor condition,
with recurrent acute abdominal pain, low-grade fever, up to
38C and muscular weakness. She had a history of COPD and
biliary colic, but free from any other serious underlying disease.
During her hospitalization, her condition was progressively
deteriorating and a diagnostic laparotomy was performed, with
no signiﬁcant results. A week later, although no accurate
diagnosis was established, she developed a septic syndrome.
A triple scheme of antibiotic chemotherapy was initiated, but
unfortunately, the patient passed away. The blood cultures
developed Com. testosteroni. Patient (B) was a 75-years old
female patient, admitted for an acute skeletal back pain. She had
a history of cardiac failure and cardiac valve insufﬁciency. She
also reported COPD and recent episodes of biliary colic pain.
Five days after admission, she developed low-grade fever and
blood samples were taken for culture. The laboratory ﬁndings
were indicative for infection, with raised CRP, WBCs and SR.
She was started on tazobactam 5.2 (1 · 3), with complete
remission of symptoms. The blood culture developed Com.
testosteroni. The patient was discharged in a good condition.Com.
testosteroni was identiﬁed by Api20NE system and tested for
susceptibility by Kirby–Bauer disk diffusion method. PFGE
revealed a high similarity level in molecular proﬁle, of both
isolates.
Conclusions: Both infections were characterized as nosocomial.
The source of infection was not identiﬁed, although in literature,
intra-abdominal abnormalities are reported to be associated
with Com. testosteroni infections. These cases should alert
microbiology laboratories for uncommon bacteraemia-causing
nosocomial pathogens.
Immunology, host defences, immunotherapy
P1843
Comparison of the virus neutralisation test
(VNT), ELISA and dot immunoassay (DIA) for
detection of mumps antibodies
F. Ghadyani , M. Roostaee , T. Bamdad, H. Soleimanjahi ,
A. Ghaemi (Tehran, IR)
Objective: Although mumps is a transmissible benign infection,
it is believed to be responsible for viral meningitis as the second
causative agent after entroviruses. Rapid laboratory diagnoses
are required to detect viral infection.
Method: Hooshino strain of the virus was cultured in Vero cell
and its titre was determined. The VNT was carried out using
100TCID50 of the virus. An indirect ELISA test was developed
using the plates coated with the puriﬁed virus. The DIA test was
developed with a proper quality of viral antigen attached to
nitrocellulose paper followed by adding serum samples and
HRP conjugated antihuman. The results were justiﬁed on the
basis of brown dots appearing in the ﬁeld of white paper.
Results: The sensitivity and speciﬁcity of the DIA test in 400
serum samples compared to VNT was 92.69 and 80.80 percent,
respectively. The results were almost similar to those of obtained
with ELISA test with 90.36% sensitivity and 81.80% speciﬁcity.
Conclusion: With respect to some notable features such as
feasibility, requiring minute amount of serum and the intrinsic
validity of the test ELISA can be replaced with DIA.
P1844
Evaluation of serological methods for the
diagnosis of echinococciasis
S. Mavrea, P. Douramani, E. Anastasakou (Athens, GR)
The echinococciasis (e.) is a world wide parasite zoonosos. The
diagnosis is based on clinical and radiological ﬁndings and is
conﬁrmed with serological techniques which detect the speciﬁc
antibodies that are produced from the presence of active echino-
coccus cyst. Aim of the study is the comparison between indirect
hemagglutination (IHA) and ELISA-IgG in the diagnosis of e.
Material and Method: We study 40-serum samples of patients
with e. The diagnosis of e. was detected with clinical and
radiological ﬁndings. The control group was 10 patients with
other parasite infections and 20 healthy people. The examination
was done with the IHA method and with ELISA. Positive were
considered the titres of IHA >1/320 and for ELISA-IgG (15 U/ml
Results: The speciﬁc antibodies of e. were observed in 37 of 40
patients with ELISA method and in 38 of 40 patients with IHA.
The sensitivity of ELISA (92.5%) and of IHA (95%) and the
speciﬁcity of ELISA (90%) and of IHA (96.7%).
Conclusions: The identiﬁcation of antibodies with IHA seems
to be more sensitive and more speciﬁc than ELISA-IgG. The
combination of two serological methods seem to show a better
result in e. noting that none of these methods can test 100%
positive in all patients of e.
References Sbihi Y, Rmiqui A, Rodriguez-Cabezas MN,
Orduna A, Rodriguez-Torres A, Osuna A.: Comparative sensi-
tivity of six serological tests and diagnosis value of ELISA using
puriﬁed antigen in hydatidosis. J Clin Lab Anal 2001;15(1):4–8.
Pinel H, Fricker B, Chumpitazi R, Ambroise-Thomas GR.: The
immunodiagnostic value of six serological technics in hydati-
dosis. Serodiagnosis and Immunotherapy Infectious Diseases
1989;3:231–40.
Force L, Torras J, Carrilo A, Busca J;: Evaluation of eight
serological tests in the diagnosis of human echinococcosis and
follow-up. Clinical Infectious Diseases 1992, 15:472–480.
P1845
Leptospirosis: incidence in an Athens hospital
S. Mavrea, P. Douramani, D. Alepopoulou,
E. Anastasakou (Athens, GR)
Leptospirosis is a zoonosos which is caused by L. Interrogans
(L.i.) and is transmitted by direct or indirect contact from water
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contaminated by rodents urine. The incidence of the disease is
higher in areas where there is standing water or increase
rainfall. We examined 130 samples from different Departments
of our Hospital from November 2001 to October 2002 for
Leptospirosis. 8 (6.1%) patients were positive. From November
2002 to October 2003 205 patients were examined for
Leptospirosis and 23 (11.2%) were positive. Two methods
were applied: (a) The identiﬁcation of L.i. in urine sample
with microscopical examination (b) The identiﬁcation of IgM
antibodies in serum with ELISA. In our Laboratory we observed
an increase in the demand for L.i. (59.2%) and an increase of
positive samples to the amount of 5.0%. For the years 2001–2002
the 91.3% of positive patients came from rural areas whereas the
2002–2003 70.4% of positive patients came from rural areas and
29.6% from whole area of Attiki. The increase of this incidence
must be due to the higher percentage of rainfall for the years
2002–2003 as well as the increase in roadworks. The sewerage
rodents are now coming into contact with the citizens of Attiki
resulting an increase in the incidence of L.i. in this population.
References Vinetz JM,: Detection of Leptospirosis in India.
Arch.DIs.Child 2003 Dec;88(12):1070–5. Karande S, BhattM,
Kelkar A, Kulkarni M, Varaiya A: An observational study to
detect leptospirosis in Mumbai, India, 2000. Arch. Dlis. Child
2003 Dec;88(12):1033.Belmaker J, Alkan M, Barnea A, Dukhan L,
Yitzhaki S, Gross E.: Risk of transmission of leptospirosis from
infected cattle to dairy workers in southern Israel. Isr. Med.
Assoc. J. 2004 Jan;6(1):24–7.
P1846
Three cases of anicteric leptospirosis from
Turkey: mild to severe complications
F.S. Erdinc, S.T. Koruk, C.A. Hatipoglu, S. Kinikli,
A.P. Demiroz (Ankara, TR)
Objective: Leptospirosis is a worldwide zoonosis and among
patients ill with leptospirosis, 90% have the milder anicteric
form of the disease. Presumptive diagnosis may be based on the
microscopic agglutination test used for determination of anti-
body titre and tentative identiﬁcation of serotype. Three cases
with positive Leptospira microagglutination titre (MAT) to
L australis var bratislava and positive urinary IFAT are presen-
ted here.
Case 1: A 71-year-old male patient living in rural area admitted
with fever, nausea, myalgia, coughing and diarrhoea. Laborat-
ory studies revealed decreased platelet count (60000/mm3),
increased blood urea, creatinine, AST and ALT. Ceftriaxone was
started with the diagnosis of pneumonia. MAT was positive at
1:400. After 2 weeks, the patient was discharged with no
evidence of his illness.
Case 2: A 55-year-old female patient living in rural area
admitted with fever, headache, nausea, vomiting, nuchal rigid-
ity and lumbar pain. Laboratory studies revealed decreased
platelet count (44000/mm3), and increased blood urea, creati-
nine, AST, ALT, and CPK. CSF analysis revealed pleocytosis
with 140/mm3 and normal levels of glucose and protein. MAT
was positive at 1:400. The patient transferred to the intensive
care unit and with deteriorated respiratory and neurological
ﬁndings she died on the third day of admission despite
ceftriaxone therapy.
Case 3: A 32-year-old female patient with a history of travel to a
rural area presented with fever, headache, nausea, vomiting,
nuchal rigidity, artralgia and myalgia. Laboratory studies
revealed the platelet count of 90000/mm3 and increased blood
urea, creatinine, ALT and CPK levels. CSF analysis revealed
pleocytosis with 180/mm3 and normal levels of glucose and
protein. Combination therapy with ceftriaxone and acyclovir
was started. MAT was positive at 1:200. The patient was
discharged from the hospital without any complication on the
tenth day of admission.
Conclusion: Our ﬁrst case admitted with clinical presentation
of pneumonia and two cases presented with aseptic meningitis.
There are reported cases of icteric leptospirosis with thrombo-
cytopenia and acute renal failure from Turkey. The three cases
presented here had thrombocytopenia and acute renal failure as
complication of anicteric leptospirosis. One of the cases had fatal
outcome but could not be strictly correlated with leptospirosis.
P1847
Actinobaculum schaalii infections: clinical
relevance, identiﬁcation and antibiotic
susceptibility
M. Reinhard, J. Prag, M. Kemp, K. Andresen, B. Klemmensen,
N. Højlyng, S.H. Sørensen, J.J. Christensen (Viborg, Copenhagen,
Odense, Roskilde, DK)
Objectives: Genus Actinobaculum is an example of clinical
important organisms that recently have been separated from a
large group of poorly-deﬁned Gram-positive rods. We here
describe the clinical pictures and bacteriologic characteristics in
9 cases of Actinobaculum schaalii infections.
Methods: Data were collected from the clinical records. Eight
strains of A. schaaliiwere available for phenotypic and molecular
characterization. From one patient presence of DNA from
A. schalii was demonstrated in pus from kidney cysts, but
without bacterial growth. The strains were characterized by
conventional methods, API Coryne and API Rapid ID 32A. For
molecular analysis, DNA was extracted from strains and
analysed by real-time PCR of part of the 16SrRNA gene (526-
bp fragment). Amplicons produced were DNA sequenced and a
BLAST search in the NCBI GenBank was done. Obtained results
were compared.
Results: Nine strains of A. schaalii were identiﬁed in three
Danish departments of clinical microbiology. Six strains of
A. schaalii were from one department of clinical microbiology
covering 230,000 persons and collected over a period of six
months. Except for one case the urinary tract was suspected as
the focus of the infection. These eight patients were elderly and
predisposed to urinary tract infections (UTI) because of either
urinary tract or neurological diseases. A. schaalii was isolated
from the blood in three cases, from the urine in six cases, from
kidney cysts in one case and from an intradural abscess in one
case. All patients received antibiotics and recovered from their
infection. The strains were identiﬁed with 16S rRNA gene
sequence analysis, but identiﬁcation with the API Coryne and
the Rapid ID32A test systems is also possible although the
numerical codes are not yet registered in the manufacturer’s
database. The isolates were susceptible to a wide range of
antibiotics, including b-lactam agents and showed little inter-
isolate variability.
Conclusion: A. schaalii causes UTI and search for it is especially
relevant in cases of unexplained pyuria, especially when there is
divergence between the microscopic ﬁndings and the growth
results under aerobic conditions. Samples, then, should be
cultured on appropriate media and incubated in an anaerobic
atmosphere. A. schaalii is easily overlooked as isolation of the
organism requires 24 to 48 h of incubation in an anaerobic or
CO2 enriched atmosphere and even then is easily disregarded as
a contaminant.
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P1848
Chronic fatigue syndrome
E. Cecchini, M. Greco, S. Acun˜a (La Plata, RA)
Objective: To describe frequency of clinical and epidemiolog-
ical features in outpatients chronic fatigue syndrome (CFS).
Methods: A retrospective observational study was performed.
A cohort of 25 patients fulﬁlling the Centers for Disease Control
and Oxford, UK criteria (1994) for CFS was included.
Results: Eighteen patients were female (72%) and 28% male
(p < 0.001, RR 2.6) with a mean age for women 37.5 ±
11.7 years and for male patients 38.3 ± 7.6 years. The mean
time before the ﬁrst consult to the Institute was 6.3 months.
Prior history of C. trachomatis infection was related in 27.7%
women and 28.6% men and allergic condition in 44.4% and
57.1% respectively. In the following table are synthesized the
frequency of subjective symptoms. In all patients serology was
no reactive for HBV, HCV, HIV e IgM CMV. Positive serology
was found for IgG toxoplasmosis (84%), IgG EBV (80%), EA EBV
(32%) and brucellosis (4%). Total immunoglobulin was
increased in 20% and lowered in 24%. Multitest (7/8) showed
hypo or anergy in 77.8%. Active lymphocytosis was a ﬁnding in
32% and increased liver enzymes in 24%.
Conclusions: This syndrome affects quality of life and status
performance in the productive age group. There was net
predominance of women. It must be noted the high incidence
of prior history of infection for C. trachomatis when compared
with general adult population (3–5%) in our country.
P1849
The importance of phagocytic index for
determining the early period efﬁcacy of treatment
modalities, and its relationship with metabolic
control parameters in diabetic patients with foot
infections
C. Top, O. Oncu¨l, A. Cevikbas, A. Soyogul, S. Cavuslu,
M. Danaci (Istanbul, TR)
Objectives: Diabetic patients are more prone to infections and
show high morbidity and mortality rates. Prior to the advent
of modern antimicrobial therapy, infection accounted for
much of the morbidity in diabetics. The aim of this study
was to investigate the phagocytic activity changes of neu-
trophils in type 2 diabetic patients with foot infections during
short treatment course and to evaluate the importance of
phagocytic index for determining the efﬁcacy of the treatment
modalities and its relationship with metabolic control param-
eters.
Methods: The phagocytic activity of neutrophils were deter-
mined in blood samples of 38 type 2 diabetic patients with foot
infections (14 women and 24 men), mean age and mean duration
of diabetes were 66.3 ± 9.4 and 19.1 ± 11.2 (yrs) respectively. All
patients receive standard treatment (intensive insulin therapy,
antibiotherapy, hyperbaric oxygen therapy and surgical debri-
dement ). Phagocytic activity of neutrophils was determined by
a standard method . The phagocytic index, i.e. the number of
microbial bodies absorbed by an average leukocyte, and per-
centage of leukocytes that have phagocytized, i.e. the number of
leukocytes out of 100 that have revealed the phagocytic activity
and phagocytic index, that is the correlation between the
product of phagocytic index and percentage of phagocytosis.
Phagocytic activity of neutrophils, C-reactive protein and
metabolic control parameter (HbA1c) were determined before
the therapy and 2 weeks later.
Results: We observed signiﬁcant differences in phagocytic
index and CRP before and after short-course therapy
(p < 0.001, *Wilcoxon signed ranks test). The phagocytic index
(%) and CRP(mg/L) before and after 2 weeks therapy were
47.7 ± 11.4 and 62.5 ± 15.6 p < 0.001, 41.4 ± 36.7 and 17.4 ± 18.2
p < 0.001 respectively. The correlation analysis showed a signi-
ﬁcant relation between phagocytic index and CRP, HbA1c
(r = 0.52, p < 0.05 and r = )0.41, p < 0.05 respectively).
Conclusions: The derangement in the carbohydrate metabolism
in diabetic may be the reason for the impairment in the
bactericidal ability of PMN leucocytes of poorly controlled
diabetic patients making them more susceptible to recurrent
infections. However the importance of phagocytic activity
changes in diabetics has been little studied up to the present
time. Our data show that the phagocytic activity changes during
short-course therapy have a signiﬁcant value for determining
the efﬁcacy of treatment in diabetic foot infections.
P1851
Diagnostic power of peripheral blood phagocyte
Fcg receptors expression in bacteraemia
J.A. Bernal, M.A. Escobar, A.A. Garcia-Egido, E. de la Hoz,
J.M. Aparicio, B. Dominguez, A. Romero, P. Ruiz, M. Rosety,
C. Rivera, F. Gomez (Cadiz, E)
Background: Early markers of bacteraemia are useful for
prognosis and, in decision making for i.v. antibiotic therapy.
Objectives: To assess the diagnostic power of the surface
expression of Fc receptors for IgG (FcgRs) for the prediction of
bacteriemia in febrile patients.
Methods: We performed a 4 year prospective case-control
study on 127 consecutive patients (pts) with an episode of
bacteriemia as compared to 136 randomly selected concurrent
febrile pts with negative blood cultures (control). Demographic
and clinical data were collected by chart review and/or
questioning their attending physicians. Plasma levels of
C-reactive protein (CRP), TNFg, IL-1a, IL-6, IL-8 and IL-10
were determined. The surface expression of Fc receptors for
IgG (FcgRs): FcgRI, FcgRII and FcgRIII on peripheral blood
monocytes (M) and granulocytes (G) was assessed by ﬂow
cytometry. These studies were done concomitantly with blood
cultures.
Results: Both groups were not different for age, sex, previous
administration of immunosuppressants or antibiotics, clinical
Symptom Total (%) +++ ++ + = degreee of intensity
Fatigue 100 +++ = 76% ++ = 24% -
Reduction of previous
levels of activity
100 +++ = 72% ++ = 24% + = 4%
Memory impairment 100 +++ = 24 ++ = 40% + = 36%
Muscle pain 96 +++ = 4% ++ = 20% + = 72%
Depression 96 +++ = 8% ++ = 24% + = 64%
Joint pain 92 ++ = 28% + = 64%
Headache 88 ++ = 20% + = 68%
Unrefreshing sleep 88 ++ = 16% + = 72%
Tender lymph nodes 84 +++ = 12% ++ = 20% + = 52%
Throat discomfort 70 ++ = 10% + = 60%
Nocturnal sweat 64 +++ = 12% ++ = 20% + = 32 %
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severity index or comorbid conditions. In univariate analysis,
cases had signiﬁcantly higher levels of CRP (p < 0.001), TNFg
(p < 0.001), IL-1a (p < 0.001) and IL-6 (p < 0.01) than controls.
The expression of FcgRIIA and FcgRIII by M and, that of FcgRI
on G was signiﬁcantly enhanced (p < 0.001) in bacteriemic
patients as compared to culture-negative febrile pts; while the
expression of FcgRIIB by either M or G was signiﬁcantly
decreased (p < 0.03). Setting a cut-off value = 25% of the mean
ﬂuorescence intensity over controls for FcgRs surface expression
and, assuming a prevalence of bacteriemia of 5–10% among
hospitalized patients undergoing blood cultures, results in a
sensitivity, speciﬁcity, positive and, negative predictive values
of: 77%, 97%, 74%, and 98%, respectively for M-FcgRIIA, 73%,
96%, 74% and 97%, respectively for M-FcgRIII, 58%, 93%, 49%
and 95%, respectively for G-FcgRI and, 71%, 91%, 57% and 83%,
respectively for G-FcgRIIB.
Conclusions: Our results suggest that the surface expression of
Fc receptors for IgG on peripheral blood monocytes and
granulocytes may help clinicians to rule out bacteraemia in
febrile patients.
P1852
The inﬂuence of mixed staphylococcal
populations on the activity of phagocytes
B. Sadowska, M. Wieckowska-Szakiel, W. Rudnicka,
B. Rozalska (Lodz, PL)
Objectives: Staphylococcus aureus invades the hosts from the
skin or mucosa, which are always colonized with commensal
microorganisms including S. epidermidis. Thus at an early stage
of S. aureus invasion polymicrobial rather than monomicrobial
infection occurs. If so, the phagocytes, which are a key
component of innate immunity, interact with the mixed bacterial
populations. We hypothesised that the interaction of the
phagocytes with a mixture of staphylococci may differ from
their interaction with homogeneous populations of these bac-
teria.
Methods: A clinical S. aureus B1 strain, a parental S. aureus
8325-4, alpha-toxin negative mutant S. aureus DU 1090 and
S. epidermidis RP12 were used for the study. The mouse
granulocytes and macrophages were infected with the bacteria
of each strain separately or with the mixture of two bacterial
strains. FITC-labelled staphylococci were prepared to determine
their adherence to the phagocytes. To estimate the ingestion and
intracellular killing of these bacteria a colony forming units-
assay was used. The production of IL-12 and TNF-alpha by
phagocytes infected with different cultures of staphylococci was
measured with DuoSet ELISA.
Results: For all strains of S. aureus, irrespective of the tested pair
of bacteria and type of phagocytes, their adhesive properties
were stronger in mixed populations than in unispecies. On the
other hand, the adherence of S. epidermidis to the phagocytes in
the presence of each S. aureus strain was reduced. In the
phagocytic cells infected with any mixed population of
staphylococci the bacterial uptake and intracellular killing
were diminished as compared with the cells infected with
homogeneous population of these bacteria. The production of
IL-12 was below detection limit, even after 2 hours incubation of
bacteria with phagocytes. The level of TNF-alpha depended on
the time of incubation of the cells with bacteria, but the
stimulatory effect of homo- and heterogeneous cultures of
staphylococci was similar.
Conclusions: Our data suggest that phagocytes can discrimin-
ate between various strains of staphylococci. The differences
in the process of phagocytosis of congeneric and mixed
staphylococcal populations could also result from the intercel-
lular bacterial communication. Collectively, our data contribute
to a better understanding of the role of commensal bacteria in
the interaction of the phagocytes with bacterial pathogens.
Supported by Grant No. 3PO4C08124 (KBN).
P1853
Increased monocyte apoptosis correlates with
improved survival in patients with ventilator-
associated pneumonia and sepsis
D. Plachouras, F. Baziaka, T. Tsaganos, S. Kollias,
E.J. Giamarellos-Bourboulis, H. Giamarellou,
C. Roussos (Athens, GR)
Objective: Monocytes constitute the main cells eliciting enor-
mous responses of proinﬂammatory cytokines with an import-
ant role in the pathogenesis of sepsis. Little evidence exists on
the apoptotic proﬁle of monocytes in septic patients.
Methods: Fifty-four patients with sepsis (according to ACCP/
SCCM 1992 criteria) and ventilator associated pneumonia
(VAP) were enrolled in the study. Peripheral blood monocytes
were isolated each second day after advent of symptoms of
sepsis after density gradient centrifugation of heparinized
venous blood over Ficoll and incubation for one hour in RPMI
supplemented with 10% FBS and 2 mM glutamine. Non-
adherent cells were discarded. Isolated monocytes were incu-
bated with Annexin V conjugated with FITC and Propidium
iodide (PI). Monocytes labeled with Annexin V but not PI, as
determined by ﬂow cytometry, were considered apoptotic,
while monocytes labeled by both Annexin V and PI were
considered necrotic. Apoptosis was expressed as percentage of
apoptotic monocytes and comparisons were undertaken
between survivors and non-survivors after follow-up for
28 days.
Results: The mean ± SE percentage of apoptotic monocytes of
days 1, 3, 5 ad 7 of survivors was 60.9 ± 6.53, 44.02 ± 7.52,
43.89 ± 7.53 and 43.79 ± 9.74% respectively. Respective value in
non-survivors were 34.21 ± 8.24 (p 0.029 compared to survi-
vors), 34.26 ± 10.90 (pNS), 22.79 ± 5.17 (pNS) and 27.82 ± 7.78%
(pNS).
Conclusions: Sepsis is a process attributed to an exaggerated
systemic inﬂammatory host response, orchestrated mainly by
cells of the monocytic system by the production of a wide array
of pro-inﬂammatory cytokines. A signiﬁcantly increased rate of
monocytic apoptosis was correlated to survival in patients with
sepsis caused by VAP. These ﬁndings indicate a beneﬁcial effect
of apoptosis of monocytes possibly due to a resulting attenuated
inﬂammatory response.
P1854
Role of gene polymorphisms of interleukin-10
and CD14 in meningococcal disease
R.A. Foster, J. Timms, S.C. Naylor, R. Borrow,
M.W. McKendrick, E.B. Kaczmarski, R.C. Read (Shefﬁeld,
Manchester, UK)
Objectives: Susceptibility to, and severity of meningococcal
disease has been shown to be partly genetically determined. The
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quality and intensity of the proinﬂammatory response is a
critical determinant of this infection. Interleukin-10 is an anti-
inﬂammatory cytokine that is strongly associated with outcome
of meningococcal disease. It has numerous functional single
nucleotide polymorphisms (SNP) including a promoter SNP at
819) nucleotides relative to the transcriptional start site
(IL10[)819]). CD14 is involved in the cellular recognition of
lipopolysaccharide; it has a functional promoter SNP at )159
(CD14[)159]. We genotyped these two markers in a cohort of
1096 patients with microbiologically proven meningococcal
disease presenting in England & Wales in the period July 2000
– November 2003, and 744 controls derived from anonymised
northern English blood donors.
Methods: In both groups DNA was genotyped at IL10[)819]
and CD14[)159] using the TaqMan allelic discrimination test.
Results: The genotyping results for both groups are shown in
the following table. Genotype is denoted 11 (homozygote for the
common allele), 22 (homozygote for the rare allele) and
12 (heterozygote). There were no signiﬁcant differences between
the genotype frequencies in disease and control groups, or
related to disease severity in this study for either IL10[)819]or
CD14[)159]. However there was a trend for association of death
with carriage of the rare allele at IL10[)819], (OR 1.53: [95% CI;
0.97–2.43].
Conclusions: The gene polymorphisms CD14[)159] and IL10
[)819] do not have a signiﬁcant relationship with acquisition
or severity of meningococcal disease in this group of patients,
but it is possible that haplotypes of IL10 may have some
involvement.
P1855
Differences in induction of ex-vivo pro-
inﬂammatory cytokine release between
susceptible and resistant isolates of Escherichia
coli
A. Antonopoulou, M. Kyriakopoulou, M. Bristianou,
D. Plachouras, M. Raftogiannis, H. Giamarellou,
E.J. Giamarellos-Bourboulis (Athens, GR)
Objective: A drug resistant phenotype in isolates of
Pseudomonas aeruginosa has been associated with decreased
potential for stimulation of monocytes and attenuated virulence
in experimental models. It was hypothesized that similar effects
might be observed in Escherichia coli strains.
Method: Ten susceptible and 10 multi-drug resistant (MDR)
isolates from clinical urine specimens by patients with pyelone-
phritis were studied. Human monocytes by a healthy volunteer
were isolated. Brieﬂy heparinized whole blood was centrifuged
over Ficoll–Hypaque and the mononuclear cell fraction was
incubated in RPMI supplemented with 10% FCS for 30 min. The
non-adherent cells were discarded and adherent monocytes
were harvested after trypsinization and resuspended in culture
medium. Monocytes were triggered by an inocullum of 6 log of
each E. coli strain for 2, 4 and 6 hours. Tumour necrosis factor
alpha (TNF-a), interleukin 6 (IL-6), interleukin 8 (IL-8) and
interleukin 12 (IL-12) were measured by immunoassay in each
supernatant.
Results: See Figure 1.
Conclusions: MDR isolates of Escherichia coli induce markedly
increased TNF-a, IL-6 and IL-8 but not IL-12 release by human
monocytes after 2 and 4 hour ex vivo stimulation compared to
susceptible ones. This observation contrasts with the ﬁndings of
similar studies in P. aeruginosa. Potential clinical implications
need further study.
P1856
Cytokine proﬁle in Mediterranean spotted fever
N. Popivanova, M. Murdjeva, I. Haydushka (Plovdiv, BG)
Objectives: Mediterranean spotted fever (MSF) is a tick-bite
rickettsiosis caused by Rickettsia conorii. The pathogen invades
and damages the endothelial cells of the small blood vessels and
gives rise to multifocal lymphohistiocyte vasculitis. The mech-
anism of the organism defence against rickettsiae is not fully
elucidated. Similar to other diseases with obligatory intracellular
pathogens, the cellular immunity is suggested to play a crucial
role. Deﬁning the cytokine proﬁle in the early acute stage of MSF
helps to elucidate certain mechanisms of the human defence
against the disease.
Methods: The cytokines were analysed by ELISA with kits of
BioSourse Europe S.A., Belgium. MSF was veriﬁed by IFA in the
Referral Laboratory for Rickettsioses.
Results: Eighty patients with MSF were enrolled in the study.
The cytokines IL-1beta, TNF-alpha, IL-6, IL-8, IL-2, IL-12,
IL-10, INF-gamma are studied in the burst of the disease on
the third to fourth day from the appearance of the ﬁrst
symptoms, just after the rash come into view. Patients show a
Table 1. Genotyping results for IL10[-819] and CD14[-159].
Genotype is denoted 11 (homozygote for the common allele), 22
(homozygote for the rare allele) and 12 (heterozygote).
IL10[-819] Genotype 11 12 22 Totals
Meningococcal
disease
Survivors 458 309 46 813
Deaths 37 39 5 81
Anonymised
blood donors
Controls 195 105 20 320
Totals 690 453 71 1214
CD14[-159] Genotype 11 12 22 Totals
Meningococcal
disease
Survivors 137 251 119 502
Deaths 14 27 14 50
Anonymised
blood donors
Controls 160 326 152 638
Totals 306 599 285 1190
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manifold increase in the activity of IL-6 (250.47 ± 74.26 pg/ml,
p < 0.001), IL-8 (180.59 ± 28.68 pg/ml, p < 0.001) and INF-
gamma (8.40 ±1.13 pg/ml, p < 0.001) compared with the
control subjects. Statistically signiﬁcant increase in the values
of IL-12 (249.22 ± 21.88 pg/ml, p < 0.001) is also found.
IL-1beta increases its activity more than 6 times
(60.91 ± 13.15 pg/ml, p < 0.001) and TNF-alpha – about 3.5
times (22.83 ± 3.40 pg/ml, p < 0.001) compared with the
control group. Although moderate the increase in the IL-10
level also reaches statistical signiﬁcance (5.94 ± 0.83 pg/ml,
p < 0.001), while the increase in IL-2 is short of statistical
signiﬁcance compared with the level in the control group
(0.18 ± 0.07 pg/ml, p > 0.05).
Conclusion: It is postulate that the necessity of cell-mediated
immune response in rickettsial infection depends particularly on
the cytokine background during the induction of immune T-
lymphocytes. Our study ﬁndings reveal that the culmination of
MSF is characterized by a cytokine proﬁle with prevalence of
TH1 response. The elevated serum levels of the pro-inﬂamma-
tory and regulatory cytokines in the acute phase of MSF
probably contribute to the rickettsiae healing processes by
mobilization of complex rickettsiocide biochemical and immune
mechanisms.
P1857
IL-10 gene polymorphisms and susceptibility to
brucellosis
M. Rasouli, S. Kiany, A. Alborzi (Shiraz, IR)
Background: Brucella spp. is a gram-negative facultative intra-
cellular bacterium and causative agent of brucellosis. It is
clariﬁed that type-1 immunity is important to control Brucella
infection. In this regard, macrophages have critical role. IL-10 is
a Th2-type cytokine that inhibit macrophage activation. It is
known that production of IL-10 is affected by its gene promoter
polymorphisms. In this study we investigated the relationship
between IL-10 gene promoter polymorphisms and susceptibility
to brucellosis.
Materials and Methods: One hundred and ninety patients with
brucellosis, 186 healthy individuals who were members of
patients’ family and 82 healthy animal husbandmen who had
infected animals with Brucella were included in this study. All
individuals were genotyped for three bi-allelic IL-10 gene
promoter polymorphisms at positions (1082(G/A), (819(T/C),
and (592(A/C) using PCR-RFLP.
Results: Genotype and allele frequencies of )592(A/C) and
)819(T/C) were signiﬁcantly different between patients and
animal husbandmen groups (P < 0.05).
Discussion: There are some reports showed that A allele at
position )592 of IL-10 gene is associated with lower IL-10
production in-vitro or in-vivo. According to the results, higher
frequency of A allele at position )592 in animal husbandmen
may cause these individuals more resistant to disease.
P1858
Polymorphisms of IL-10 gene promoter in
patients with kala-azar
S. Kiany, M. Rasouli, A. Khoshdel, A. Alborzi (Shiraz, IR)
Objectives: Visceral leishmaniasis is caused mostly by
Leishmania infantum in south of Iran. Manifestations range
from asymptomatic infection to fatal disseminated visceral
disease. Protective immune response against Leishmania is cell-
mediated immunity and it is known that IL-10 can down-
regulate this kind of response. Researchers showed that
polymorphisms in IL-10 gene promoter can regulate IL-10
production. The aim of this study was to determine the
relationship between IL-10 gene polymorphisms and outcome
of the disease.
Methods: One hundred and twenty paediatric patients
involved with kala-azar, 57 healthy individuals who were
patients’ siblings and 102 healthy individual who lived in
endemic area without any history of kala-azar or cutaneous
leishmaniasis and with positive Leishmanin skin test were
included in this study. Polymorphisms of IL-10 gene promoter
()1082G/A, (819T/C, (592A/C) were determined using PCR-
RFLP.
Results: There were no signiﬁcant differences in genotype and
allele frequencies of investigated IL-10 gene polymorphisms
between the groups.
Conclusion: It is documented that protective immunity against
leishmaniasis is cell-mediated immunity. Therefore the presence
of Th2-type cytokines during the disease can worsen the
condition of the patients. Since the results showed no signiﬁcant
differences in genotype and allele distributions between the
groups, study of the cytokine proﬁles and other cytokine gene
polymorphisms are recommended.
P1859
Deoxycholate and lipid amphotericin B
formulations (AMBF) regulate cytokine
and chemokine expression in human
monocytes
M. Simitsopoulou, J. Dotis, M. Dalakiouridou, H. Andreadou,
T.J. Walsh, E. Roilides (Thessaloniki, GR; Bethesda, USA)
Objectives: Innate antifungal host defense includes expression
of various genes of cytokines and chemokines by phagocytes.
Since amphotericin B is a microbial product, AMBF [deoxych-
olate amphotericin B (DAMB), lipid complex (ABLC), liposomal
(LAMB), and colloidal dispersion (ABCD)] may modulate
expression of such genes in MNCs.
Methods: 10 · 6 monocytes (MNCs) obtained from healthy
donors by ﬁcoll centrifugation/plastic adherence were incuba-
ted with 5 mg/L DAMB and 25 mg/L lipid AMBF at 37C for
0.5, 1, 2, 6 and 22 h. Total RNA was isolated and mRNA proﬁles
for TNF-a, IL-1b, IL-1ra, MCP-1 and MIP-1bwere determined by
semi-quantitative RT-PCR. Quantitation of mRNA was per-
formed by UViDOC program. Experiments were repeated 3
times.
Results: While there was no loss of viability induced by the
drug concentrations studied, there was a progressive decline of
all 5 cytokine/chemokine mRNAs expressed by untreated
MNCs between 0.5 and 22 h. DAMB induced a 39% increase
of IL-1b as compared to untreated MNCs after short incubation
(2 h). In contrast, it increased IL-1ra by 640% after 22 h,
simultaneously with the return of IL-1b mRNA levels to
baseline. DAMB induced maximal increases of MCP-1, MIP-1b
and TNF-a at 6 h. By comparison, LAMB, ABLC and ABCD
induced decreases in the IL-1b at 0.5 h by approximately 48%
compared to untreated MNCs, which then returned to baseline
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values. Lipid AMBF did not enhance the expression of IL-1ra
within 0.5–6 h but maintained it stable as compared to decreas-
ing mRNA levels in untreated MNCs. While MCP-1 decreased
progressively in untreated cells, all AMBF maintained its mRNA
levels equal to that measured in untreated cells at 0.5 h. In
addition, while DAMB, LAMB and ABCD induced increased
production of MIP-1b at 6–22 h, ABLC did not cause such an
increase. In contrast to DAMB and ABCD that induced peak
levels of TNF-a at 2 and 6 h, LAMB and ABLC did not affect
TNF-a expression.
Conclusions: DAMB and ABCD induce gene expression of
proinﬂammatory cytokines/chemokines in higher degree than
ABLC and LAMB. This difference potentially may explain the
differences in infusion-related reactions as well as suggesting
potential modulation of antifungal host immune response due to
AMBF.
P1860
A common human toll-like receptor 4 mutation is
associated with increased mortality in children
with invasive meningococcal disease
M.F. Knuf, P.J. Faber, P.E. Habermehl, G. Gemmer, A. Russo, C.
Murdoch, A. Finn, M. Mueller, W. Zenz, C. Meyer, B.-U. Zabel,
H.-J. Schmitt, F. Zepp (Mainz, D; Graz, A; Bristol, Shefﬁeld,
UK)
Objectives: Human Toll-like receptor 4 (TLR4) is the major
endotoxin-signalling receptor of the innate immune system and
is required for efﬁcient recognition of gram-negative bacterial
infections. We investigated a possible association between the
common TLR4 mutation Asp299Gly and mortality due to
invasive meningococcal disease in children.
Methods: 197 children (ages 2–215 months, mean 59 months)
with clinically and/or microbiologically proven invasive men-
ingococcal disease from ﬁve different European countries were
analysed for the Asp299Gly mutation by Lightcycler allele
speciﬁc ﬂuorescent hybridisation probe assays and direct
sequencing. Genotyping results were correlated with fatal or
none fatal outcome. Statistical analysis was performed applying
Pearsons Chi-Square test (two-sided).
Results: The overall allele frequency of the Asp299Gly
polymorphism was 9.4% (165 Asp/Asp, 27 Asp/Gly, 5
Gly/Gly) among the analysed patients with meningococcal
disease. A total of 19 patients (9.6%) succumbed to the
disease. Interestingly the heterozygous TLR4 Asp299Gly
mutation was signiﬁcantly associated with fatal disease
outcome: In the none-survivor group 6 out of 19 patients
(31%) had a heterozygous Asp299Gly polymorphism whereas
this was only the case in 21 out of 178 patients (11.8%) in the
survivor group (p = 0.029). There was no signiﬁcant
(p = 0.459) difference between the mutation in homozygous
state in the survivor (5/178, 2.8%) and none-survivor group
(0/19, 0%).
Conclusions: Our data suggest that the analysed TLR4 muta-
tion Asp299Gly is associated with increased mortality in
heterozygous state and might have an important impact on
the clinical course and outcome of meningococcal disease in
childhood.
P1861
Association between Manosse-binding lectin
deﬁciency and shock in patients with acute
pyelonephritis
A. Smithson, A. Mun˜oz, B. Suarez, S.M. Soto, A. Soriano,
J.P. Horcajada, J.A. Martinez, F. Lozano, J. Vila,
J. Mensa (Barcelona, E)
Background: Mannose-Binding Lectin (MBL) trigger comple-
ment activation after binding to microbial surfaces. Previous
studies have demonstrated that MBL deﬁciency is associated
with increased susceptibility to severe bacterial infections. The
aim of the study is to analyze the possible association between
polymorphism’s of the MBL gene and the incidence of bac-
teraemia and shock in female patients after an index episode of
acute pyelonephritis (AP) due to E. coli.
Methods: Blood samples from 63 patients with AP were pro-
spectively collected. AP was deﬁned as the presence of fever,
lumbar tenderness and leukocyturia in the absence of other focus
of fever. All patients had a positive E. coli uroculture. Six single
nucleotide polymorphism’s ()550 G/C, (221 C/G, 4 C/T, 52
CGT/TGT, 54 GGC/GAC and 57 GGA/GAA) in the MBL2 gene
were genotyped using PCR and sequence speciﬁc primers.
Results: Mean age of the patients included in the study was
44 years (range 18–94). 27 (43%) patients developed E. coli
bacteraemia. Comorbidity (diabetes mellitus, cirrhosis, cortico-
steroid treatment, renal insufﬁciency) was present in 14% of the
non bateremic AP and in 55% of the bacteremic AP. 7 developed
septic shock, 1 was a non bacteremic AP (2.7%) and 6 were
bacteremic AP (22%). No signiﬁcative differences in the incidence
of low-producingMBLgenotypeswas observed in the bacteremic
E. coli AP (7 out of 27 patients) (26%) compared with the non
bacteremic AP (4 out of 36 patients) (11%) (p = 0.18, Fisher). 4 out
of the 7 patients (57%) with septic shock had low-producingMBL
genotypeswhile 7 out of the 56patients (12.5%)without shockhad
low producing MBL genotypes and this difference was statisti-
cally signiﬁcant (p = 0.014, Fisher). Of the 4 patients with septic
shock and low producing MBL genotypes, 3 had comorbidity.
Conclusions: Our results support that MBL deﬁciency may
predispose to septic shock in patients with bacteremic E. coli AP.
There is a tendency towards a higher proportion of low
producing MBL genotypes in bacteremic E. coli AP although
the differences were not statistically signiﬁcant.
P1862
Evaluation of treg cells in vivo and in vitro in
leprosy patients
F. Ilahn, H. Akbulut, V. Bulut (Elazig, TR)
Objective: T-cell defect is a common feature in lepromatous
leprosy (LL) patients as compared to tuberculoid type (TT)
patients. In this study, it was aimed to research for the role of T
regulatory cells (Treg) in leprosy:40 (29 male, 11 female) inactive
lepramatous leprosy patients whose mean of age 60 ± 2.28 and
mean of years in diagnosis 30.66 ± 2.93 were obtained.
Method: Peripheral blood lymphocyte and peripheral blood
mononuclear cells (PBMC) culture were analysed for lympho-
cyte subgroup and Treg cells. PBMC were stimulated in 24-well
ﬂat bottom plates with sonicated M. leprae extract. Cells were
harvested for ﬂow cytometric analysis on 24 hour.
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Result: Mean ratio of CD4+CD25+ Treg cells in blood samples:
5.82 ± 3.11 and second ratio from culture: 10.95 ± 4.88 in
percentage (p < 0.05). In healthy controls these ratio was
found 2.85 ± 1.08 (p < 0.05). CD8+ cytotoxic T cells were
determined higher and CD4+/CD8+ ratio lower than healthy
controls (p < 0.05). There was no difference in CD4+ cells
between patient and control group.
Conclusion: An increased surface expression of CD25 was
observed when PBMC of LL (lepromatous) patients were
stimulated in vitro. In PBMC culture not all CD4+CD25+ cells
are Treg many of them are stimulated CD4+ cells but in patient
peripheral Treg ratio was found two times higher than controls.
Thus, Treg cells which produce IL-10 appears to have a little
regulatory role in peripheral blood of leprosy patients.
Antibiotic resistance: nosocomial pathogens
P1863
Trends in prevalence of multidrug-resistant
bacteria in patients undergoing intensive therapy
M. Wroblewska, J. Rudnicka, H. Marchel, M. Luczak (Warsaw,
PL)
Objectives: The analysis of change in prevalence and resistance
to antibiotics of bacteria isolated from patients hospitalized in
two intensive care units (ICU) of a tertiary care hospital.
Methods: The clinical specimens comprised blood, pus,
sputum, bronchial aspirates, wound swabs and peritoneal
swabs taken intraoperatively. An analysis comprised 1673
bacterial strains isolated over a period of two years: 861
(51.5%) strains from ICU-A and 812 (48.5%) strains from ICU-
B of a university-afﬁliated hospital (1200 beds). Identiﬁcation of
the isolates were done with API and VITEK automated tests
(BioMerieux), while susceptibility testing – by a disk-diffusion
method according to the NCCLS recommendations.
Results: Prevalence of Gram-positive cocci in ICU-A decreased
from 35.3% in 2002 to 19.1% in 2003, while in ICU-B from 27.7% to
16.4%, respectively. There was an increase in the frequency of
isolation of non-fermenting Gram-negative rods (ICU-A: from
32.9% to 49.3% and in ICU-B from 41.2% to 48.8%) in the analysed
period. Prevalence of Gram-negative rods of the Enterobacteri-
aceae family and enterococci remained stable in both ICUs.
Overall a higher percentage of multi-drug resistant strains was
isolated from ICU-A patients in comparison to ICU-B. An
emergence of Acinetobacter spp. strains resistant to imipenem
was recorded in ICU-A (from 3.6% in 2002 to 12.1% in 2003) and
ICU-B (from 2.9% to 6.7%, respectively). There was a marked
increase in HLAR strain isolation in ICU-A (from 22.7% in 2002 to
86.4% in 2003) and ICU-B (from 29.4% to 90.0%, respectively).
However, frequency of methicillin-resistant S. aureus declined in
ICU-A from 69.6% to 44.1%, while in ICU-B from 70.0% to 64.1%.
Conclusions: (1) A rise in prevalence of Gram-negative rodswas
observed, particularly of the non-fermenters group. (2) Overall a
higher percentage of multi-drug resistant strains was isolated
from ICU-A, corresponding to longer patients mean stay in
comparison to ICU-B. (3) Imipenem-resistant strains of Acinetob-
acter spp. have emerged in both ICUs. (4) Monitoring of bacterial
prevalence and susceptibility patterns helps in determining
optimal empiric therapy of infections in critically ill patients.
P1864
Linezolid susceptibility testing results in Europe:
report from the Worldwide ZAAPS Program
(2003)
J. Ross, T. Fritsche, H. Sader, R. Jones (North Liberty, USA)
Objective: To compare and contrast susceptibility (S) testing
results for linezolid (LZD) in European isolates of Gram-positive
cocci (GPC) with those from the rest of the world (ROW; North
and South America, Asia). Results from the Zyvox Annual
Appraisal of Potency and Spectrum (ZAAPS) Program surveil-
lance study of LZD activity initiated in 2002 worldwide (7921
strains) were compared to program results continued in 2003.
Methods: The ZAAPS Program monitors for oxazolidinone
(LZD) resistance (R) in (60 medical centers worldwide, each
country or site sending 200 isolates to a central laboratory for
reference NCCLS testing. In 2003, a total of 8089 strains were
tested, 1349 strains from Europe (7 countries; 18 sites). Inter-
pretive criteria of the NCCLS M100-S15 (2005) were applied
(LZD-R or non-S at ‡8 mg/L) for staphylococci and enterococci;
and ‡4 mg/L for streptococci. LZD-R strains were studied to
determine the mechanism via target site sequencing, and patient
demographics were also sought.
Results: Six groups of GPC were monitored: S. aureus (SA),
coagulase-negative staphylococci (CoNS), Enterococcus spp.
(ENT), S. pneumoniae (SPN), viridans group streptococci (VgS)
and beta-haemolytic streptococci (BST). The 1349 European
strains were processed and results compared to ROW data, see
table: Characteristics of the European collection included: (1)
26.7% MRSA; (2) 76.4% MR-CoNS; (3) 5.3% VRE, 58% vanA; (4)
SPN penicillin-R and macrolide-non-S at 17.2% and 25.0%,
respectively; and (5) macrolide-R BST at 29.0%. Seven LZD-R
ENT had G2576U ribosomal target mutations (6 from USA, 1
from Greece; separately submitted, not in ZAAPS monitored
nations). No signiﬁcant changes in LZD potency by organism
group or in rates of LZD-R strains were detected between 2002
and 2003 samples.
Conclusions: LZD, as monitored by the ZAAPS Program,
remained highly active against European isolates of GPC,
having a potency identical to that observed in other geographic
regions and invariouspre-marketing trials (ZAPS). LZD-R strains
(ENT) appeared in patient infections in the USA, each with
established ribosomal target alternatives. Continued monitoring
seems prudent, but LZD-R rates remain very low at 0.07%.
P1865
The importance of distinguishing between
bacterial colonisation versus infection in
assessing risk factors
E. Tacconelli, M.A. Cataldo, D. Manno, G. De Angelis, G. Fadda,
R. Cauda, E.M.C. DAgata (Rome, I; Boston, USA)
Objective: The majority of published studies use infection or
clinical cultures as the outcome of interest when assessing risk
LZD MIC (mg/L) % S
Organisms (no. tested) Range 50% 90% Europe ROW
SA (375) 0.12-2 2 2 100.0 100.0
CoNS (263) 0.25-2 1 1 100.0 100.0
ENT (264) 0.5-2 2 2 100.0 99.2
SPN (307) 0.12-2 1 1 100.0 100.0
VgS (62) 0.25-2 1 1 100.0 100.0
BST (78) £0.06-1 1 1 100.0 100.0
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factors for antimicrobial-resistant pathogens. We hypothesize
that risk factors differ between colonization and infection.
Methods: Patients with Pseudomonas aeruginosa (PA) blood-
stream infections (BSI) were identiﬁed during a prospective
surveillance study (2002–2004) in a large University hospital,
and pts with and without PA rectal colonization, respectively,
were identiﬁed from a cross-sectional rectal screening of 1036
hospitalized pts. Two case-control studies were performed
which included 87 randomly selected pts with PA-BSI (group-
1), 29 with PA positive rectal screening (group-2) and 87
randomly selected pts with negative rectal screening (group-3).
Exclusion criteria for group-2 and -3 were the detection of a
clinical culture positive for PA during hospitalization.
Results: Mean age ±SD of population was 58 ± 16 in group-1
and 66 ± 8 y.o. in group-2 (P = ns vs group-3) while the mean
length of hospitalization before entering the study was 27 ± 44
in group-1 (P < 0.01) and 35 ± 37 in group-2 (P < 0.01). Resist-
ance to the following drugs was detected more frequently
among infecting than colonising strains: imipenem (28% vs 24%,
P = ns), ciproﬂoxacin (55% vs 24%, P < 0.01), ceftazidime (32%
vs 31%, P = ns), gentamicin (26% vs 17%, P = ns) , and
piperacillin (18% vs 10%, P = ns). Multidrug resistance (2
classes of drugs) was reported in 50% of PA in group-1 vs
27% in group-2 (P = 0.04). At multivariate regression analysis,
prolonged length of hospitalization (>17 days; group-1,
OR = 2.8; group-2, OR = 3.7) and previous use of cephalospo-
rins (group-1, OR = 6.9; group-2, OR = 9.3) and aminoglyco-
sides (group-1, OR = 35.1; group-2 OR = 12.4) were
independent risk factors for both PA colonisation and BSI
(P < 0.05). Patients with PA-BSI had a higher Charlson score (>3;
OR = 20.5) and were more likely to have had a ICU admission
(OR = 5.8) and quinolones therapy within 30 days (OR = 4.3)
(P < 0.01). The presence of wheel chair or bed-bound status was
independently associated with PA colonisation (OR = 10.6,
P < 0.01) but not with BSI.
Conclusion: This study provides novel information that may be
used to better design future case-control or cohort studies
analysing the epidemiology of antibiotic-resistant infections.
Taking into consideration the differences between colonization
or infection as the outcome of interest may reduce bias and help
better design hospital interventions.
P1866
Signiﬁcant increases in the rate of
ﬂuoroquinolone resistance among Gram-negative
bacilli: six-year (1999–2004) report from the USA
MYSTIC Programme
P. Rhomberg, T. Fritsche, H. Sader, R. Jones (North Liberty, USA)
Objective: To utilize the Meropenem (MEM) Yearly Suscepti-
bility Test Information Collection (MYSTIC) Programme, a
global longitudinal surveillance network of (100 medical centers,
to monitor the activity of broad-spectrum agents in hospitals
actively using carbapenems. Between 1999 and 2004, 10–16 USA
medical centers referred 200 consecutive, non-duplicate isolates
from clinical infections to a central laboratory.
Methods: 15,990 strains were submitted over 6 years. Entero-
bacteriaceae (ENT; 7229), P. aeruginosa (PSA; 2254) and Acine-
tobacter spp. (ASP; 489) strains were tested for susceptibility (S)
using current NCCLS reference methods and interpretative
criteria (M100-S15; 2005). Antimicrobials tested included: MEM,
imipenem (IMP), ceftriaxone, ceftazidime, cefepime, aztreonam,
gentamicin (GENT), tobramycin (TOB), piperacillin/tazobac-
tam, ciproﬂoxacin (CIPRO), and levoﬂoxacin (LEVO). Strains
demonstrating multi-drug R (MDR) from the same site were
further characterized by automated ribotyping and PFGE to
determine clonality.
Results: The rates of CIPRO R within ENT increased from 3.7%
in 1999 to 12.9% in 2004 (range, 0.0–4.3%; average 1.8% increase/
year). The greatest increases in CIPRO-R were noted among
indole-positive Protease (IPP; +24.0%), E. coli (EC; (16.6%),
Enterobacter spp. (EBS; +8.8%) and P. mirabilis (+4.9%). Between
2003 and 2004, an 89.9% increase in CIPRO-R was observed for
EC. During the same period, the% R for the comparators against
ENT remained stable (range, (0.3 to (+0.7%) except for GENT
(+4.1%) and TOB (+2.3%). Among PSA, the CIPRO-R rate
increased from 11.9% in 1999 to 25.3% in 2003, but decreased in
2004 to 21.2%. Percent R for IMP and MEM also decreased 13.6%
and 10.3%, respectively. The CIPRO-R rate among ASP strains
increased from 25.0% to 44.4% (average 3.9% increase/year).
LEVO-R rate (2003–2004) was consistently lower than the
CIPRO-R rate for all ENT and ASP, but slightly higher against
PSA. In 2004, clonal spread of MDR (including FQ-R) strains
was detected in 12 of the 15 hospitals (EC and ASP clusters in 6
sites each).
Conclusions: During the monitored period (1999–2004), the rate
of FQ-R in ENT tested within the MYSTIC Programme has
increased most dramatically for IPP and EC strains. FQ-R has
emerged to an even greater degree amongst ASP and PSA.
Continued surveillance within the MYSTIC Programme partici-
pant sites is warranted to monitor the escalating loss of FQ
activity against Gram-negative pathogens.
P1867
Antibiotic resistance in the south-eastern
Mediterranean: preliminary results from the
ARMed Project
M.A. Borg, E.A. Scicluna, E. Tiemersma on behalf of ARMed
Steering Group
Objectives: Few standardised studies have looked at the
prevalence of antibiotic resistance in the south-east Mediterra-
nean. The Antibiotic Resistance Surveillance & Control in the
Mediterranean Region project (Acronym: ARMed) was initial-
ised in January 2003 and is ﬁnanced by the European Commis-
sion under INCOMED-FP5. This project extends European
surveillance studies – EARSS, ESAC and HARMONY – to
southern and eastern Mediterranean partner countries to
improve epidemiological analysis of antimicrobial resistance
and antibiotic consumption and to identify infection control
practices in participating centres [www.slh.gov.mt/armed].
Methods: A total of 29 laboratories from Cyprus, Egypt, Jordan,
Malta, Morocco, Tunisia and Turkey are taking part. Targeted
surveillance of antibiotic resistance is being undertaken by
means of collection of comparable antimicrobial susceptibility
results through the use of a standardised protocol and selection
of speciﬁc medically important bacteria isolated from blood
cultures and cerebrospinal ﬂuid. A methodology conformant
with that adopted by the European Antimicrobial Resistance
Surveillance System (EARSS) [www.earss.rivm.nl] has been
agreed. Results are validated by a concurrent quality assurance
and proﬁciency testing programme.
Results: Methicillin resistance in Staphylococcus aureus appears
to be the major challenge of the region with rates ranging from
17.8% to 66.1%. In four of the participating countries, methicillin
resistance was detected in more than 40% of isolates. Resistance
in other nosocomial isolates was signiﬁcantly more heteroge-
nous. Third generation cephalosporin resistance in Escherichia
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coli varied widely from 3.7% in Malta up to 76.6% in participa-
ting Egyptian hospitals. There was less variation in quinolone
resistance within the same species with a range of 12.5–39.6%.
Vancomycin resistance in enterococci is relative rare with only
Turkey reporting 1.1% of strains showing glycopeptide non-
susceptibility. Penicillin resistance in Streptococcus pneumoniae is
on the whole low, with Jordan and Egypt being the only two
countries where levels exceed 15%, although macrolide resist-
ance is more common.
Conclusion: This initial antimicrobial susceptibility data indi-
cates that the epidemiology of resistance in the south-eastern
Mediterranean shows a signiﬁcant heterogeneity but is on the
whole equal or at times higher than identiﬁed in northern
countries of the same region by the EARSS network.
P1868
Risk factors associated with the development of
multiresistant micro-organism bacteraemia in an
intensive care unit
R. Zaragoza, A. Artero, J. Camarena, S. Sancho, M. Crespo,
A. Del Castillo, J.M. Nogueira (Valencia, E)
Objectives: The development of a Multiresistant bacteria infec-
tion has become in one of the most important problems in
critically ill patients due to its high morbidity and its inﬂuence
on outcome. The aim of this study was to know the prevalence
of bacteraemia due to multiresistant microorganisms (MRB) in
an ICU, to describe its main clinical features and etiologies, and
ﬁnally to identify independent risk factors for developing MRB,
in order to prevent it.
Material and methods: Prospective study of all the clinical
signiﬁcant bacteremias in a medical-surgical intensive care unit
in a teaching hospital during ﬁve years (from 1999 to 2004). The
resistance pattern of the isolated pathogens was considered as
Multiresistant when the strain was not susceptible to two or
more antibiotic families tested. To analyze the predisposing
factors for developing MRB appropriate clinical and epidemi-
ological variables were recorded from clinical charts. We used
stepwise logistic regression analysis to determine independent
predictors of MRB. SPSS (9.0) software was used for data
analysis.
Results: Fifty-three (37.8%) of 140 ICU bacteremias were MRB.
The mean age of patients with MRB was 63.7 ± 11.7 years and
the relation between men/women was 2.1. The principal origins
of MRB were: respiratory (39.6%), unknown (28.3%) and
catheter (22.6%) Their main etiologies were: Acinetobacter bau-
mannii (51%), CNS (26.4%) and Pseudomonas aeruginosa (7.5%).
Septic shock was present in 54% of MRB. The mean length of
stay in the hospital was 44.5 ± 35 days. The global and related
mortality rate for MRB was 66% and 33.9%.Risk factors for MRB
in the multivariate analysis were nosocomial origin of bacterae-
mia (OR 4.02; IC 95%1.05–17.1:p = 0.04), ventilator associated
pneumonia (VAP) as focus of bacteraemia (OR 3.10; IC 95%
1.15–8.30: p = 0.02), catheter related bacteraemia (OR 7.60;
IC95% 1.72–32.7: p = 0.006), and the presence of abdominal
drainage (OR 4.40; IC 95% 1.19–16.2: p = 0.02). The previous use
of betalactams or quinolones and the length of stay were not
associated with the development of MRB.
Conclusions: The prevalence of MRB was excessively high in
our study. MRB must be suspected when VAP or catheter were
the source of bacteraemia in order to avoid inadequate empirical
antibiotic treatment. VAP and catheter infection preventive
measures are needed to diminish the incidence of MRB.
P1869
Prevalence and antimicrobial resistance of
pathogens isolated from patients with
bacteraemia in an intensive care unit
D. Mylona-Petropoulou, A. Karabinis, G. Ganderis,
E. Paramythiotou, M. Papadoyianni, H. Malamou-Lada (Athens,
GR)
Objectives: To study the prevalence and antimicrobial resist-
ance of pathogens isolated from patients with bacteraemia in the
ICU.
Methods: From January to September 2004, a total of 73 patients
presented one or more episodes of bacteraemia. The identiﬁca-
tion and MIC determination of the isolated strains were
performed by the VITEK II system (bioMerieux, France),
conventional methods and the E test method (Solna, Sweden).
Results: Bacteraemia was detected in 73/289 (25%) patients.
Polymicrobial bacteraemia was observed in 18/73 (25%). A total
of 302 strains were isolated. Of them, 146/302 (48.34%) were
gram-positive, 149/302 (49.34%) gram-negative bacteria and 7/
302 (2.32%) yeasts. Among Gram-positive, the most prevalent
were coagulase-negative Staphylococci (CNS), 116/146 (80%),
followed by S. aureus 12/146 (8%) and Enterococci 17/146 (12%).
The most prevalent of CNS was S. epidermidis 84/116 (72%),
oxacillin resistant in 96%. Two strains (2.4%) were identiﬁed as
glycopeptide intermediate Staphylococcus epidermidis (GISE).
Enterococcus faecalis was the most common and Van A pheno-
type resistance was observed in 5/17 (29%). The most frequent
among Gram-negative bacteria were Acinetobacter baumanii 48/
149 (32%), Klebsiella pneumoniae 44/149 (29%), Pseudomonas
aeruginosa 36/149 (24%) and Proteus mirabilis 6/149 (4%). 9/48
(18.7%) Acinetobacter baumanii strains were multiresistant. Their
resistance rate (%) was: Imipenem 70, ceftazidime 97, ciproﬂ-
oxacin 97, piperacillin/tazobactam 92.7 and ticarcillin/clavula-
nate 97.5. Klebsiella pneumoniae strains produced ESBLs and Amp
C-b-lactamases in 41/44 (93.2%). Resistance to carbapenems was
observed in 26/44 (59%). Five out of 36 (13.8%) Pseudomonas
aeruginosa strains were multiresistant. Their resistance rate was
(%): Aztreonam 77, ciproﬂoxacin 67, ceftazidime 55, imipenem
52.5. One out of 6 strains Proteus mirabilis was resistant to
imipenem.
Conclusion: A very high incidence of multiresistant strains
causing bacteraemia were isolated from patients admitted to
ICU in our hospital. Continuing regular monitoring for the
emergence of further development of bacterial resistance to
antibiotics is mandatory.
P1870
Comparison of antibiotic resistance patterns in
community and hospital urinary isolates of
Gram-negative bacilli in Toronto, Canada
A.K. Chan, K. Green, S. Pong-Porter, Y. Rzayev, A. Sarabia,
T. Mazzulli, D.E. Low (Toronto, CAN)
Background: The purpose of this study was to compare
resistance patterns in relevant antibiotics to common commu-
nity and hospital urinary tract isolates of gram negative bacilli in
Toronto, Canada to determine if similar patterns existed.
Methods: Between Dec 2003 and Jan 2004 in the Greater
Toronto Area, 1975 consecutive outpatient urinary tract isolates
were collected by MDS Laboratories (which services the com-
munity), and 2038 consecutive inpatient isolates were collected
from the Toronto Medical Laboratory/Mt. Sinai Hospital Micro-
biology Department (which services 11 hospitals). Antimicrobial
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susceptibility of isolates was tested by NCCLS broth microdi-
lution methods and resistance rates were determined using
NCCLS criteria.
Results: The frequency of organisms identiﬁed of the 4013 total
isolates included: E. coli (71.8%), K. pneumoniae (11.1%), P.
mirabilis (5.4%), P. aeruginosa (2.7%), SPICE organisms (7.0%).
SPICE organisms included: Serratia spp., Providentia spp.,
P. vulgaris, M. morgagni, Citrobacter spp., and Enterobacter spp..
Antibiotic activity against these isolates to beta-lactams, ﬂuor-
oquinolones (FQ), nitrofurantoin, gentamicin and trimethro-
prim–sulfamethoxazole (TMP/SMX) are listed in the Table (see
graphic) below.
Conclusion: The rate of FQ resistance is signiﬁcantly higher in
hospital urinary isolates of E. coli, K. pneumoniae and SPICE
organisms, compared with the community. Rates of resistance in
E. coli isolates to all antibiotics (beta-lactams, FQ, gentamicin
and TMP-SMX) other than nitrofurantoin are signiﬁcantly
higher in hospital isolates compared with the community. This
indicates a compromised spectrum of ﬁrst-line agents in both
inpatients and outpatients.
P1871
Microbiological surveillance of blood cultures in
an intensive care unit in a Greek hospital
P. Karapavlidou, K. Koraki, M. Tsivitanidou,
D. Soﬁanou (Thessaloniki, GR)
Objectives: To investigate the pattern and antibiotic resistance
of blood culture isolates from an intensive care unit (ICU) in a
tertiary care hospital in Greece.
Methods: Blood cultures from ICU patients were performed
using the BacT Alert 30 automated system. Vitek 2 automated
system (bioMerieux, France) was used for identiﬁcation and
susceptibility testing.
Results: A total of 497 bacterial strains were isolated from blood
cultures, originating from ICU patients, between January 2001
and October 2004. Acinetobacter baumannii was the most preval-
ent pathogen (42.2%), followed by Klebsiella spp (15.3%),
Pseudomonas aeruginosa (13.2%), Enterococcus spp (12.2%), coag-
ulase negative staphylococci (6.4%), Proteus mirabilis (2.4%),
Enterobacter spp (2.2%), Stenotrophomonas maltophilia (2%), Sta-
phylococcus aureus (1.8%), Citrobacter spp (1.4%), Serratia marces-
cens 0.2%. In 32 (6.4%) positive blood cultures, more than one
microorganism was isolated. Resistance rates to commonly used
drugs like ceftazidime, amikacin, ciproﬂoxacin and imipenem
were 96.2%, 67.6%, 97.2% and32% respectively for A. baumanni
and 66.6%, 77.3%, 71.2% and 36.4% respectively for P. aeruginosa.
Klebsiella spp isolates presented 90.9% resistance to ceftazidime,
28.6% to amikacin, 23.4% to ciproﬂoxacin but all isolates were
susceptible to imipenem. All P. mirabilis isolates expressed an
AmpC-type beta-lactamase producing phenotype and full
resistance to quinolones. Among staphylococci, all isolates
were resistant to penicillin but they were susceptible to
glycopeptides. Resistance to aminoglycosides was 76.3% for
gentamicin and 91.4% for tobramycin. 66.6% of S. aureus and
96.5% of CoNS were oxacillin resistant. A high degree of
resistance to penicillin (63.9%) and to high level aminoglyco-
sides (70%) was reported for Enterococcus spp. Two vancomycin
resistant Enterococcus isolates (Van A phenotype) were detected
(1 E. faecalis, 1 E. faecium).
Conclusion: A. baumannii and P. aeruginosa were mainly
responsible for ICU bacteremias in our hospital. Alarmingly
high resistance rates underline the need for more judicious
selection of antibiotics in order to reduce resurgence of multi-
drug-resistant isolates.
P1872
Distribution and susceptibility of urine and
blood uropathogens in a long-term care facility
D. Gronich, Y. Ben-Israel, G. Mendelson, R. Raz (Pardes-Hanna,
Afula, IL)
Objectives: The Haim Shoham centre is a geriatric home care
institute with a population of 850 inhabitants. Urinary tract
infections (UTI) is the most frequent infection in geriatrics and
the most common source of bacteraemia. Since antimicrobials
are started empirically, the knowledge of microbiological pat-
terns and susceptibility of uropathogens in urine and blood is
mandatory in order to choose the most adequate treatment.
Methods & Results: From 01/2002 to 10/2003, 3161 urine
cultures were sent; 2581 (81.6%) grew microorganisms; 93%
gram-negative (E. coli 38%, ESBL+ 27.6%, P. mirabilis 21% and
183 (7%) gram positive cocci (E. fecali 6%). Out of 2265 blood
cultures, 296 were positive (13%), 258 of them (87.1%) grew
gram-negative bacteria (E. coli 18%, ESBL+ 15%), and 38 (12.8%)
gram-positive cocci. As in previous studies, E. coli, P. mirabilis
and K. pneumonia bacteraemia are more sensitive to antibiotic
than the microorganisms growing in urine. Only P. aeroginosa
bacteraemia in more resistant than this pathogen growing in
urine.
Conclusions: The high levels of resistance of the uropathogens
growing in urine and blood in our geriatric home care obligate a
constant surveillance in order to offer the patients the most
adequate treatment.
P1873
Antimicrobial susceptibility of invasive isolates
of Enterobacteriaceae collected in Austria
C. Jebelean, H. Mittermayer and the ASTRA Study
Group (Austrian Surveillance and Tracking of Resistance to
Antimicrobials)
Objective: To investigate the epidemiology of antimicrobial
resistance of Enterobacteriaceae isolated from blood cultures in
Austria.
Methods: 538 strains of Enterobacteriaceae (341 E. coli, 74
Klebsiella spp., 40 Enterobacter spp., 40 Proteus spp., 43 strains
of other species) isolated in clinical laboratories from 7 different
regions of Austria between December 2002 and august 2003
were tested for susceptibility to ampicillin/sulbactam (A/S),
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piperacillin/tazobactam (P/T), cefazolin (CZ), cefoxitin (FOX),
cefuroxim (CXM), cefotaxim (CTX), ceftazidim (CAZ), cefepim
(FEP), gentamicin (G), ciproﬂoxacin (CI), fosfomycin (FOS) and
meropenem (MEM) using an agar dilution method. The strains
with CAZ or CTX MIC >1 mg/L were further investigated for
the production of ESBL using 3 E-test strips: TZ/TZL, CT/CTL,
PM/PML. The breakpoints used for interpretation of FOS
results were (16 mg/L for susceptibility and >128 mg/L for
resistance. For the other antibiotics we used the breakpoints
recommended by NCCLS.
Results: Overall, the rates of susceptibility were: A/S 77%, P/T
93%, CZ 67%, FOX 84%, CXM 86%, CTX 95%, CAZ 93%, FEP
98%, G 96%, CI 88%, FOS 93% and MEM 100%, lower in Tirol,
Salzburg and Vienna than in other regions of the country. For CI
higher resistance rates were encountered in Tirol (19%), Vienna
(17%) and Salzburg (16%), for FOS in the Steiermark 17% and for
G in Vienna (7.4%). The CI, FOS and G resistance were higher in
Proteus spp., 18%, compared to E. coli: 13%, 2.6% and 2.3%,
respectively. The rates of resistance to b-lactams were higher in
the ICUs were Enterobacter and Klebsiella spp. were more
frequently recovered, together with a higher rate of AmpC
derepressed mutants (13%) and ESBL strains (6.6%), whereas the
rates of resistance to CI (25%) and G were higher in the Urology
departments.
Conclusions: Although the overall antimicrobial resistance
rates were moderate (with the exception of CZ and A/S), the
emergence of CI resistance in invasive isolates of Enterobacte-
riaceae and the association with potent ESBLs in some strains is
of great concern.
P1874
Epidemiology and resistance pattern of
bacteraemia pathogens in medical patients over
an 8-year period
E. Tamvakos, T. Peppas, I. Binikos, K. Maltezis,
N. Alexandratou, B. Kandyla, M. Savvala, S. Pappas
(Piraeus, GR)
Objective: To estimate difference regarding epidemiology, out-
come and resistance (R) to antimicrobials of medical patients
with bacteraemia (B), over 8 years
Methods: Prospective demographic, clinical and microbiology,
as well as hospital stay and outcome, data entry of medical
patients with documented B. Time Jan 1997 to Oct 2004. Data
entry and analysis in IBM compatible PC using EPI5-Info (CDC,
1993) programme. Sensitivity as by Kirby–Bauer, statistics by
Yates corrected (2
Results: Documented B patients were 357 (M: 46-F: 54%) m. age
69.7 years. Chronic disease present in 79.8%, and B was
nosocomial in 26% of patients. More frequent pathogens were
E. coli (39.6) and S. aureus (15.1%), most common origin of B
being the urinary tract (48%) Main differences between ﬁrst and
second half of the studied period was the considerable rise of
Klebsiella sp and Acinetobacter Bs and relative rise of Enterococcal
B and Candidaemias. Regarding R data of Gram( pathogens,
signiﬁcance was most prominent was R to 3rd generation
cephalosporins [rising from 6.9 to 22.1%, p = 0.0057] and
ciproﬂoxacin [8.7–21.3%, p = 0.004], and several multiresistant
strains. The annual rise of Gram( cocci percentage is noted, with
constant MRSA rates (~45%), but no glycopeptide R. Mean
hospital stay was 13.5 days and mortality during stay was
17.4%, though not always directly attributed to B.
Conclusions: The constant variability of B pathogens, the
appearance of less expected ones, and mainly R proﬁle changes
deem continuous surveillance and awareness, to ensure the
optimal empirical antimicrobial choice based on the most recent
data of the given milieux.
P1875
Epidemiology and resistance pattern of urinary
pathogens in medical patients over a 6-year
period
H. Lydataki, T. Peppas, A. Koutsibiri, P. Matsoukas, E. Falidea,
G. Sdralias, M. Savvala, S. Pappas (Piraeus, GR)
Objective: To estimate difference regarding epidemiology, out-
come and resistance (R) to antimicrobials of medical patients
with documented urinary tract infection (UTI), over a 8 years.
Methods: Prospective demographic, clinical and microbiology,
as well as hospital stay and outcome, data entry of medical
patients with documented UTI Time Jan 1997 to Oct 2004. Data
entry and analysis in IBM compatible PC using EPI5-Info (CDC,
1993) programme. Sensitivity as by Kirby–Bauer, statistics by
Yates corrected chi-square
Results: DocumentedUTI,was recorded in 501 patients (M: 37.7-
F: 62.3%) m. age 73.1 years. Chronic disease present in 85%, and
UTIwas nosocomial in 34%.More frequent pathogenswereE. coli
(50.6%), Pseudomomonas sp (8%) Klebsiella sp 7.5, and S. faecalis
(6.4%). Main difference between ﬁrst and second half of the
studied period was the rise of Pseudomonas from 5.8 to 13.2% and
Proteus sp [7.4–11.8%], both p < 0.001, while other pathogens
ﬂuctuated . Regarding Gram( pathogens R, signiﬁcant were the
increase to cotrimoxazole [31–48%, p < 0.01] and gentamicin
[13.6–32.2%, p = 0.004]. Also of note was the rise of ciproﬂoxacin
R, [19–29.6%, ns] even among community acquired E. coli . Mean
hospital stay was 10.6 days andmortality during stay was 10.4%.
Conclusions: The constant variability of UTI pathogens, others
rising, others decreasing, the appearance of unexpected ones,
and mainly R proﬁle changes deem continuous surveillance and
awareness, to ensure the optimal empirical antimicrobial choice
based on the most recent data of the given milieux. Designing
and implementing local guidelines for hospital and community
setting is obviously warranted
P1876
Trends in antimicrobial resistance in urinary
isolates of E. coli from patients hospitalised at a
teaching hospital Maribor, Slovenia
R. Saletinger, Z. Baklan, N. Gorisek Miksic, D. Novak (Maribor,
SVN)
Objective: To assess the prevalence and trends in antimicrobial
resistance in urinary isolates of E. coli.
Methods: We studied resistance rates to different antimicrobial
agents in urinary isolates of E. coli from patients hospitalised at
TeachingHospitalMaribor, Slovenia in years 1998, 2000 and 2003.
The isolationwas performed by standardmethods . Susceptibility
was determined by disc diffusion test according to the NCCLS.
Results: Results are collected in Tabel 1.
Conclusion: E. coli remains the most common uropathogen
representing between 39% to 40.3% of all urine isolates.We
have noticed signiﬁcant increase in resistance rates in E. coli
strains to some commonly used antibiotics in the last six years.
Susceptibility to amoxicillin–clavulanate, cephalosporins of
second and third generation and aminoglycosides remained
stable, although the resistance rates to trimethoprim–sulfa-
methoxazole and ciproﬂoxacin are increasing very rapidly. We
believe that surveillance of antimicrobial resistance is very
important for giving recommendations about empirical antibi-
otic treatment.
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Table 1 Resistance rates of E. coli isolates to different antimicro-
bial agents in the years 1998, 2000 and 2003
Year 1998,0 2000,0 2003,0 *P value
Total number of Isolates 2563 2327 2456
Percentage of E.coli (%) 39,1 39,4 40.3
Resistance rates of E.coli (%) % % %
Amoxicillin/ampicillin 39,5 38,4 43,1 0,0230
Amoxicillin clavulanate 15,4 10,5 14,0 NS
Cephalotin 7,8 5,7 11,9 0,0046
Cefaclor 2,8 2,2 2,7 NS
Ceftriaxon ND 0.8 0.8 NS
Ciproﬂoxacin 4,9 6,9 11,9 0.0001
Gentamicin 2,3 2,2 3,5 NS
Cotrimoxazole 15,0 18,4 22,0 0,0001
*P value of chiquadrat test, NS not statistically signiﬁcant. ND No
Data.
P1877
Bacterial spectrum and antibiotic resistance of
uropathogens in hospitalised urological patients
with urinary tract infections (1994–2004) and
consequences for the empiric antibiotic therapy
F.M.E. Wagenlehner, A. Niemetz, K.G. Naber (Straubing, D;
Weisskirchen, A)
Objectives: Surveillance of the bacterial spectrum and antibi-
otic resistance of uropathogens is important for the right
antibiotic choice. Uropathogens causing complicated urinary
tract infections (UTI) in the years 1994–2004 were surveilled.
Methods: In the years 1994–2004 all uropathogens of hospital-
ized urological patientswere identiﬁed and the susceptibilitywas
tested against 14 antibiotic substances (trimethoprim (TMP)/
sulfamethoxazole (SMZ), ciproﬂoxacin, ampicillin, mezlocillin,
ampicillin/ sulbactam, piperacillin/ tacobactam, cefuroxime,
cefpodoxime, cefotaxime, ceftazidime, gentamicin, penicillin,
oxacillin and vancomycin). Since 2002 levoﬂoxacin, gatiﬂoxacin,
piperacillin/ sulbactam and linezolid were tested additionally.
Results: 1. There was no general trend in the emergence of
resistance, except with TMP/SMZ and ciproﬂoxacin in E. coli.
2. Vancomycin or linezolid intermediate or resistant staphylo-
cocci or enterococci were not observed.
3. The lowest rate of resistance was observed with piperacillin/
tazobactam; carbapenems however were not tested regularly.
Conclusion: If the uropathogens are stratiﬁed into Gram pos-
itive and negative bacteria, for oral application ciproﬂoxacin or
levoﬂoxacin showed the lowest resistant rates for Gram negat-
ive, ampicillin/sulbactam, gatiﬂoxacin or linezolid for Gram
positive uropathogens. After further differentiation of uropath-
ogens with quick and simple methods, i.e. catalase, coagulase,
oxidase testing, the empiric antibiotic therapy can be done more
taylored. In order to be able to do so, the urologist has to become
involved in the analytic processing of the urine probe.
P1878
Resistance to third generation cephalosporins in
Klebsiella pneumoniae: a ﬁve years multicentric
Tunisian study (1999–2003)
I. Boutiba-Ben Boubaker, M. Saidani, F. Mahjoubi, H. Smaoui,
W. Achour, A. Ben Hassen, A. Ke´chrid, A. Hammami,
S. Ben Redjeb (Tunis, TN)
Objective: The massive use of third generation cephalosporins
(3rdGC) was subsequently followed by a marked increase in
their resistance incidence. Klebsiella pneumoniae is the most
common Gram negative bacteria exhibiting this resistance
pattern. In order to assess the impact of resistance to 3rdGC, a
multicentric study was carried out over a ﬁve years period
(1999–2003), in 4 teaching hospitals.
Methods: Isolates were identiﬁed by Api 20E system and their
antimicrobial susceptibility was determined by the disc- diffu-
sion method in Mueller–Hinton agar with regular quality
control. Data analysis was done using the Whonet 4 software
Results: Over the 6378 strains of K. pneumoniae collected, 34.1%
were resistant to 3rd GC. Their annual rate has increased from
26.4% in 1999 to 38.9% in 2003 without difference between
hospitals except for paediatric hospital in 1999 (65.2%). These
isolates were recovered mainly from paediatrics (38.2%), Medi-
cine (18.2%), urology (12.4%), intensive care units (11.7%) and
surgery (10.2%). They were more frequently isolated from urines
(49.7%), blood cultures (23.3%), and pus (13.3%). Associated
resistance rates were as follows: 18.4% to cefoxitin, 88.3% to
gentamicin, 62.5% to amikacin, 43.4% to chloramphenicol, 80.3%
to trimethoprim–sulfamethoxazol and 40.6% to ciproﬂoxacin.
All isolates were susceptible to imipenem.
Conclusion: The alarming rate of K. pneumoniae resistant to
3rdGC needs the implementation of infection control measures,
hand washing and rational use of antibiotics.
P1879
Antimicrobial resistance, epidemiology, and
outcome of Clostridium difﬁcile associated
diarrhoea
J. Bishara, Y. Bloch, J. Bachor, Z. Samra (Petah-Tiqva, IL)
Objectives: To determine susceptibility patterns of clinical
C. difﬁcile isolates obtained from hospitalized patients in a
tertiary medical centre in Israel, and to delineate epidemiolog-
ical characteristics and predictors of mortality in patients with
C. difﬁcile associated diarrhoea CDAD.
Methods: The enzyme immunoassay (EIAs) TOX A/Bwas used
for toxin detection. Isolation attempts of C. difﬁcile were per-
formed only onC. difﬁcile toxin positive stool samples. All isolates
underwent screening for antimicrobial susceptibility to metroni-
dazole (5 lg), vancomycin (30 lg), rifampicin (5 lg), fucidic acid
(10 lg), doxycycline (30 lg), and linezolid (30 lg). Minimal
inhibitory concentration (MIC) was determined by the E-test if
disc diffusion was in the inhibition zone of (30 mm. Bacterial
typing was performed on isolates resistant to any of the studied
drugs, and on four randomly selected pan-sensitive isolates were
studied for clonal relatedness by the random ampliﬁcation of
polymorphic DNA (RAPD)-PCR ampliﬁcation assay.
Results: Resistance to metronidazole was found in 2% (1/49
isolates) of isolates (MIC ‡ 256 lg/mL); linezolid in 2% (1/48
isolates) (MIC = 24 lg/mL), and one isolate had a combination
of resistance to fucidic acid (by disc diffusion test) and
rifampicin (MIC > 32 lg/mL). All isolates were sensitive to
doxycycline and vancomycin. Molecular typing method showed
an absence of clonality among the resistant isolates, while pan-
sensitive isolates were monoclonal. On multivariate analysis,
predictors of mortality were previous treatment with ﬂuoroqu-
inolones, hypoalbuminemia, dementia, renal failure, and admis-
sion from a nursing home.
Conclusions: Our study demonstrates that resistance of
C. difﬁcile to metronidazole and other antimicrobials including
linezolid exists in our institution. This ﬁnding should promote
exploration of this problem in Israel, clarify the impact of
resistance on clinical course and outcome, delineate risk factors
and mechanisms for developing resistance, and search for new
alternative therapies and prevention of CDAD.
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P1880
Antibiotic resistance of 69 Klebsiella strains
isolated from a paediatric clinic over three years
G. Sengoz, F. Yildirim, K.K. Yasar, Y.B. Durdu, G. Altay,
G. Ergin, S. Elmi, O. Nazlican (Istanbul, TR)
Objective: Blood cultures taken from patients of Paediatric
clinics of Health Ministry Haseki Education and Research
Hospital have been evaluated for 3 years.
Methods and Results: The growth rate in blood cultures were
303/1019, 357/1062, 321/1019, in years 2002, 2003, and 2004,
respectively. The ratio of Gram positive bacteria to Gram
negative bacteria were 230/46 in 2002, 296/48 in 2003, and
234/55 in 2004. Gram negative bacteria were 1/5 of the total
grown bacteria. Ratio of Klebsiella spp. among the grown Gram
negative bacteria was 16/46 in 2002, 21/48 in 2003, and 32/56 in
2004. When the distribution of Klebsiella spp. according to
months is examined, it is seen that there is no accumulation in
2002, while 10 bacteria were accumulated in June and July in
2003, and 21 bacteria were accumulated in May, June and July in
2004. As a result of examination of susceptibilities of the strains
to antibiotics; in 2002 88% of the strains were susceptible to
amikacin, 62% to seftiakson, 94% to sefepime, 100% to imipe-
nem. These rates were as 71%, 71%, 95%, 100% in 2003
respectively, and 53%, 46%, 81%, and 100% in 2004, respectively.
Conclusion: In 2004, Klebsiella strains resistant to imipenem
were isolated from especially the ICU of our hospital. The
paediatrics clinic is a ward where patients stay for a long time
and where wide spectrum antibiotics are used and Klebsiella
bacteria are being watched closely for carbapenem resistance
and ESBL formation since they spread in the clinic and caused a
hospital epidemic.
P1881
TARGET Surveillance, a part of the LIBRA
initiative: susceptibility of Enterobacter spp. and
Klebsiella spp. isolated during 2003
I. Morrissey, A. Colclough, M. McKeon, K. Dowling, L. Viljoen,
T. Veltman (London, UK)
Objectives: To assess the antibiotic (ABX) susceptibility of
Enterobacter (E). sp and Klebsiella (K). sp circulating in France,
Germany, Italy, Mexico, South Africa, Spain and the USA during
2003.
Methods: MICs for ampicillin (AMP), amoxycillin/clavulanate
(AMX/C), ceftazidime (CTZ), ceftriaxone (CTX), ciproﬂoxacin
(CIP), gentamicin (GEN), imipenem (IMI), nitrofurantoin (NIT),
piperacillin (PIP), piperacillin/tazobactam (PIP/TAZ) and
Trimethoprim/sulphamethoxazole (TM/SX) were determined
by microbroth dilution.
Results: Percent ABX susceptibility (sus) of all K. sp and E. sp
collected are shown in the Table (N, number of isolates
collected). Against both pathogens, IMI and GEN were the
most active parenteral agents and CIP the most active orally
available ABX. For E. sp, lower sus was observed in Italy and
Mexico: CTZ or CTX (50–60%), GEN (70–80%), PIP (~50%) or
PIP/TAZ (~60%). TM/SX sus was also low in Mexico (~60%)
and CIP slightly lower in Italy (82.2%). Lower sus to CTZ or CTX
(~60%), CIP (71.6%), PIP (60.3%), PIP/TAZ (67.8%) or TM/SX
(82.9%) was seen in France. Interestingly, NIT sus was low in
France and Germany (13–20%) but higher in Mexico or Spain
(~50%). Higher E. sp sus was observed in Germany (except
NIT), Spain or the USA, with (90% sus to CIP, GEN, IMI or TM/
SX. Higher CIP sus also occurred in South Africa ((95%).
Generally K. sp sus was lower in Mexico and South Africa but
isolates were still over 90% sus to IMI or CIP. Higher K. sp sus
was observed in Spain and the USA ((90% for all ABX except
AMP or PIP). However, K. sp showed low AMP or NIT sus
worldwide.
Conclusion: K. sp is generally more sus to ABX than E. sp. Of
the ABX included within the study only CIP, GEN or IMI
showed consistent activity against E. sp within each country
investigated. Of these CIP would be the most suitable for step-
down and/or community use against E. sp or K. sp infection.
Susceptibility testing methods
P1882
Antibiotic susceptibility tests on P. aeruginosa
isolated in ICU using the Uro-Quick system
F. Cavallini, S. Cagnacci, D.L. Rocca, E. Maioli, S. Roveta,
A. Marchese, E.A. Debbia (Genoa, I)
Objective: P. aeruginosa is responsible of severe infections,
especially in nosocomial settings. This species is also character-
ized by an easy evaluation toward resistance against antimicro-
bial agents. The management of infections sustained by
P. aeruginosa in fact requires a treatment based on a combination
of drugs. Because the therapy needs the use effective drugs,
laboratory tests are challenged to support clinicians in a timely
manner. In order to gain time in the evaluation of antimicrobial
susceptibility in P. aeruginosa, Uro-Quick, an automatic instru-
ment capable to test antibiotic resistance, was used to perform
antibiotic susceptibility against this pathogen.
Material and methods: Appropriate concentrations of bacterial
cultures were used to test different media containing various
concentrations of KCl and Tween 80. Susceptibility tests were
carried out exposing P. aeruginosa isolates to antibiotics in ﬁxed
concentrations. Ciproﬂoxacin (CIP), amikacin (AN), gentamycin
(GM), imipenem (IPM), ceftazidime (CAZ), piperacillin/tazo-
bactam (TZP) were used. All tests were carried out under
aerobic environment.
Results: After evaluation of growth conditions in different
media, P. aeruginosa was routinely cultured in MH broth
containing KCl 2% and Tween 80, 0.2%. The growth rate of P.
aeruginosa in this medium, using an inoculum of 106 CFU/ml,
was found faster than in the usual MH without any other
ingredients. The instrument printed out the results after 3–
4 hours in comparison with 6 hours required under the stand-
ard conditions.Susceptibility tests, read after 4 hours of incuba-
Abstracts
622
tion, demonstrated an agreement >95% (CIP 96%, AN 96%, GM
100%, IPM 92%, CAZ 92%, TZP 92%) between Uro-Quick and
Kirby–Bauer method.
Conclusions: The Uro-Quick system may be very useful for the
evaluation of antimicrobic susceptibility in P. aeruginosa because
of its rapid achievement of the results.
P1883
Evaluation of MicroScan Dried Overnight Panels
compared to a NCCLS reference panel for
daptomycin susceptibility testing with a
challenge set of organisms
R. Rennie, C. Brosnikoff, S. Shokoples, L. Turnbull, S. Mirrett,
L.B. Reller, P. Iwen, R. Noel, M. Bacsafra, S. Connell, J. Johnston,
B. Zimmer (Edmonton, CAN; Durham, Omaha, Sacramento, USA)
Objectives: The accuracy and reliability of MicroScan Dried
Overnight Gram-positive panels compared to the NCCLS frozen
reference broth microdilution method for susceptibility testing
of daptomycin were assessed during a multi-site evaluation.
Methods: Accuracy was evaluated at one site with 75 challenge
isolates (34 S. aureus, 11 coagulase-negative Staphylococci, 19
Enterococcus spp., and 11 group B beta-hemolytic Streptococci),
selected to provide a range of on-scale results. The inoculumwas
prepared with the turbidity and Prompt methods of inoculation
and the panels were tested with the WalkAway System, the
autoSCAN-4 instrument, and manual readings. Reproducibility
was evaluated at three sites using 10 gram-positive organisms,
including the recommended NCCLS quality control strains. The
reproducibility strains were tested in triplicate for three days at
each site with both inoculation methods. Results obtained with
the WalkAway System and the autoSCAN-4 were compared to
the mode and median of the manual panel readings.
Results: Essential agreement for challenge isolates tested with
the turbidity inoculationmethodwas98.7%(74/75) for all reading
methods when compared to the reference panel. Essential
agreement with the Prompt inoculation method was 94.7% (71/
75) for the WalkAway, 96% (72/75) for the autoSCAN-4, and
90.7% (68/75) for the manual readings. Categorical agreement
was >95% for all combinations. Inter-laboratory reproducibility
(manual readings) was 100% for both inoculation methods.
Reproducibility was 100% (275/275) for both the WalkAway
and autoSCAN-4 with the Prompt inoculation method. For the
turbidity inoculation method, reproducibility was 98.5% (271/
275) for theWalkAway and 99.6% (274/275) for the autoSCAN-4.
Conclusion: MicroScan Dried Overnight Gram-Positive panels
used with WalkAway, autoSCAN-4 instrumentation and
manual readings and with either turbidity or Prompt inocula-
tion methods correlated well with the NCCLS reference broth
microdilution method for susceptibility testing of daptomycin.
P1884
Evaluation of the MicroScan Dried Overnight
Panel and Instrumentation for antimicrobial
susceptibility testing of mupirocin
B. Zimmer, M. Bacsafra, G. Enscoe, G. Mendoza-Morales,
R. Salzman, G. Williams (Sacramento, USA)
Objectives: The MicroScan System (Dade Behring Inc.) pro-
vides automated, semiautomated or manual antimicrobial sus-
ceptibility testing for the clinical laboratory. Mupirocin is a
topical antimicrobial agent active against staphylococci. Gram-
Positive panels containing mupirocin were introduced as part of
LabPro V1.55. Panels were evaluated in comparison to an
NCCLS reference panel with fresh and stock Staphylococci. The
performance of automated MicroScan instrumentation (WalkA-
way, autoSCAN-4) in reading panels was also assessed.
Methods: A total of 288 Staphylococci were tested for mupirocin
MIC determination using MicroScan Dried panels and reference
NCCLS broth microdilution. Mupirocin concentrations tested
were 1–512 lg/ml. Agreement was assessed using both manu-
facturer’s skin and nasal interpretive breakpoints. In addition, a
total of 126 Staphylococci were tested on multiple MicroScan
instruments to evaluate automated performance in comparison
to manual read of the same panels. Both susceptible and
resistant organisms were tested. There were 212 data points
established for these staphylococci for the WalkAways and 534
data points established for the autoSCAN-4s. Both turbidity and
Prompt inoculation methods were used for all studies.
Results: The essential agreement (± one doubling dilution)
between the MicroScan panel and the reference panel was
100%. There were no major or very major errors using either
interpretive breakpoint. For WalkAway automated reads, the
essential agreement between instrument and manual read was
99.5%. There were no major or very major errors using nasal
breakpoints; there was one (1/56,1.8%) very major error with a
S. aureus using skin breakpoints. For autoSCAN-4 reads,
essential agreement between instrument and manual read was
98.7%. There was one very major error (1/67, 1.5%) for a S.
aureus using skin breakpoints and a second very major error (1/
44, 2.3%) for a S. epidermidis using nasal breakpoints.
Conclusion: This study showed that the new MicroScan Dried
Overnight gram-positive panels containing mupirocin give
excellent automated performance and excellent correlation
with an NCCLS broth microdilution reference panel.
P1885
Comparison of Uro-Quick and Kirby–Bauer
methods to detect ESBL-producing strains
S. Cagnacci, S. Roveta, F. Cavallini, D.L. Rocca, A. Marchese,
E.A. Debbia (Genoa, I)
Objectives: To evaluate the Uro-Quick system for detection of
extended-spectrum beta-lactamase (ESBL) in nosocomial strains
that exhibit ceftazidime resistance phenotype, and/or in isolates
requiring conﬁrmatory tests for the identiﬁcation of strains
producing these enzymes.
Methods: A total of 160 strains collected from nosocomial
patients were tested for antibiotic susceptibility by the Uro-
Quick system. About 106 cell/ml were used to seed 2.5 ml of
broth in vials containing ceftazidime (20 mg/l) and ceftazidime
(20 mg/l) plus clavulanic acid (10 mg/l). After incubation the
results were plotted as growth curves. All result were conﬁrmed
by Kirby–Bauer method. Control strains included E. coli ATCC
25922, and a TEM-4 producer.
Results: Using an inoculum of 106 cell/ml, the instrument was
capable to print out the result after 5 hours of incubation.
Among the pathogens studied, 34 strain resulted resistant to
ceftazidime (presence of growth) and showed susceptibility to
the combination of this cephalosporin with clavulanic acid
(absence of growth). These results were then compared with
those obtained with the Kirby–Bauer method, and it was found
that among these 34 ceftazidime-resistant clones all were ESBL-
producers, even if 5 showed an intermediate, and 6 a susceptible
antibiotic phenotype by Kirby–Bauer method.
Discussion: Present ﬁndings suggest that Uro-Quick represents
a useful technology to detect ESBL-producing strains especially
those that required further conﬁrmatory tests for their identiﬁ-
cation. The period of time needed to achieve the results, in some
cases less than 5 hours, is a sure advantageous over the usual
methodologies.
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Evaluation of the essential equivalency of the
antimicrobial susceptibility test GN09 Card on
the bioMerieux VITEK 2 and the VITEK 2
Compact System
C. Brosnikoff, R. Rennie, S. Shokoples, L. Turnbull (Edmonton,
CAN)
Objective: The objective of this trial was to compare and
conﬁrm equivalency between the new bioMe´rieux VITEK 2
Compact System and VITEK 2 using the VITEK 2 Gram
Negative Antimicrobial Susceptiblity Test (AST) GN09 card. The
three components of this study included reproducibility, chal-
lenge and Quality Control (QC) testing.
Methods: Thirty-two (32) reproducibility strains were tested for
three days, and twenty replicates of QC were performed using
E. coli ATCC 25922, E. coli 35218 and P. aeruginosa ATCC 27853.
135 challenge strains were also included in this study. These
strains encompassed a range of both fermenting and non-
fermenting Gram-negative bacilli and were chosen to cover the
range of results provided by the systems in order to detect a
signiﬁcant process shift should one exist. Two AST GN-09 cards
were inoculated from the same inoculum and one card was put
onto each automated system.
Results: The challenge set of organism yielded good results.
There were no dilution differences between the 2 systems for
94.2% of results. Only 5.3% showed one dilution difference.
Essential agreement for all strains was 99.5%. The essential
agreement for on-scale results was 98.7%, with 80.7% of results
showing no dilution difference. Reproducibility tests
showed100% essential agreement. The QC in-range results for
VITEK 2 were 98.9% and 99.0% for the VITEK 2 Compact.
Conclusions: The essential equivalency of bioMe´rieux VITEK
2 and the new VITEK 2 Compact were evaluated with the
GN09 antimicrobial susceptibility card. The studies performed
challenged the range of antimicrobial agent – organism combi-
nations offered for laboratory testing of aerobic gram-negative
bacilli. For reproducibility and challenge studies, observed
performance exceeded the minimum level of acceptable per-
formance. All acceptance criteria were met when data were
restricted to on scale results. These data provide convincing
evidence that VITEK 2 AST results will be essentially equiv-
alent regardless of the system used for testing.
P1887
Rapid antimicrobial sensitivity testing: direct
from positive blood cultures
S. O’Hara, M. Green (Southampton, UK)
Objectives: This study describes a new approach which allows
a pathogens susceptibility pattern to be determined in 4–5 hours
direct from positive blood cultures. The test is based on using
adenylate kinase (AK) as a sensitive and quantitative marker of
cell biomass. AK catalyses the equilibrium reaction 2ADP to
ATP ( AMP and can be used as a cell marker by monitoring the
ATP produced using ﬁreﬂy luciferase. The AK technique is
>1000,000 fold more sensitive than optical techniques (e.g.
turbimetric, colorimetric) used in current commercial systems
and shows signiﬁcantly better correlation with organism num-
bers. This allows changes in microbial populations to be
detected very early in the growth curve, many generations
before any signal can be measured by optical methods.
Methods: The study was divided into 2 phases. The ﬁrst phase
examined techniques to extract bacteria from the blood culture
specimen matrix to prevent blood culture components interfer-
ing with the antibiotic sensitivity test (AST)results. The second
phase compared AST results achieved using the ’Rapid AK’ test
to AST results determined using traditional approaches, for the
12 organisms most commonly associated with blood infection.
The study looked at both qualitative (breakpoint) and quanti-
tative (NCCLS MIC) methods of AST.
Results: After examining a range of extraction approaches a
modiﬁed lysis centrifugation technique was shown to reliably
extract common blood isolates at numbers consistent with those
present in positive blood cultures (105 orgs/ml). There was no
determinable effect on organism growth rates or AST results
using this technique. The rapid AK AST allowed the correct
determination of the antibiotic susceptibility for all organism/
antibiotic combinations tested, using qualitative or quantitative
approaches, direct from blood cultures within 5 hours.
Conclusion: The results of this study suggest that the ’rapid AK
assay’ can be used to accurately and rapidly determine the
antimicrobial susceptibility of common clinical pathogens direct
from positive blood cultures. This is a signiﬁcant improvement
over current methods which generally require overnight incu-
bation. Further work is progressing to further reduce timescales
and to examine a wider range of clinically important organ-
isms/resistance mechanisms.
P1888
Accuracy of three automated systems for
susceptibility testing selected Gram-negative
bacilli against ﬁve broad-spectrum beta-lactam
agents
H. Sader, K. Fedler, B. Cookson, C. Brace, T. Fritsche,
R. Jones (North Liberty, USA)
Objectives: To evaluate the accuracy of three automated sys-
tems; MicroScan WalkAway (MSWA), Vitek 2 (VT2) and Vitek
Legacy (VTL), for susceptibility (S) testing P. aeruginosa (PSA)
and various Enterobacteriaceae (ENT) species against aztreonam
(AZT), cefepime (CPM), ceftazidime (CAZ), imipenem (IMP)
and piperacillin/tazobactam (P/T).
Methods: Recent clinical strains (100 PSA and 20 ENT) from
North American hospitals were selected to over-represent
isolates with CPM and P/T MIC values within ±1 log 2 dilution
of the current NCCLS S and resistant (R) breakpoints for the
studied compounds. Categorical results from automated sys-
tems were compared to the consensus of 3 reference/standard-
ized methods: broth microdilution, E-test (AB BIODISK, Solna,
Sweden) and disk diffusion. Categorial disagreements were
classiﬁed as: in very major (VM, false-S), major error (MA, false-
R) and minor errors (MI; involving the intermediate category).
Results: The consensus testing S/R rates (%) among PSA
strains were 45/55 for P/T, 46/40 for CAZ, 48/35 for CPM,
69/27 for IMP and 36/35 for AZT. A summary of the categorial
disagreements for PSA is shown in the Table. All three systems
showed a high, unacceptable rate of VM for P/T (21–32%). For
other drugs VM rates ranged from 0 to only 4% (IMP tested on
VT2). MA rates were acceptable for comparisons (0–3%) and MI
rates were generally elevated (5–33%), reﬂecting the high
proportion of consensus results within the intermediate category
or skewed, erroneous results for CPM (VT2 and VTL) and AZT
(all systems). Among ENT (20 strains), VM was 5% for AZT and
0% for P/T, CAZ, CPM and IMP (100% S) on all 3 systems, and
MA was detected only on MSWA (0–15%). MI rates were higher
for P/T [20 (VT2) to 35% (MSWA and VTL)] and CPM [15 (VTL)
to 35% (MSWA)].
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Conclusions: The results of this study demonstrates that the
automated systems (MSWA, VT2 and VTL) generally failed to
accurately detect P/T-R among PSA. The criteria used to select
the strains (MIC values close to breakpoints or within R range)
increased the sensitivity of detecting signiﬁcant categorical
disagreements, dominated by MI. Re-evaluation of the P/T
testing for PSA would be prudent for these systems to minimize
adverse therapeutic outcomes worldwide.
P1889
Detection of carbapenemase production
in the Bacteroides fragilis group using the
MBL E-test strip: correlation with broth
microdilution testing
K.E. Aldridge (New Orleans, USA)
Objective: Resistance to beta-lactam agents among bacteria is
often due to beta-lactamase (BLa) enzymes. The majority of the
Bacteroides fragilisgroup (Bfg) produceBLa andare easilydetected
using thenitrocephin assay.MBLare alsoproducedbya small per
cent of Bfg and renders them resistant to all beta-lactam agents
including carbapenems. The nitrocephin assay does not distin-
guish between substrate proﬁles of these various enzymes which
can have therapeutic implications. The AB Biodisk MBL E-test
strip provides a simple test that allows the detection of MBL
enzymes through the simultaneous testing of imipenem(IMI)/
imipenem-EDTA(IMI-E)on a single test strip. This study was
designed to test the correlation of MBL E-test results with results
from Broth Microdilution (BMD) testing of the Bfg.
Methods: A challenge group of 100 Bfg isolates were tested.
MBL E-test strips were placed on inoculated prereduced Brucella
blood agar plates according to the manufacturers recommenda-
tions with simultaneous inoculation of BMD plates containing
two-fold dilutions of IMI and meropenem(MERO) in supple-
mented Brucella broth. All plates were incubated anaerobically
at 35C for 48 h and read. The ellipse MIC endpoint was
determined for the IMI and IMI-E potions of the MBL strips. A
positive result for production of MBL was an MIC 4-fold or
more lower for the IMI-E portion of the strip than for the IMI
portion. For BMD the MIC was the lowest concentration of IMI
or MERO that inhibited the visible growth of the test isolate.
BLA was also determined using the nitrocephin assay. QC was
performed using B. fragilis ATCC25285 and B. fragilis TAL3636.
Results: All isolates produced BLa in the nitro cephin assay.
Based on BMD MICs 19 isolates were resistant(R) to IMI and
MERO; 2 were intermediate(I); and 79 were susceptible(S). All
19-R isolates were positive by MBL E-test assays with MIC
results of 16/<1 to >256/<1. For the 2-I isolates the MBL tests
were negative with results of <4/<1. All 79-S isolates were MBL
negative with all results <4/<1. The MIC endpoints for the MBL
strips were easily read with the exception of the 2-I isolates
which had colonies into the inhibitory zone and repeat testing
gave the same results. Overall the two tests correlated 98% of the
time. For S and R isolates the correlation was 100%. The I isolates
had discrepant results suggesting elevated MICs due to non-BLa
mechanisms.
Conclusion: The performance of the MBL E-test correlated very
well with NCCLS BMD in the detection of Bfg isolates that
produced MBL.
P1890
Evaluation of a microdilution sensitivity test
which uses 384 Well plates
B. Wiedemann, A.C. Rodloff, I. Noll (Bonn, Leipzig, D)
Objectives: Antibiotic susceptibility tests are themost frequently
used tests in clinicalmicrobiology.Due to economicpressure fully
or partly automated test systems are developed in order to reduce
personal and reagents costs. In this study, we compare the
MICRONAUT system using a 384 well microtiter plate with a
conventional microdilutionmethod according to DIN guidelines.
Methods: The MICRONAUT system uses vacuum dried anti-
biotics in a 384-well-plate. The inoculum is applied with an
automatic dispenser with a ﬁnal inoculum of 1 · 105 cells/lL in
50 lL cation adjusted Mueller–Hinton medium with the addi-
tion of 0.025% phytagel. As the comparator we used the
microdilution method according to DIN 58940-8. Evaluation
was performed by the comparison of (i) the performance of
quality control strains (E.coli ATCC 25922, P. aeruginosa ATCC
27853, S. aureus ATCC 29213, and E. faecalis ATCC 29212), and
(ii). the natural sensitivity of clinical isolates of common
pathogens (E. coli, P. aeruginosa, E. faecalis and S. aureus). For
each species-antibiotic-combination meeting the conditions for
comparison (at least ﬁve-dilution-series with a mode at the third
dilution of the naturally sensitive population) two ﬁgures are
calculated to determine the degree of similarity of the MIC-
distributions: the mode and the percentage of strains within the
range of ± one dilution step of the mode. Results:The results for
the QC-strains match to 100% for 23 strain–antibiotic pairs. For
16 pairs there is a difference of 1 dilution step for the mode MIC,
and only once (S. aureus and Penicillin) the mode MIC varied for
2 dilution steps. The results for the MIC-distributions of the
natural sensitive population show in 10 out of 15 cases an
excellent match with regard to the peak and the width of the
MIC-distributions. For imipenem and gentamicin with P. aeru-
ginosa, for vancomycin, moxiﬂoxacin and meropenem with
E. faecalis differences of the mode are one dilution step only. The
percentage of values within the range of ± one dilution step of
the mode for the above mentioned exceptions is nearly identical.
Conclusions: In general, both methods show nearly identical
results. Differences in mode MICs rarely exceed one dilution
step, although not identical batches of the test medium were
used for both methods. This way of evaluation seems more
reliable than the use of already evaluated results with S, I and R
categories describing major and very major errors.
P1891
Susceptibility patterns for amoxicillin/
clavulanate tests mimicking newly indicated
formulations and pharmacokinetic relationships:
does the 2:1 ratio MIC accurately reﬂect activity
against beta-lactamase-producing H. inﬂuenzae
and M. catarrhalis
R. Jones, T. Fritsche, H. Sader (North Liberty, USA)
Background: Amoxicillin/clavulanate (A/C) has recently
undergone formulation changes (XR and ES-600) that represent
Error rates (%)
System/Error type AZT CPM CAZ IMP PIT
MSWA
VM 0 0 0 1 21
MA 0 1 1 1 1
MI 33 14 11 11 -
VTL
VM 3 0 1 0 26
MA 0 0 1 0 0
MI 32 22 12 5 -
VT2
VM 0 2 2 4 32
MA 1 0 3 1 0
MI 28 23 12 12 -
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14:1 and 16:1 ratios of A/C. These ratios greatly differ from the
2:1 ratio used in initial tablets or for in vitro susceptibility (S)
testing, and produce a serum concentration ratio of approxi-
mately 9:1. The effects of these altered ratios on the S test was
assessed.
Methods: Activity of A/C was determined by NCCLS broth
microdilution methods (M7-A6; 2003) against H. inﬂuenzae [HI;
19 strains, 12 beta-lactamase-positive (BL+)] and M. catarrhalis
(MCAT; 23 strains, 16 BL+ including BRO-1 and -2). A/C was
tested in 8 combinations reﬂecting formulation and serum PK
ratios (4, 5, 7, 9, 14 and 16:1; 0.5 and 2 mg/L ﬁxed C conc.) and
compared with 2:1 MIC results. Mueller–Hinton broth was
modiﬁed to HTM for testing HI.
Results: The reference A/C (2:1) MICs for HI BL+ and BL)
strains ranged from 0.5–4 and 0.25–2 mg/L, respectively. BL+
MCAT A/C MICs (MIC90, 0.25 mg/L) were routinely ‡16-fold
higher than BL- strains showing incomplete enzyme inhibition
by C. All A/C MIC ratio test results were unchanged for BL)
isolates compared to 2:1 ratio MICs. However, trends toward a
2-fold higher A/C MIC were observed for all ratio tests of >5:1
and >4:1 for BL+ HI and MCAT, respectively. Both C ﬁxed
concentration MIC tests were equal to or lower than 2:1 MICs,
however the Cmax for C was only 1.5–2.2 mg/L (1.7–2.0, new
formulations) questioning the PK/PD validity of the C level at
the current NCCLS breakpoint (S at £4/2 mg/L).
Conclusions: The A/C MIC test using the 2:1 ratio was estab-
lished prior to contemporary PK/PD calculations and before
current altered formulations signiﬁcantly modiﬁed drug ratios.
At ratios of ‡4:1 the inhibition of BL+ strains was less efﬁcient
resulting in a 2-fold greater A/C MIC and reducing the probab-
ility of favorable clinical responses. Re-evaluation of A/C MIC
testing should be considered by S test standard organizations.
P1892
Validity of antimicrobial susceptibility results
from 29 Mediterranean laboratories in the
ARMed Project
E.A. Scicluna, M.A Borg, N. Bruinsma, C. Walton on behalf of the
ARMed Steering Group
Objective: The Antibiotic Resistance Surveillance & Control in
the Mediterranean Region (ARMed) project is a ten-country
multi-centre surveillance network coordinated by the Infection
Control Unit of St. Luke’s Hospital, Malta and funded by the
European Commission under the INCO-MED FP5 programme.
In order to validate the results of the ARMed-EARSS antimi-
crobial susceptibility component of the project, the 29 laborat-
ories from 6 Euro-Mediterranean countries, participate in a
yearly external quality assessment (EQA) exercise.
Methods: This EQA exercise was organised through the link
with EARSS (European Antimicrobial Resistance Surveillance
System) in collaboration with UK NEQAS (United Kingdom
National External Quality Assessment Scheme) for Microbio-
logy, Centre National de Re´fe´rence des Antibiotiques (CRAB)
and the members of the EARSS EQA committee. The strains
were distributed to the participating laboratories by UK-NEQAS
through the ARMed co-ordinators and the laboratories are
asked to report clinical susceptibility categorisation (S, I, R). The
results are analysed and considered concordant if the reported
categorisation agreed with the designated interpretation of the
reference laboratories.
Results: The overall response rate of the EQA in the ﬁrst year of
the ARMed network was 89%. These results showed that there is
room for improvement in routine susceptibility testing. For
Streptococcus pneumoniae, 23% of laboratories failed to detect
penicillin non-susceptibility. Moreover, 31% of laboratories
missed detection of an MRSA that caused epidemics in
Europe. This strain is difﬁcult to detect since the resistance
phenotype is heterogeneously expressed and maybe this prop-
erty even contributes to its spread. For the fully susceptible
Staphylococcus aureus, the overall concordance was 100% for
species identiﬁcation and for most of the antibiotics tested. The
ESBL production of the Escherichia coli strain was correctly
identiﬁed by 90% of the laboratories.
Conclusion: This ARMed-EARSS EQA exercise showed that,
overall, laboratories of the southern and eastern Mediterranean
counties are capable of delivering susceptibility data of good
quality and that can be compared between different laboratories
and countries. The exercise has also allowed a number of
participating laboratories to identify aspects of routine culture
and sensitivity that need improvement can improve.
P1893
Evaluation of antimicrobial susceptibility of
bacteria containing plasmid mediated qnrA and
FOX-5 beta-lactamase by four automatic systems
J.M. Rodriguez-Martinez, C. Conejo, L. Martinez-Martinez,
M. Eliecer-Cano, C. Velasco, A. Pascual (Seville, Santander, E)
Objectives: Resistance to quinolones may be caused by plas-
mids expressing qnrA. These plasmids usually also code for
beta-lactamases, including FOX-5. The accuracy of automatic
systems for susceptibility testing of organisms expressing qnrA
has not been assessed yet. The purpose of this study was to
evaluate the performance of four automated instruments for
susceptibility testing to ﬂuoroquinolones and beta-lactams of
four clinical isolates of Klebsiella pneumoniae (UAB1, N5, 1960
and 1132) producing both QnrA and FOX-5 and their respective
four Escherichia coli transconjugants. No transconjugants con-
taining qnrA from strain 1132 are available.
Methods: The automatic systems BD Phoenix, MicroScan Walk-
Away, Vitek-2 and Wider were used, according to manufac-
turer’s instructions. MICs of ciproﬂoxacin (CIP), nalidixic acid
(NAL), norﬂoxacin (NOR), oﬂoxacin (OFL), cefoxitin (FOX),
ceftazidime (CAZ), cefotaxime (CTX) and ampicillin (AMP)
were determined by microdilution according to NCCLS guide-
lines. MICs obtained either by reference microdilution or by the
automatic systems were translated into clinical categories
according to the NCCLS.
Results: Considering quinolone testing, very major errors
(VME, false susceptibility) were observed for NAL in Phoenix
for N5 and transconjugants derived from UAB1, N5 and 1960,
and in Wider for the same strains and transconjugants and
UAB1. VME were also noted for OFL and NOR in Vitek-2 for
strain UAB1. Major errors (ME, false resistance) were only
observed for CIP and both Phoenix and Wider for 1960. Minor
errors (intermediate with one method and resistant or suscept-
ible with the other method) were noted with all 4 systems for at
least one quinolone/strain combination. When testing beta-
lactams, VME were only found for CAZ when testing the
transconjugant from UAB1 with Phoenix or Wider. One ME for
CTX was observed when testing N5 with Phoenix. Minor errors
were noted with all 4 systems for CAZ (15 out of the 32
performed tests) and with CTX (3 out of 32 tests). No errors were
found for FOX or AMP with any system.
Conclusion: Automated systems are not completely reliable for
establishing clinical categories of quinolones against K. pneumo-
niae strains or transconjugants derived from them producing
QnrA. While these systems are reliable for detecting FOX
resistance usually associated to QnrA production, there are also
problems for detecting resistance to CAZ or CTX in these strains.
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P1894
Direct susceptibility testing of Gram-negative
rods from positive BacT/Alert blood cultures by
using disc diffusion method
Sp Fokas, St. Fokas, M. Tsironi, I. Sarris, M. Kalkani,
M. Dionysopoulou (Sparta, GR)
Objectives: To evaluate the accuracy of direct antimicrobial
susceptibility testing of aerobic gram-negative rods (GNRs) from
positive BacT/Alert blood cultures by using disk diffusion
method compared to standardized testing with isolated colon-
ies.
Methods: Our study was carried out over a 10-months period
(1–10/2004) and included 50 positive BacT/Alert blood cultures
showing gram-negative rod-like morphology in Gram smears
and yielding monomicrobial aerobic GNRs in subculture. A 8-ml
sample from the positive blood culture bottle was aspirated into
a serum separator tube and centrifuged at 3,000 · g for 10 min.
The supernatant was discharged and the bacterial pellet was
harvested from the surface of the gel with a cotton swab to make
a suspension of McFarland 1.0 standard. Then, susceptibility
tests to 15 antibiotics were done by disk diffusion method
(NCCLS guidelines). Identiﬁcation to species level and suscep-
tibility testing with isolated colonies were also performed for
comparison. The results were analysed for categorical agree-
ment (discrepancies were categorized as minor, major and very
major errors).
Results: Of the 50 GNRs isolated, 45 (90%) corresponded to the
family Enterobacteriaceae and 5 (10%) were non fermenters. A
total of 750 antimicrobial-organism combinations were inter-
preted. Thirty six of 50 (72%) gram-negative isolates showed
complete categorical agreement. Analysis of errors by antimi-
crobial agent yielded 16 (2.1%) minor, 1 (0.13%) major, and 1
(0.13%) very major errors. An overall categorical agreement of
97.6% for the drugs tested was observed and discrepancies were
occurred with cephalothin (6, 0.8%), ampicillin (4, 0.53%),
amoxicillin–clavulanic acid (3, 0.4%), ampicillin–sulbactam (3,
0.4%), and piperacillin (2, 0.27%).
Conclusions: The direct susceptibility testing of aerobic GNRs
isolated from positive BacT/Alert blood cultures by using disk
diffusion method with a centrifugation step performed well
since high categorical agreement and low error rates were noted.
The direct method cannot replace the standard procedure, but
given the beneﬁts on patient care the laboratories should
evaluate the possibility of applying this method for routine
use.
P1895
Direct susceptibility testing of positive BacT/
Alert blood cultures with and without charcoal by
using MicroScan panels
J.C. Alados Arboledas, A.I. Aller, J.L. De Francisco, C. De
Miguel, M.D. Lopez Prieto, L. Calbo (Jerez de la Frontera, E)
Objectives: The rapid and reliable detection of bloodstream
infections, including bacterial identiﬁcation and antimicrobial
susceptibility testing is one of the most important tasks of
clinical microbiologists. We performed a prospective study in
which MicroScan panels were directly inoculated with different
BacT/Alert blood culture broth (with and without charcoal),
and susceptibility and identiﬁcation results were compared with
those obtained by standard inoculation method.
Methods: A total of 110 positive aerobic blood cultures collec-
ted from patients suspected of having bacteriemia were studied.
Forty-four were standard aerobic media (SA) and 66 with
charcoal aerobic (FA) and paediatric (FP) media. Specimens that
yield more than one microorganism in subculture control plates
were discharged. MicroScan Combo Negative 1S and Positive
2SA (DADE BEHRING, California, USA) were used for gram-
negative and gram-positive isolates, respectively.
Results: Forty isolates were gram positive cocci and 70 isolates
were gram negative bacilli. Seven (17.5%) gram positive cocci
strains were misidentiﬁed by the direct method, all of them
being coagulase negative. All gram negatives rods (n = 58)
belonging to Enterobacteriaceae family were correctly identiﬁed
by the direct method (DM). The DM yielded 3 (0.25%) very
major, 6 (0.5%) major, and 34 (2.8%) minor errors for gram-
negative rods and 14 (2.2%) very major, 10 (1.6%) major, and
11(1.7%) minor errors for gram-positive cocci. When we com-
pared categorical agreements for blood culture media with and
without charcoal, no differences were found for gram positive
cocci (94.7% vs 94.4%), but statistical differences (p < 0.05) were
detected for gram negative bacteria (overall errors rate were of
4.3 and 2.2% for blood culture medium with and without
charcoal, respectively).
Conclusion: We found that direct inoculation of microScan
panels provide an acceptable bacterial identiﬁcation and sus-
ceptibility testing, in comparison with standard method, when
gram negatives bacilli were observed by gram-stain of blood
culture, and subculture plates show monomicrobial culture. As
we have detected signiﬁcant differences between culture
medium with or without charcoal, the latest should be avoided
whenever possible. This method improves signiﬁcantly the
turnaround time of blood cultures reports.
P1896
A novel gradient technique for combination
testing: conﬁguration and applications
A. Bolmstro¨m, A. Engelhardt, A˚. Karlsson, P. Vidh (Solna, S)
Objectives: Combination therapy regimens of serious infections
are seldom guided by in vitro testing due to the lack of simple
yet reliable quantitative technique. Currently used methods
such as checkerboard titrations (CT) are non-standardised and
imprecise while kill curves are cumbersome to set up and
interpretations remain arbitrary. A novel gradient technique,
Xact (AB BIODISK) for quantiﬁcation of drug interactions is
described using a trim/sulpha (TR+SU) synergy model and
other drug combinations/applications are also addressed.
Method: Xact consists of a 50 mm or 75 mm square carrier with
a gradient quadrant of two or more test drugs in perpendicular
alignment that gives a predeﬁned concentration pattern with
225 or 484 unique drug ratios. Xact gradients for TR + SU across
0.016–256 and 0.001–2048 lg/mL were compared to CT using 2
E. coli, 1 E. cloacae, 1 S. aureus and 1 S. epidermidis tested in 10
replicates. The carrier was placed onto an inoculated agar
surface and left for 1 hour to transfer the gradient imprint to the
agar after which the carrier was removed. After overnight
incubation, FICIs (Fractional Inhibitory Concentration Indices)
were read where the inhibition isobologram intersected the
predeﬁned FICI grid. Xact was used with other drug/organism
models to evaluate potential applications for yeast, rapid
growing Mycobacteria (RGM) and for bactericidal interactions
by relica-plating of the inhibition isobolograms.
Results: Maximum synergy was seen at MIC:MIC ratios of
TR+SU for all strains with excellent reproducibility of FICIs
(n = 50, SD. of <25% of the mean FICI value at 95% CI. ) and
good agreement with CT. Models for yeast and RGM showed
various interactions with the antifungal and antimycobacterial
Clinical Microbiology and Infection, Volume 11, Supplement 2, 2005
627
combinations studied. Xact could be used to demonstrate
bactericidal interactions using the replica plating method.
Conclusion: The novel gradient technique was equivalent to CT
as assessed with a TR + SU synergy model. It is simple to use to
quantify interactions over a wide range of drug ratios. It could
also be used for yeast and RGM testing and was able to
demonstrate bactericidal interactions. Xact deserves further
investigation as a potential tool for combination testing.
Surveillance of nosocomial infections
P1897
Surveillance of nosocomial infection: extension,
organisation and methods in European countries
and regions
J. Fabry, I. Russell, A. Savey, C. Suetens and the coordinators of the
Surveillance Networks
In the context of European harmonisation of communicable
diseases surveillance, EU countries and Norway were surveyed
to assess the status of surveillance of nosocomial infections (NI)
nationally and/or regionally. The questionnaire was completed
by the network’s coordinators. Twenty-six networks were
created in 17 countries (or regions) between 1992 and 2003,
and were still functioning in September 2004. Six countries
targeted Surgical Site Infections (SSI) only, one infections in ICU
patients only and ten in both. Nineteen networks in 14 countries
use a HELICS-compatible protocol and already contribute to the
HELICS European database. Other countries or regions are
initiating incidence or prevalence pilot surveys, with the
objective of implementing a stable HELICS-associated network.
Usually a national Public Health Institute runs the programme,
sometimes in connection with other bodies. Around 2000
European hospitals participate (usually voluntarily) in a struc-
tured surveillance network, yielding an estimated coverage of
30%. Half of them receive funding from their Ministry of Health,
with 8 receiving additional funding from a health agency,
hospital organisation or from hospitals themselves. The funding
covers expenses of information technology and variable levels of
coordination staff in the networks. Except in Germany, the data
collection in ICU networks is patient-based. Only 6 out of 16 SSI
networks organise post-discharge surveillance (PDS). Surveil-
lance is continuous in a few cases, with others being discon-
tinuous. Data is entered locally in all networks, except in 4
where it is entered at the coordinating centre. Control of data
quality is always performed but with different means and scope.
Surveillance of NI is expanding in Europe and the HELICS
programme has allowed the progressive harmonisation of data.
However, persisting discrepancies should be addressed: (1)
resources required for coordination and data collection should
be deﬁned more precisely, (2) the need for training materials
and exchange of experience between networks, (3) collaborative,
multi-centre research should address the unresolved problems
of PDS and (4) monitoring of the validity of data.
P1898
The HELICS Database Management Software
project: electronic exchange of nosocomial
infection surveillance data across Europe
K. Mertens, M. Behnke, M. Rohland, I. Russell,
C. Suetens (Brussels, B; Berlin, D; Lyon, F)
Objectives: As deﬁned in the HELICS Database Management
Software (HDBMS) project, software was developed to enable
input, analysis and export of Nosocomial Infection (NI) surveil-
lance data at the hospital level and to collect, validate and
prepare data at National Coordinating Centers (NCC), the
HELICS Coordinating Center (HCC) and the Collaborating
Centers (COCs).
Methods: Following the HELICS data-ﬂow organization and
data speciﬁcation rules contained in the Operating Manual and
the ICU and SSI protocols, development relied on a joint effort of
the HCC and COCs in Lyon, Brussels and Berlin. Development
using available IT-resources within COCs will also facilitate
helpdesking for NCCs and future updates.
Results: In support of hospitals participating in HELICS sur-
veillance, the HELICSwin software was developed. This Micro-
soft Access-based application enables manual input of data of
surveillance of ICU-acquired infections and surgical site infec-
tions, as well as analysis and export of data for send-up to the
NCC. A separate module supports the automatic import of
surveillance data from Microsoft Excel format into HELIC-
Swin.In support of NCCs organizing HELICS surveillance,
dedicated STATA-tools were created which enable processing
of incoming HELICSwin export data, the validation and analysis
of these data as well as preparation for send-up to the HCC in
Lyon. In addition, the HELICSval software enables NCCs and
the HCC to control, validate and prepare HELICS data. This
Microsoft .NET based application processes NCC data in ASCII
format to validate – giving detailed feedback if these do not
conform data to speciﬁcations – and convert these to the XML-
format (Extensible Markup Language) for send-up to the HCC.
HELICSval also allows the HCC to append incoming XML data
into a Microsoft SQL Server Relational Database, which was set
up for collected HELICS data to be stored in a secured and
authorized manner, thus constituting the European database of
NI Surveillance data. Furthermore, to guarantee data conﬁden-
tiality and authenticity, the HELICS Data Exchange Speciﬁcation
was set up, describing the procedure of data ﬂow between the
NCC and HCC as well as between the HCC and the COC. The
GnuPG application was chosen for encryption and signature of
data ﬁles to be exchanged.
Conclusion: In guaranteeing HELICS data input, validation,
analysis and exchange at the hospital, network and European
level, the HDBMS will contribute considerably to achieving the
objectives of the HELICS project.
P1899
Surgical site infections in the Helics network:
results from 11 European surveillance networks
C. De Laet, C. Suetens, A. Asensio, C. Brandt, H. Carsauw,
B. Grandbastien, P. Heczko, N. Looker, O. Lyytika¨inen,
E. Smyth, J. Reilly, S. Van Den Hof, J. Wilson, J. Fabry on behalf of
the HELICS network
Objective: Surveillance of surgical site infections (SSI) is a
priority in many countries. However, comparability of results
from different national or regional networks is uncertain. An
objective of the Helics cooperation is to enhance comparability
of SSI surveillance for selected surgical procedures using
uniform data collection protocols.
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Methods: A protocol was agreed between the partners in 2003.
Data collected by the networks from 2000 through 2003 were
translated into this common protocol. Infection rates were
expressed as the proportion of surgical procedures that led to
SSI. In addition, the incidence was expressed as incidence
density: the number of in-hospital SSI per 1000 patient-days
prior to infection. This takes account of the variation in follow-
up period associated with different approaches to, or absence of,
post-discharge surveillance. All incidences were calculated by
surgical procedure and by NNIS risk index group. Compatibility
of data with the protocol and differences between countries
were explored.
Results: Data on surgical procedures (n = 169,575) from Bel-
gium, Finland, France, Germany, the Netherlands, Spain, Poland
and the UK (England, Northern Ireland, Scotland and Wales)
were received. Compatibility with the protocol was high, over
90% for mandatory or required variables (such as components of
the NNIS risk index). Most countries had a high completeness of
data for the components of the basic NNIS risk index (wound
contamination class, ASA classiﬁcation and duration of opera-
tion) while the reporting of endoscopy data was less homogen-
eous. Overall incidence was 6.4 SSI (detected in-hospital) per
1000 patient days for colon surgery, 3.6/1000 for caesarean
section, 2.8/1000 for cholecystectomy, 2.7/1000 for CABG, 1.7/
1000 for hip prosthesis and 0.6/1000 for laminectomy. For most
surgical procedures the SSI incidence increased with increasing
NNIS risk index levels, except for CABG. Inter-country differ-
ences related to variation in the types of procedures undertaken
(e.g. in hip prosthesis), scoring of the NNIS risk factors and the
reporting of superﬁcial SSI’s were observed.
Conclusion It is feasible to pool data on SSI from different
European countries and strict adherence to common protocols
makes comparisons meaningful. The data has also highlighted
interesting differences between countries, however, some of
these are likely to be related to healthcare provision and caution
should be used when comparing results between countries.
P1900
Results from the minimal dataset of the European
surveillance of ICU-acquired infections (HELICS-
ICU), 2000–2004
C. Suetens, A. Savey, I. Morales, P. Gastmeier, E. Gomes da
Silva, M. Palomar, M. Hiesmayr, A. Lepape, J.C. Schmit, S. van
den Hof, C. De Laet, J. Fabry on behalf of the HELICS network
Objective: Data from 8 national or regional networks for ICU-
acquired infection surveillance (Austria, Belgium, Germany,
Spain, France-SE, Luxemburg, The Netherlands and Portugal)
were pooled in order to assess the compatibility with the
HELICS-ICU (HI) protocol (http://helics.univ-lyon1.fr), to ana-
lyze indicators issued by the minimal data set (unit-based ’’level
1’’ surveillance) and to explore inter-country differences.
Methods: Seven patient-based and 1 unit-based (Germany)
surveillance networks contributed data on 243,817 patients,
8479 episodes of ICU-acquired pneumonia (PN) and 4029
bloodstream infection (BSI) episodes from 617 ICUs between
2000 and June 2004. Since the HI protocol excludes patients with
a length of stay (LOS) of <3 days in the ICU, data from Germany
(including patients with LOS of <3 days) were excluded for the
calculation of indicators, but included for the description of
infections.
Results: The overall percentage of non-missing values for
minimal HI data was 88%. Of 82,996 patients staying more
than 2 days in the ICU, 6.8% acquired a PN and 3.1% developed
a BSI in the ICU. The crude incidence was correlated with LOS
in the ICU (Spearman correlation coefﬁcient PN 0.73; BSI 0.74)
and the percentage of intubated patients, a proxy of severity of
case-mix (Spearman PN 0.54; BSI 0.47). The overall incidence
density was 8.4 PN episodes per 1000 patient-days (pd)
(distribution ICUs P25 3.4; P50 7.3; P75 11.9) and 3.9 BSI
episodes/1000 pd (P25 1.9; P50 3.5; P75 6.0). The incidence
density varied from 5.3 PN and 2.6 BSI/1000 pd in ICUs with <
30% intubation to 10.8 PN and 4.7 BSI per 1000 pd in ICUs "d
60% intubation. The most frequently reported micro-organisms
were P. aeruginosa (18%), S. aureus (16%), Candida sp. (8%),
Klebsiella sp. (7%) and Enterobacter sp. (7%) in PN and coagulase-
negative Staphylococci (25%), S. aureus (13%), Enterococcus sp.
(12%), P. aeruginosa (9%) and Candida sp. (8%) in BSI. Prospective
data (2003–2004) showed that the diagnosis of PN was con-
ﬁrmed by quantitative culture in 85% in FR, 62% in ES and 22%
in BE.
Conclusion: Although underlying differences in diagnostic
practices persist, the compatibility with the HI protocol was
already quite high (while further adaptations are made) and
allowed for drawing ﬁrst EU reference ﬁgures. Level 1 HI data
provide sufﬁcient indicators for continuous follow-up of infec-
tion rates within the ICU and limited risk-adjusted inter-ICU
comparisons with a low workload.
P1901
Nosocomial infections survey in a university
hospital: results of the last 5 years
I. Ozgunes, N. Erben, H. Colak, E. Doyuk Kartal, F. Aksit,
B. Senocak, G. Usluer (Eskisehir, TR)
Objectives: Nosocomial infections develop in at least 5% of
patients admitted to hospitals. The ﬁrst aim of surveillance is to
determine endemic rates of infection. In this study nosocomial
infections surveillance results of last 5 years in a university
hospital were evaluated.
Methods: The study was performed using a computer based
surveillance program. 50155 patients were survived from
January 2000 to October 2004. Infection control nurse and
infectious diseases specialist analysed the patients by active
surveillance method. The diagnosis of nosocomial infections
was established according to Center for the Disease Control and
Prevention criteria. The data were collected using a computer
program (NosoLine-Hospital Infections Society of Turkey).
Results: A total of 3226 nosocomial infection episodes were
detected in 5 years period. The rate of nosocomial infections was
detected as 6.07% for 2000, 6.01% for 2001, 8.08% for 2002, 6.86%
for 2003 and 5.84% for 2004 in Osmangazi University Hospital.
The most common nosocomial infections were bacteraemia
(28.74%), surgical site infections (21.95%), urinary tract infec-
tions (21.79%) and respiratory tract infections (13.01%). The
most common microorganisms isolated from nosocomial infec-
tions and their isolation rates for each year respectively were
found as Acinetobacter spp (20.53%, 22.87%, 18.5%, 21.77%,
17.5%), Pseudomonas spp. (21.3%, 16.8%, 11.47%, 11.37%,
12.94%), Staphylococcus aureus (19.75%, 22.22%, 23.72%, 17.99%,
13.21%). Candida spp isolation rates for each year from 2000 to
2004 were found as C. albicans (1.1%, 0.26%, 8.93%, 6%, 10.09%)
and non-albicans Candida spp (1.26%, 0.39%, 3.16%, 5.38%,
6.07%). The most common probable risk factors were found as
transfusion (68%), urinary catheterization (64.9%), vascular
catheters (55.8%) H2 blocker 55.2%, nasogastric tubes 40.4%,
various operation drains (27.8%), and mechanical ventilation
(27.1%).
Conclusion: The surveillance results of nosocomial infections in
our hospital pointing out the most common three bacteria as
well as increasing problem of Candida infections.
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P1902
Prevalence of nosocomial infections in Italy:
results of the INF NOS Project in 2003
G. Ippolito, G. Gesu, L. Giuliani, F. Marchetti, G. Privitera for the
INF NOS Study Group
Introduction: Hospital acquired Infections (HAI) represent an
important cause of morbidity and mortality in patients admitted
to hospitals. Surveillance is the main tool for driving pro-
grammes for the control of HAIs. The INF NOS Project, which
started in 2001, consists of repeated yearly prevalence surveys of
HAIs and associated risk factors in a sample of Italian hospi-
tals.We report here the results for the year 2003.
Methods: Intensive Care Units (ICU), surgical and medical
wards of the participating hospitals were enrolled. All adult
patients present in the participating wards on the day of the
survey were screened for presence of a HAI and/or of risk
factors for HAI. CDC criteria and deﬁnitions of HAI were
adopted.
Results: In October–November 2003, 41 Italian hospitals parti-
cipating in the INF NOS Project surveyed 2813 patients. Male
patients were 53.7%, the mean age was 64.2 years (SD 18 years),
the mean hospital stay was 7.8 days. Co-morbidities were
detected in 73.7% of patients; the most frequently encountered
being cardiovascular diseases (42.1%), cancer (20.6%), chronic
pulmonary diseases (18.6%) and diabetes (15. Invasive proce-
dures were described in 46.1% of patients, 98.4% in ICUs and
23.7% in medical wards. The HAI-associated invasive proce-
dures were surgery (30.9%), urinary catheter (25.6%) or central
venous catheter (12.1%). Overall observed prevalence of HAI
was 6.4% (95% CI 5.1–6.8) involving 5.7% (95% CI 4.8–6.6) of the
patients surveyed. The prevalence of infected patients in ICU,
surgical and medical wards was 43.4% (95%CI 28–42), 2.5%
(95%CI 1.7–3.5) and 4.6% (3.4–5.7), respectively. The most
frequent HAIs detected were pneumonia (22.9%), urinary tract
infections (17.9%) and sepsis (16.8%), Staphylococcus spp (16.3%),
MRSA (10.7%), Pseudomonas aeruginosa (15.7%) and Enterobac-
teriaceae (15.1%) were the main isolated pathogens in HAI.
Conclusions: The INF NOS Project represents a shared tool for
HAI surveillance, allowing comparisons between participating
hospitals. The 2003 INFNOS survey results conﬁrm rates of HAIs
comparable with those of other studies with the exception of a
higher rate of lower respiratory tract infections, the latter result
due to a likely overrepresentation of ICUs in the INFNOS sample.
P1903
The prevalence of hospital-acquired infections in
a Danish county
R.A. Leth, J.K. Møller (Aarhus N, DK)
Objectives: To estimate the prevalence of hospital-acquired
infections (HAI) and the prescription of antibiotics at the
hospitals in the County of Aarhus, and to compare the results
with previous surveys.
Methods: Only patients from departments open seven days a
week were included. The prevalence-survey took place in
September 2003 and comprised 1510 patients. Teams consisting
of a clinical microbiologist and an infection control nurse/
worker visited the departments on a particular day. They
registered for all patients hospital-acquired and community-
acquired infections. Data on antibiotic treatment and microbio-
logical ﬁndings were furthermore registered.
Results: The overall prevalence of HAI in hospitals in Aarhus
Countywas 10.0% and ranged for the variousmedical specialities
from 7 to 28%. The relative distribution of the most frequent HAI
was urinary tract infection (33%), postoperative wound infection
(19%), pneumonia (12%), skin infection (10%), and blood-stream
infection (9%). Blood-stream infection and pneumoniaweremore
prevalent in ICU patients. A total of 456 patients (30.2%) received
antibiotics at the prevalence-day. Antibiotics were given prophy-
lactic in 64 (14%) of the patients receiving antibiotics. The relative
distribution of prescriptions of the various groups of antimicro-
bial agents was penicillins (42%), cephalosporins (17%), metroni-
dazoles (9%), quinolones (8%), aminoglycosides (8%),
sulphonamides/trimethoprim (5%), antimycotics (4%), and gly-
copeptides (2%). Beta-lactam drugs accounted for more than half
the prescriptions of antimicrobial prophylaxis.
Conclusion: The prevalence of HAI in 2003was similar to that of
a previous prevalence-survey in 1999. Fewer infections, however,
were seen in intern medicine and more in abdominal surgery
(almost a doubling of HAI) in 2003.Compared to a prevalence
study in a single hospital in Aarhus County in 1994, the
prevalence of antibiotic prescriptions in that hospital has
increased. The relative use of the various groups of drugs in the
hospital has also changed with a substantial increase in prescrip-
tions of cephalosporins and quinolones and a decrease in use of
sulphonamides and in antimicrobial prophylaxis in general.
P1904
Incidence study of nosocomial infections in ten
intensive care units in Greece
S. Dima, S. Metalidis, P. Nikolaidis, S. Levidiotou, G. Nakos,
A. Karabinis, N. Maguina, F. Klouva, S. Kartali, E. Maltezos,
M. Roubelaki, I. Tselentis, A. Gikas (Athens, Thessaloniki,
Ioannina, Alexandroupolis, Heraklion, GR)
Objectives: To determine the incidence of nosocomial infec-
tions, the device utilization ratios and the device-associated
infection rates in the intensive care unit setting.
Methods: Aprospective study for the surveillance of nosocomial
infections was conducted among ICU patients in seven general
hospitals in Greece. Intensive care units from three hospitals in
Athens, one in Heraklion, one in Thessaloniki, one in Alexand-
roupolis and one in Ioannina participated in the study. Each ICU
was surveilled for a minimum period of six months. Data
collection included patient demographics, site of infection, date
of onset of infection, ventilator, central venous catheter and
urinary catheter use, total length of stay in the ICU and outcome.
Device utilization ratios were deﬁned as the number of device-
days/numberofpatient days. Infection rates are alsopresentedas
incidence densities, by using as a denominator urinary catheter-
ization, central vascular catheterization or ventilation days.
Results: The overall incidence of nosocomial infections was 34/
1000 patient-days. Bloodstream infections were the most
common nosocomial infections (14/1000 patient-days), followed
by pneumonias (11.5/1000 patient-days), urinary tract infections
(4.8/1000 patient-days), surgical site infections (1.5/1000
patient-days) and other sites of infection (2.3/1000 patient-
days). The central line utilization ratio was 0.93, the ventilator
utilization ratio was 0.83 and the urinary catheter utilization
ratio was 0.97. The central line-associated bloodstream infection
rate was 15/1000 central line-days. The ventilator-associated
pneumonia rate was 13.8/1000 ventilator-days and the urinary
catheter-associated UTI rate was 4.9/ 1000 catheter days.
Conclusion: Estimation of site-speciﬁc infection and device
utilization ratios is a useful tool for comparison and improve-
ment of quality within ICU’s. Incidence studies to calculate
infection rates and device utilization ratios in the ICU’s have not
been previously performed in Greece. This study is the ﬁrst
effort to calculate infection and device utilization ratios in ten
ICU’s in our country
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P1905
Hospital infections in a Brazilian neonatal
intensive care unit
S.M. Colares, L.R. Martins, T.C.T. Sukiennik, D.S. Branco, I.G.
Rocha,D.Wiltgen,A.P.Amaral,A.C.Pasqualotto (PortoAlegre, BR)
Objectives: To describe the incidence and etiology of nosoco-
mial infections in the neonatal intensive care unit of Santa Casa
Complexo Hospitalar, Brazil.
Methods: Prospective study conducted during the period com-
prising October 2003–October 2004 in a large Brazilian neonatal
intensive care unit. During this period, active surveillance for
nosocomial infections were performed by infection control
nurses, using the criteria proposed by the Centers for Disease
Control and Prevention (CDC) and National Nosocomial Infec-
tions Surveillance (NNIS) methodology.
Results: During the period of study, a total of 7,774 patient day
were followed by active surveillance. Among those, 655 patients
admitted to the neonatal intensive care unit, 124 developed
nosocomial infections (18.9%). Table 1 shows the topography of
these infections. The etiology of the nosocomial infection was
obtained in 41cases, as shown in table 2.
Conclusions: This study has documented the incidence of
nosocomial infections in a single large Brazilian neonatal inten-
sive care unit, and the main sites and etiologies of nosocomial
infections in these patients. Most of these infections were caused
by gram-positive strains (56.1%), followed by gram-negative
strains (29.3%), and fungi (14,6%). Staphylococcus epidermidis was
the most prevalent organism (51.2%). Since the epidemiology of
nosocomial infections shows large variations in different institu-
tions, it is very important to characterize local epidemiology.
P1906
Nosocomial infections in neurology intensive
care unit of a university hospital
B.Kurtaran,N. Saltoglu,A. Inal, Y. Tasova,A.Ozeren (Adana,TR)
Objectives: To determine the types of nosocomial infections
and the frequency and resistance rates of pathogens isolated
from neurology ICU in a university hospital.
Materials and Methods: Between March 2002 and April 2004,
type of nosocomial infection and risk factors for patients were
determined in neurology ICU patients prospectively. The
identiﬁcation and susceptibility to antibiotics has been per-
formed Vitek 2 as described by the NCCLS.
Results: Ninety-six nosocomial infections were diagnosed in 89
patients. Of the patients 53(60%) were male. Mean age was
59 years. Isolates from ICU patients were recovered from
urinary tract infection 42(47%), primary bacteraemia 25 (28%),
nosocomial pneumonia 11(12.3%), secondary bacteraemia
7(7.9%), decubitus infection 2(3%) and meningitis 1(1.5%). 42
patients with nosocomial urinary infection had 53 episodes. Five
of them were bacteremic. Candidemia was determined in
7(7.9%) of them. Nosocomial urinary infection was the most
frequently observed infection type in neurology ICU. Primary
bacteraemia was the second reason of infection in ICU. 62.5% of
the pathogens were gram-negative, 26.5% were gram-positive
bacteria and 11% were Candida species. The most frequently
isolated gram-negative bacteria was E. coli (24%), followed by
Pseudomonas spp. (18%), Acinetobacter spp. (12.5%) and K.
pneumoniae (17.3%). In nosocomial urinary infections, E. coli
(35.7%), P.aeruginosa (26.7%), Candida spp (14.2%) and
A. baumannii (8.9%) were the most frequently isolated patho-
gens. Coagulase-negative Staphylococci (21.7%) and S. aureus
(34.7%) were the most common pathogens isolated in primary
bacteraemia. The rest of the pathogens were Acinetobacter spp.
(21.7%) and Candida spp (8.6%) Resistance to antimicrobials in E.
coli strains were as follows: ampicillin 94%, quinolone 81%,
piperacillin 81% and cefepime 5%. High resistance rate was
determined in Acinetobacter spp to quinolones (60%) and
aminoglycosides (40%). The most effective antibiotics against
Acinetobacter spp were cefepime (80%) and imipenem (90%).
Resistance to antimicrobials in Pseudomonas spp were as follows:
quinolones (23%), aminoglycosides (23%), ceftazidime (31%),
carbapenems (8%).70% of the S. aureus and CNS strains isolated
in our study were found to be methicillin-resistant.
P1907
Hospital infection surveillance in a neurosurgical
intensive care unit
L. Scorzolini, P. Martino, A.R. Buttiglieri, V. Vullo, M. Vanditti,
G. Rosa, C. Franchi, G. d’Ettorre, G.B. Orsi (Rome, I)
Objectives: Hospital infection surveillance by the infection
control team (ICT) was carried out in the Neurosurgical
intensive care unit (Neurosurgical-ICU) of the teaching hospital
Policlinico Umberto I in Rome.
Methods: Starting from 1.1.2002, all patients admitted in the
Neurosurgical-ICU for ‡48 hours were included in the study.
According to CDC case deﬁnitions we considered the following
site-speciﬁc infections: blood stream infections (BSI), pneumonia
(PNE), urinary tract infections (UTI), surgical site infections (SSI)
and prosthesis infections (PI). Furthermore risk factors (i.e. age,
sex, ASA), invasive procedures (i.e. endotracheal intubation,
Table 1. Topography of nosocomial infection in the ICU of Santa
casa complexo Hospitalar, Brasil
Major speciﬁc site n (%)
Rate of noso comial infections/
1000 patients per day
Bloodstream infection 66 53.2 8.5
Gastrointestinal system infection 14 11.3 1.8
Pneumonia 9 7.3 1.2
Central nervous system infection 8 6.4 1.0
Surgical site infection 7 5.6 0.9
Cardiovascular system infection 5 4.0 0.6
Skin and soft tissue infection 5 4.0 0.6
Lower respiratory tract infection, other than pneumonia 4 3.2 0.5
Eye, ear, nose, throat, or mouth infection 4 3.2 0.5
Urinary tract infection 1 0.8 0.1
Systemic infection 1 0.8 0.1
Total 124 100.0 15.9
Table 2. Etiology of nosocomial infection in the ICU of Santa
casa complexo Hospitalar, Brazil
Organism n (%)
Rate of nosocomial
infections/l000 patient day
Staphylococcus epidermidis 21 51.2 2.6
Candida spp. 6 14.6 0.8
Klebsiella oxytoca 3 7.3 0.4
Klebsiella pneumoniae 4 9.8 0.5
Escherichia coli 2 4.9 0.3
Acinetobacter baumanni 1 2.4 0.1
Enterobacter cloacae 1 2.4 0.1
Enterococcus spp. 1 2.4 0.1
MRSA (Staphylococcus aureus) 1 2.4 0.1
Pseudamonas aeruginosa 1 2.4 0.1
Total 41 100.0 5.3
Number of Pathogens is olated from Neurology ICU
Microorganism Number (percent)
E. coli 20 (%24)
P. aeruginosa 15 (% 18)
A. baumannii 10 (%12.5)
S. aureus 10 (%12.5)
Candia spp. 9 (%11)
Coagulase negative Staphylococcus 6 (%7)
Enterococcus spp 6 (%7)
K. pneumoniae 5 (%6)
S. maltophilia 1 (%1)
Burkholderia cepacia 1 (%1)
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vascular and urinary catheterisation), microbiological isolates
and their antibiotic susceptibility were screened.
Results: An overall of 318 patients (156M and 162F) admitted in
the Neurosurgical-ICU were investigated. The mean age was
53.4 ± 17.6 years (range 1–91), the length of stay in the Neuro-
surgical-ICU 26.1 ± 30.0 days (range 2–284), the ASA score was
2.86 ± 1.47, the Infection Risk Index (IRI) 1.40 ± 0.73. Crude
mortality was 16.4%. Overall, 61 (19.2%) patients developed 111
Neurosurgical-ICU acquired infections, 34 BSI, 34 PNE, 25 UTI,
10 SSI and 8 PI during the study period. The general wound
infection rate was 5.3% (6.1% for craniotomy). Also infection
rates associated to invasive procedures were considered. CVC-
associated BSI rate 7.2/1000, Ventilator-associated PNE rate
(9.0/1000), Urinary catheter-associated UTI rate (4.2/1000).
Wound infection was signiﬁcantly (p < 0.01) associated to
external ventricular drainage. Overall mortality associated
with infection was RR 1.87; 95% CI 1.11–3.14; p < 0.02. During
the study period, we observed a general infection rate decrease
from 19.5% in 2002 to 13.1% in 2004 (particularly SSI). Among
the infected patients, the most common microorganisms isolated
were Pseudomonas spp. (27.6%), Klebsiella spp. (10.2%), E. coli
(7.7%), Candida spp. (12.2%), MRSA (9.0%), CNS-MR (6.4%),
Enterococcus spp. (5.8%) and others (21.1%).
Conclusions: Although the overall wound infection rate was
high (5.3%) and risk associated with external ventricular
drainage (p < 0.01), however the study showed that following
the ICT activity an infection reduction was achieved. On the
contrary, infection rates associated to invasive procedures were
not high. Surprisingly most microorganisms responsible for
infection were Gram( rather than Gram+.
P1908
Which isolates from ICU patients are most likely
to cause nosocomial infections? Data from two
surveillance systems in ICUs: SARI (Surveillance
of antimicrobial use and antimicrobial resistance)
and KISS (German hospital infection
surveillance system)
E. Meyer, F. Schwab, C. Geffers, P. Gastmeier, H. Ru¨den,
F.D. Daschner (Freiburg, Berlin, Hannover, D)
Objectives: To analyze the percentage of pathogens recorded in
the SARI data base that are responsible for causing nosocomial
infections and to analyze whether there are differences between
different pathogens.
Methods: All SARI-ICUs also take part in KISS. KISS prospec-
tively collects data on device-associated primary bloodstream
infections, urinary tract infections, and pneumonia. Up to 4
pathogens can be recorded for each infection. SARI-ICUs collect
data on the 13 most important pathogens responsible for
nosocomial infections. Isolates are non duplicate and are not
differentiated according to whether they have caused infection
or colonisation. The analysis covered the period 02/2000–12/
2003. Data was stratiﬁed by pathogen and type of infection.
Results: From 02/2000–12/2003, 36 ICUs collected data on
448,275 patient days and 41,989 pathogens and reported these to
SARI. In KISS, 4,669 pathogens associated with nosocomial
infection were reported. Approximately, 10% of all the patho-
gens isolated and reported to SARI caused one of the three
commonest nosocomial infections. MRSA was responsible for
10.9%, MSSA for 8.7%, P. aeruginosa for 11.7% and E. cloacae for
14.8% of the infections. S. maltophilia was only responsible for
5.8% of the cases of nosocomial infection, while at 27.4%,
Klebsiella was responsible for the highest infection rate.
Conclusion: Nosocomial infections caused by pathogens isola-
ted from ICUs patients ranged from 5.8% (S. maltophilia) to
27.4% (K. pneumoniae). MRSA was responsible for nosocomial
infections in 10.9% of the cases.
P1909
Epidemiology and outcome of community-
acquired and nosocomial bloodstream infections
at a Veterans Affairs medical centre, San Juan,
Puerto Rico
M. Colon-Candelaria, S. Saavedra, G. Gonzalez, C. Rivera,
J. Gutierrez, D. Vera (San Juan, PR)
Background: Bloodstream infections (BSI) remain an important
cause of morbidity and mortality. The true incidence of
nosocomial BSI is unknown but has been reported as low as
15% and as high as 36% in bone-marrow transplant units.
Overall mortality from BSI is estimated at 22–29%.
Objectives: 1) To prospectively determine the epidemiology
and outcome of BSI at the San Juan VAMC; 2) To determine the
variables most strongly associated to mortality in BSI; and 3) To
recommend strategies for decreasing mortality associated to BSI.
Methods: A prospective review of all BSI is being performed at
the San Juan VAMC. All positive blood culture (B/C) results are
collected on a daily basis. The patient’s charts are reviewed
collecting data prospectively which includes: demographic data,
date of admission, date of B/C collection, date of 1st positive B/
C, clinical conditions such as temperature, blood pressure, WBC
count and presence of central venous catheter. Blood cultures
are followed until ﬁnal organism identiﬁcation. Outcome of
patients with positive B/C results are followed until the patient
is discharged from the hospital, the patient’s death or up to
30 days after the date when the B/C was collected, which ever
occurs ﬁrst. Determinations include: contaminant rate, distribu-
tion of bacteremias (community vs. nosocomial), attack rate,
outcome, crude mortality and attributable mortality. Statistical
analysis will be performed.
Results: A total of 66 episodes of bacteraemia were documented
in 59 patients admitted to the hospital. In 14 of the 59 patients
the bacteraemia was considered as a contaminant and for the
remaining 45 it was considered a true bacteraemia. In the 45
patients with true bacteraemia, 51 episodes were documented
(53% community-acquired and 47% nosocomial). See Table I for
data collected.
Conclusions: In spite of adequate availability of antibiotics, BSI
is still an important cause of morbidity and mortality. MRSA has
become an important etiology in both nosocomial and commu-
nity BSI. Although there is few studies available that review
community-onset BSI, our data demonstrate that this is an
important group with a signiﬁcant associated mortality.
Table 1
Data Result
Mean age 75 years
Contaminant Rate of Cultures 2% (absolute positivity rate 17%)
Community-Acquired BSI 53%
Nosocomial BSI 47% (absolute rate 3.2%)
Most Common Pathogen MRSA Community Acquired
(30%) Nosocomial (38%)
Most common community gram
negative organism
E. coli 22%
2nd most common nosocomial organism K. peumoniae 16%
3rd most common nosocomial organism C. parapsilopsis (12%)
Mean time of bacteremia
(from date of admission)
20.5 days* 75% occurred
at >12 days of admission
Associated to central line 26%
Crude mortality in nosocomial BSI 39%
Crude mortality in community-acquired BSI 21%
Abstracts
632
P1910
Nosocomial infections among earthquake victims
in a backup university hospital after 1999
Marmara earthquake, Turkey
H. Akin, H. Atalay, M. Bicakcigil, D. Tan, N. Bakirci, F. Babacan,
G. Culha, Z. Odabasi, L. Mulazimoglu, V. Korten (Istanbul, TR)
Objectives: To analyze the epidemiology and risk factors for
nosocomial infections in earthquake related trauma patients
after the 1999 Marmara Earthquake.
Methods: Data regarding nosocomial infections and presumed
risk factors were prospectively collected by a form prepared one
day after the earthquake. All isolates were stored at )70C
freezer for further epidemiologic analysis. Pulsed ﬁeld gel
electrophoresis (PFGE) was used for molecular epidemiology of
selected pathogens. Univariate and multivariate analysis were
performed to identify risk factors for nosocomial infections.
Results: From a total of 476 patients referred to our hospital,
128 needed to be hospitalized 3 or more days and were included
in the study. Eighty six (67%) of these patients developed crush
syndrome. Prophylactic or preemptive sulbactam/ampicillin
was given to 96 patients for a median 10 (1–72) days. At least one
nosocomial infection was detected in 52 (41%) of these patients.
The most frequent nosocomial infection was wound infection
(%39), following blood-stream infections (16%), urinary tract
infections (13%), pneumonia (12%), and others (19%). Enterob-
acter spp. was the most frequently isolated microorganism
(24%), following P. aeruginosa (23%), MRSA (15%), C. albicans
(12%), A. baumannii (6%), Enterococci (4%), C. freundii (4%), E. coli
(3%), S. maltophilia (3%) and Clostridium septicum (1%). PFGE
revealed that 4 clones of Enterobacter spp., 3 clones of P.
aeruginosa and 1 clone of E. faecium were responsible for
nosocomial outbreaks and suggests cross-contamination
between patients in different wards. On univariate analysis
crush injury, fasciotomy, amputation, duration of hospitaliza-
tion, duration of antibiotic usage, type of ward and care giving
team, hemodialysis, percentage of crushed body area, time
under rubble were found to be signiﬁcant risk factors for
nosocomial infections. After logistic regression analysis only two
risk factors were identiﬁed: fasciotomy (OR: 3.6, CI95, 1.1–12.0)
and duration of hospitalization (OR: 12.1, CI95, 1.7–85.6). Eight
of 12 deaths were infection related.
Conclusion: Fasciotomy signiﬁcantly increases nosocomial
infections and should be considered carefully. Prophylactic
antibiotic use in earthquake related trauma patients seems to
provide little beneﬁt, but increases superinfections.
P1911
Analysis of risk factors for surgical site infections
in a tertiary care hospital in Turkey
M. Korkmaz, M.A. C¸evik, A. Erbay, N. O¨ztoprak, E. Akinci,
N. Balaban, H. Bodur (Ankara, TR)
Objectives: To identify the risk factors for the development of
surgical site infections (SSI).
Methods: Prospective surveillance was conducted. Patients,
whom underwent surgery between May–Oct 2003 were inclu-
ded in the study and evaluated before the surgery and followed
30 days after surgery for the development of SSI. SSI was
deﬁned according to CDC criteria. Potential risk factors were
analysed by univariate and multivariate analysis.
Results: 245 patients were followed during study period. Mean
age was 49.6 and 153 (62.4%) were female. SSI developed in 44
(18%) of them. After the surgery, SSI developed at an average of
8.6th day. 32% of the infections were diagnosed after discharge.
Of the SSI, 50% were superﬁcial, 40.9% involved an organ or
space and 9.1% were deep. According to operation classiﬁcation,
the incidence of SSI was 6.3% in clean, 28% in clean-contamin-
ated, 38.4% in contaminated and 53.3% in dirty. Antibiotic
prophylaxis was given to 83.2% of the patients. The most
commonly used antibiotic was cefazoline (75%). Procedures
involving colon, small bowel and rectosigmoid were associated
with higher rates of SSI (36.4%). A positive culture was obtained
from 22 patients. Escherichia coliwas the most frequently isolated
microorganism (39.1%), followed by Pseudomonas aeruginosa
(19.6%) and methicilline resistant Staphylococcus aureus (13%).
Of the 22 positive cultures, 9 (40.9%) were polymicrobial. Factors
associated with SSI found by univariate analysis (p < 0.05)
included; age, diabetes mellitus, preoperative infection, emer-
gent surgery, prophylactic antibiotic use more than 24 hours
before the operation, longer duration of antibiotic prophylaxis,
preoperative longer hospital stay, wound classiﬁcation, ASA
(American Society of Anestiology) score, NNIS (National
Nosocomial Infections Surveillance) risk index, transfusion of
blood and blood products, total parenteral nutrition, >2
comorbidity, hyperglycemia, anemia, number and duration of
surgical drains and type of surgery. Logistic regression analysis
showed that preoperative high blood glucose levels (OR 2.68;
95% CI 1.4–5.1, p = 0.003), wound classiﬁcation (OR 2.04; 95% CI
1.3–3.1, p = 0.002) and duration of surgical drain (OR 1.17; 95%
CI 1.1–1.3, p = 0.0001) were the most signiﬁcant predictors of
SSI.
Conclusion: SSI infection rate was high. Poor control of diabe-
tes mellitus before surgery, dirty wound operations and pro-
longed duration of surgical drains signiﬁcantly increased the
rate of SSI.
P1912
The effect of performance feedback on wound
infection rate in abdominal hysterectomy
J.F. Garcı´a Rodrı´guez, E. Canedo, M.V. Lorenzo, A. Rivera,
M.J. Carballo, C. Parada, J. Ferro, J. Martı´nez Pe´rez-Mendan˜a
(Ferrol, E)
Objective: To ascertain the effect of an infection control
program, using performance feedback, on wound infection
(WI) rate in abdominal hysterectomy.
Methods: All patients with abdominal hysterectomy attended
in our Centre between 1999 and 2003 were prospectively
followed for 1 month after operation to know WI rate. CDC
deﬁnitions were used. A complete set of tests including age,
underlying illnesses, cancer, diabetes mellitus, immunosuppres-
sion therapy, albumin, ASA risk, inpatient preoperative stay,
date of intervention, hygiene and preoperative antimicrobial
prophylaxis, type of surgical operation, duration of surgery,
surgeon, WI, were collected in each case. After data collection
for 1999 concluded, we communicated every year surgical WI
rates to surgeons (service and surgeon-speciﬁc). A logistic-
regression analysis was performed to compare the WI rates with
the observed in 1999.
Results: We recruited 831 females. Mean age, 50.6 ± 10.7 years,
range 22–90.25% patients were cancer cases, 5.3% diabetes
mellitus, 0.5% immunosuppression therapy, 26.8% ASA 1, 57.5%
ASA 2, 14.4% ASA 3 and 1.2% ASA 4. In 7 (0.8%) patients
surgery was done urgently and in 824 programmed, 724 in the
morning and 100 in the afternoon. There were no differences
between the years of study in the surgery with urgency, and in
the frequency of risk ASA 3 and 4; the surgery in the afternoon
was more frequent in the years 2000 (23.9%) and 2001 (19.1%)
than in 1999 (12%), 2002 (6.9%) and no patient in 2003. The mean
of days of preoperative stay was 2.6 ± 3.05, range 1–28. The
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types of surgical operations were total abdominal hysterectomy
752 (90.5%), subtotal hysterectomy 53 (6.4%) and Wertheim in 26
(3.1%). In the multivariate model the factors associated with
surgical WI were albumin (OR 0.97; IC 95%: 0.94–0.99) and the
antimicrobial prophylaxis (OR 0.13; IC 95%: 0.04–0.43). The
mean values of albumin and the number of patients with
perioperative antimicrobial prophylaxis ﬂuctuated between
years. The surgical wound infection rate improved from 10.7%
(IC95% 5.8–15.6) in the year 1999 as far as 6.6% (–38.3%) in 2003.
Conclusions: The effect of performance feedback to individual
surgeons can reduce the infection rates of surgical wound
infection.
Environmental impact on nosocomial infections
P1913
Water inﬁltration and fungal contamination: an
environmental and mycological investigation
H. Kennedy, C. Williams (Glasgow, UK)
Background: A wide variety of ﬁlamentous fungi may cause
disease in compromised individuals. However, as fungal spores
are ubiquitous, they may also contaminate laboratory cultures.
A scanty growth of Myriodontium sp. was observed on several
culture plates inoculated with specimens of sputum from
different patients in Yorkhill Hospital, Glasgow. All of the
specimens had been processed in the C L 3 laboratory. Although
it was agreed that this mould was a probable contaminant, its
continuing presence was a cause for concern.
Objectives: To identify the source of fungal contamination, take
remedial action and eradicate the contamination.
Methods: (i) One-hour settle plates containing Sabouraud
dextrose agar were placed at several sites within the C L 3
laboratory and in the corridor directly outside. (ii) A visual
inspection of the laboratory was performed. (iii) Swabs were
taken of the probable source of contamination (identiﬁed by (ii)).
Results: Myriodontium sp. was detected on all settle plates
except those placed in the corridor outside the laboratory. Very
few other moulds were evident. From site to site within the
laboratory there was a gradient in counts of Myriodontium sp.
with a 4-fold increase between the door area and the bench in
front of the window. Counts of Myriodontium sp. on the settle
plates in the safety cabinet exceeded those at all sites except the
window area (a distance of 1 metre away). The visual inspection
revealed a brown/black, moist area (85 · 15 cm) on a wooden
ledge below the window. (This area was not readily visible as it
lay behind a vertical timber support at the back of a bench.) A
faint narrow line running down the adjacent wall indicated
water penetration from above. Further investigation revealed
that a leak in the roof was permitting slow but frequent
penetration of rainwater into the laboratory. Swabs from the
brown/black deposit yielded a heavy growth of Myriodontium
sp. with a light growth of Trichoderma sp. and Aspergillus niger.
Remedial action was taken in the laboratory and on the roof.
Conclusions: Inﬁltration of water into the C L 3 laboratory
permitted fungal growth in a warm, moist environment. Spores
drawn into the safety cabinet under negative pressure probably
contaminated plates as they were being inoculated.
P1914
An attempt to detect the trace of faecal materials
in drinking water of dairy farms around Tehran,
Iran
M.J. Panahandeh (Tehran, IR)
Objectives: Ther has been numerous reports of outbreaks of
water born diseases in humans and farm animals throughout
the world even from developed countries.This phenomenon
demonstrates that transmission of pathogens by drinking water
remains a signiﬁcant cause of illness.
Materials: Water samples of reservoir tanks which received
water from deep wells were taken from 28 dairy farms around
Tehran-Iran. To distinguish total count and water pollution
samples were cultivated on Agar blood and MacConkeys media.
Positive samples to enterobacteriace were followed by bio-
chemical tests.
Results: Total counts were reported from 20 to 1200 bacteria per
milliliter.18(64%),16(57%), 14(50%) 6(21%), 5(17%), and 1(3.5%)
out of 28 samples were positive to E. Coli, Aerobacter aeroginosa,
E. coli+A.aeroginosa, Salmonella typhimurium, E.Coli+A. Aeroginos-
a+S. typhimurium and Shigella dysentria as well as E. Coli+
A. Aeroginosa+S. dysentria respectively.
Discussion: Presence of coliform group specially E. Coli is used
to determine water fecal contamination. According to this study
most of reservoir tanks(64%) of water in dairy farms around
Tehran have been polluted with human or animal fecal
materials.Existence of Salmonella typhimurium approved contam-
ination of water with animal feces but the risk of pollution with
human fecal matters still exists because of pollution with E. coli
and Aerobacter aeroginosa in 14 samples synchronously. Only in
one sample pollution with human feces was approved certainly
because of Shigella dysentria. Therefore treatment of drinking
water of dairy farms in this area to stop the risk of water born
diseases is a must.
P1915
Microbial contamination in dental unit
waterlines
D. Go¨ksay, A. Cotuk, Z. Zeybek (Istanbul, TR)
Objectives: The dental unit waterline (DUWL) provides an
ideal environment for microbial colonization and proliferation
primarily due to the high surface/volume ratio in the tubing
and the character of ﬂuid dynamics in narrow, smooth-walled
waterlines. It is known that DUWLs are contaminated by
numerous species of microorganism. Two case reports are
described where medically compromised patients have been
infected with Pseudomonas aeruginosa originating from DUWL.
A single fatal case of L. dumofﬁi pneumonia has been reported in
a Californian dentist exposed to contaminated water from his
practise. The aims of our study were to investigate microbial
contamination of DUWLs in Turkey and to warn dentists to
check their dental units (DUs) for public health care.
Methods: Water samples were collected from 12 private dental
ofﬁces. These samples were taken from air-water syringes, high-
speed handpiece, oral rinsing cup and reservoir. R2A Agar was
used for Total Viable Counts(TVC), Sabouraud Dextrose Agar
was used for fungus, Buffered Charcoal Yeast Extract Agar was
1999 2000 2001 2002 2003
Albumin 3.35 ± 1.4 3.64 ± 0.9 3.60 ± 0.7 3.86 ± 0.3 3.88 ± 0.3
Prophylaxis 53/150 (35.3%) 41/163 (25.2%) 62/162 (38.3%) 33/173 (19.1%) 53/183 (29%)
W. Infection 16/150 (10.7%) 14/163 (8.6%) 8/162 (4.9%) 17/173 (9.8%) 12/183 (6.6%)
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used for Legionella. Gram negative strains were identiﬁed by
API20E, API20NE systems.
Results: We found that most of units exceed American Dental
Association recommendation (Anonymous 1996) for DU water
quality (range 200–50000 CFU/ml). In 12 units studied, TVCs
were higher in the high-speed handpiece(91.6%) than the air-
water syringe(8.3%). Microorganisms isolated from DU: Pseudo-
monas ﬂuorescens, Moraxella spp, Photobacterium damsela, Ochro-
bacterium anthropi, Pasteurella haemolytica. Fungus were identiﬁed
as Aspergillus ﬂavus, Penicillium expansum. All water samples
were negative for Legionella sp.
Conclusion: Numerous studies showed that DUWLs contain
high densities of bacteria, mainly Gram negative, aerobic,
heterotrophic bacterial species many of which have been
implicated in human infection. We suggested that microbial
contamination in DUs should be controlled to eliminate oppor-
tunistic pathogens and to provide water for dental treatment
which meets public health standarts for ADA recommendation.
P1916
Antibiotic resistance of bacterial strains isolated
from water samples and ﬁsh
G. Zakas, C. Papadopoulou, S. Levidiotou, H. Gessouli,
C. Salamoura, C. Dontorou, I. Apostolou, E. Economou,
G. Filioussis (Ioannina, GR)
Objectives: The presence of resistant bacterial strains in surface
fresh and marine waters, in drinking waters and edible cultured
and free-catch fresh water and marine ﬁsh was investigated in
order to assess potential risks for public health.
Methods: A total of 1580 samples (240 from drinking water, 50
from lakewater, 400 from riverwater, 450 frommarinewater, 230
from free catch and 210 from cultured ﬁsh) were collected during
a 4 year survey (2000–2003) from different point sources in the
region of Northwestern Greece. All samples were processed
following standard microbiological methods and susceptibility
tests to antibiotics used in the routine medical practice were
performed, using the disk diffusion and the MIC test (E-test).
Results: There were isolated 104 E. coli strains, 147 S. aureus, 106
E. faecalis, 55 E. faecium and 207 Pseudomonas spp. The strains from
cultured ﬁsh exhibited remarkable multiresistance: 64.3% of
E. coli strains from cultured ﬁsh were resistant to Ampiciline,
35.7% to Cefuroxime and 7.14% to Ceftazidime and Ciproﬂoxa-
cine. On the contrary, only 5% of the strains from free-catch ﬁsh
were resistant toCeftazidimeand37.33%of theE. coli isolates from
water samples were resistant to Ampiciline. None of the S. aureus
strains isolated during this survey was resistant to Vancomycine
andTeicoplanine.Themost commonly isolatedEnterococci species
were E. faecalis (66.6%) and E. faecium (33.3%). However, there
were no Vancomycin resistant Enterococcus spp., but there were
isolated E. faecium strains resistant to Ampicillin (7%).
Conclusion: The presence of resistant bacterial strains in the
aquatic environment and in the food chain originating from the
aquatic environment is an important health issue and the
potential impact on public health has to be addressed in relation
to food safety concerns.
P1917
Pattern of extended-spectrum beta-lactamase
producers in coastal seawater of Northern
Portugal after a four-year period
J. Rocha, H. Ferreira (Porto, P)
Objectives: Access the presence of extended-spectrum beta-
lactamase (ESBL) producers, in coastal seawater of Oporto
urban area in 2004 and compare with those obtained in 2000.
Methods: Coastal seawater samples were collected monthly,
between February and July 2004. Isolates were selected by
membrane ﬁltration technique and the ﬁlters were placed on
Mac Conkey agar and Mac Conkey agar with ceftazidime
(5 mg/l) or cefotaxime (2 mg/l). Colonies of lactose fermenters
were randomly selected and screened for ESBL production by
the double disc synergy test. Identiﬁcation of the selected strains
was achieved by classic biochemical tools and ID 32 GN.
Susceptibility to antimicrobial agents was determined according
to the NCCLS guidelines. Beta-lactamases were characterized by
isoelectric focusing.
Results: ESBL producers were found in marine coastal waters
of Oporto urban area over the mentioned period of time, in 2004.
Actual work, shows a pattern of different types of ESBL and
different associations of beta-lactamases, by opposition to the
clonal characteristic of ESBL-producing E. coli isolates in 2000.
Conclusion: The presence of isolates showing different ESBL
and different beta-lactamases association patterns, as expected,
in sea coastal water in different dates, seems to indicate distinct
epidemiological relationships associated to a persistent, incom-
ing of ESBL producers to the natural environment, providing a
track for environmental dissemination of resistant bacteria and
genes, that may create a source of transferable traits for
emerging pathogens, via natural reservoirs of resistance, rele-
vant in terms of public health and environmental protection.
P1918
Antibiotics in the aquatic and terrestrial
environment – Is there a problem?
R. Alexy, K. Ku¨mmerer (Freiburg, D)
Introduction: In most cases, antibiotics are excreted in unme-
tabolized form and are then discharged into hospital efﬂuent or
municipal sewage water. Unused drugs and remainders thereof
are sometimes disposed of down drains. The drugs and their
metabolites that are not eliminated in the sewage treatment
plant (STP) pass through it and enter the aquatic environment,
where if they are not eliminated or (bio)degraded they may
eventually enter drinking water. If they are eliminated by
sorption onto STP sewage sludge which is later used as a
fertiliser they may later reach soil. Antibiotics may also end up
in soil when they are used as growth promoters in animal
husbandry. The antibiotics may disturb microbial activity in
sewage treatment processes and soils and affect biodegradation
of contaminants and natural organic matter. Furthermore,
resistant bacteria may be selected in the aeration tank of
sewage treatment plants and in soils, and eventually reach
humans via drinking water or the food chain.
Methods: In this study antibiotic input into municipal sewage
was estimated and its concentration analysed. The biodegrad-
ability of some clinically important antibiotics and their effects
against environmental bacteria were examined.
Results: The concentration of antibiotics in hospital efﬂuent
was calculated as being as high as 300 lg/L for single com-
pounds, and in total approximately 40 lg/L in municipal
sewage. As much as 120 lg/L have been analysed for single
compounds in hospital efﬂuent. The biodegradability of most
compounds investigated was very low. Some compounds such
as ciproﬂoxacin sorbed strongly onto sewage sludge. Concen-
trations calculated for hospital efﬂuents and the MICs for
sensitive bacteria were in the same order of magnitude. The
genotoxicity of some compounds was not eliminated.
Conclusion: It can be concluded that the input of antibiotics
into the aquatic environment should be reduced. In general, the
environmental signiﬁcance of therapeutic drugs should be
included in the curricula of doctors and pharmacists.
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P1919
A change in cleaning can reduce environmental
bacterial contamination
K.J. Hardy, B.A. Oppenheim, F. Gao,
P.M. Hawkey (Birmingham, UK)
Objectives: To determine the levels of total bacterial and
methicillin resistant Staphylococcus aureus (MRSA) environmen-
tal contamination of an Intensive Care Unit (ICU), and to
evaluate the effect of measures introduced to reduce the
bacterial burden.
Methods: The counts of MRSA and total bacteria were deter-
mined before and after cleaning on an ICU on 6 occasions. On
each screen 4 samples were taken from each of the bed spaces
(under the bed, the workstation, a ledge behind the bed space
and the monitor) and MRSA detected using broth enrichment.
Total bacterial counts were determined for under the bed and
workstation using RODAC plates. Evaluation of the results
demonstrated that cleaning was not effective, therefore a change
in the cleaning product and positioning of the product within
the bed space was implemented. The environment was sampled
before and after cleaning as above on a further 11 occasions to
determine the effect.
Results: The six evaluations of the cleaning regime which was
in place showed higher levels of environmental contamination
with MRSA after cleaning on 3 (50%) occasions. When a change
in cleaning was implemented higher levels of MRSA after
cleaning were only found on 1 (9%) occasion. Before a change in
cleaning total bacterial counts were higher under beds after
cleaning on 42.6% (20/47) occasions and on the workstations on
53.1% (25/47) occasions. After a change in cleaning protocol
these rates fell to 27.7% (23/83) and 31.3% (26/83) for under the
bed and workstation respectively. In addition not only was a
change in the total bacterial counts after cleaning observed, but
the overall counts were lower for both under the bed and
workstation.
Conclusions: The cleaning on ICU was shown to be ineffective
in removal of bacterial contamination. A change in cleaning
protocol resulted in an increased effectiveness of cleaning,
thereby lowering the total bacterial burden and decreasing the
opportunities for transmission to patients.
P1920
Hygienic quality of some infant formula milk
C. Voidarou, P. Apostolidis, I. Skoufos, D. Vassos,
A. Alexopoulos, E. Bezirtzoglou (Orestiada, Athens, Arta, GR)
Objectives: During the last years research has been focused to
improve the quality of infant formula milk by adding substances
beneﬁcial to the infant health, such as nucleotides, calcium, and
vitamins. Addition of such substances in infant milk seems to
promote a beneﬁcial intestinal microﬂora to newborns by
lowering the buffering capacity of the milk. This last condition
allows maintenance of a low pH, which inhibits the develop-
ment of anaerobic putrefactive bacteria and enables the prolif-
eration of a beneﬁcial microﬂora.
Methods: Two types of infant formula milk were examined in
our study (1) Pediasure (Abbot Lab) supplemented milk with
calcium, phosphorus, vitamin D and iron and (2) Similac
Advance (Abbott Lab) supplemented with nucleotides. Milk
powder was homogenized in peptone water, followed by
decimal dilutions in Ringer’s solution. From each decimal
dilution were plated 5 different solid agar media, such as
Plate count agar, Chapman agar, Mac Conkey agar, Columbia
agar, Blood Columbia agar. Furthermore, the new selective
medium LS (Lactose-sulﬁte) broth was used for detection of
C. perfringens. This medium permits the speciﬁc estimation of
C. perfringens at 101. An aliquot of the Ringer’s solution was
heated for 10 mn at 800C before seeding to a plate for
recovering of the germinated spore-forms. A total of 50 milks
were been studied from each milk powder.
Results: The main advantage of LS medium is the extremely
low level of C.perfringens detection (101). It is important to
mention here that the usual agar cultures media detect from
102 CFU. In the Pediasure powder, Bacillus sp were found in one
milk (0.5 %) and spores of C. perfringens in 2 (1%), but always in
extremely low levels, because the usual detection level of these
bacteria associated with foodborne disease is reported to 105
microbial cells at least. Concerning the Similac Advance powder
milk enriched with nucleotides, just in one case (0.5%) spores
C. perfringens were found at 101. All isolated strains, were
examined for their antimicrobial activity. Both germs showed
resistance to vancomycin, ceftiofur, ampicillin, penicillin, neo-
mycin, tetracycline, cephalexin, amoxicillin. Furthermore, C. perf-
ringens,was resistant to gentamycin and sulphamethoxazol .
Conclusion: Checking of the microbiogical and hygienic quality
of infant formula milk must be done in order to have an estimate
of the sources involved in the chain contamination and protect
the ﬁnal quality of the product.
Tuberculosis: clinical aspects and surveillance
P1921
Activity of mycobacteriological laboratories in
the Slovak Republic in 2003
L. Langsadl Bratislava, SVK
Objectives: One part of TB surveillance in the Slovak republic is
report about activity of mycobacteriological laboratories.
Methods: All 17 mycobacteriological laboratories in the Slovak
republic received questionnaire containing 19 tables. Natl.
reference laboratory carried out data processing with using
Excel and Epi–Info 2002 programmes
Results: Mycobacterial laboratories in the Slovak republic
investigated 125990 biological samples and carried out 125
897 examinations in 2003. Mycobacterial strains were isolated
from 2150 examinations (1.71% positive examinations). Sputum
was the most frequent biological sample. From 95,301 samples
of sputum were isolated 1899 strains of Mycobacterium tuber-
culosis/ 1.99% positive samples/ in 2003. The strains were
isolated from 534 patients. The prevalence of Mycobacterium
tuberculosis in inhabitants of the Slovak republic was 9.92 in
2003. Multiresistant M. tuberculosis strains were isolated from
60 patients .
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P1922
Distinctiveness of Mycobacterium abscessus
genotypes from cystic ﬁbrosis patients
B. Ko¨nig, I. Tammer, W. Ko¨nig (Magdeburg, D)
Objectives: An increasing prevalence of non-tuberculous My-
cobacteria (NTM) colonisation among patients with Cystic
Fibrosis (CF) is observed. Mainly due to the misidentiﬁcation
of M. abscessus its role for the clinical outcome in CF is not yet
clear. Our purpose was to analyze the sputum samples from CF
patients from 2001 to 2004 for the presence ofM. abscessus and to
determine their intra- and interpatient genetic heterogeneity.
Methods: Genomic DNA was prepared from all isolates and for
identiﬁcation the samples were processed for sequencing the
hsp65 gene and the 16S–23S intergenic gene sequence (ITS); for
analysis of their genetic heterogeneity we performed RAPD-
PCR and ﬂuorescent ampliﬁed fragment length polymorphism
(fAFLP) analysis. RAPD-PCR was performed with four different
primer constellations and for fAFLP analysis we used two
enzyme combinations and four selective ampliﬁcation primer
pairs.
Results: We screened 1700 sputum samples and identiﬁed 46
M. abscessus isolates from a total of 7 CF patients. We detected
two different hsp65 and correspondingly two ITS sequence
variants belonging to M. abscessus type I and type II; there were
no intrapatient sequence variabilities within the individual
sequevars. With regard to the RAPD pattern we detected ﬁve
main M. abscessus types among the patients. Two patients
harboured two differentM. abscessus strains over the time period
under study. Four of the RAPD clusters showed identical AFLP
patterns also, but one could be resolved in subcluster by AFLP.
Conclusion: Our results show that CF patients may be colon-
ized/infected by different M. abscessus strains, over a long time
period as well as at the same time point. These ﬁndings are
important for the characterization of the species and for future
analysis to understand the pathogenicity and epidemiology of
this organism.
P1923
Polyclonal infection by Mycobacterium kansasii
A. Gaafar, M.J. Unzaga, M.V. Leal, I. Gerediaga, A.B. Lopez,
C. Ezpeleta, R. Cisterna (Bilbao, E)
Objectives: The aim of this work is to trace changes in the
genotyping patterns of Mycobacterium kansasii isolates under the
stress of antituberculous chemotherapy.
Methods: 46 isolates from 20 patients (2–4 isolates per patients,
isolated at different times during the course of treatment) have
been genotyped by three typing methods: PCR-RFLP of the
hsp65 gene, RAPD-PCR using two primers, and AFLP using
three different selective primers.
Results: According hsp65 PCR-RFLP genotyping all strains
belonged to type I Mycobacterium kansasii. All multiple isolates
from the same patients generated the same patterns by RAPD-
PCR and AFLP typing methods except isolates from 2 patients
(patients Bas 071 and Sma 002). The patient Bas 071 was a HIV
positive, 30 years old male. Four strains were isolated from
pulmonary specimens. The ﬁrst two strains were isolated in
January and February 2000 respectively. After 7 months of
treatment, the other two strains were isolated in August and
November of the same year. The ﬁrst 2 strains generated the
pattern B1 by RAPD analysis and the pattern 111 by AFLP
analysis, while the other two strains generated the pattern A1 by
RAPD and the pattern 122 by AFLP.The patient Sma 002 was a
55 years old female living in Bilbao. Three strains were isolated
from pulmonary samples in October 1999, Jun 2000, and August
2000 respectively. The ﬁrst isolate generated the pattern B1 by
RAPD analysis and the pattern 111 by AFLP analysis. The
second and third strains generated the pattern A1 by RAPD and
the pattern 122 by AFLP.
Conclusions: It was curious that in both patients, and nearly
after 7 months of initiating treatment, the isolated M. kansasii
shifted from the cluster 111-B1 to the cluster 122-A1. These
results were conﬁrmed by 2 different isolates at 7 and 9 months
of starting treatment. This change affected both AFLP and
RAPD patterns. This observation may be due to exposure of
these patients to a polyclonal infection from an environmental
source, and due to some differences in the sensibility to
antituberculous therapy; one subspecies was selected under
the effect of chemotherapy, while the other was eradicated.
P1924
Emerging epidemiological features of
tuberculosis in Italy, and public health-related
concerns
R. Manfredi, S. Sabbatani, G. Legnani, F. Chiodo (Bologna, I)
Introduction: Tuberculosis (T) is borne by increasing morbid-
ity-mortality rates in industrialized and developing countries.
Changes in epidemiology patterns, atypical manifestations, and
spread of chemotherapy-resistant strains, are of concern. The
modiﬁcation of predisposing factors is altering T epidemiology
and presentation: the HIV pandemic, advancing age and
concurrent illnesses, increasing immunodeﬁciency, alcoholism
and drug abuse, and especially immigration.
Methods and Results: An analysis of patients (p) hospitalized
from 1996 allowed us to identify 90 p with conﬁrmed T. These 90
episodes were assessed to compare the features of Italian vs
extra-Western Europe p with T. Signiﬁcant differences were
found among the 62 Italian p, and the 28 p coming from abroad
(50% from northern Africa). Compared with foreigners, Italian p
had a greater median age (51.7 vs 29.9 years; p < 0.001) and
more frequent and varied underlying disorders (prior diagnosis-
familial history of T, chronic pulmonary, heart, liver, or kidney
disease, diabetes, malignancies, and collagen vascular diseases;
p < 0.05), a higher incidence of HIV/AIDS (31.1% of Italian
cases; p < 0.001), with a predominant pleuropulmonary locali-
zation compared with lymph node and/or disseminated ones
among HIV-infected p vs non-HIV-infected p (p < 0.01).
Immigrants had more frequent generic risk factors (low
income, social-economic problems, cigarette smoke, and drug-
alcohol use; p < 0.05 vs Italian patients). No appreciable
difference was found as to lung radiological ﬁndings, when
excluding HIV-infected p.
Discussion: Two different T patterns may be observed in our
area. While immigrants are represented by young, otherwise
healthy p with predominant lung localization, Italian p are
mostly represented by elderly, with underlying diseases and
speciﬁc risk factors for T, a more frequent HIV co-infection (and
a more common extrapulmonary disease). The epidemiologic-
clinical features reﬂect a distinct proﬁle between immigrants
and Italians, but we cannot exclude that the signiﬁcant spread of
T, the continued immigration, and growing predisposing con-
ditions in the general population, may lead to a further increase
of diagnoses. Surveillance and preventive strategies of control of
T need an update, to avoid the spread of T, due to the merging
of risk factors of immigrants and supporting risks of the natives,
which is expected to prompt a health care emergency in inner
cities, where integration of immigrants meets a vulnerable
native population.
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P1925
The phenomenon of emerging tuberculosis in
Italy. Which role for concurrent HIV infection?
R. Manfredi, S. Sabbatani, F. Chiodo (Bologna, I)
Introduction: Tuberculosis (T) is borne by increasing morbid-
ity-mortality rates, due to changes in its epidemiology, presen-
tation, and spread of drug-resistant strains. The recent variation
of predisposing factors (advancing age, concomitant illnesses,
alcoholism and drug abuse, immigration from endemic regions,
and HIV disease), play a signiﬁcant role.
Methods and Results: Among 98 consecutive patients (p) with
conﬁrmed T hospitalized since 1996, signiﬁcant differences were
found between the 63 Italian p, and the 35 p coming from outside
of Western Europe. When compared with foreigners, Italian p
had a higher frequency of HIV/AIDS (31.7% of Italian cases;
p < 0.001),with a predominant pleuropulmonary involvement vs
with lymph node and/or disseminated one among HIV-infected
p vs non-HIV-infected ones (p < 0.01). Compared with foreign-
ers, Italians showed a higher median age (p < 0.001), and more
frequent and varied underlying disorders (personal-familial
history of T, chronic pulmonary, heart, liver, or kidney disease,
diabetes mellitus, malignancies, and collagen vascular disease
treatedwih steroids; p < 0.05), while immigrants had generic risk
factors (low income, social-economic problems, cigarette smoke,
and drug-alcohol use; p < 0.05 vs Italians). Our 8-year experience
shows that 2 different patterns of Tmay be observed. Italian p are
mostly represented by the elderly, with underlying diseases and
speciﬁc risk factors for T, a more frequent HIV co-infection (and a
more common involvement of sites other than pulmonary ones),
while immigrants are represented by young, otherwise healthy p
with predominant lung disease.
Discussion: Physician awareness of T needs improvement,
especially when high-risk p are of concern (like HIV-infected
p), to ensure a rapid diagnosis and cure, and reduce T spread.
The epidemiologic-clinical features of our T p show a signiﬁ-
cantly different pattern between Italians and immigrant, but we
cannot exclude that the spread of T, the continued immigration,
and growing predisposing conditions in the general population
may lead to a further increase of diagnoses especially towards
extreme life ages. Surveillance and preventive strategies of
screening, diagnosis, therapy, and control of T need a continu-
ous monitoring, to avoid further T spread, due to the merging of
risk factors of immigrants, which is expected to represent a
health care threaten in inner cities, where the progressive
integration of immigrants may meet exposed and vulnerable
natives, including elderly and HIV-infected p.
P1926
AIDS-associated Mycobacterium kansasii
infection: a thirteen-year follow-up of
microbiological and clinical features
R. Manfredi, L. Calza, F. Chiodo (Bologna, I)
Introduction and objective: A prompt and effective diagnosis
and a timely and appropriate treatment of atypical mycobacte-
riosis (especially Mycobacterium kansasii disease), remains a
serious challenge for clinicians engaged in the management of
the immunocompromised host, including HIV disease.
Methods and Results: Fifteen HIV-infected patients with a
microbiologically-conﬁrmed Mycobacterium kansasii infection
have been observed in a 13-year period, out of over 3200
hospitalizations performed because of HIV-associated disorders.
These episodes were carefully assessed from an epidemiologi-
cal, bacteriological, clinical, and therapeutic point of view. The
proportionally reduced crude frequency of atypical mycobacte-
riosis as HIV-related complication, which virtually disappeared
after the introduction of potent antiretroviral combinations
(highly active antiretroviral therapy, HAART) in the year 1996,
proves evident, since only three cases were registered since
1997. In early nineties, the lack of effective antiretroviral
regimens made frequent the association of this opportunism
with full-blown AIDS, a mean CD4+ lymphocyte count of nearly
20 cells/lL, and extremely variable chest X-ray features. The
recent detection of three further episodes of pulmonary M. kans-
asii infection was due to a late recognition of a far advanced HIV
disease (the so-called AIDS presenters), complicated by mul-
tiple opportunistic disorders. All isolated M. kansasii strains
tested resistant to cycloserine and streptomycin, while ethion-
amide-resistance regarded 11 strains of 13; a favourable suscep-
tibility pattern was shown to rifampicin and ethambutol (all 13
strains testes sensitive), while protionamide, capreomycin, and
kanamicin had 2–5 resistant isolates.
Discussion: Mycobacterium kansasii respiratory or disseminated
infection continues to occur, and pose relevant diagnostic
problems, including late or missed identiﬁcation due to slow
culture and frequently HIV-associated concurrent opportunistic
disease. Serious therapeutic difﬁculties, due to the unpredictable
in vitro antimicrobial susceptibility proﬁle of these organisms,
and the need to start as soon as possible an effective combina-
tion therapy which do not interfere with other medications
(especially protease inhibitors and other antiretroviral agents),
are of particular concern.
P1927
Epidemiology of non-pigmented rapidly growing
Mycobacteria in a university hospital
J.I. Garcı´a-Cı´a, A. Ortiz, J. Esteban, R. Ferna´ndez-
Roblas (Madrid, E)
Objectives: To analyze the epidemiology of rapidly growing
Mycobacteria by using RAPD during a 12 year period.
Methods: Rapidly growing Mycobacteria (RGM) obtained
during the period 1990–2002 were maintained frozen since
their isolation until the experiments were performed. Bacteria
were reidentiﬁed and a study using RAPD techniques was
performed. We made use of the protocol described by Zhang et
al. using primers OPA-2 and OPA-18. Bacteria were grouped by
species. We also included strains from an epidemic outbreak of
postsurgical infections due to RGM that were sent to us as a
reference laboratory as a control for the technique. Band proﬁles
were compared by using the Bio-Proﬁl software (BioGene, USA).
Results: During the studyperiod 53patients had clinical samples
where RGM were isolated. The isolates were identiﬁed as
M. chelonae (23),M. fortuitum (15),M. peregrinum (8), M. abscessus
(3) and M. mucogenicum (4), 36 isolates (16 M. chelonae, 11
M. fortuitum, 7 M. peregrinum, 1 M. abscessus and 1 M. mucogen-
icum) were isolated during the period 1995–1997. No clear
relationship between patients could be found after reviewing
their clinical charts. RAPD showed readable proﬁles for all but
one strains. The primer OPA-2 demonstrated a discriminative
power similar to the OPA-18 one. Using OPA-2 one cluster was
detected with a 1% homology coefﬁcient (UPGMA), and 2 more
different clusters appeared when a 5% homology coefﬁcient was
applied, all of them being M. chelonae strains. Using OPA-18 no
cluster was detected for 1% homology coefﬁcient, but when 5%
homology coefﬁcient was applied 4 clusters were detected. No
predominant strain was detected in the isolates of the period
1995–1997.
Conclusions: An increase of the isolates of RGM was detected
in a 3-year period, despite no changes in the protocol were
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performed. No predominant strain or outbreak was detected, so
the increase of the number of isolates could be due to other
causes than the existence of predominant strains. RAPD is an
easy and valuable technique for evaluating the epidemiological
relation between strains when the isolates are included in the
same gel.
P1928
Use of the expanded set of VNTR-MIRU loci for
the differentiation of Mycobacterium tuberculosis
Beijing family isolates
V. Nikolayevskyy, T. Brown, K. Gopaul, Y. Balabanova,
F. Drobniewski (London, UK)
Several studies have shown that a high proportion of Russian TB
isolates belong to the Beijing family. A genotyping system
capable of discriminating Beijing strains would be useful for this
population. The recent identiﬁcation of variable number tandem
repeats (VNTRs and MIRUs) in Mycobacterium tuberculosis has
raised the possibility of a rapid ampliﬁcation-based techniques
with comparable discrimination to RFLP-IS6110.Objective: to
evaluate the effectiveness of an expanded set of VNTR-MIRU
loci for discrimination of TB strains in Russia, particularly for
Beijing family strains and to determine the most useful poly-
morphic loci for automated and/or manual screening of isolates.
Materials and methods:A total of 185 M. tuberculosis strains
isolated from civilian and prison patients collected in 2001–2002
in Samara oblast were analysed. Crude DNA extracts were
obtained by heating cell suspensions with chloroform at 80C.
All 185 TB isolates were tested using the original set of 12 MIRU
loci and 3 ETR loci described previously (Supply et.al., 2001).
Beijing strains were identiﬁed using spoligotyping and detection
of IS6110 insertion in dnaA-dnaN region. Beijing isolates were
then subjected to VNTR-MIRU analysis using an expanded
panel of loci (0424, 0531, 1955, 1982, 2074, 2163a, 3232, 3239,
3336, and 3690). Primers were designed in order that fragments
could be analysed using a capillary electrophoresis system
(Beckman Coulter SEQ8000).
Results and discussion: 129 isolates were identiﬁed as being of
the Beijing family (69.7%). 15 loci VNTR-MIRU analysis yielded
10 clusters (sized from 2 to 75 isolates) and 58 unique VNTR-
MIRU patterns. The two largest clusters consisted of 31 strains
and 75 strains (223325173533423 and 223325153533423 proﬁles
respectively). For all strains MIRU analysis showed a higher
degree of discrimination than that seen with spoligotyping
(HGDI 0.747 versus 0.572). However, the discriminative power of
15 loci MIRU analysis was shown to be insufﬁcient for differen-
tiation within Beijing family. 129 Beijing strains were subjected to
MIRU analysis using an expanded set of loci (see above). This
provided a higher degree of discrimination within the Beijing
group (HGDI 0.870 versus 0.625). Overall three loci (MIRU 26,
VNTR 1982, and 3232, 0.3 < h < 0.6) were shown to be
sufﬁciently polymorphic for the differentiation of Beijing family
strains and useful for either automated or manual screening.
P1929
Long-term efﬁcacy of a six-month treatment
regimen (6HR2Z) for HIV-negative miliary
tuberculosis
J.F. Garcı´a Rodrı´guez , V. Trasancos, M.V. Lorenzo, H. A´lvarez,
B. Bun˜o, P. Sesma (Ferrol, E)
Objective: To investigate the long-term efﬁcacy of a six-month
treatment regimen (6HR2Z) for miliary tuberculosis (MTB) in
the HIV-negative population.
Methods: All HIV-negative patients with MTB attended in our
Centre entered a six-month treatment protocol (6HR2Z) and
were prospectively followed in our Tuberculosis Unit for a
period of 68 ± 53 months. The diagnosis of MTB was based on
cultures, pathology of specimens, and/or clinic-radiological
presentation. Daily doses employed in the 6HR2Z protocol
were: isoniazid (H), 5 mg/kg; rifampin (R), 10 mg/kg; and
pyrazinamide (Z), 30–35 mg/kg. Demographics as well as a
complete set of tests (including complete physical examination,
analysis, BCG, Mantoux, chest x-ray and CT scan, and assess-
ments of treatment tolerance and illness evolution) were
collected in each case.
Results: We recruited 25 patients with HIV-negative MTB.
There were 8 female and 17 male (68%). Mean age,
55.7 ± 17.7 years; range, 18–90 years. Twenty patients had initial
chest x-ray alterations: 17 miliary pattern, 2 cavitation and 1
pleural effusion .The ﬁnal diagnosis was established in 16 (64%)
patients by the demonstration of M. tuberculosis in cultures, in 4
patients by the demonstration of caseating granulomas on
histopathology specimens, and in 5 patients by clinic-radiologi-
cal presentation (4 miliary pattern in chest x-ray). All patients
were initially treated according to the six-month 6HR2Z proto-
col. In one patient treatment modiﬁcation was required and
prolonged because fever by rifampin. As to the outcome, 16/24
(66.7%) patients were cured, 5 (20.8%) died of tuberculosis
during the ﬁrst days of treatment, and 3 (12.5%) died of
unrelated causes 1, 2 and 3 months after starting treatment,
respectively. Sixteen of the 25 patients who entered the study
(64%) completed the treatment as initially planned (i.e. 6-month
therapy); any of them had some late sequelae. Six patients
developed adverse reactions to the treatment (abdominal dys-
comfort in 2; arthralgias in 2, peripheral neuropathy in 1 and
eruptive rash in 1) and 2 toxic hepatitis; all these complications
resolved spontaneously so that no treatment modiﬁcation was
required. Mean follow-up in this group of 16 patients was
68 ± 53 months (range, 8–141; person–months, 1088).
Conclusion: Our results suggest that a six-month treatment
regimen (6HR2Z) is optimal for miliary tuberculosis in the HIV-
negative population.
P1930
Is directly observed therapy necessary in all
patients with tuberculosis?
J.F. Garcı´a Rodrı´guez , H. A´lvarez, M.V. Lorenzo, V. Trasancos,
B. Bun˜o, A. Marin˜o (Ferrol, E)
Objective: To identify frequency and predictors of nonadher-
ence to antituberculosis treatment, treatment failure and relapse
rates.
Methods: All patients with tuberculosis (TB) attended in our TB
Unit from 1990 to 2004 were prospectively followed by a
medical doctor. The diagnosis of TB was based on cultures,
pathology of specimens, and/or clinic-radiological presentation.
Demographics as well as a complete set of tests including sex,
age, employment, marital status, previous TB, homeless, alco-
holism, injection drug use, HIV infection, concomitant treat-
ments, regimens of antiTB treatment, side effects, nonadherence,
resistances and illness evolution were collected in each case. We
use educational strategies directed at the patient and patient´s
family, and reminder phones calls to patients who defaulted.
The patients were revisited at ﬁrst, second month, and at the end
of treatment; if they were any side effects or treatment default
were revisited more frequently. A logistic-regression analysis
was performed to identify predictors of nonadherence to antiTB
treatment, treatment failure and relapse.
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Results: We recruited 1159 patients, 689 (59.4%) males, 470
female. Mean age, 38.9 ± 19.7 years (range 10–95). Single 572,
separated-divorced 50, unemployed 135, homeless 8, previous
TB 132, alcoholism 191(16.5%), injection drug use 66 (5.7%), HIV
57, concomitant treatments 229. Fixed-dose combination therapy
1.137 (98.1%) [772 with HRZ]; 6-month regimens 912 (90.5%)
[877 with Z] and 247 others. Serious hepatic toxicity 104 (9%)
patients and other side effects 332 (28.6%). The therapy regimen
was unobserved in 1105 patients and 49 default (4.4%). The
predictors of treatment default were: injection drug use (OR 40;
IC 95%: 15.6–61.7) and alcoholism (OR 3.9; IC 95%: 1.9–7.8). The
therapy regimen was directly observed in 54 (4.6%) [23 alco-
holism, 5 homeless, 4 injection drug use, 22 others] and all
completed treatment. Resistances: H 1.9% and R 0.2%. Treat-
ment failure 15/1.159 (1.3%) and relapses 15/1.159. The treat-
ment default was predictor of treatment failure (OR 482.3; IC
95%: 61.7–3.771) and relapses (OR 13.2; IC 95%: 2.6–67.4). Mean
follow-up 27 ± 25 months (range, 1–157); person-months,
31.304.
Conclusion: The treatment programme is very satisfactory in
our unit. The treatment failure and relapses are low and are
associated with treatment default. DOT can get better treatment
adherence in patients with injection drug use and alcoholism.
P1931
Ways to reorganise the laboratory service for TB
diagnosis in Russia
V.I. Golyshevskaya (Moscow, RUS)
Presently one of the most urgent objectives is to rationalize
organization of microbiology studies. This will improve effect-
iveness and quality of microbiology diagnosis of TB in Russia.
Thereupon, many Russian regions have started centralization of
microbiology studies and establishment of a common laboratory
network involved in microbiology diagnosis of TB. It will
include laboratories subject to different departments. The whole
network is based on the system of quality assurance. All
elements of this system will be implemented by the central
bacteriology laboratory of the regional TB service. To coordinate
performance of bacteriology laboratories and assure quality of
studies in Russia, it is planned to establish a network of
reference-laboratories, according to the Russian Health Ministry
order. The network will consist of 2 federal reference-laborat-
ories, 7 reference-laboratories of the federal districts and
regional reference-laboratories. Draft statute to regulate refer-
ence-laboratories performance is prepared. Establishment of
reference-laboratories network will allow to standardize micro-
biology methods of studies, obtain comparable data, carry out
laboratory monitoring of level and degree ofM. tuberculosis drug
resistance. In 2003 113993 new TB cases were registered. Out of
them only 4104 were detected by microbiology methods, which
was 3.6%. The radiological method with bacterioscopy consid-
ered 26.1%, culture–48%. Quality control of subject laboratories
implemented by reference-laboratories, continuous staff training
and supervision of laboratories will enable to signiﬁcantly
improve effectiveness of TB detection and treatment.
P1932
Epidemiology of tuberculosis in Marageh (Iran)
between 2001 and 2003
M. Kafshnochi, A.A. Khaki, H. Montazam, A. Tanomand,
M. Elmi (Bonab, Tabriz, Marageh, IR)
Objectives: The tuberculosis have been an important problem
of human society in last centuries. Human had spent his big
ﬁnancial sources for ﬁght with the problem mentioned above.
This problem established by a special bacteria which named
Mycobacterium tuberculosis The aim of this research was the
epidemiologic study of the tuberculosis in maragheh area and
also assessment of its treatment programmes .
Methods: The method of study in this research was a descrip-
tive cross-sectional. The recent study was a research which in
maragheh centre for gampaigan to tuberculosis done on the 1430
person who they were doubtful to tuberculosis between 2001
and 2003. we collected sputum from doubtful persons and
studied by culture and direct examination methods. We used
radiologic and clinical signs and symptoms for deﬁnite diagno-
sis sometimes. ﬁnally we used SPSS software and descriptive
statistic.
Results: We found tuberculosis in 66 person, where 65 per cent
of them were female and 35 per cent were male. Also 58 per cent
of them were staying in town and 42 per cent in villages of
maragheh. The results of culture and direct examination were
corresponded to each other.
Conclusion: Based on the ﬁndings which mentioned above the
frequency of tuberculosis in Maragheh were same between the
2001 and 2003. Also the involvement of the female two times
more than male were corresponded with the previous results
which done in Tehran and Qhom. Extra pulmonary tuberculosis
were seen more than the pulmonary tuberculosis which was an
interesting result and need to more research and screening
methods, on the extra pulmonary tuberculosis.
P1933
Epidemiological characteristics of non-
tuberculosis Mycobacteria isolated from adult
patients in a teaching hospital in Madrid from
January 2000 to August 2004
J. Dı´az-Regan˜o´n, D. Domingo, D. Monclu´s Arroyo, S. Abanades,
M. Lo´pez-Brea (Madrid, E)
Objectives: 1) To determine the Mycobacteria isolated from
adult patients in a Teaching Hospital in Madrid from January
2000 to August 2004. 2) To study the epidemiological charac-
teristics of the atypical Mycobacteria isolated in that population.
Methods: We evaluated retrospectively 20228 samples sent to
the Microbiology laboratory for mycobacterial research from
January 2000 until to 2004 in adult patients. Samples were
processed following standard procedures and cultured in solid
medium (Coletsos) and liquid medium (modiﬁed Middlebrook
7H9). The growth in solid medium compatible withMycobacteria
and those detected as positive in the liquid medium system
were stained with the Ziehl–Neelsen technique. Identiﬁcation
was performed by hybridation probes (Accuprobe-Gen Probe)
for M. tuberculosis and MAC, and in a national referral centre
for the rest of them. Epidemiology information was obtained for
further studies.
Results: From the total of the 20228 samples sent to the
laboratory, 1015 were rejected as inadmissible (5.02%), 623
were contaminated (3.08%) and 17954 were negative after
2 months (88.76%). 636 samples were positive for Mycobacteria
(3.14%) being 71.70% M. tuberculosis (456 samples), 21.38% slow
grow Mycobacteria (136 samples of which 86 were MAC, 13
M. simiae, 13 M. xenopi and others), 6.29% rapid grow Mycobac-
teria (40 samples with 14 M. fortuitum, 12 M. chelonae and others)
and 0.63% not viable atypical Mycobacteria (4 samples). Sputum
was the most common sample sent to the laboratory (60.55%)
and the Neumology Department was the origin in 39.44% of the
cases. In 100 cases the patients were male (55.55%) and in 80
cases female (44.45%). We considered signiﬁcant the isolation of
the same Mycobacteria in two or more samples and 34 patients
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had this condition being the microorganisms isolated: MAC in
18 patients, M. simiae in 4, M. xenopi in 3, M. chelonae and
M. kansasi in 2 and M. gordonae, M. abscessus, M. lentiﬂavum,
M. mucogenicum andM. senegalense in 1 patient. In 18 of them the
isolation was in more than three samples.
Conclusions: Non tuberculosis Mycobacteria are an important
burden of work in our laboratory and the clinical signiﬁcance of
these microorganisms remains controversial in an important
number of cases.
P1934
Mycobacterial diseases in an intensive care unit
D. Fontaneda Lopez, A. Olmos Linares, M. Llorente
Herranz (Leon, E)
Objectives: Our aim was to study retrospectively the clinical
presentation of mycobacterial diseases (MD) in a ICU over a
period of 10 years (1993–2003).
Methods: The diagnosis was carried out by means positive
acid-fast bacillus smears, positive Lowenstein cultures of differ-
ent clinical specimens, and/or histologic evidence of granuloma
formation.
Results: Of 6356 admissions, a total of 36 patients were
diagnosed MD, 34 M. tuberculosis (Mt),1 M. avium (Ma) and 1
M. xenopii (Mx). The average age was 59.51 (25–82) years, 23
were male and 13 female. The mean APACHE II score, on the
ﬁrst day of ICU was 20.10 (10–30). Twenty-one patients had risk
factor (1 HIV,7 immunosuppressant drugs treatment, 4 alcohol-
ism,6 silicosis and 3 previous MD) Twenty patients had
pulmonary disease (8 pneumonia and 12 ARDS), 2 had menin-
gitis, 6 had disseminated diseases and 9 patients admitted to the
ICU for other reasons were found to have MD. The diagnosis
was clinically suspected in 22 patients. The average time to
clinical suspicion of tuberculosis after ICU admission was 2.5 (1–
15) days. Deﬁnitive diagnosis was made 18.21 (10–62) days after
ICU admission. Twenty-six patients were treated. In 15 patients
the treatment had commenced before conﬁrmation of diagno-
sis.The average ICU length of stay was 17.4 (1–47) days and 20
patients died in the ICU.
Conclusion: The incidence of MD in our ICU over study period
is 5.6 of 1000 admission.Mt is the organism most commonly
isolated. The most common form of MD was pulmonary
tuberculosis (55.5%). Twenty-six per cent of the patients were
treated for another condition. The ICU mortality for patients
with MD was 50%
P1935
Erythema induratum, what is the role of
Mycobacterium tuberculosis?
A. Alothman, M. Al Qahtani, S. Al Khenaizan (Riyadh, SA)
Introduction: The name Erythema Induratum (EI), was given
by Bazin to a nodular eruption occurred on the leg of young
women who had tuberculosis. For the past few decades, many
investigators have examined EI lesions histopathologically and
microbiologically. Some authors reported that at least 50% of EI
lesions were positive for Mycobacterium tuberculosis on PCR test.
Case Report: We are reporting 2 cases, 63 and 35 year old Saudi
females, both of them were presented with lower limbs painful
lesions typical of erythema induratum conﬁrmed by character-
istic biopsy ﬁndings. Both patients were having positive PPD
skin test and high ESR tests, but culture from the biopsy for
mycobacterium tuberculosis and PCR were negative. They
received anti-tuberculosis treatment for a total of 6 months
and they showed a dramatic clinical response with gradual
decline in ESR.
Discussion: There are some controversies in the literature
regarding erythema induratum and its status as a tuberculous
infection. More reported cases supporting the association with
Mycobacterium tuberculosis based on positive PPD test, marked
response to anti TB treatment and low concentration MTB-DNA
in some lesions by PCR. In our reported cases we failed to
document a positive culture for Mycobacterium tuberculosis or a
positive PCR but both cases showed a dramatic response to anti-
TB treatment. With the increased incidence of EI cases in our
hospital we recommend to start an anti-TB therapy for any case
of EI and wait for results of investigation 6–8 weeks later as
evaluations need to be done.
P1936
Tuberculous pericarditis at a national guard
hospital: experience over 10 years
A. Alothman, N. Al Johani (Riyadh, SA)
Background: Pericarditis is a rare manifestation of tuberculous
disease. Tuberculosis (TB) is common in Saudi Arabia, partic-
ularly in our institution. TB is responsible for 4% of cases of
acute pericarditis, 7% of cardiac tamponade, and 6% of con-
strictive pericarditis.
Methods: A retrospective chart review for cases of TB-pericar-
ditis was studied at our hospital, i.e. King Fahad National guard
Hospital. TB-pericarditis case deﬁnition includes any case of
pericarditis with microbiologic culture of Mycobacterium tuber-
culosis, or histopathologic evidence of pericardial biopsy for
tuberculosis, or response to anti-TB therapy.
Results: Number of cases with TB-pericarditis was 10 cases,
between January 1992 and December 2001. The mean age for
patients was 50 years, and 90% were males. Clinical features of
TB-pericarditis patients were fever (70%), dyspnea (70%), chest
pain (50%), and pericardial rub (40%), laboratory tests were
normal white blood count (100%), and elevated erythrocyte
sedimentation rate (90%). All cases had cardiomegaly on chest x-
ray. Cases who had pericardial effusion were 100% (50% had
large, moderate 10%, and mild 40%) on echocardiography. Five
cases had pericardiocentesis and they showed evidence of
infection. 50% of the cases did not have a pericardial biopsy
done, however, the ﬁve other cases had a pericardial biopsy,
which showed evidence of tuberculosis in four of them (4/5,
80%). Mycobacterium tuberculosis culture was done on 3 patients
and it was positive in 2 patients. All patients received anti-TB
therapy. 70% received oral steroids. 70% of the patients were
subjected to surgical intervention. Among the patients of TB
pericarditis, 70% recovered.
Conclusion: TB-pericarditis at our hospital is still rare at an
average incidence of one case per year (1.5% cases of TB). Early
diagnosis and management is necessary to avoid signiﬁcant
morbidity and mortality.
P1937
Role of bone marrow mycobacterial cultures,
histopathology and PCR in the diagnosis of
disseminated/miliary tuberculosis
N. Gupta, G. Dagar, U. Singh (New Delhi, IND)
Objectives: To study bone-marrow aspirate and trephine
biopsy in disseminated tuberculosis using LJ and BACTEC TB
culture media, histopathology, and PCR for M. tuberculosis and
to conclude on their clinical relevance.
Methods: Newly diagnosed adult patients with disseminated
tuberculosis underwent bone marrow aspiration and trephine
biopsy for microscopy, acid-fast bacillus stain, mycobacterial
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culture on Lowenstein-Jensen and BACTEC TB20 media, and
detection of a polymerase chain reaction product using a MBP64
probe. Other investigations as warranted were carried out.
Results: A total of 46 patients with disseminated tuberculosis,
age range 16–65 years (mean 36 + 16) were included and
stratiﬁed into 2 groups based on microbiological results, I)
Conﬁrmed TB when evidence of M. tuberculosis could be
demonstrated in one or more of the available tissues like
sputum, lymph node, aspirates, liver, bone-marrow, and II)
Clinical TB when patient had compatible clinical features AND a
full clinical response to empirical antitubercular therapy, in
absence of a demonstrable positivity. Conﬁrmed TB constituted
43% of the patients. Bone marrow contributed to diagnosis of
tuberculosis in 15/46 (32.6%) cases. Eleven had bone-marrow
granulomata, and another six had PCR positivity for M. tuber-
culosis. Two cases had both. Bone marrow granulomata were
distributed evenly between the conﬁrmed and clinical TB,
constituting 25% and 23% of respectively. Eight of the granulo-
mata were amongst military TB category (constituting 50%)
whereas only three were from non-miliary disseminated TB
(constituting 10%), p value 0.002. Two cases had caseation (both
from military TB) whereas one revealed acid-fast bacilli (from
non-miliary category) in bone biopsy. None of the bone-marrow
aspirate cultures on LJ or BACTEC TB yielded any positivity.
PCR on bone marrow aspirate was positive for M. tuberculosis in
6/46 (13%), comprising 6.3% and 16.7% respectively of miliary
and non-miliary categories, p value 0.32.
Conclusion: Bone marrow granulomata and PCR for M. tuber-
culosis contributed to diagnosis in a third of cases with
disseminated tuberculosis, and were equally likely between
the conﬁrmed TB and clinical TB groups. The yield was
signiﬁcantly higher in military tuberculosis. Bone-marrow
aspirate smear and culture for Mycobacteria were of no value.
P1938
Antibiotic treatment of oedematous
Mycobacterium ulcerans disease reduces the need
for radical surgery and enhances the
inﬂammatory response
R. Phillips, S. Etuaful, K. Asiedu, K. Nyarko, P. Awuah,
C. Horsﬁeld, S. Lucas, M. Wansbrough-Jones (London, UK;
Agroyesum, GH; Geneva, CH; Nkawie, Tepa, GH)
Objectives: Oedematous disease is an acute form of M. ulcerans
disease (Buruli ulcer) needing aggressive surgery to excise all
oedematous tissue. Recently it was shown that when early
lesions of MUD were treated with rifampicin and streptomycin
for 4 weeks, excised tissue was culture negative. Therefore we
have investigated the clinical beneﬁt of antibiotic treatment in
patients with oedematous disease.
Methods: 21 patients presenting to 3 hospitals in Ghana with
oedematous MUD were treated with rifampicin (10 mg/kg) and
streptomycin (15 mg/kg) for 2–8 weeks prior to surgery. Sur-
gery to excise necrotic tissue was undertaken when maximum
resolution of oedema had occurred. Diagnosis was by punch
biopsy before therapy or on excised tissue by staining for AFB,
culture on LJ medium, PCR for IS2404 repeat sequence of MU
and histology. Resolution of oedema was judged clinically and
recorded in photographs.
Results: Patients were aged from 2 to 44 years (mean 11).
Oedema involved the majority of one part of a limb, the trunk or
the head in all. Tissue from all patients had positive PCR
conﬁrming the diagnosis of MUD. In all patients, oedema
resolved during antibiotic therapy leaving a much reduced
central area requiring excision. Three patients received antibi-
otics for 2 weeks, 7 for 4 weeks, 1 for 6 weeks and 10 for
8 weeks before oedema resolved and surgery was undertaken.
Before therapy, there were large areas of subcutaneous necrosis
containing clumps of extracellular Mycobacteria but few inﬂam-
matory cells. After therapy, a vigorous inﬂammatory reaction
including granulomas was seen with intracellular Mycobacteria
in macrophages and neutrophils.
Conclusion: Treatment with rifampicin and streptomycin
reduced the area requiring excision surgery in oedematous
MUD. A vigorous inﬂammatory response and phagocytosis of
Mycobacteria was seen after therapy presumably as a result of
cessation of mycolactone production.
P1939
Disseminated Mycobacterium avium complex in
patients with human inmunodeﬁciency virus.
Report of two cases
J. Ruiz Herna´ndez, S. Suarez, M. Hemmersbach-Miller,
F. Rodriguez Otero, J. Arencibia Borrego, M.E. Arkuch Saade,
M. Leon Mazorra, P. Betancor Leon (Las Palmas de Gran
Canaria, E)
Objectives: Describe two cases of MAC plus VIH with
particular clinical features
Methods: Brief review plus clinical records.
Results: Disseminated MAC infection is a common complica-
tion of late-stage HIV-1 infection, even in the HAART era, in
developed countries. However in Spain we ﬁnd a low incidence
of this opportunistic disease. Case 1: Male, 37 years old,
remitted to hospital for treatment of ocular pathology related
to CMV. Antecedents of VIH, CD4 below 50/ll, receiving
antiretroviral treatment plus MAC prophylaxis (azitromycine).
Lab ﬁndings: leukocytes 2000/mm3, haemoglobin 10 gr/dl,
platelets 249,000/mm3. GSV 120 mm/h. CT showed multiple
intraabdominal adenopaties with no visceromegalia. Bone
marrow positive for Mycobacteria. The patient received multiple
intravenous treatment and suffered 4 episodes of venous
thrombosis related to peripheral and central venous catheteri-
zation. No hypercoagulability state was proved. He received
prophylaxis with LMW heparin.
Case 2: Male, 44, antecedents of consuming inhaled cocaine.
Heterosexual. Consulting for weight loss and tiredness. Occa-
sionally haemorrhagic diarrhoea. Dysphagia for solids. Clinical
ﬁndings: oropharyngeal mycosis, cervical adenopathies. Hepato
and splenomegalia. Outer haemorrhoids. Bradypsichia,
unsteady wandering and intentional tremor. Lab ﬁndings:
Haemoglobin 10.3, leukocytes 2090 (2 CD4/ll), platelets
179,000. GSV 40. Biochemical parameters were normal except
LDH 703l/l and Beta2microglobuline 3.71 lg/ml. Total body
CT: cavitary lesions in upper pulmonary lobes. Bone marrow
biopsy was normal. Gastroscopy revealed duodenal lyphan-
giectasis. Mantoux 0mm. Microbiological ﬁndings: HIV positive
(new diagnosis), more than 750,000 copies/ml. BAL positive for
Mycobacteria. CMV antigen positive, as well as hepatitis C
serology. The duodenal biopsy gave the certain diagnosis of
Mycobacterium avium intracelulare. Treatment of MAI was
established with perspectives of HAART instauration but the
patient died dew days after diagnosis.
Conclusions: Case 1 makes us think in MAI as playing a main
role in the patophysiology of thrombosis for direct toxicity
against endothelium. Case 2 suggested us at the beginning a
lymphoma, but it turned into a rare case of intestinal affectation
of MAI and disseminated disease as cause of death in a naı¨ve
HIV patient. As potential serious complications can derive from
MAI, prophylaxis seems to be indicated.
Abstracts
642
P1940
Chronic bursitis by Mycobacterium chelonae
P. Alvarez Garcia, M. Garcia Campello, M. Pascual Duran,
V. Pulian Morais, M. Hernandez Blanco, R. Ojea de Castro,
J. Mosquera Martinez (Pontevedra, E)
Objectives: Mycobacterium chelonae is one of the most antibiotic-
resistant species of the pathogenic rapidly growing Mycobacteria
(RGM). It has been implied in three basic types of infectious
disease: the most common type is the disseminated cutaneous
disease in chronically immunosuppressed patients, the second
type are localized infections following trauma or surgical
procedures in normal hosts and the third one is catheter-related
infections. The objective is to present ﬁrst documented case of
Mycobacterium chelonae olecranon bursitis in our country.
Case report and methods: A 70-year-old patient who had been
treated with oral corticosteroids for chronic arthropathy during
15 years was referred to study a chronic olecranon bursitis in
right elbow. A drainage was performed to establish the
diagnosis. Specimen was gram stained and seeded in blood
agar, chocolate agar and into a liquid system BACTEC 9120
(Becton Dickinson).
Results: Microscopic examination of specimen was negative.
Culture in liquid medium showed growth of Mycobacteria after
5 days. Culture was conﬁrmed as rapidly growing Mycobacteria,
nonpigmented. Mycobacterium chelonae was identiﬁed in basis of
biochemical and growing characteristics. Susceptibility testing
of the isolate was performed by disk-diffusion method (Kirby–
Bauer technique) and revealed resistance to cefoxitin, amikacin,
sulfamethoxazole, doxycyclin but susceptibility to clarithromy-
cin. Intermediate sensibility was observed to ciproﬂoxacin and
oﬂoxacin. On three consecutive occasionsMycobacterium chelonae
was isolated from ﬂuid aspirated from olecranon bursa. At the
moment, surgical debridement combined with appropriated
antimicrobial therapy is under evaluation.
Conclusions: Mycobacterium chelonae has been involved in
localized infections following trauma and sporadic localized
wound infections following medical or surgical procedures.
However, in our case neither of these situations have been
presented, only immunosuppressive therapy seems to be the
predisposing factor to develop this infection. We want to draw
the attention of microbiologist and clinicians to this pathogen
because of the increasing incidence of interaction between
humans and Mycobacteria in coming years.
P1941
Genito-urinary tuberculosis: review of 34 cases
C. Sala Jofre, G. Rufı´ Rigau (L’Hospitalet de Llobregat, E)
Objectives: Genitourinary tuberculosis (GUTB) is the most
frequent extrapulmonary affection following pleural and gan-
glionar forms of the disease. As it usually presents with subtle
clinical manifestations, diagnostic delay is frequently observed.
The objectives of the study were to describe the clinical and
epidemiological ﬁndings of GUTB, as well as clinical conse-
quences and sequellae.
Methods: We retrospectively reviewed 34 adult cases of HIV-
negative patients with a diagnosis of GUTB based in a positive
urine culture for Mycobacterium tuberculosis and/or a biopsy
with caseating granulomes from the genitourinary tract,
between 1996 and 2004.
Results: 34 cases of GUTB were reviewed (22 men), with a
mean age of 59.52 years. Underlying diseases were present in 18
patients (52.94%). 2 patients had previously had tuberculosis (1
pleural, 1 orquiepididimitis). 2 patients had tuberculosis in other
organs. Two or more genitourinary structures were involved in
16 patients: kidney (23), urethers (14), urinary bladder (9), testes
(6), prosthata (3) and anexial affection with peritoneal implan-
tation (1). More than one clinical manifestation was present in 18
patients: urinary irritative syndrome (17), lumbar pain (13),
hematuria (10), fever (10), genital pain (6), toxic syndrome (3),
chronic scrothal supuration (2) and methrorrages (1). Time
between ﬁrst symptom and treatment was 15.06 months. Urine
Ziehl–Neelsen (ZN) was positive in 4 of 33 patients and
Lo¨wenstein culture was positive in 26 of 33 patients. 15 of 17
biopsies were diagnostic. ZN of biopsied material was positive
in 3 of 10 patients, as was Lo¨wenstein culture in 5 of 6 patients.
Nephrectomy was performed in 10 patients, percutaneous
nephrostomy in 5, ureteral cateterization in 4, orquiecthomy in
5, cistoplastic augmentation in 3, prostatectomy in 1 and
laparoscopic exploration in 1. Mean clinical and microbiologic
follow-up was 27.53 (4–59) and 26.33 (3–59) months respect-
ively. 63.33% patients remained asymptomatic, 37.50% devel-
oped renal failure (2 requiring dialysis). Microbiologic cultures
were negative in all surviving patients. 3 patients died (1
unknown cause, 1 disseminated disease, 1 not-related cause).
Conclusions: Diagnostic delay is still frequent, so high clinical
suspect is required for GUTB diagnosis. Antituberculous ther-
apy is curative in most patients, but many of them require
nephrectomy or reconstructive surgery, and a signiﬁcant pro-
portion develop renal failure.
P1942
Optochiasmatic tuberculoma and tuberculous
lymphadenitis developed during treatment of
multiple intra-cranial tuberculomas with anti-
tuberculous agents: a case report with 18 months
follow-up by MRI
A. Kalkan, S. Serhatlioglu, M. Ozden, A. Denk, K. Demirdag,
S. Kilic (Elazig, TR)
Case: A 15-year-old girl was admitted with complaints of fever
and vomiting for 7 days and progressive alteration of sensorium
for 4 days. Examination of the cerebrospinal ﬂuid (CSF)
revealed protein concentration of 85 mg/dL and a cell count
of 140 leukocytes/mm3 with predominant lymphocytes. Smear
of CSF revealed acid-fast bacilli. MRI revealed minimal con-
trasting in the dura, and milimetric tuberculomas were deter-
mined in the left cerebellum, left temporo-occipital and right
fronto-temporal areas. A diagnosis of intra-cranial tuberculoma
was made and she was treated with anti-tuberculous drugs
(isoniazid, rifampicin, pyrazinamide and streptomycine), and
dexamethasone (started to reduce the dose on day 15 and ceased
on day 30). Since the patient’s condition deteriorated despite the
treatment, her CSF and radiological ﬁndings were re-evaluated
one month later. Cell count of CSF increased from 140 mm3
(35% PNL, 65% lymphocytes) to 970 mm3 (35% PNL, 65%
lymphocytes). Prominent contrasting (abscess) in dura, increase
in the size of tuberculomas and additional new tuberculomas in
right pontocerebellar, craniocervical junction, bulbus anterio-
rum, cerebellar tonsils and localization towards the optic nerve
were seen in MRI. The M. tuberculosis determined in the ﬁrst
culture was found to be sensitive to all antituberculous drugs
and thus the same treatment continued. The patient was
followed up and CSF and MRI ﬁndings were evaluated at
three monthly intervals. Three and a half months after the
treatment, it was determined that tuberculous lympadenitis
developed in the right side of the neck (extracranial involve-
ment) turned into conglomerate LAP (smear negative) which
was then excised and healed within 10 months. In the follow-up
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of the patient, it was observed that dural contrasting, number
and size of intracranial and chiasmal tuberculomas were
increased despite the treatment, and then full recovery of
dural contrasting (3rd month check up), CSF ﬁndings (12th
month check up), opthalmological ﬁndings and tuberculomas in
the optic chiasma (15th month check up) and intracranial
tuberculomas (18th month check up) were seen. The treatment
was then ceased on the 18th month.
Conclusion: The case presented here has shown that tubercu-
lomas in the chiasma opticum and extracranial localization
developed during treatment may completely recover with
application of efﬁcient treatment and thus not require addition
of long term steroid administration to the treatment.
P1943
Postoperative infection of a prosthetic aortic
valve by Mycobacterium chelonae
I. Uc¸kay, J. Garbino, R. Matulionyte, M. Djordjevic, P. Rohner,
G. Khachatourian, D. Pittet (Geneva, CH)
Postoperative endocarditis can be caused sometimes by atypical
pathogens. We present a case of an infection of a bio-prosthetic
aortic valve/of the aortic root by Mycobacterium chelonae in an
immuno-competent host.
Case report: A 72-year-old woman with aortic stenosis of
degenerative origin underwent in February 2003 an elective
replacement of the aortic valve by a bio-prosthesis Shelhighaˆ
and of the enlarged aortic root by a tube Shelhigh N23. In
November 2003 she was re-hospitalised because of cardiac
decompensation, inﬂammatory parameters and nocturnal tran-
spiration without weight loss. Echocardiography revealed a
displacement of the aortic valve without vegetations. Blood
cultures, even with prolonged incubation periods, for microor-
ganisms remained sterile. Angiography before surgery showed
sacculations of the aortic root; suspecting an infection. In
December 2003 surgery was performed. The surgeons remarked
several cavities of cold abscesses in the aortic root. The annulus
was destructed by these abscesses protruding also into the
pulmonary artery. Infection could not be excised in total. An
intervention according to Bentall by insertion of a new Shel-
highaˆ bio-prosthesis was performed and the coronaries re-
implanted. An atrio-ventricular block III necessitated a perma-
nent pacemaker. Acridine strain revealed the presence of
Mycobacteria spp. which did not grow in culture. PCR sequen-
cing technique identiﬁed M. chelonae. A large empiric intraven-
ous antibiotic therapy including amicacin, rifampicin,
ethambutol, co-trimoxazol, clarithromycin and ciproﬂoxacin
was begun. The i.v. regimen was changed to a peroral regimen
three weeks after by omitting amikacin. After conﬁrmation of M.
chelonae the antibiotic sixtatherapy was reduced to a peroral
regimen of co-trimoxazol, ciproﬂoxacin and clarithromycin,
scheduled for at least 6 months. Clinically the treatment was
fully successful already after 5 weeks. The origin of this unusual
pathogen remained unclear, the possibility of contamination
during the operation or contamination during fabrication could
be a possibility. In March 2004 the patient suddenly died of
ventricular ﬁbrillation. Autopsy identiﬁed a dehiscence of the
implantation of the right coronary artery as the cause. There
were no signs of activity of the former infection. The abscesses
had disappeared.
Conclusion: Successful empiric antibiotic therapy with surgery
even for large size prosthetic aortic valve and aortic root is
possible.
P1944
Central nervous system tuberculosis: a 4-year
review
A. Negoita, A. Hristea, D. Nae, V. Arama, R. Sandu, V. Molagic,
A. Streinu-Cercel (Bucharest, RO)
Objective: To compare clinical presentation, laboratory, ima-
ging data and outcome among deﬁnite, probable and possible/
uncertain tuberculous meningitis (TBM).
Methods: We retrospectively studied 106 cases (60 M, 46 F,
mean age 34.7) of CNS tuberculosis (TB), most of them with
TBM, diagnosed between 2001 and 2004 at an infectious diseases
centre in Bucharest. The inclusion criteria were diagnosis of CNS
TB and/or culture of M. tuberculosis (MT) from CSF. For CSF
changes consistent with TBM, we evaluated the diagnosis
according to the following criteria: (1) culture of MT from
CSF-deﬁnite TBM, (2) a) evidence of TB elsewhere or b) chest
x-ray consistent with miliary/pulmonary TB and/or hydro-
cephalus on CT brain scan + improvement on treatment-prob-
able TBM (3) cellular CSF and/or raised CSF protein and/or
reduced CSF glucose and a favorable response to speciﬁc
therapy-possible/uncertain TBM.
Results: We compared deﬁnite (39 cases-36.8%), probable (28–
26.4%) and possible/uncertain (39 cases) TBM. We noted clinical
ﬁndings (mean duration of symptoms before presentation 14.3/
9.8/11.4 days, respectively, fever 36/21/35, abnormal mental
state 29/17/15, localizing neurological signs 19/11/11, history
of contact with/prior TB 16/88/10), laboratory data (CSF cells
number, mean CSF protein level 228/255/381 mg/dl, low
sodium level in 17/9/7 patients). In 3/67 cases of deﬁnite/
probable TBM, the patients with paraparesis had spinal TB
(arachnoiditis-myeloradiculitis in 1 case and tuberculoma, single
or multiple, in 2 cases). In 2 patients with spinal TB we remarked
an extremely high protein level: 5980 and 4260 mg/dl. The
results of MRI (spinal TB) and cerebral CTs of 27/21/14 patients
with TBM are shown. We studied the correlation between the
stage of the disease at presentation (stage 1–45 (42.5%) patients,
stage 2–41 (38.7%), stage 3–20 (18.9%)) and the outcome: 19
(17.9%) patients died, 73 (68.9%) survived, 14 (13.2%) were lost.
We found a statistically signiﬁcant difference between stage 3 at
presentation and death for deﬁnite TBM compared with the two
other categories (33.3%/17.9%/2.6%). In 4 cases MT was isolated
from CSF, but the patients did not receive speciﬁc therapy
before isolation, with an unfavorable outcome.
Conclusion: CNS TB is a serious threat in Romania (39 deﬁnite
cases in one institution), the diagnosis is difﬁcult, TBM might be
over diagnosed (39 patients were deﬁned as having clinical
TBM) or under diagnosed (4 cases).
P1945
The evaluation of 38 patients with tuberculous
meningitis
S. Cavuslu, O. Oncul, A. Karakas (Istanbul, TR)
Objectives: In this study, 38 tuberculous meningitis (TbcM)
patients were evaluated for symptoms, clinical signs, laboratory
ﬁndings, therapy and prognosis, retrospectively.
Methods: In this study, 38 patients with TbcM were evaluated
in GATA Haydarpasa Training Hospital Department of Infec-
tious Diseases between 1992 and 2004. Im the study patients had
undergone the following investigations: chest radiographs,
Mantoux test, sputum, urine, blood and cerebrospinal ﬂuid
smear and culture for acid fast bacilli, Compureterized Tomog-
raphy scan and serial Magnetic Resonance Imaging (MRI) of the
brain. The deﬁnitive diagnosis was performed with positive CSF
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smear, culture for acid fast bacilli, PCR and MRI ﬁndings.
Probable diagnosis was performed with chest radiographs,
manthoux test and other CSF examinations.
Results: In our study, 38 consecutive patients were evaluated.
The ages of the patients ranged from 20 to 63 years (mean
23.3 ± 9.6 years). Thirty-ﬁve (92.1%) patients were male and
three (7.9%) were female. The mean duration of neurological
symptoms prior to admission was 35.4 ± 21.9 (7–100) days. The
most frequent presenting symptoms were headache (97.4%),
fever (65.8%) and fatigue (52.6%). The most frequent presenting
signs were alterations in consciousness in nine cases, speaking
disorders in four cases and convulsion in four cases. The
deﬁnitive diagnosis was performed in two cases (5.3%) patients
with identiﬁcation of bacilli from cultures, in two patients (5.3%)
with polymerase chain reaction and in 16 (42.1%) cases with
MRI ﬁndings. Antituberculosis therapy was used along 12–
18 months in all cases. Short-time corticosteroid therapy was
given to 13 cases. Sequels developed in six (15.8%) cases. The
sequels were paralysis of third cranial nerves in two cases, sixth
cranial nerves in two cases, and ﬁfth cranial nerves paralysis in
one case. Mortality developed in ﬁve (13.2%) patients.
Conclusion: Because untreated TbcM is almost always fatal, it
must be evaluated in differantial diagnosis of central nervous
system infections.
P1946
Non-culturability ofMycobacterium smegmatis in
stationary phase
E.G. Salina, M.O. Shleeva, G.N. Vostroknutova,
A.S. Kaprelyants (Moscow, RUS)
Objectives: The latent tuberculosis infection is believed to keep
a possibility to reactivate in the human host due to presence of
population of dormant cells. Mycobacterium smegmatis, the fast
growing relation of Mycobacterium tuberculosis, is known to form
’non-culturable’ (NC) cells in stationary phase in response to
growth under suboptimal conditions, and such cells could be
reactivated (Shleeva et al, 2004). We have suggested that NC
cells in vitro may be considered as dormant and serve a model
the persistent state of MTB in the human host.
Methods: M. smegmatis strain mc2 155 was cultured into
modiﬁed Hartman’s-de-Bont medium. Respiratory rate of the
cells was detected polarographically. The level of DPI-reducing
activity was measured spectrophotometrically. Inhibitory com-
pound was isolated from supernatant by absorption chroma-
tography followed by TLC and analyze by NMR, IR and MS.
Results: We found that the addition of bovine serum albumin
into the growth media facilitates the transition of M. smegmatis
cells to NC state during the cultivation in the stationary phase.
After 70 hours growing in the modiﬁed Hartman’s-de-Bont
medium with the presence of 0.5 % BSA cfu of the culture is
zero. Such NC cells could be resuscitated by co-cultivation with
Micrococcus luteus cells. The level of NC cells respiration was
found very low (about 1–2% of the active cells respiration level).
Similarly, the rate of DPI-reductase activity of NC cells was close
to zero simultaneously. NC cells are characterized by elevated
ﬂoating density probably due to different changed protein/lipid
ration in NC and active cells. The formation of NC cells is
accompanied by accumulation of inhibitor in the supernatant.
This inhibitor represents the mixture of fatty acids, and the
major component of this mixture is oleic acid. It is not detected
in the supernatant of active culture. The addition of oleic acid to
active cells on concentrations similar to that found upon
transition stopped cell growth and decreases respiration rate
and DPI-reductase activity.
Conclusions: 1.1.The presence of 0.5 % BSA in medium
signiﬁcantly facilitates transition of viable cells of M. smegmatis
to NC cells. 2.2.NC cells are characterized by very low rate of
metabolic activity. 3.3.Cells during transition to NC state produce
an inhibitor, which represents the mixture of free fatty acids.
P1947
Atypical cerebrospinal ﬂuid and clinical
presentation of tuberculosis meningitis: a case
report followed by MRI
A. Kalkan, I. Celik, M. Ozden, S. Serhatlioglu, A. Denk,
K. Demirdag, S.S. Kilic (Elazig, TR)
Objectives: It was presented a tuberculous meningitis case that
exhibited polymorphonuclear (PMN) dominant pleocytosis in
cerebrospinal ﬂuid (CSF) throughout her clinical course, sup-
pressed with non-speciﬁc antibiotic therapy over the two
months, and followed by serial MRI for detecting the disap-
pearing time of meningeal lesions.
Case: A 15-year-old girl admitted in our clinic with a low-grade
intermittent fever, sore throat, headache, nausea, vomiting, and
loss of consciousness for the last 4 days. The biochemical and
microbiological features revealed a CSF glucose of 7 mg/dL
(blood glucose 102 mg/dL), CSF protein 370 mg/dL, 1450 white
blood cells (WBC) per ll (86% polymorphonuclear) and organ-
isms were absent on Gram and acid-fast stain. A CSF polym-
erase chain reaction (PCR) for M. tuberculosis was negative.
According to the clinical and CSF ﬁndings, bacterial meningitis
diagnosis was made and empirical ceftriaxone + ampicillin
were started. On second day of this therapy, her clinical
condition was improved. After 5th day of cessation of this
treatment, she was become lethargic and meningeal irritation
ﬁndings were become positive. A second lumbar puncture (26th
day of admission) was performed and WBC was 130/mm3 (73%
polymorphonuclear), no microorganisms were found at smears,
cultures and PCR. Then, vancomycin and chloramphenicol was
started. On day 3rd, fever and clinical ﬁndings were again
improved. At 40th day of her admission, Mycobacterium tuber-
culosis grew on Lowenstein Jensen medium that cultured from
the ﬁrst performed CSF. She was continued on the anti-TB
medications (600 mg rifampicin, 300 mg isoniazid, 2 g morpha-
zinamide, 1 g streptomycin and 10 mg pyridoxine daily), and
dexamethasone was commenced. Antituberculous therapy dis-
continued at 12th month. In serial MRI follow ups, pathological
changes were continue still at 20th months of clinical course
even her clinical condition was totally improved.
Conclusion: This was a rare case report demonstrates that
polymorphonuclear pleocytosis can be found over the months
of the tuberculosismeningitis.When evaluate the clinical ﬁndings
with PML pleocytosis, a misdiagnosis can be made as bacterial
meningitis. Being interesting in this case is clinical improvement
with non-speciﬁc treatment. After 8 month of the antituberculous
treatment, going on the meningeal enhancement is the other
important ﬁnding that can contribute to the current literature.
P1948
High rates of tuberculosis infection in recent
immigrants from high prevalence regions in
Greece
I. Katsarou, A. Christopoulos, K. Papadopoulos,
E. Ikonomopoulou, S. Logothetis, E. Tsimara (Zakynthos, GR)
Introduction: Persons emigrated from areas of the world with
high rates of TB have incidence rates approaching those of their
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countries of origin for the ﬁrst several years after arrival in
Greece. For this reason they are considered as a high-risk group
for developing active TB disease.
Aim: To identify the incidence of TB infection in immigrants
recently arrived from high prevalence countries in the island of
Zakynthos.
Method-Materials: All immigrants in Greece are evaluated for
TB in order to receive a "green card" (residence permit). In
Zakynthos there is an excellent opportunity to study TB
infection as all subjects are evaluated in a single ofﬁce in our
hospital. Tuberculin skin testing was performed by the Mantoux
method, using 5 IU PPD-S Merieux.
Results: 793 immigrants, 20–45 years old, (648 males and 145
females) were registered during the last 2 years (2001–03). They
were mainly from Albania (668), ex-USSR (118) and other Balkan
countries (27). From the patients without history or scar of BCG
vaccination, 172 males (26.5%) and 56 females (38,6%) respon-
ded with a skin reaction 15–19 mm, while 64 males (9.8%) and
20 females (13.8%) with history of BCG vaccination responded
with ‡20 mm.
Conclusion: High raters of TB infection among recent immi-
grants from high prevalence countries, require tuberculin testing
for administrative purposes to be replaced by targeted tubercu-
lin testing, to identify person with Latent Tuberculosis Infection
who would beneﬁt by treatment.
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